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Abstract  
Carbon nanomaterials, including carbon nanotubes and graphene, with various unique 
physical and chemical properties are emerging as extraordinary materials for biomedical 
applications.  The aim of this thesis was to functionalise single walled carbon nanotubes 
and reduced graphene oxide with range of biomolecules including, peptides, peptoids, 
and ribonucleosides.  
The first study investigated the noncovalent interaction between single walled carbon 
nanotubes and fluoro tagged nano-1 peptide with 
19
F NMR.  
In the second study single walled carbon nanotubes were noncovalently functionalised 
with a series of antibacterial, chiral, amphiphilic peptoids. The peptoids varied in the 
number of aromatic residues on the hydrophobic surface of the helix. It was found that 
peptoid’s ability to individually disperse single walled carbon nanotubes increased with 
increasing the number of aromatic residues.  
The third study presented the first experimental noncovalent interaction of 
ribonucleosides, nucleobases, and ribose with purified and oxidised single walled 
carbon nanotubes. It was found that cyclic and aromatic ribonucleosides and 
nucleobases are too small to disperse the hydrophobic nanotube surface by π-π stacking. 
Furthermore, results showed that the ribonucleosides dispersion ability towards 
nanotubes depends on the number of oxygen-containing functional groups on the 
nanotube surface.  
In the final research it was found that the flat rigid surface of reduced graphene oxide 
has a critical role in its noncovalent interaction with peptides and peptoids. Results 
  
showed that biomolecules with higher backbone flexibility can give a higher dispersion 
affinity towards reduced graphene oxide. Also, it was found that ribonucleosides and 
their nucleases, and ribose moieties have very limited dispersion affinity towards 
reduced graphene oxide. Finally, the covalent functionalisation of reduced graphene 
oxide with cell penetrating peptoid, thymidine, and adenosine was investigated. 
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1. THESIS AIMS AND OUTLINE 
 
Many potential applications have been proposed for carbon nanomaterials, carbon 
nanotubes (CNTs) and graphene, in the ﬁelds of nanotechnology, biology, and 
medicine. For biomedical and biological purposes, the dispersion of carbon 
nanomaterials in aqueous solvents is a major criteria for their biocompatibility and 
their bioapplications; hence the use of their composites in therapeutic delivery should 
meet this basic prerequisite. However, the difficulty of the solubilisation of pristine 
carbon nanomaterials in aqueous solvents is a potential obstacle to realising their 
application, mainly due to their hydrophobic character which, coupled with the 
strong π–π interactions, causes them to aggregate as bundles. Since the unique 
structure of biomolecules, such as peptide, protein and DNA, endow them with their 
distinctive biological functions, there is increasing interest in the combination of 
biomolecules with CNTs unique properties, such as high aspect ratio, light weight, 
high mechanical strength and electrical and thermal conductivity. However, so far 
the nature of this interaction yet in not well understood. Thus the aim of this thesis is 
to investigate the aqueous covalent and noncovalent functionalisation of single 
walled carbon nanotubes (SWNTs) and graphene based nanomaterials, with a series 
of biomolecules, including peptides, peptoids, and ribonucleosides in water, both to 
improve the carbon nanomaterial dispersibility in water and to gain a better 
understanding of the nature of the interactions. The outline of this thesis is as 
follows: 
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Chapter 2 introduces the CNT and its production methods, properties, purification 
methods, and functionalisation techniques. It further reviews the literature on the 
biomolecules used for the dispersion of SWNTs.  
Chapter 3 summarises the analytical techniques that have been used in this thesis to 
characterise CNTs and biomolecules. A brief background of the techniques is 
provided; but the focus is on how these techniques can be used to analyse CNTs and 
biomolecules. 
Chapter 4 investigates the effect of the N-terminus acetylation of nano-1 peptide on 
its ability to disperse SWNTs. Additionally; this chapter studies the use of 
19
F NMR 
to monitor the binding between a fluorinated nano-1 peptide and the SWNTs surface. 
Finally, the stability of the nano-1 peptide/SWNT complex against enzyme digestion 
is investigated. 
Chapter 5 investigates the synthesis and characterisation of a series of chiral linear 
peptoids and their noncovalent interaction with SWNTs which aid dispersion in 
aqueous medium. 
Chapter 6 investigates the interaction between ribonucleosides and SWNTs in 
aqueous medium. The combined effect of ribonucleoside substituent groups and the 
oxygen-containing functional groups of the SWNT surfaces on adsorption are 
investigated 
Chapter 7 studies the covalent and noncovalent functionalisation of rGO with 
biomolecules, specifically peptide, peptoid, and ribonucleosides. The difference in 
interaction between peptides and peptoids with rGO is explored. The covalent 
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functionalisation sections studies the functionalisation of rGO with cell penetrating 
peptoid and ribonucleosides to improve its solubility in water.  
Chapter 8 summaries the thesis results and future work of the whole thesis. 
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2. INTRODUCTION TO CARBON NANOTUBES 
 
2.1. Background 
After the discovery of fullerenes by Kroto et al,
1
 in 1985, it became evident that sp
2
 
hybridised graphene layers exist not only in planar honeycomb sheets like in 
graphite, but also in spherically curved and closed cages. Later, in 1991, Sumio 
Iijima synthesised and studied a cylindrical form of the buckyball, known as a carbon 
nanotube. Initially double walled carbon nanotubes (DWNTs) and multi walled 
carbon nanotubes (MWNTs) were reported along with their crystal structures.
2
 Two 
years later single walled carbon nanotubes (SWNTs) were independently synthesised 
by Iijima and Ichihashi,
3
 and Bethune et al.
4
 Since then, carbon nanotubes (CNTs) 
have attracted considerable research interest across a range of disciplines, including 
physics, chemistry, materials science, medicine, and engineering, owing to their 
extremely interesting properties and potential for a range of applications.  
 
2.2. Structure of Carbon Nanotubes  
In general, CNTs can be described as a graphene sheet that is rolled into a seamless 
cylinder and capped with half a buckyball at both ends. Similar to graphite, the 
structure of a CNT is the orientation of the six-membered carbon bonds (called 
hexagonal) in the honeycomb periodic lattice along the axis of the nanotube.  
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Although CNTs and graphite are built of the same basic units, hexagons of sp
2
 
hybridised carbon atoms, there is a substantial difference between the physio-
chemical properties of these materials. A CNT can be viewed as a hollow cylinder 
formed by seamlessly rolling a graphene sheet capped at both ends in a hemispherical 
arrangement of carbon networks (Figure 2-1).  
 
Figure  2-1: Rolling up a graphene sheet to form a nanotube. 
 
The closure of the cylinder results from the inclusion of pentagonal and heptagonal 
structures during the growth process. Therefore, the character of C–C bonds in CNTs 
differs from that of graphite as the carbon atoms in a nanotube are pyramidalised due 
to the curvature of the nanotube sidewall. Additionally, their curvature will cause 
quantum confinement and σ–π rehybridisation.5  
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Figure  2-2: Diagram showing the π–orbital in planar graphene and its change when bent to 
from CNTs. Reprinted figure with permission from (6). Copyright (2011) by the American 
Physical Society. 
 
As shown in Figure 2-2, the three σ bonds which lie in the sp2 plane are slightly 
shifted out of plane. As a result, the π–orbital is more delocalised outside the 
nanotube. That is a big difference with respect to graphite in which the sp
2
 hybrid 
orbitals form three in-plane σ bonds with an out-of-plane π–orbital. The electron 
cloud distortion induced by the curvature, yields a rich π–electron conjugation 
outside the tube. This can make CNTs more electrochemically active and electrically 
and thermally more conductive than graphite. In addition, the CNTs curvature allows 
topological defects such as pentagons and heptagons to be incorporated into the 
hexagonal network to form capped, bent, toroidal, and helical nanotubes. The 
electrons will be localised in pentagons and heptagons because of redistribution of π 
electrons.  
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2.2.1. Types of Carbon Nanotubes  
The number of cylinders that constitute a CNT can vary from one to several, giving 
rise to different kinds of CNTs, namely single walled carbon nanotubes (SWNTs), 
double walled carbon nanotubes (DWNTs) up to generic multi walled carbon 
nanotubes (MWNTs).
7
 MWNTs were the first to be characterised at atomic 
resolution (1991)
2,8
 followed by their single walled counterparts in 1993
3,4
 (Figure 2-
3). MWNTs generally have a larger outer diameter (2.5-100 nm) than SWNTs (0.6-
2.4 nm) and consist of a varying number of concentric SWNT layers, with an 
interlayer separation of ~ 0.34 nm.
9
 SWNTs have a better defined diameter, while 
MWNTs are more likely to have structural defects, resulting in a less stable 
nanostructure.
10,11
 SWNTs and MWNTs are often seen as straight or elastic bending 
structures individually or in ropes.  
 
Figure  2-3:  High resolution TEM images of CNTs: (Left) MWNTs with varying number of 
graphene layers 5, 2, and 7, Reprinted by permission from Macmillan Publishers Ltd: 
[Nature] [2], copyright (1991), (Right) bundled SWNTs, from [12]. Reprinted with 
permission from AAAS. 
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2.2.2. Chirality of Carbon Nanotubes 
The size and orientation of the rolled graphene layer are essential for the structure of 
the nanotube and therefore its properties.
13
 The angle between C–C bonds and the 
axis of the tube can vary, and the so-called chirality of a SWNT depends on this 
angle. Therefore, the atomic structure of SWNTs may be described by the tube 
chirality, or helicity, which is defined by the chiral vector (Ch) and the chiral angle 
(θ).14 The chiral vector can be described in terms of the lattice translational indices 
(n, m) and the unit vectors a1and a2, as shown in equation below: 
Ch 1 2 
Where a1 and a2 are the unit factors and n and m (integers) are the steps along the 
directions. The chiral angle θ, determining the degree of “twisting" of the tube, is 
defined as the angle between the vectors Ch and a1, which varies in the 0° ≤ |θ| ≤ 30° 
range.
15,16
 Thus, according to the rolling angle of the graphene sheet, SWNTs can be 
classified into two groups’ structure wise, achiral and chiral. Achiral carbon 
nanotubes are defined as a SWNT whose mirror image has an identical structure to 
the original one. The achiral tubes are known as armchair (θ = 30°) and zig–zag (θ = 
0°) as shown in Figure 2-4.  
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Figure  2-4: SWNT helicity map and examples of (n, m) chiral vectors that give rise to 
armchair, zig–zag and chiral nanotube structures with metallic or semi-conducting electronic 
character. Reproduced from [17] with permission of The Royal Society of Chemistry. 
 
Despite the structural similarity to a single sheet of graphite (graphene), which is a 
semiconductor with zero bandgap, CNTs may be either metallic or semiconducting.
18
 
In general, SWNTs are a mixture of metallic and semiconducting material, while 
MWNTs are regarded as metallic conductors.
19
 If the difference n - m is non-zero 
and divisible by three, the nanotube is considered semi-metallic with a bandgap of 
the order of meV. If the difference is equal to zero, the nanotube is metallic with a 
bandgap of zero and is referred to as an armchair-type nanotube. In all other cases 
where the difference n – m is non-zero and not divisible by three the nanotube is 
semiconducting with a band gap ranging from approximately 0.5 to 1 eV.
20
 
 
 
Chapter 2 
7 
 
2.3. Synthesis of Carbon Nanotubes 
The unique chemical and physical properties of CNTs are determined by the 
structure of CNTs. Therefore, the synthesis of CNTs with a controlled diameter, 
chirality, number of graphite layers, length and quality has been a crucial part of 
CNT research. Several techniques have been successfully applied for the production 
of CNTs, including electric arc-discharge (EA) method, laser ablation (LA), 
chemical vapour deposition (CVD), and high pressure decomposition of CO (HiPco). 
Each technique has both advantages and challenges.  
 
2.3.1. Electric Arc-Discharge (EA) 
The electric arc-discharge method (EA), initially used for producing C60 fullerenes,
21
 
was the first reported and is still one of the most widely used techniques for the 
production of SWNTs.
2
 Both fullerenes and nanotubes can be produced once the 
synthesis conditions are optimised. In this method, an electric arc is struck between 
two pure graphite electrodes in an inert atmosphere, such as of helium or argon. The 
arc produces temperatures of around 3000 °C, causing the graphite to evaporate. 
CNTs are formed by consuming the positive electrode during the process and 
depositing it on the negative electrode, accompanied by nanoparticles or disordered 
carbon.
3,22
 Figure 2-5 shows a schematic diagram of an arc-discharge system.  
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Figure  2-5: Schematic diagram of an arc-discharge system. Reproduced from [23] with 
permission of John Wiley and Sons. 
 
If both electrodes are graphite and without catalysts, the main product will be 
MWNTs. Typical sizes for MWNTs are an inner diameter of 1 – 3 nm and an outer 
diameter of approximately 10 nm. In order to produce SWNTs, the anode has to be 
doped with a metal catalyst, such as a transition metal.
3,4,24,25
 Usually the diameter of 
SWNTs is in the range of 1.2 to 1.4 nm. The quantity and quality of the nanotubes 
obtained depend on various parameters such as the metal concentration, inert gas 
pressure, kind of gas, the current and system geometry.
26
 By adjusting the pressure 
and catalyst carefully, the diameter of SWNTs and MWNTs can be controlled to a 
certain degree. Compared to other methods, arc discharge is a more common and 
easy way to produce a less defective, large scale product. However, more by-
products such as amorphous carbon, multi-shell graphite particles and catalytic metal 
particles are formed during the process and are typically present in amounts up to 30 
% by weight of the product.
25
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2.3.2. Laser Ablation (LA) 
The laser ablation technique for synthesising CNTs was first reported by Guo et al in 
1995.
27,28
 In this method, a graphite target containing small amount of catalyst 
particles is vaporised by an intense laser beam at a temperature of around 1200 °C in 
an inert atmosphere. The nanotubes formed are then brought away from the high 
temperature region by an inert gas flow and cooled down on a collector.
27
 Figure  2-6 
shows the laser ablation setup. 
 
Figure  2-6: Schematics of a laser ablation setup for production of CNTs. Reproduced [23] 
with permission of John Wiley and Sons. 
 
CNTs produced by laser ablation are purer (up to about 90 % purity) than those 
produced in the arc discharge process.
12
 The average nanotube diameter and diameter 
distribution is found to vary according to the growth temperature, catalyst 
composition and other process parameters. Unfortunately, the laser technique is not 
economically advantageous because the process requires high-purity graphite rods, 
the laser powers required are high, and the amount of SWNTs that can be produced 
per day is not as high as the arc-discharge method.
27
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2.3.3. Chemical Vapour Deposition (CVD) 
Chemical vapour deposition of hydrocarbons over a metal catalyst is a classical 
method that since the 1960s has been used to produce various carbon materials like 
carbon fibers and filaments.
29
 Both SWNTs and MWNTs can be grown using a 
similar approach by decomposing an organic gas over a substrate covered with metal 
catalyst particles.
30
 Figure 2-7 shows CVD setup for nanotube synthesis.  
 
Figure  2-7: Schematics of a CVD deposition oven. Adapted from [31]. 
 
Generally, CVD process includes catalyst assisted decomposition of hydrocarbons in 
a tube reactor at high temperatures. A typical set up for the growth of carbon 
nanotubes includes blowing acetylene over cobalt and iron catalysts supported on 
silica or zeolite.
32,33
 Although this method is very easy to scale up, it results in a 
relatively high density of defects along the nanotube walls,
34
 which is prohibitive for 
commercial uses.  
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2.3.4. High Pressure Decomposition of CO (HiPco) 
The high pressure CO disproportionation process (HiPco) is a technique for catalytic 
production of SWNTs in a continuous-flow gas phase using CO as the carbon 
feedstock.
35,36
 The catalysts used in the HiPco process are formed in the gas phase 
from a volatile organometallic catalyst precursor introduced into the reactor. The 
organometallic species decomposes at high temperature, forming metal clusters on 
which SWNTs nucleate and grow. In this method, SWNTs are produced by flowing 
CO, mixed with a small amount of the catalyst, such as Fe(CO)5 through a heated 
reactor. Figure 2-8 shows the layout of a CO flow-tube reactor.  
 
Figure  2-8: Layout of CO flow-tube reactor, showing water-cooled injector and 
‘showerhead’ mixer. Reprinted from [36], Copyright (1999), with permission from Elsevier. 
 
The average diameter of HiPco SWNTs is approximately 1.1 nm, which is typically 
smaller than SWNTs produced by the laser-oven process, where the average 
diameter is about 1.3 – 1.4 nm. The dominant impurity in HiPco nanotubes is the 
metal catalyst, which is encased in thin carbon shells and distributed throughout the 
sample as 3 – 5 nm size particles.37 Compared with other techniques, production by 
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the HiPco method has the advantages of high quality, ease of purification and large 
scale commercial products. 
 
2.4. Purification of Carbon Nanotubes  
Regardless of the method used for their production, CNTs always contain a number 
of impurities that are an impediment to more detailed characterisation of their 
properties and thus their future applications.
13
 The most prominent impurities are 
metallic catalyst particles, amorphous carbon, carbon nanoparticles containing 
metals, fullerenes, and polyaromatic fragments of graphene sheets. The basic 
principle of the purification techniques takes the advantage of difference in aspect 
ratio, oxidation rate between CNTs and carbonaceous impurities, solubility of CNTs, 
size of CNTs. Thus, purification techniques of CNTs can be categorised into two 
main group’s namely chemical and physical methods. Figure 2-9 shows the 
difference between as-synthesised CNTs and chemical and physically purified CNTs. 
 
Figure  2-9: Difference between as-synthesised CNTs, chemically and physically purified 
CNTs. Reproduced from [38] with permission of The Royal Society of Chemistry. 
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The chemical purification techniques separate CNTs as a function of their reactivity. 
Compared with CNTs carbonaceous impurities are easily oxidised due to the 
presence of more dangling bonds and structural defects. The most commonly used 
chemical puriﬁcation involves the oxidation of as-synthesised CNTs in both wet and 
dry conditions, due to the method’s practicality, relative simplicity, applicability to 
both metal catalysts and amorphous carbons, and capability of purifying large 
quantities of nanotubes. Moreover, oxidation techniques can often introduce 
oxygenated functional groups, such as carboxylic acids, which serve as a good 
starting point for subsequent nanotube surface chemistry.
39
 The wet condition 
generally refers to the oxidation using a solution of concentrated acids or strong 
oxidants; meanwhile the dry condition mainly refers to the oxidation by air, oxygen, 
or other gases at a controlled temperature. Gas phase oxidation is based on the 
principle of a selective oxidative etching process, wherein the other carbonaceous 
species are oxidised at a faster rate than the actual CNTs themselves. After 
destruction of carbonaceous species, such as amorphous carbon and graphitic carbon 
layers, the metal catalysts can be removed using acid treatment (e.g. HCl washing). 
Meanwhile, liquid phase oxidation is most commonly used and typically involves 
reacting CNTs with oxidising agent (HNO3, HCl, KMnO4/H2SO4, etc.) and/or 
refluxing in water or H2O2. The hydrochloric acid, however, can only attack directly 
accessible metal particles, whereas concentrated nitric acid leads to quite an efficient 
removal of metal because the oxidising power of the acid enables it to attack CNTs 
side wall and even to open the closed tips of nanotubes by generating functional 
groups containing oxygen, like COOH, C=O, etc. However, upon prolonged acidic 
action and at high density of defects, the tubes are markedly reduced in length. Thus, 
the main disadvantage of liquid phase treatments is that they tend to destroy not only 
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impurities but also the nanotubes. However, with proper control of the reaction 
conditions, purification of as-synthesised CNTs through the removal of metal 
catalyst particles may result in higher purity as well as the tips opening.  
Besides the removal of foreign material, there is another crucial aspect in the 
puriﬁcation of CNTs. Any of the procedures presented in Sections 2.3 yields tubes 
with different structure indices (n, m), that vary in diameter and electronic properties. 
In general, the physical purification techniques are used to remove graphitic sheets, 
carbon nanospheres (CNSs), aggregates or separate CNTs with different 
diameter/length ratios. They are based on the differences in diameter, physical size, 
aspect ratio, gravity and magnetic properties etc. Although they are relatively mild 
and do not cause severe damages to the tubes, they are normally more complex and 
less effective compared to the chemical methods, thus leading to a lower purity of 
CNTs.  
 
2.5. Properties of Carbon Nanotubes 
2.5.1. Chemical Properties  
CNTs and graphite are built of the same basic units, hexagons of sp
2
 hybridised 
carbon atoms. However, the curvature-induced pyramidalisation and misalignment of 
the π-orbitals of the carbon atoms in CNTs induces a local strain,40-42 thus CNTs are 
expected to be more reactive than a flat graphene sheet (Figure 2-10).  
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Figure  2-10: Diagrams of (a) metallic (5,5) SWNT, (b) pyramidalisation angle (θP), and (c) 
the π-orbital misalignment angles (φ) along the C1-C4 in the (5,5) SWNT and its capping 
fullerene, C60. Reprinted with permission from [43]. Copyright (2002) American Chemical 
Society. 
 
The strain in non-planar conjugated organic molecules arises from two principal 
sources: pyramidalisation of the conjugated carbon atoms, and π-orbital 
misalignment between adjacent pairs of conjugated carbon atoms.
44,45
  
The curvature in CNTs introduces misalignment of π-orbitals within the rolled 
graphene sheet.
43
 Therefore, the π-orbitals of a nanotube are not pointed directly 
towards the central axis of the nanotube, and some adjacent carbon π-orbitals have a 
misalignment angle, ϕ, between them.46 The reactivity of CNTs arises due to their 
topology and thus their π-orbital misalignment is likely to be the main source of 
strain in the CNTs. 
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It is conceptually useful to divide the CNTs into two regions: end caps and sidewall. 
The origins of the strain in the end caps and the sidewall of CNTs are somewhat 
different. In the (5,5) SWNT shown in (Figure 2-10, a) which is capped by a 
hemisphere of C60, the pyramidalisation angles are as follows: θP ≈ 11.6° (end cap) 
and θP ≈ 6.0° (side wall).
41,43
 The end cap of a CNT can be regarded as a 
hemispherical fullerene, and the C–C bonds in this region of the carbon nanotube 
therefore experience a similar degree of strain due to pyramidalisation to that of the 
equivalent fullerene. The reactivity of the fullerenes, which is primarily driven by the 
enormous strain engendered by their spherical geometry, is reflected in the 
pyramidalisation angles of the carbon atoms (Figure 2-10, c). All of the carbon 
atoms in fullerenes have a pyramidalisation angle θP of 11.6°.
47
 For a sp
2
 hybridised 
(trigonal) carbon atom, planarity is strongly preferred, and this implies a zero 
pyramidalisation angle θP, whereas a sp
3 
hybridised (tetrahedral) carbon atom 
requires a pyramidalisation angle θP of 19.5 (Figure 2-10, b). As, all of the carbon 
atoms in fullerenes and end cap of CNTs have θP = 11.6°, therefore, it is immediately 
clear that their geometry is more appropriate for tetrahedral than trigonal 
hybridisation. The curvature in the sidewall of a CNT is much less than that in a 
fullerene of equivalent diameter. The curvature and misalignment of the π-orbitals of 
the (5,5) SWNT generates a pyramidalisation angle θP of 6.0° at the side wall, while 
the hemifullerene end-cap is under significantly more curvature-induced strain, with 
a pyramidalisation angle θP of 11.6°. Therefore, the C–C bonds in the sidewall of a 
CNTs are much less reactive than those in the end cap.
17
 There are two types of C–C 
bonds in the sidewall: Those that run parallel to the circumference plane (which is 
perpendicular to the axis of the CNT), and those at an angle to the circumference 
plane. As may be seen in Figure (2-10, c), the first bond is similar to the situation in 
Chapter 2 
17 
 
the fullerenes with perfect alignment of the lobes of the π–orbitals, whereas the 
second bonding geometry requires a twist of the π–bond. In the latter case, the angle 
between the lobes of the π–orbitals of the adjacent carbon atoms is 0° and 21.3°, 
respectively; this source of strain in the CNTs that is absent in the fullerenes.
43
 This 
strain due to orbital misalignment leads to a differentiation between the bonds in the 
CNTs that may be reflected in their relative reactivity. The pyramidalisation angles 
and the π-orbital misalignment angles of CNTs scale inversely with the diameter of 
the nanotubes; a differentiation is expected between the reactivity of carbon 
nanotubes of different diameters. Furthermore, Bonds that are perpendicular to the 
tube axis, present in armchair CNTs (high chiral angle, 30°) are under greater strain, 
making these species more reactive than zig–zag CNTs (low chiral angle, 0°) of the 
same diameter.
48
 
 
2.5.2. Thermal Properties 
With the continually decreasing size of electronic and micromechanical devices, heat 
removal has become a crucial issue for continuing progress in the electronics 
industry owing to increased levels of dissipated power.
49
 Therefore, there is an 
increasing interest in materials that conduct heat efficiently for designing the next 
generations of integrated circuits (ICs) and 3D electronics to prevent structural 
damage.
50
 CNTs occupy a unique place in terms of their thermal conductivity and 
stability that stem from  their unique structure and tiny size.
51
 The thermal 
conductivity of nanotubes along their axis appears superior to that of all materials, 
including diamond, due to the beneﬁts derived from the strength and toughness of the 
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sp
2
 bond and from the 1D character of nanotubes. The thermal conductivity of bulk 
mats of SWNTs has been experimentally found to be as high as 200 W/mK at room 
temperature.
52
 Although it has been theoretically predicted that the thermal 
conductivity of an individual ideal SWNT at room temperature could be as high as 
6.600 W/mK, the practical value is usually less owing to the presence of defects in 
the walls of nanotubes.  
CNTs also exhibit excellent thermal stability. However, modified CNTs in general 
show lower thermal degradation temperatures, as most modification processes 
involve either damage to CNT structure or introduction of organic materials on 
CNTs. The damaged CNTs result in the production of amorphous carbon particles 
that can be burned easily in air flow, and the functional moieties attached on the 
CNT are also easily burned.  
 
2.5.3. Mechanical Properties   
As previously mentioned, CNTs are constructed from sp
2
 hybridised carbon atoms of 
the rolled graphene sheet, which is known to be mechanically stable. Therefore, 
CNTs mechanical properties are closely related to that of graphene. Among the many 
types of measurements to determine mechanical strength, the two that arguably stand 
out the most are Young’s Modulus and the tensile strength. The Young’s Modulus 
describes the ratio of stress applied to the amount of resulting strain on the material. 
The tensile strength describes the maximum amount of stress a material can be 
subjected to before it breaks. The in plane Young’s modulus of graphite is 1.06 
TPa.
53
 However, in graphite, weak interplanar interactions weaken the system via 
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shearing of planes from the three dimensional crystal, even at weak applied forces. In 
contrast to planar graphene, the 1D cylindrical shape provides CNTs with many 
unique mechanical properties,
54
 including a high Young’s modulus and a low 
specific weight. The Young’s modulus of SWNTs has been determined to be higher 
than 1 TPa,
55
 which makes them suitable candidates for reinforcing composites and 
in ultrahigh frequency nano-mechanical resonator applications.  
 
2.6. Functionalisation of Carbon Nanotubes 
The lack of solubility and the difficulty of manipulation in many solvents have 
imposed great limitations to the use of CNTs. As-produced CNTs are insoluble in all 
organic solvents and aqueous solutions. They also have the tendency to aggregate 
into bundles/ropes, due to the substantial van der Waals bonding in the tube–tube 
interactions.
56-58
 The substantial intermolecular cohesive forces of 0.5 eV nm
-1
 that 
exist between the tubes render them insoluble in common organic and aqueous 
solvents.
59
 This lack of solubility is a major disadvantage as it makes them difficult 
to process and handle. Although, CNTs can be dispersed in some solvents by 
sonication, precipitation immediately occurs when this process is interrupted.  
Sonication also damages the sidewalls of the nanotubes.
60,61
 Therefore, several 
approaches for the modification of these quasi one-dimensional structures have been 
developed. These approaches include side wall functionalisation, endohedral 
functionalisation, defective sites functionalisation, and noncovalent functionalisation; 
Figure 2-11 illustrates the possible CNT functionalisation approaches.
62
 CNTs 
biomedical applications depend on their chemical modifications. Carbon itself has 
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good biocompatibility, however, when it forms the CNT nanostructure, it can show 
toxicity.
63,64
 The property of water-insolubility is another factor that confines the use 
of CNTs in the biomedical field. Furthermore, CNTs are considered as ideal carriers 
for drug delivery, which requires proper chemical functionalisation. Accordingly, 
chemistry of CNTs in biomedical fields has multiple purposes, such as water-
solubilisation, enhancement of functions, and lowering the toxicity of CNTs. 
 
Figure  2-11: Schematic representation of different strategies for the functionalisation of 
CNTs. 
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2.6.1. Covalent Functionalisation of Carbon Nanotubes 
Covalent functionalisation is perhaps the most efficient form of obtaining well 
dispersed CNTs in aqueous solution due to the presence of polar functional groups 
on the CNT surfaces.
65
 Dispersion of covalently functionalised CNTs is achieved 
through the disruption of the van der Waals forces between nanotube bundles by the 
introduction of functional groups on the CNT surfaces. The drawbacks of covalent 
functionalisation are that they invariably introduce defects to the sidewalls, thus 
resulting in significant changes in the CNTs physical properties.
66
 Defects in CNTs 
are important as they offer an option for further functionalisation. Defects, therefore 
are a promising starting point for the development of the covalent chemistry of 
CNTs.
62
 The end caps of CNTs tend to be composed of highly curved fullerene-like 
hemispheres, which are therefore highly reactive compared with the side walls. The 
sidewalls themselves contain defect sites such as pentagon-heptagon pairs called 
Stone-Walls defects, sp
3
-hybrideised defects, and vacancies in the nanotube lattice 
(Figure 2-12). 
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Figure  2-12: Typical SWNT defects: (A) bend in structure due to Stone-Wales defects, (B) 
sp
3
 hybridised carbons, (C) holes in the sidewall and (D) SWNT open end terminated with 
COOH groups. Reproduced from [62] with permission of John Wiley and Sons. 
 
CNTs’ direct covalent functionalisation can be performed at either at the end caps of 
nanotubes or at their sidewalls which have many defects. This process can be made 
by reaction of a CNT with molecules of a high chemical reactivity,
67
 such as 
fluorine, nitrenes, carbenes, and radicals. However, this approach is usually 
associated with a change in CNTs’ hybridisation from sp2 to sp3 and a simultaneous 
loss of conjugation. Table 2-1 summaries the most common covalent 
functionalisation methodologies of CNTs.  
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Methodology Functional 
Group Added 
Degree of 
Functionalisation 
Solubility 
Diazonium
68-71
 Aryl 1 FG in every 10 carbons 
in SDS/water and 1 FG in 
every 25 carbons in 
organic solvent or neat 
0.8 mg mL
-1
 
in DMF 
Fluorination
72
 Fluorine 1 FG in every 2 carbons 1 mg mL
-1
 In                   
2- propanol 
Radical  Chemistry
73
 Alkyl - - 
Nitrene
74
 Aziridene 1 FG in every 50 carbons 1.2 mg mL
-1
 
in DMSO 
Bingel reaction
75
 Cyclopropane 1 FG in every 50 carbons  
Dichlorocarbene
76
 Cyclopropane 1 FG in every 25 carbons - 
Free-radical additions
77
 Perfluorooctyl - - 
Reductive alkylation
78
 Alkyl 1 FG in every 31 carbons  
Table  2-1: Common SWNT Sidewall Functionalisation Methodologies.  
 
The most common direct functionalisation approach is via carboxylation. In addition 
to improving the purity of CNTs, carboxylation increases CNT dispersion by 
reducing the van der Waals forces between nanotubes bundles. However, the 
oxidation by acids introduces defects on the CNT walls, shortens the length of tubes, 
and invariably changes the intrinsic chemistry of the CNT. Generally, CNT oxidation 
affords opened tubes with oxygen-containing functional groups at both the sidewall 
and the tube endings. These groups can then be used as chemical anchors for further 
derivatisation. 
Indirect covalent functionalisation takes advantage of chemical transformations of 
carboxylic groups at the open ends and holes in the sidewalls.
67
 These carboxylic 
groups might have existed on the as-grown CNTs and also be further generated 
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during oxidative purification. These functional groups have a rich chemistry and 
allow the CNTs to be used for further chemical reactions, such as silanation, polymer 
grafting, esterification, thiolation, alkylation and arylation and even some 
biomolecules.
79,80
 The CNTs functionalised in this way are soluble in many organic 
solvents because the addition of a polar group makes the normally hydrophobic tubes 
hydrophilic.
62
  
 
2.6.2. Noncovalent Functionalisation of Carbon Nanotubes 
Functionalisation of CNTs using covalent methods has shown promising results for 
providing useful functional groups on the CNTs surface, thus yielding a very stable 
and effective derivatisation. However, covalent functionalisation process inevitably 
creates a large number of defects on the sidewalls and/or the end tips of CNTs. In 
many extreme cases, CNTs are broken into smaller pieces, resulting in severe 
degradation of the mechanical and electronic properties of the CNTs and disruption 
of their π electron system.46  
On the other hand, noncovalent functionalisation of CNTs enhances the dispersibility 
and solubility of pristine CNTs while preserving the sp
2
 structure of the nanotubes 
and, thus, their electronic characteristics. Therefore, noncovalent functionalisation is 
an alternative method to overcome the drawbacks of the covalent functionalisation. 
The term dispersion refers to homogeneously distributed nanotubes in a colloidal 
state also including small bundles, while solution implies that the nanotubes appear 
individualised, e.g. the nanotube bundles are exfoliated. According to the interactions 
between the CNTs and the guest molecules, the noncovalent functionalisation 
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methods can be further classified as the, wrapping,
81
 adsorption,
82
 and endohedral 
methods.
83
 
The large aromatic and hydrophobic character of CNTs make them ideal surfaces for 
noncovalent interaction with molecules via van der Waals, π–π stacking or 
hydrophobic forces. Therefore, long chain molecules such as polymers and peptides, 
and DNA (containing π electrons) which featuring a helical shape are especially apt 
to wind around nanotubes.
84
 The π–π interaction is an electrostatic interaction in 
which the offset and/or orientation of the π orbitals on opposing molecules maximise 
the σ-π attractive interactions while minimising the opposing π-π repulsive 
interactions. Such interactions with CNTs can be surprisingly strong, depending on 
the molecules, and even capable of withstanding temperatures > 400 °C. The 
physical adsorption of molecules such as anionic surfactants onto the SWNTs surface 
is designed to lower the surface tension of SWNTs, effectively preventing the 
formation of aggregates. The surfactant-treated SWNTs overcome the van der Waals 
attraction by electrostatic/steric repulsive forces.
85
 The efficiency of this method 
depends strongly on the type of surfactants used and chemistry of the medium. 
Another approach for the noncovalent modification of SWNTs is the filling of their 
inner cavity; in this method, guest atoms, molecules, inorganic nanoparticles, such as 
C60, Ag, Au, and Pt, or biomolecules, such as proteins, are stored in the inner cavity 
of SWNTs through the capillary effect.
46, 65
 Comparison of the catalytic activities of 
immobilised enzymes with those of the free species in the hydrolysis of penicillin 
showed that a significant amount of the inserted lactamase remained catalytically 
active, implying that no drastic conformational change had taken place. DNA can 
also be entrapped in the inner hollow channel of nanotubes by simple adsorption to 
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form natural nano test tubes. Molecular dynamic simulations showed that both van 
der Waals and hydrophobic forces were important for the dynamic interactions of the 
components.
86,87
 The combination of CNTs and guest molecules is particularly useful 
in catalysis, energy storage, nanotechnology, nanofluidics, and molecular scale 
devices because the incorporation process allows their individual properties to be 
integrated in the hybrid materials, thus creating unique properties that cannot be 
achieved with individual components acting alone.
32
 
 
2.7. Aqueous Dispersion of Carbon Nanotubes 
Considerable effort has been made to develop approaches for reproducible dispersion 
of individual CNTs. Mechanical dispersion methods separate nanotubes from each 
other, but can also fragment the nanotubes, decreasing their aspect ratio.
88
 Chemical 
methods based on surface functionalisation of CNTs improve their chemical 
compatibility with the target medium and reduce their tendency to agglomerate. 
However, aggressive chemical functionalisation usually introduces structural defects 
resulting in inferior properties for the tubes. Thus, noncovalent treatment is 
particularly attractive because of the possibility of adsorbing various groups on 
CNTs surface without disturbing the system of the graphene sheets. The aqueous 
dispersion of noncovalent approaches are based on interactions of the hydrophobic 
part of the adsorbed molecules with nanotubes sidewalls while aqueous solubility is 
provided by the hydrophilic part of the molecules.
89
 The charging of the nanotube 
surface by adsorbed amphiphilic molecules prevents nanotube aggregation by the 
coulombic repulsion forces between modified CNTs. The noncovalent treatment of 
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CNTs with biomolecules has been widely used in the preparation of both aqueous to 
obtain high weight fraction of individually dispersed nanotubes. 
 
2.7.1. Polymers Composites  
CNTs are considered ideal materials as reinforcing fibers due to their exceptional 
mechanical properties. Therefore, CNT/polymer composites will not only possibly 
improve the mechanical and electrical properties of polymers, but are also considered 
to be a useful approach for incorporating CNTs into polymer-based devices. 
Noncovalent functionalisation with polymers usually involves the physical 
adsorption and/or wrapping of the polymer to the CNTs surface. A common strategy 
to impart functionality, water solubility, and biocompatibility to CNTs is the 
noncovalent functionalisation via PEGylation.
90-92
 The formed composites exhibit 
high stability in aqueous solutions at different pH values, at elevated temperatures, 
and in serum. Therefore, PEGylated/CNTs are very powerful materials for in vivo 
applications, including drug delivery or imaging.
93-95
 
 
2.7.2. Surfactants 
Surfactant molecules offer one of the highest potentials when considering 
noncovalent approaches to nanotube dispersions in water.
69,96,97
 The dispersion 
mechanism is believed to be primarily due to hydrophilic and hydrophobic 
interactions, where the attraction between the CNT surface and the surfactant’s 
hydrophobic segment facilitates adsorption while the hydrophilic group associates 
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with water.
85
 Surfactants can be classified as anionic, cationic, non-ionic or zwitter-
ionic according to the charge on their hydrophilic group.
98
 The adsorption of 
surfactants onto the CNT surface usually depends on the chemical characteristics of 
the surface, surfactant molecules and solvent. Thus, CNT dispersions involving ionic 
surfactants are believed to be stabilised by electrostatic repulsion between the 
hydrophilic head groups.
99
 The mechanism by which non-ionic surfactants adsorb 
onto a CNT hydrophobic surface is based on a strong hydrophobic attraction between 
the solid surface and the surfactant's hydrophobic tail.
98
 Thus, the ability of non-ionic 
surfactants to suspend CNTs is due the size of the hydrophilic group, with the 
efficiency of the surfactant increasing with molecular weight due to enhanced steric 
repulsion.
100
  
The physical adsorption of surfactant onto the CNT surface is designed to lower the 
surface tension of CNTs, thus preventing the formation of aggregates. The 
surfactant-treated CNTs overcome the van der Waals attraction by electrostatic/steric 
repulsive forces. The efficiency of this method depends strongly on the surfactant 
type, surfactant concentration, CNTs diameter
101,102
 and dispersion conditions.  
The presence/absence of different functional groups defines the efficiency of the 
dispersion of CNTs in solution. Vaisman et al.
98
 suggested that non-ionic surfactants 
be reserved for dispersing nanotubes in organic solvents while ionic surfactants are 
preferable for creating aqueous dispersions. However, the anionic sodium 
dodecylbenzene sulfonate (NaDDBS) had the highest dispersive in water ability ratio 
followed by non-ionic Triton X-100 (TX100) and lastly anionic sodium 
dodecylsulfate (SDS). π–π stacking interactions of the benzene rings on CNT surface 
are believed to increase the adsorption ratio of surfactants. Thus, NaDDBS and 
Chapter 2 
29 
 
TX100 were believed to disperse SWNTs better than SDS because they contain a 
benzene ring, which allows for a greater interaction with the SWNTs. However, the 
difference between TX100 and NaDDBS was attributed to head group size; the 
larger head group of TX100 lower its packing density compared to NaDDBS. 
Although, SDS and NaDDBS have the same length of the alkyl chain but the latter 
has a phenyl ring attached between the alkyl chain and the hydrophilic group. The 
presence of the phenyl ring makes NaDDBS surfactant more effective for 
solubilisation of nanotubes than SDS, due to the aromatic stacking formed between 
the SWNTs and phenyl rings of NaDDBS within the micelle (Figure 2-13).  
 
Figure  2-13: Schematic representation of how surfactants may adsorb onto the nanotube 
surface. Reprinted with permission from [103]. Copyright (2003) American Chemical 
Society. 
 
Similarly, Rastogi et al.
104
 found that benzene ring in a series of non-ionic 
surfactants, TX100, Tween 20, Tween 80 and SDS, affects their dispersion ability 
towards MWNTs. They found that TX100 displayed the highest dispersing power of 
the four which was again attributed it to its ability to adsorb more strongly than the 
others to the MWNTs through π–π stacking. Tween 80 was the next best because of 
its longer tail while Tween 20 was more effective than SDS due to its bulkier head 
group which provided greater steric stabilisation. 
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2.7.3. Protein  
Proteins, also known as polypeptides, are naturally amphiphilic organic compounds 
consisting of amino acids arranged in a linear chain and folded into 3D form. 
Interactions between proteins and CNTs could play a key role in the biological 
applications of CNTs.
105
 Thus, proteins have become widely used as CNT dispersing 
agents and extensively reviewed.
106,107
 Proteins consist of numerous active groups 
such as hydroxyl, amino, thiol, carboxyl acidic, and others, which provides sites for 
further surface functionalisation of the CNTs.
108,109
 Thus, interaction between a 
protein and a CNT surface are most likely to be complicated by involving many 
types of noncovalent forces such as electrostatic, π–π stacking, and hydrophobic 
interactions. Due to the aromatic nature of CNTs, it is rather common that protein-
CNT interactions are rationalised in terms of π–π stacking with aromatic amino 
acids. In particular, histidine and tryptophan appear to have the highest affinity for 
CNTs.
110
 However, studies found that protein amphiphilicity is another key property 
that appears to promote interaction of proteins with CNTs in aqueous media.
111
 
Although, electrostatic interactions are generally considered to play a minor role in 
protein-CNT binding, they have been reported in various studies, often taking into 
consideration the relation between protein charge and pH. For example, Nepal et 
al.
112
 demonstrated that proteins, including lysozyme, histone, hemoglobin, 
myoglobin, ovalbumin, bovine serum albumin, trypsin, and glucose oxidase, were 
good dispersing agents for SWNTs and that their suitability depends on various 
factors including the primary structure and pH. Kam et al.
113
 used the oxidised 
SWNTs to bind three proteins such as streptavidin protein A (SpA), bovine serum 
albumin (BSA), and cytochrome c (cyt-c). AFM images showed that the density of 
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proteins on the sidewalls of SWNTs is the highest for cyt-c, followed by SpA and 
BSA. Thus, it is most likely that an electrostatic force, between the negatively 
charged SWNTs and the positively charged protein domains, also contributes to the 
non-speciﬁc binding besides hydrophobic interactions. 
Although, direct protein adsorption on CNTs is probably the simplest method to 
achieve noncovalent binding, it is not devoid of drawbacks. For example, 
noncovalent adsorption of proteins onto CNTs may partially unfold them and thus 
lose their biological function. Matsuura et al.
114
 studied the interaction of egg white 
lysozyme (LYS), bovine serum albumin (BSA), pepsin and porcine pepsin proteins 
with SWNTs in water. The main driving force for the dispersion is thought to be by 
π–π stacking interaction between the side walls of SWNTs and the aromatic groups 
of the residues in the protein. Although aromatic residues exist on the studied 
protein, unfolded LYS and BSA can individually disperse SWNTs in aqueous 
solutions, whereas weakly unfolded pepsin and pepsin cannot. This suggests that the 
deference in the dispersion properties is probably attributable to protein structural 
changes that occur during the dispersion process.  
On the other hand, indirect adsorptions of proteins to CNTs via anchor molecules not 
only preserve CNTs properties but also protein structure. Chen et al.
115
 reported the 
use of a bifunctional molecule, 1-pyrenebutanoic acid succinimide ester, as a linker 
to immobilise proteins on SWNT surface. The pyrene moiety in the bifunctional 
molecule would be π–π stacking with the graphitic nanotube sidewall so that the 
succinimidyl ester group at the other end of the bifunctional molecule would be 
available for reaction with primary and secondary amines in the proteins (Figure 2-
14). 
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Figure  2-14: Anchored succinimidyl ester to formamide bonds for protein immobilisation on 
SWNTs. Reprinted with permission from [115]. Copyright (2001) American Chemical 
Society. 
 
The hollow nature of CNTs allows them to be considered as potential tubular vectors 
to be filled with biomolecules. The encapsulation of protein into CNTs may control 
and decrease the overall CNT cytotoxicity. Furthermore, upon the protein 
encapsulation of a specific protein, the loaded protein could be delivered to the 
desired site of action, thus protected from protease.  Tsang et al.
116
 confirmed the 
encapsulation of a series of small proteins, Zn2Cd5-metallothionein, cytochrome C3 
and p-lactamase, into end cap opened CNTs by high-resolution transmission electron 
microscopy (HRTEM). The encapsulated proteins kept a significant amount of their 
catalytic activity, which indicates that no drastic conformational change had taken 
place during their immobilisation inside CNTs. Kang et al.
117
 explored the diameter 
selectivity of the protein encapsulation in CNTs via molecular dynamics simulations. 
They suggested that a protein is encapsulated into a CNT with an appropriate 
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diameter to ensure encapsulation in a spontaneous process; CNTs that are too large 
offer insufficient initial van der Waals attraction to the protein, for it to move inside 
the nanotubes. 
 
2.7.4. Peptides 
Peptide conjugation is another alternative and attractive technique for noncovalent 
dispersion of CNTs in aqueous solution. The peptide dispersal agents function as 
surfactants in the sense that they lower the surface tension of water around the 
nanotubes. They have effective hydrophobic and hydrophilic surfaces that are used to 
interact with both the CNTs and water. Peptides can bind to CNTs via hydrophobic 
interactions,
118,119
 π–π stackings,110,120,121 and electrostatic interactions.122 Among 
them, the π–π stacking interactions between aromatic residues of peptide and CNTs 
have been listed as a particularly important factor in the binding process. Salzmann 
et al.
123
 illustrated the importance of the balance between (charged) hydrophilic and 
aromatic amino acid residues in polypeptides for the successful dispersion of 
SWNTs. The π–π stacking interaction between the aromatic amino acids of the 
polypeptides and the extended π-electron system of CNTs is considered to be the 
main driving force for polypeptide adsorption onto SWNTs. In this context, they 
found that tryptophan residues interact more strongly with the SWNTs than tyrosine 
residues making the peptide of tryptophan and lysine a better dispersing agent for 
SWNTs compared to the peptide of tyrosine and lysine. Dieckmann et al.
124
 designed 
an amphiphilic helical peptide denoted as nano-1. This artiﬁcial peptide was 
constructed on the basis of the preliminary works of Wang et al.
125
 who used phage 
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display to identify several peptides with a high affinity for CNTs. An analysis of 
nano-1 peptide conformations has suggested that the binding sequence is ﬂexible and 
folds into a structure matching the geometry of the nanotube. Figure 2-15 
schematically illustrates the structure of the peptide and its interaction with a SWNT. 
The more polar residues are located on one face and have surfactant properties so 
spontaneously assemble in aqueous solution to minimise the exposure of the 
hydrophobic surface to the solvent and to present the hydrophilic surface to the 
aqueous environment  
 
Figure  2-15: Model illustrating potential interactions between nano-1 and SWNT. (A) 
Cross-section view of a SWNT wrapped by six peptide helices. (B) View of peptide-
wrapped nanotube illustrating the nano-1 peptide helices used in the model. Reprinted with 
permission from [124]. Copyright (2003) American Chemical Society. 
 
When nano-1 folded into an α-helix, as proposed on the basis of CD spectroscopy, 
the hydrophobic valine and phenylalanine residues create an apolar surface of the 
peptide suitable for interacting with the nanotube sidewall. The polar nano-1 residues 
promote self-assembly through charged peptide‐peptide interactions. Zorbas et al.120 
altered the number of heptad-residue repeats and the number of phenylalanine 
residues (Phe) of nano-1 peptide. It was found that peptides with fewer Phe residues 
had a decreased ability to disperse SWNTs, suggesting that nano-1 mainly uses Phe 
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residues to interact with the SWNT side wall through the π-π stacking effect. Li et 
al.
126
 studied the effect of pH and degree of oxidation of the electrostatic interaction 
of two polypeptides, polylysine and polytryptophan, with MWNTs and SWNTs. 
They found that the adhesion force between polylysine and oxidised MWNTs 
increased with decreasing pH value and increasing oxidation time. However, the 
corresponding pH and oxidation-time dependences for SWNTs were found to be 
much weaker than those of MWNTs. This is thought to be due to the carboxylate 
groups only attached onto the nanotube tips in the SWNTs, whereas onto both the 
nanotube tips and sidewall in the MWNTs. Arnold et al.
127
 found that the MWNTs 
dispersion using amphiphilic anionic and cationic peptide is controlled by pH of the 
dispersion. The tested peptides consist of a hydrophobic alkyl chains covalently 
attached to an amino acid sequence, thus, the net ionic charge of the peptides vary 
with pH. For instance, at neutral and basic pH, the peptide sequence of PA 1 
molecules is negatively charged. In this state, PA 1 molecules homogeneously 
disperse and functionalise the MWNTs. By reduction of the net charge of the peptide 
sequence, the ionic repulsion among free peptide amphiphilic molecules and among 
peptide amphiphilic functionalised MWNTs can be reduced, leading to aggregation.
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3. CHARACTERISATION OF CARBON NANOTUBES AND 
BIOMOLECULES 
 
This section describes the techniques that have been used to characterise CNTs as 
well as the biomolecules that have been used in this thesis.  
 
3.1. Characterisation of CNTs  
Several characterisation and observation methods are available for carbon 
nanomaterials, each one provides complementary information. The imaging of the 
carbon nanomaterial morphology is usually performed by electron or probe 
microscopy. Spectroscopic methods are often applied to characterise the structural 
and chemical properties of the nanomaterials. This section will focus on both 
microscopic and spectroscopic techniques used to characterise the synthesised and 
modified carbon nanomaterials in this thesis.   
 
3.1.1. Vibrational Spectroscopy Techniques  
Vibrational spectroscopy is concerned with vibrational transitions due to absorption 
and emission of electromagnetic radiation. Molecular vibrations can be excited by 
the absorption of photons of frequencies that exactly match the vibrational 
frequencies of the molecule, which depend on the forces between its atoms and its 
geometry.
128
 The vibrational energies of the molecule can be studied by vibrational 
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spectroscopy. Therefore, a Raman spectroscopic method has been used to probe the 
oscillation of the atoms in carbon nanomaterials to yield complementary types of 
information about their structure. 
 
3.1.1.1. Raman Spectroscopy 
Raman spectroscopy is a non-destructive powerful technique used to study 
vibrational, rotational, and other low-frequency modes in a molecule, thus yields 
spectroscopic fingerprints from the studied sample.
129
 It principally differs from IR 
spectroscopy in that it is concerned with the frequency of the scattered photons by 
molecules as they undergo rotations and vibrations rather than change in dipole 
moments due to the absorption of photons. When monochromatic light, usually from 
a laser in the visible, near-infrared, and near-ultraviolet range, impinges upon a 
molecule and interacts with the electron cloud of the bonds, a virtual transition to a 
higher energy level occurs. The molecule then relaxes and returns to the ground state 
by emission of a photon resulting in two types of light scattering, elastic and inelastic 
scattering.
128,130
 Figure 3-1 shows the types of photon scattering. In elastic 
scattering, the light interacts with the molecule but the net exchange of energy (E) is 
zero, so no change occurs in photon frequency, this process is known as Rayleigh 
scattering.  
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Figure  3-1: Energy-level diagram showing Rayleigh scattering, stokes and anti-stokes 
Raman scattering. 
 
The Raman effect occurs when the very small part of the incident light is 
inelastically scattered. The inelastic light scattering is usually accompanied by the 
shift in photon frequency due to excitation or deactivation of molecular vibrations in 
which either the photon may lose some amount of energy or gains energy. As a 
result, the emitted photon frequency will be either shifted to lower or higher energy 
(blue or red shifted, respectively). The red shifted photons are the most common and 
usually known as stokes shift, while the blue shifted are designated as anti-stokes 
Raman scattering respectively.
130
 This shift in the frequency is called the Raman shift 
and is generally represented in wavenumbers (cm
-1
), inverse of wavelength. In 
contrast to infrared spectroscopy, Raman spectroscopy is dependent on a change in 
the polarisability during the vibration, and the Raman intensity is concerned with the 
polarisability of the vibrating atoms and their bonds present. Raman spectroscopy is 
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commonly used to characterise all sp
2
 graphitic carbon structures from three to zero 
dimensions, such as 3D graphite,
131
 2D graphene,
132
 1D carbon nanotubes,
15,133
 and 
0D fullerenes.
15,132,134
 Raman spectroscopy of sp
2
 carbons provides unique 
information about crystallite size, clustering of the sp
2
 phase, the presence of sp
2
-sp
3
 
hybridisation and the introduction of chemical impurities, doping, defects and other 
crystal disorder, nanotube diameter, chirality, curvature, and finally the metallic vs. 
semiconducting behavior.
135
 All carbon nanostructures exhibit two characteristic 
features in their Raman spectra, in the region 800 − 2000 cm-1, the so-called G 
(graphitic) and D (disordered) peaks, which are sensitive enough to provide unique 
information about the similarities and differences between them.
136
 A typical Raman 
spectrum of SWNTs can be divided into four important regions; the radial breathing 
mode (RBM), the disorder mode (D band), the tangential mode (G band), and the G´ 
(or 2D) band. Figure 3-2 shows a representative Raman spectrum of SWNTs excited 
at 633 nm. 
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Figure  3-2: Resonance Raman spectrum of purified SWNTs excited at 633 nm and 
normalised at G-band. 
 
The radial breathing mode (RBM) Raman features corresponds to the atomic 
vibration of the C atoms in the radial direction in the relation to nanotubes axis. 
These features are unique to CNTs and occur with frequencies ωRBM between 120 
and 350 cm
−1
 for SWNTs for diameters in the range 0.7 nm − 2 nm.15 These RBM 
frequencies are therefore very useful for identifying whether a given carbon material 
contains SWNTs, through the presence of RBM modes, and for characterising the 
nanotube diameter distribution in the sample. The RBM frequency (ωRBM) is 
inversely proportional to the diameter of the nanotube (dt) following the equation 
below:  
 
Chapter 3 
41 
 
The A and B parameters are determined experimentally and dependent on 
environmental effects, such as the degree of individualisation or wrapping of 
surfactants. Different values of these parameters have been reported which are 
summarised by Hennrich et al.
137
 For large diameter tubes (d > 2 nm) the intensity of 
the RBM feature is weak and is hardly observable.
138
 Because of the diameter-
selective resonance Raman effect,
139
 study of the RBM frequencies for various Elaser 
values can be used for characterising the diameter distribution of SWNTs in a 
sample. The second important Raman feature is the G-band, which is a Raman-active 
mode of sp
2 
carbons (graphite) and thus all graphitic materials show this spectral 
feature. The G band in SWNTs which corresponds to tangential planar vibrations of 
carbon atoms appears in the region between 1500 and 1600 cm
-1
. Differently from 
other graphite base nanomaterials, the tangential G mode in SWNTs is a sum of up to 
six high-energy tangential modes that basically originate from breaking the 
symmetry of the tangential vibration when the graphene sheet is rolled into a 
tube.
137,140
 However, just the two most intense peaks of the G band are normally 
considered, these peaks are labelled G
+
,
 
which is given by vibrations along tube axis, 
and the G
−
, due to vibrations in the circumferential direction. The G band frequency 
can be used for nanotubes diameter characterisation; the G
+
 band is independent from 
the diameter, whereas the G
−
 band is usually diameter dependent. The G
−
 band 
frequency (ωG
-
) decreases when decreasing nanotubes diameter (dt), and this 
decrease becomes larger as the curvature of the sheet increase. Therefore, the 
splitting the G band into G
+
 band G
−
 band and can be used for diameter 
characterisation. Additionally, the G-band is used to distinguish between metallic 
and semiconducting SWNTs, through strong differences in G band line shapes. The 
line shape of the G
−
 mode depends on whether the tube is semiconducting or 
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metallic. The G
−
 feature is broadened for metallic SWNTs. Furthermore, the G-band 
is used to probe the charge transfer arising from doping a SWNT through the G
+
 
frequency (ωG
+
) which is sensitive to charge transfer from dopant additions to 
SWNTs. The ωG
+
 up-shifts electron acceptors, and downshifts for donors as in 
graphite intercalation compounds (GICs). Another important Raman is the D band 
(diamond band, or disorder band), which is observed in the 1300 – 1400 cm−1 range 
and usually shifts to higher wavenumbers as the laser excitation energy is increased. 
This mode is associated with disorder, specifically, the sp
3 
hybridised carbon atoms 
present in the tube or in the carbonaceous impurities. Therefore, the intensity of this 
band can be used to determine the defects in the structure, usually expressed as ID/IG 
ratio. Moreover, the full-width-at-half-maximum (FWHM) intensity of the D-band of 
the various carbon impurities is generally much broader than that of CNT D-band, 
and thus D-band line-width could give an indication of SWNTs purity level. There 
are other less significant bands that typically present in a SWNTs Raman spectrum, 
among them is the G′ band. This band is the second strongest after the G mode, but it 
is actually the overtone of the defect‐induced D mode, even though being present 
even in defect‐free nanotubes. 
This technique is also used to characterise MWNTs witch show similar Raman 
features to SWNTs; however, they do not present a defined RBM, because the outer 
MWNTs tubes restrict their breathing mode. Moreover, the D band is quite intense, 
often more than the G-band, because of the high extent of defects usually present in 
MWNTs. Consequently, it is difficult to appreciate an increase in the ID/IG ratio due 
to functionalisation. Lastly, the G band splitting is small and smeared out because of 
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the diameter distribution within MWNTs and the G band usually exhibits a weakly 
asymmetric line shape.
141
 
 
3.1.2. Electronic Spectroscopy Techniques 
Electronic spectroscopy is concerned with the absorption, emission, and scattering 
associated with the interaction of ultraviolet-visible (UV-Vis) radiation with the 
chromophoric system in the molecule.
142
 In this type of spectroscopy, the absorption 
is associated with excitation of electrons from lower to higher energy levels. Since 
the energy levels of matter are quantised, only light with the precise amount of 
energy (exact wavelength), can cause transitions from one level to another. This 
usually involves −orbitals and lone pairs (non-bonding). Figure 3-3 illustrates a 
simple schematic of electronic transitions in the UV-Vis region.  
 
Figure  3-3: Electronic transitions in the UV-Vis region. 
 
In this thesis, ultraviolet-visible-near infrared (UV-Vis-NIR) spectroscopy has been 
used to characterise the changes of electronic properties of carbon nanomaterials 
upon their modification.  
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3.1.2.1. Ultraviolet-Visible-Near Infrared (UV-Vis-NIR) Spectroscopy 
UV-Vis-NIR spectroscopy is an analytical technique which is ideally suited for the 
characterisation of carbon nanomaterials due to its sensitivity to the changes in their 
electronic structure and so their optical properties. The electronic structure of CNTs 
is related to a 2D graphene sheet. However, owing to the 1D nature of the nanotubes, 
their electronic density of states (DOS) is singular due to folding of the 2D energy 
bands of graphene layer into the 1D bands of SWNT with an increasing energy 
separation at decreasing number of energy bands.
143,144
 As a consequence, the 
continuous DOS in graphene divides into a series of spikes in SWNTs known as van 
Hove singularities (vHSs)
14,145-147
 (Figure 3-4). 
 
Figure  3-4: Theoretical phonon density of states for 1D quantum (Black line) dots, 2D 
graphene (Red line), 3D graphite (Green line), and CNTs (Blue line). From [146] with 
permission from AAAS. 
 
The optically allowed electronic transitions between vHSs of SWNTs arise as a 
series of characteristic sharp peaks in the UV-Vis-NIR range. The sharpness of the 
peaks usually is not fully appreciable due to the overlap of similar transitions given 
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by different diameters and chiralities. Each (n, m) SWNTs exhibits a different set of 
vHSs in its valence and conduction bands; in particular the energy gap varies with 
the SWNT diameter (d) as 1/d
2
.
148
 Therefore, optical absorption can be used to 
determine nanotube diameter and chirality. The possible electronic transitions in the 
DOS of semiconducting and metallic SWNTs are explained in Figure 3-5.  
 
Figure  3-5: Schematic representation of the electronic density of states of a semiconducting 
and metallic SWNT and the possible transitions between the van Hove singularities. The 
valence bands are blue colour and the conduction bands are white colour. Reproduced from 
[149] with permission of The Royal Society of Chemistry. 
 
In SWNTs absorption of UV-Vis-NIR light, the electrons in the vHSs of the valence 
band are elevated to the corresponding energy levels in the conduction band; denoted 
as S11 and S22 in semiconducting SWNTs and M11 in metallic SWNTs.
150
 The M11 
transitions for metallic SWNTs are seen as absorption bands in the visible range 
between ~ 440 − 645 nm. The E11 and E22 transitions for semiconducting SWNTs are 
seen between 830 − 1600 nm and 600 − 800 nm.151,152 A typical absorption spectrum 
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of HiPco SWNTs dispersed in an aqueous solution of SDS (1 wt %) after sonication 
and ultracentrifugation is displayed in Figure 3-6.   
  
Figure  3-6: UV-Vis-NIR absorption spectrum of HiPco SWNTs aqueous dispersion in 1 wt 
% SDS showing the M11, S11 and S22 regions. 
 
The disadvantage of this characterisation is that its usefulness is usually limited to 
SWNTs. In fact, the UV-Vis-NIR absorption of MWNTs derive from the overlap of 
many different contributions of each tube, consequentially does not result in the 
typical well-defined van Hove features of a SWNT spectrum.  
The UV-Vis-NIR absorption spectroscopy of SWNTs is widely used to determine 
their individualisation degree, purity,
153-155
 efficiency of separation procedures,
156
 
and dispersion efficiency.
157
 The nanotube concentration in the supernatant can be 
calculated through application of the Beer-Lambert Law,
158,159
 which states that the 
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absorbance, A, of a sample is dependent on the light path length (l) the concentration 
(C) of the species and the extinction coefficient (є). It is therefore possible to 
determine the solubility of a CNT sample in a particular solvent from its UV-Vis-
NIR spectrum if the extinction coefficient is known.  
 
3.1.3. Microscopic Techniques   
3.1.3.1. Atomic Force Microscopy (AFM) 
Atomic force microscope (AFM) is a high resolution scanning probe microscopy 
technique, which is widely applied to study materials surface properties from the 
atomic to the micron levels. AFM was used to quantitatively characterise the 
morphology and roughness of carbon nanotubes surface.
160-162
 Figure 3-7 shows the 
basic principles of AFM.  
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Figure  3-7: Block diagram of principle operation of a (multimode) AFM.163 
 
The technique uses a tip that is precisely situated on a flexible silicon cantilever and 
mounted to a piezoelectric driver for scanning. When the voltage is applied, the tip is 
brought to a chosen point over the sample surface where the force can repel or attract 
atoms from the tip leading to a deflection of the cantilever according to Hooke’s 
low.
164
 Therefore, the AFM detection system does not directly measure the force 
between the tip and the sample surface; instead, it senses the deflection of the 
cantilever. The degree of cantilever deflection, which is caused by the surface 
topography, is usually measured using a laser light reflected from the surface of the 
cantilever into a position sensitive detector. AFM can be operated in two modes: 
namely the contact mode, noncontact mode or “tapping mode”. In contact mode the 
tip actually touches the surface, thus possibility moving objects or damaging soft 
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samples. In non-contact mode, the tip scans instead the surface at a certain distance 
and the cantilever is oscillated at a frequency slightly above its resonant frequency 
where the amplitude of oscillation is typically few nanometres.
165
 Thus, this mode 
does not suffer from tip or sample degradation effects, making it preferable to 
contact AFM for measuring carbon nanomaterials samples in this thesis. The AFM 
technique can be used as fast method for the examination of the generation of three-
dimensional reconstruction of the sample topography with atomic resolution, and 
also allows collecting information on the morphology of CNTs, the functional groups 
present on nanotube surface and diameter/length, dispersion and exfoliation of 
bundles.
166,167
 
 
3.1.3.2. Transmission Electron Microscopy (TEM) 
Transmission electron microscope (TEM) is a powerful imaging technique that based 
on the detection of a high energy electron beam transmitted through a thin sample to 
provide high-resolution morphologic, compositional and crystallographic 
information. Therefore, it is an important tool for the characterisation of carbon 
nanomaterials. The basic components of TEM equipment are illustrated in Figure 3-
8.  
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Figure  3-8: Schematic diagram of transmission electron microscope. 
 
TEM operates on the same basic principles as the light microscope but uses electrons 
instead of light. TEMs use electrons as "light source" and owing to their much lower 
wavelength it is possible to get a resolution a thousand times higher than with a light 
microscope.
168
 A "light source" at the top of the microscope emits the electrons that 
travel through vacuum in the column of the microscope. Instead of glass lenses 
focusing the light in the light microscope, the TEM uses electromagnetic lenses to 
focus the electrons into a very thin beam. The electron beam then travels through the 
specimen under study. Depending on the density of the material present, some of the 
electrons are scattered and disappear from the beam. At the bottom of the microscope 
the unscattered electrons hit a fluorescent screen, which gives rise to a "shadow 
image" of the specimen with its different parts displayed in varied darkness 
according to their density. The image can be studied directly by the operator or 
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photographed with a camera.
169
 The image quality of a certain sample can be 
manipulated by adjusting the speed of electrons through the electron gun by voltage 
modification. During the transmission, the speed of electrons directly correlates to 
electron wavelength: the faster the electrons move, the shorter wavelength and the 
greater the quality and resolution of the image.
170
 
TEM is a key technique in the structural characterisation of CNTs: it provides 
information on dispersibility, diameter, purity grade, presence of defects, length, and 
also functionalisation of the nanotubes. However, TEM requires very thin samples, 
which are electron transparent. Therefore, for TEM analysis, nanotubes are typically 
deposited on commercial TEM grids. This procedure has two problems: in the 
deposition process the nanotubes can be damaged, and it does not work reliably if the 
nanotube density is too low.  
 
3.1.4. Thermogravimetric Analysis (TGA) 
Thermogravimetric analysis (TGA) is a destructive analytical technique that 
determines the thermal stability of materials by monitoring the weight as a function 
of temperature under a controlled atmosphere, optimised according to the experiment 
needs; either in inert (N2 or He), or oxidative (air or pure O2) atmosphere.
59
 Although 
TGA provides quantitative weight change information about decomposition and 
volatilisation, it does not generally provide information about the identity of specific 
gaseous material evolving during the experiment. Therefore, it is often coupled with 
gas phase mass spectrometry (TGA-MS), and the temperature at which the groups 
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come off can be indicative of covalent functionalisation since the attached groups 
will come off at considerably high temperatures compared to adsorbed groups.
171
 
TGA analysis has been used to study the thermal stability of carbon nanomaterials. 
Different forms of nanomaterials have different thermal stability under identical 
conditions, which is consistent with the differences in their structures. For example, 
disordered or amorphous carbons tend to be less thermally stable than the well 
graphitised structures, because of their lower activation energies for oxidation or due 
to the presence of a large number of active sites.
172-174
 
TGA characterisation of SWNTs is used to quantify the quality of as-produced 
SWNT samples, as well as to track the effects of the purification and modification 
process. Their combustion temperature usually depends on a number of parameters, 
such as diameter, amount of metal catalyst particles, defects and derivatisation 
moiety on the nanotube walls.
172,174
 
TGA in an oxidising atmosphere has become a relevant tool for purity analysis by 
accurately estimating the amount of metal catalyst particles remaining in the 
sample.
173
 Metal impurities in the sample have a considerable influence on the 
thermal stability, therefore impure tubes burn at lower temperatures due to the 
presence of metal particles.
39
 Meanwhile, TGA analysis of modified SWNTs under 
inert atmospheres can be used to determine the weight loss upon heating and their 
degree of functionalisation. This is based on the fact that SWNTs have high thermal 
stability up to 800 
◦
C, where most functional moieties are not stable. Therefore, it is 
possible to ascribe the weight loss at lower temperatures to the organic material 
present in the sample to estimate the degree of functionalisation
59
 (Figure 3-9).  
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Figure  3-9: TGA analysis of pristine purified HiPco SWNTs: (Black line) under N2, (Red 
line) under air.  
 
3.2. Characterisation of Biomolecules  
The modification of CNTs with biomolecules requires knowledge of the 
concentration, structure, electronic environment, and binding stoichiometry. For this 
purpose, this section gives a brief overview of the characterisation techniques used.  
 
3.2.1. Mass Spectrometry (MS) 
Mass spectrometry (MS) is an analytical technique for determining masses of free 
ions in high vacuum for determining the elemental composition and chemical 
structures of molecules.
175
 Among the analytical techniques, the use of mass 
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spectrometry (MS) to identify and characterise biological molecules holds a special 
place because it measures an intrinsic property of a molecule with very high 
sensitivity.
176,177
 
A mass spectrometer works by introducing the sample into the ionisation source of 
the instrument. In the source, the sample molecules are ionised then extracted into 
the analyser region of the mass spectrometer where they are separated according to 
their mass (m) to charge (z) ratios (m/z). There is a variety of analysers, namely the 
magnetic sector, the quadrupole, and the time of flight. The separated ions are 
detected and the signal fed to a data system where the results can be studied and 
processed.
178
 Figure 3-10 shows a simplified schematic diagram of a mass 
spectrometer 
 
Figure  3-10: Simplified schematic diagram of a mass spectrometer. 
 
Many ionisation methods are available and the choice of ionisation method depends 
on the nature of the sample and the type of information required from the analysis. 
This data shown in this thesis depends on the data generated from liquid 
chromatography-mass spectrometry (LC-MS). The identification of molecules by 
LC-MS follows a different principle; typically liquid chromatography is coupled to 
tandem mass spectrometry. This methodology combines efficient separations of 
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biological materials and sensitive identification of the individual components by 
mass spectrometry. In a typical LC-MS experiment, the analyte is eluted from a 
reversed-phase column to separate the peptides by hydrophobicity, and is ionised and 
transferred with high efficiency into the mass spectrometer for analysis. After the 
components in the sample are separated, they pass through a mass detector. The mass 
detector response and the time it takes for a compound to pass from the injector to 
the detector (retention time) of the compound of interest may then be compared to a 
reference material.  
 
3.2.2. Matrix-Assisted Laser Desorption/Ionisation (MALDI) 
Matrix-assisted laser desorption/ionisation (MALDI) is utilised to identify the 
synthesised biomolecules. MALDI is well proven as a soft and efficient ionisation 
technique used in mass spectrometry for the analysis of biomolecules and large 
organic molecules, in which a laser is used to achieve desorption and ionisation of 
the sample of interest. Figure 3-11 illustrates the principle of MALDI-TOF-MS. 
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Figure  3-11: MALDI-TOF-MS 
 
The mechanism of ion formation in the MALDI process is not yet fully understood. 
The MALDI process is a complicated process, and there is no single mechanism that 
can explain the origin of all ions observed in a MALDI spectrum. Generally, the 
MALDI analysis involves three stages, first, mixing the analyte with the matrix, co-
crystallised on an electrically conducting target, e.g. a stainless steel plate, the matrix 
chosen should strongly absorb the laser energy and pass some of that energy to the 
analyte. Secondly, energy in the form of a short laser pulse of a specific wavelength 
is utilised to ablate and ionise the analyte/matrix mixture. The matrix will absorb the 
photon energy and rapid heating will occur which creates a microexplosion so the 
analyte is brought into the gas phase and ionised. Finally, the charged analyte ions 
are moved to the mass analyser, where the ions are accelerated in a high voltage 
region and further ion separation occurs based on the mass-to-charge ratio. This 
analyser is called time of flight (TOF). Since all ions receive the same energy, the 
lighter ions arrive earlier at the detector than the heavier ones. 
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3.2.3. High Performance Liquid Chromatography (HPLC) 
Purification of biomolecules, such as proteins, peptides, and amino acids, can be a 
challenging task because of their low solubility in both hydrophilic and hydrophobic 
media. High performance liquid chromatography (HPLC) is an analytical technique 
for identification and quantitation of a wide variety of non-volatile or semi-volatile 
organic compounds in a mixture. It utilises a compound's intrinsic affinity for both a 
mobile phase and a stationary phase to achieve the separation.   
There are three major modes of HPLC traditionally employed in peptide purification 
utilising differences in peptide size (size-exclusion HPLC [SEC]), net charge (ion-
exchange HPLC [IEX]), and hydrophobicity (reversed-phased HPLC [RP-HPLC]). 
Within these modes, mobile phase conditions may be manipulated to maximise the 
separation potential of a particular HPLC column. In this thesis the RP-HPLC has 
been used for the purification of the synthesised peptides and peptoids that have been 
used for the modification of carbon nanomaterials. RP-HPLC is generally superior to 
other HPLC modes in both speed and efficiency. In addition, the availability of 
volatile mobile phases makes it ideal for both analytical and preparative separations. 
  
3.2.4. Circular Dichroism (CD) Spectroscopy  
Circular dichroism (CD) spectroscopy is the most widespread technique used for 
estimating the secondary structure, folding, binding properties of proteins and 
polypeptides in solution.
179
 Briefly, this spectroscopic technique depends upon the 
unequal absorption of left-handed and right-handed circularly polarised light.  
Chapter 3 
58 
 
It detects wavelength-dependent differences in the absorption of right and left 
circularly polarised light by optically active molecules. This is achieved by 
determining the ellipticity of plane polarised light at different wavelengths. This 
effect occur when a chromophore is chiral (optically active) either intrinsically by 
reason of its structure, or by being covalently linked to a chiral canter, or also by 
being placed in an asymmetric environment.
180
 The major optically active groups in 
peptides and proteins are the amide bonds of the peptide backbone and the aromatic 
side chains. They have regions where the peptide chromophores are in highly ordered 
arrays, such as α-helices and β-pleated sheets.181 When circularly polarised light 
impinges on a peptide, the peptide’s electronic structure gives rise to characteristic 
bands in specific regions in the far-UV of the CD spectrum, reflecting the electronic 
excitation energies.
182
 The weakest energy transition in the peptide chromophore is 
an n→π* transition observed at 210 – 220 nm, which involves non-bonding electrons 
of the oxygen of the carbonyl group. However, the strongest energy one is an 
absorption band centered at 190 nm because of π→π* transition involved the π-
electrons of the carbonyl. Hence, depending on the orientation of the peptide bonds 
in the arrays, the wavelengths of the transitions can be increased or decreased, and 
the intensity of the transitions can be enhanced or decreased. As a consequence, 
many common secondary structure motifs, such as the α-helix, β-pleated sheets, β-
turns, and poly-L-proline II (P2), have distinctive shapes and magnitudes in the far-
ultraviolet (Figure 3-12).   
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Figure  3-12: Far UV CD spectra associated with various types of secondary structure. (Solid 
line) α-helix, (Long dashed line) anti-parallel β-sheet, (Dotted line) type I β-turn, (Cross 
dashed line) polyproline (PPII), (Short dashed line) irregular structure. Reprinted from 
[183], Copyright (2005), with permission from Elsevier. 
 
In an α-helix conformation, the peptide backbone follows a helical path and is 
stabilised by hydrogen bonds between backbone amide and carbonyl groups. The CD 
spectrum of an α-helix usually shows an intense positive band at 190 nm and a 
negative band at 208 nm. These bands arise from the exciton splitting of electronic 
transitions from the amide non-bonding π orbital to the anti-bonding π orbital, π*. 
While its negative band located at about 220 nm arises from the electronic transition 
from an oxygen lone pair orbital, n, to the π* orbital.182,184 
β-sheets form by interstrand hydrogen bonds between either parallel or antiparallel β 
strands, and are much more flexible than α-helix.185,186 The characteristic CD features 
of the β-sheet are considerably less intense signals than helices and show far more 
variation in spectral characteristics. It usually shows a small negative band at ~ 218 
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nm which is attributed to (π→π*) transitions, and positive band at ~ 196 nm assigned 
to the (n→π*) transition.185 The polyproline (PPII) helix spectrum is characterised by 
a strong negative peak at ~ 200 nm. The CD spectra above 200 nm, however, show 
considerable variation ranging from a positive band near 218 nm to a negative 
shoulder near 220 nm.
184,185
 Unordered peptide’s structures (often also referred to as 
random coil or disordered) have variable spectra that are generally similar to the PPII 
spectra,
187,188
 but tend to be slightly blue shifted, have slightly smaller amplitudes, 
and can lack the higher wavelength positive peak. They often also have small 
negative amplitudes at wavelengths at 195 nm which is attributed to (π→π*) 
transitions and a positive at ~ 212 nm due to (n→π*) transitions.189,190. 
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4. SYNTHESIS OF A FLUORINATED PEPTIDE FOR NONCOVALENT 
FUNCTIONALISATION OF SWNTs 
 
4.1. Introduction  
Peptides are particularly attractive for SWNT noncovalent functionalisation because 
of their biocompatibility and high specificity for other biomolecules and materials. 
Furthermore, they are well-known for their ability to self-assemble into a wide range 
of secondary structures.
191
 The ability of a peptide to disperse SWNTs appears to 
depend upon the peptide’s binding affinity to the sp2 hybridised surface of the carbon 
nanotube and its amphiphilic properties. Amphiphilic peptides act as surfactants in 
the sense that they lower the interfacial energy of the nanotube water interface, thus 
allowing them to be dispersed in the aqueous phase.
192,193
 Additionally, coating 
SWNTs with peptides offers a suitable noncovalent approach for debundling as they 
permit the organisation of individually dispersed SWNTs into useful assemblies.
194
 
Peptides can adopt a range of secondary structures, the most common being random 
coils, α-helices, β-strands,195 extended (micellar), and cyclic196 (Figure 4-1). 
Peptides with all of these different secondary structures have been used to disperse 
CNTs, with varying degrees of success.
197
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Figure  4-1: Molecular models of peptide secondary structures. Reproduced from [198] with 
permission of John Wiley and Sons. 
 
The simplest peptides known to bind to SWNTs are random coil peptides, whose 
sequences are not designed to form specific secondary structures, or specific peptide 
aggregates. Such peptides rely on aromatic residues to drive SWNT interactions, 
while the remaining sequence serves to stabilise the peptide-SWNTs complex and 
prevent reaggregation.
125,198
 These peptides have a high degree of freedom to 
rearrange on the SWNTs surface and obtain the most stable conformation. Therefore, 
SWNTs defects, in the form of carboxyl and hydroxyl groups, have a limited effect 
on the peptide’s affinity to disperse the SWNTs.199,200 Despite this ability to disperse 
SWNTs, with potential for biocompatibility, random coil peptides have limited 
utility as dispersal agents due to the lack of control over their arrangement on 
SWNTs. 
It has been shown that amphiphilic β-strand peptides can disperse SWNTs, and the 
composites formed lead to enhanced optical and physicochemical properties for 
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selected tube types.
118,201,202
 The dispersion ability of these peptides is proportional to 
the length of the β-strand region, as well as the length of the hydrophilic 
termini.
203,204
 These results agree with molecular mechanics and dynamics 
simulations that show that β-sheets can assemble into β-barrels wrapping around the 
SWNTs.
202,205
 However, with an increasing hydrophilic termini length the peptides 
lose the ability to form β-strand and hence successfully disperse the carbon 
nanotubes.  
The α-helix secondary structure is the most common helical form of peptides. It 
consists of a seven-residue repeating sequence (a b c d e f g) which completes 
approximately two turns of the helix.
191,206
 An amphiphilic helix presents two 
different faces, a more hydrophobic face (a and d positions) and a more hydrophilic 
face (b, c, e, f, g positions). The interactions between α-helical peptides and a SWNT 
surface can stabilise the peptide/SWNT complex, and also can control the carbon 
nanotube assembly thus creating ordered functional structures through peptide-
peptide interactions.
127
 Helical peptide interactions with a SWNT surface include 
three types of potential interactions; intra-peptide interactions, peptide–peptide 
interactions, and peptide–nanotube hydrophobic interactions. Intra-peptide 
interactions, which can be optimised by controlling a peptide’s design, are important 
in determining the helical propensity of the peptide. Helical propensity plays an 
important role in determining the peptide’s ability to disperse SWNTs.203,207,208 For 
example, highly helical peptides are not always great dispersal agents, due to their 
tendency to aggregate. While peptides with lower helical propensity are able to 
disperse nanotubes, yet may be less likely to attain an organised folded structure 
when bound to the nanotube surface.
203,207
 Therefore, it is important to fine-tune 
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intra-peptide interactions to suit the desired degree of interaction. Dieckmann et al.
124
 
designed synthesised the amphiphilic α-helix peptide, named nano-1, and 
demonstrated that it could bind to SWNTs using phenylalanine (Phe) and tyrosine 
(Tyr) (as well as artificial analogue nitro-phenylalanine) side groups distributed 
along one face of the peptide helix (Figure 4-2). Zorbas et al.
209
 isolated long, 
individual SWNTs wrapped with nano-1 peptide in aqueous solution. 
 
Figure  4-2: Model illustrating the interactions between nano-1 and SWNT. (A) Cross-
section view of a SWNT (pink cylinder) wrapped by six peptide helices. (B) View of nano-1 
peptide-wrapped SWNTs. Reprinted with permission from [124]. Copyright (2003) 
American Chemical Society. 
 
Peptide-peptide interactions, which can be driven by hydrophobic, H-bonding, and 
charge-charge interactions, in the presence of SWNTs, play an important role in 
SWNTs dispersal, as they control the assembly of the helical peptides and their 
arrangement on the SWNTs surface. Dieckmann showed that the self-assembling 
properties of helical nano-1 peptide were important in controlling the size and 
morphology of peptide/SWNT fibers. The nano-1 peptide was designed so that 
favourable charge-charge peptide-peptide interactions would occur among the 
peptides coating the exterior surfaces of separate nanotubes, leading to 
Chapter 4 
65 
 
oligomerisation of the peptide-coated nanotubes into higher-order structures. 
Additionally, they used atomistic molecular dynamics simulations (MD) of nano-1 
wrapped SWNTs to study the molecular details of the peptide-SWNT and peptide-
peptide interactions (Figure 4-3). This showed that the peptides could form inter-
peptide hydrogen bonds through their hydrophilic residues to completely shield the 
SWNTs from contact with water to stabilise the multi-peptide/SWNT complex.
210
 
 
Figure  4-3: Snapshots from MD simulations for nano-1 peptide interaction with (6,6) SWNT 
(A and B) and (8,8) SWNT (C and D) systems. (A) and (C) illustrate the initial 
conformations, whereas (B) and (D) illustrate the final conformations after 33 ns of 
simulation for (6,6) SWNT and 30 ns of simulation for the (8,8) SWNT system, respectively. 
Reproduced from [210] with permission of John Wiley and Sons. 
 
Of the three types of potential interaction, the interactions between the peptide and 
the nanotube are the most important, without this the peptide would not disperse the 
SWNTs.
126
 This interaction usually depends on the aromatic interactions between the 
hydrophobic face of a helical peptide with the carbon nanotube’s surface form one 
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side. On the other side, the aliphatic interactions of the peptide’s hydrophilic face 
with the solvent form a stable dispersion. The importance of the peptide’s aromatic 
content on the peptide-SWNTs binding aﬃnity has been highlighted by several 
researchers.
87,200,207,211,212
 Aromatic residues, such as phenylalanine (Phe), tyrosine 
(Tyr), and tryptophan (Trp), in the helical core increase the peptide–nanotube affinity 
and the efficiency of the peptide as a dispersal agent. Tomasio et al.
87
 used MD 
simulations to investigate the binding affinity of a range of peptide sequences 
adsorbed on graphite and a carbon nanotube. Their results showed that a tryptophan 
rich peptide had a stronger-binding affinity toward SWNTs than tyrosine or 
phenylalanine rich-peptides. These results agree with recent experimental 
observations, such as the direct AFM measurements reported by Li et al.,
126
 which 
revealed that poly-tryptophan exhibited greater adhesion on nanotubes than poly-
lysine. Dieckmann et al.
213
 reported that among the three aromatic amino acids 
(phenylalanine (Phe), tyrosine (Tyr), and tryptophan (Trp)) tested, sequences 
containing tryptophan showed the greatest affinity for SWNTs, while tyrosine (Tyr) 
was found to be more selective for individual SWNTs. Phenylalanine (Phe) was the 
aromatic residue with the lowest affinity for SWNTs. Atomic force microscopy 
measurements and optical absorption spectroscopy revealed that the ability to 
disperse individual SWNTs increased with an increasing number of aromatic 
residues in the peptide, indicating that π–π stacking interactions play an important 
role in peptide dispersion of SWNTs.
120
 All of the previous experimental 
measurements of SWNTs noncovalent interaction with peptides proved that various 
forms of aromatic molecules binding to SWNTs can effectively disperse the 
nanotubes, indicating that this interaction is quite strong due to the aromatic nature of 
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the π–π stacking. Therefore, it is not surprising that aromatic residues also have an 
aﬃnity for graphitic surfaces.  
Although, aromatic residues in the helical peptide increase the peptide-nanotube 
affinity and the efficiency of the peptide as a dispersal agent, it is necessary to 
balance the overall affinity of the aromatic residues with the peptide’s helical 
propensity. Overloading the hydrophobic core with high affinity aromatic residues 
has the potential to perturb helix formation and cause peptide aggregation, in which 
case the peptide might bind to the nanotube surface in a more random fashion.
198
 
Salzmann et al.
123,214
 demonstrated the importance of the balance between 
hydrophilic and aromatic residues in the dispersion of SWNTs. They found that the 
optimisation of the pyrene content in the synthesised 4-(pyren-1-yl)butanoylated 
polylysine (PBPL) dispersing agent leads to a maximal dispersing effect of the 
SWNTs. Figure 4-4 shows PBPL structure and a representation of a PBPL/SWNTs 
conjugate.  
 
Figure  4-4: (A) Chemical structure of 4-(pyren-1-yl)butanoylated polylysine(PBPL) (B) 
Schematic representation of a PBPL/SWCNT conjugate. Reproduced from [214] with 
permission of The Royal Society of Chemistry. 
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Despite the number of experimental methods which have been used to study the 
interaction of SWNTs with peptides, the nature of this interaction is not yet fully 
understood. However, understanding the mechanism(s) of peptide interaction with 
SWNTs aids the understanding of the molecular basis of increasing the solubility of 
nanotubes. Thus, their interaction mechanism(s) is a critical focus of investigation. A 
number of modelling studies have attempted to understand the nature of the peptide-
nanotubes interactions. Several studies have used a variety of computational 
methods, such as MD simulations and DFT calculations in an attempt to gain insight 
into the atomic scale mechanisms underlying the strong affinity of peptide sequences 
to nanotubes. Wallace et al.
215
 performed multi-scale MD to study the adsorption 
profile of the nano-1 peptide on a SWNTs surface. They found that the peptide 
interacts with SWNT in a preferred orientation, such that its hydrophobic surface is 
in contact with the tube. Chiu et al.,
216
 in a similar study performed full MD of a 
single nano-1 peptide at various water/hydrophobic interfaces, including 
water/graphite and water/SWNTs. They found that the peptide α-helix cannot match 
its hydrophobic face to the rigid planar graphite surface without partially unfolding. 
In contrast, it curves on the SWNT surface in α-helical conformation to 
simultaneously maximise its hydrophobic contacts with the SWNT and its hydrogen 
bonds with water (Figure 4-5).  
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Figure  4-5: Representative nano-1 configurations from the MD simulations with 
water/graphite (Right) and with water/CNT (Left). Reprinted with permission from [216]. 
Copyright (2008) American Chemical Society. 
 
Among CNTs characterisation techniques nuclear magnetic resonance (NMR) been 
used to reveal more information about SWNTs functionalisation. It has been utilised 
to study the effects of oxidisation, bending, and twisting of SWNTs on their 
electronic properties and to locate the defects in the SWNTs structure.
217-221
 Nelson 
et al.
222
 used 
1
H NMR chemical shifts to study the impact of o-, p-, and m- directing 
effects of electrophilic aromatic substituents on phenyl groups covalently bonded to 
SWNTs. Marega et al.223 used diffusion based NMR experiment (1D DOSY) for the 
characterisation of covalently modified CNT derivatives.  
Due to the considerable progress in ﬂuorescence labelling and observation 
techniques for biological molecules, SWNTs have been visualised using a 
conventional optical microscope with the aid of ﬂuorescent tags.224 Yet these 
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characterisation techniques give limited information about the type, structure, and 
degree of functionalisation to utilise the SWNTs in applications. Therefore, more 
research groups are employing NMR as a characterisation technique to reveal 
information about SWNTs functionalisation. 
19
F NMR has been employed as an 
alternative reporter nucleus in NMR studies of labelled biopolymers covalently 
functionalising nanotubes.
225
 Coleman et al.
75
 used a Bingel reaction to create 
carbene and diethyl bromomalonate, which attacks the sidewall of SWNTs. The 
resulting material was tagged with fluorine and gold, and then observed with 
19
F 
NMR and AFM. Holzinger et al.
226
 used 
19
F NMR to monitor the photo induced 
radical addition of pentafluorinated alkyl to SWNTs (Figure 4-6). The 
pentafluorinated alkyl sidewall functionalised SWNTs was confirmed with boarding 
pentafluorinated alkyl signal. Kumari et al.
227
 used the DFT methods to compute the 
full 
19
F NMR shifts to differentiate between the zig-zag and chiral forms of 
fluorinated SWNTs.  
 
Figure  4-6: Sidewall functionalisation by the addition of a radical. Reproduced from [226] 
with permission of John Wiley and Sons. 
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The introduction of ﬂuorine into organic molecules has become a very attractive area 
of synthetic and medicinal chemistry.
228
 The presence of ﬂuorine in biological 
molecules often results in signiﬁcant changes in their chemical, physical, and 
biological properties.
229
 Among the large family of bioactive ﬂuorinated compounds, 
ﬂuorinated amino acids230 and peptides231 are of value in medicinal chemistry as 
enzyme inhibitors, anti-tumour agents and antibiotics.
228
 Fluorinated amino acids 
have found a variety of applications in peptide and protein science. Incorporation of 
the unique electronic properties of fluorine into amino acids creates a new and 
exciting class of building blocks for peptide and protein modification and provides 
an opportunity to study their conformational properties and metabolic processes by 
19
F NMR.
232
  
This chapter investigates the effect of nano-1 peptide’s α-helical stability, through N-
terminus acetylation, on its ability to disperse SWNTs. Also, a synthesise of a 
fluorine tagged nano-1 peptide was carried out in order to ascertain whether           
19F NMR can be used to monitor the binding of α-helical peptides to SWNTs surface. 
Finally, the nano-1 peptide/SWNTs complex’s stability against enzyme digestion 
was investigated. 
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4.2. Results and Discussion  
4.2.1. Synthesis and Characterisation of Modified Nano-1 peptides 
The amphiphilic α-helical nano-1 peptide, which is based on a previously 
characterised peptide Coil-VaLd,
233
 is reported to act as a surfactant in order to 
disperse SWNTs in aqueous solution.
124,234
 The original nano-1 sequence is Ac-
EVEAFEKKVAAFESKVQAFEKKVEAFEHG-CONH2, which is a repeating 
heptad designated (a b c d e f g)n, where a through g refer to the positions in the 
linear sequence. When folded into an α-helix, hydrophobic residues in positions a 
and d will generate an apolar face of the helix, whereas more hydrophilic residues in 
the other positions will form a more polar surface (Figure 4-7).  
 
Figure  4-7: Helical wheel diagram showing positions of nano-1’s residues in the α-helix.  
 
The original design of nano-1 has an acetylated N-terminus, to remove charge from 
the terminus and thus making it less polar to increase its affinity for SWNTs. Several 
investigators have shown that charged residues near the peptide’s N-terminus 
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destabilise the α-helix through a repulsive electrostatic interaction with the helix 
dipole of the peptide.
235-237
 
 
It has been suggested that capping of the N-terminus may 
stabilise an α-helix by forming an additional hydrogen bond to a main chain NH 
group. Furthermore, it has been found that N-terminus capping effects are more 
prominent in a short peptide than long sequence peptides.
238
 Therefore, the first main 
focus of this section is to study the effect of peptide’s N-terminus acetylation on the 
peptide ability to disperse SWNTs by modifying the original N-terminus design of 
nano-1 peptide. In order to study the effect of N-terminus capping on short peptides 
vs. long peptides, four modified versions of nano-1 were synthesised. The second 
focus was to synthesis a fluorinated nano-1 peptide which was used to study the 
interaction between the peptides with the surface of SWNTs via 
19
F NMR.  
 
4.2.1.1. Synthesis of Nano-1 Peptides  
The original design of nano-1 peptide, (VaFd)4/4, has an acetylated and amidated N- 
and C-termini, respectively.
124
 However, in order to assess the effect of N-terminus 
acetylation on the peptide’s polarity and thus affinity towards the hydrophobic 
surface of SWNTs two versions nano-1 peptide have been synthesised. The first has 
an acetyled N-terminus and named acetylated nano-1, Ac-(VaFd)4/4. While the second 
has a free N-terminus and named free N-terminus nano-1, H2N-(VaFd)4/4. Fmoc-
SPPS was used for the synthesis of two versions of nano-1 peptide. The synthesis of 
acetylated nano-1 and free N-terminus nano-1 were carried out using an automated 
CEM Liberty microwave peptide synthesiser. Peptide synthesis was carried out on 
Rink amide (AM) resin to ensure that an amidated C-terminus was provided upon 
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cleavage from the resin, and O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium 
tetrafluoroborate (TBTU) was used as a coupling reagent. Considering that the 
synthesis of the 29 amino acid, nano-1 peptide synthesis was performed in two steps 
as shown Scheme 4-1.  
 
Scheme  4-1: Synthesis of nano-1 peptides. 
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The first step was synthesis of the first 17 amino acids in the peptide sequence, resin-
H2N-ESKVQAFEKKVEAFEHG-CONH2, named first section nano-1 (1). This 
peptide left on the resin, so it could be reloaded into the peptide synthesiser to 
complete the peptide sequence in the second step of the synthesis. A small scale 
cleavage was carried out and MALDI-TOF analysis confirmed the successful 
coupling of the first 17 amino acids of nano-1 peptide to the Rink amide resin 
(Figure 4-8).  
 
Figure  4-8: MALDI-TOF for first 17 amino acids of nano-1 peptide (1). 
 
The second step involved reloading of nano-1 first section (1) into the peptide 
synthesiser to complete the 29 amino acid nano-1 peptide sequence (2). In order to 
produce the two versions of the nano-1 peptide; the peptide linked resin (2) was then 
divided into two halves. The first half was cleaved from the resin to yield free N 
m/z [M + H]
+
 = 1962.9 
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terminus nano-1 peptide (3). MALDI-TOF analysis of the crude was used to confirm 
the presence of the correct peptide (Figure 4-9).  
 
Figure  4-9: MALDI-TOF for free N-terminus nano-1 peptide, 3 
 
The other half of the peptide linked to resin peptide was acetylated using 20 % acetic 
anhydride/DMF, and then the acetylated peptide (4) cleaved from the resin and 
MALDI-TOF analysis of the crude peptide was used to confirm the presence of the 
acetylated N-terminus nano-1 peptide (Figure 4-10).  
 
m/z [M+H]
+
= 3312.5 
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Figure  4-10: MALDI-TOF for acetylated nano-1 peptide, 4. 
 
4.2.1.2. Synthesis of Short Nano-1 Peptides  
The one heptad of nano-1 peptide, (VaFd)1/4, was first synthesised by Zorbas.et al.
120
 
to understand the importance of aromatic content in nano-1 peptide on its ability to 
disperse SWNTs. The one heptad nano-1 peptide reported had an acetylated and 
amidated N- and C-termini, respectively, Ac-EVEAFEKKY-CONH2. It had been 
suggested that N-terminus acetylation improves the stability of α-helical in short 
peptide more than in long sequence peptide.
237,238
 Therefore, the main aim of this 
section is to synthesise two versions of the one heptad nano-1 peptide, (VaFd)1/4, with 
and without acetylated N-termini. They are named as acetylated short nano-1, Ac-
(VaFd)1/4, and free N-terminus short nano-1, H2N-(VaFd)1/4, respectively. These 
peptides will be used to disperse SWNTs to understand how acetylation of the N 
terminus in a short peptide affects the dispersion of SWNTs (Section 4.2.2).  
 
m/z [M + H]+ = 3353.4 
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Both peptides, acetylated short nano-1 (Ac-(VaFd)1/4), and free N-terminus short 
nano-1 (H2N-(VaFd)1/4), were synthesised using the general microwave assisted SPPS 
procedure. The synthesis of each peptide was carried out on Rink amide (AM) resin 
using the same method used in the synthesis of nano-1 peptides (Section 4.2.1.1). 
Then synthesised peptides were cleaved from the resin, and purified using reverse 
phase HPLC (RP-HPLC). Fractions that were shown by mass spectrometry analysis 
to contain the desired were pooled and lyophilisation afforded the peptide as a white 
powder. MALDI-TOF analysis of the purified free N-terminus short nano-1(5) and 
acetylated short nano-1(6) confirms the presence of the correct peptide, (Figure 4-
11) and (Figure 4-12) respectively.  
 
Figure  4-11: MALDI-TOF of free N-terminus short nano-1, 5. 
 
 
m/z [M+H]
+
= 1141.6 
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Figure  4-12: MALDI-TOF of N-terminus acetylated short nano-1, 6. 
 
4.2.1.3. Synthesis of a Fluorinated Nano-1 Peptide 
Peptide structure, and ultimately its function, is largely induced by side chain 
interactions and determined through the specific amino acid sequence. Thus 
synthesis of non-proteinogenic amino acids has attracted wide attention in an attempt 
to create new peptide properties through modified α-amino acids.239,240 Fluorine 
tagged amino acids have been designed to provide 
19
F NMR signature spectroscopic 
signals for use as sensors for the study of binding between nano-1 peptide and the 
surface of SWNT. First a 
19
F labelled phenylalanine was synthesised and then 
coupled with the first stage of nano-1 while still attached to resin (1). The proposed 
synthetic route to the target 
19
F labelled phenylalanine (7) is shown in Scheme 4-2; 
the key step involves a Negishi coupling that will be used to form a bond between a 
substituted benzene ring and an orthogonally protected L-serine (10).  
m/z=[M+Na]= 1205.4  
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Scheme  4-2: Proposed synthetic route to amino acid target (7). 
 
The key intermediate in the synthesis was the orthogonally protected iodo-alanine 
(10), which was prepared in two steps from commercially available Fmoc-Ser-OH 
(8) (Scheme 4-3 and Scheme 4-4). The first step involved protection of the free 
carboxyl ester: this was achieved by treatment of 8 with 1.5 equivalents of 
t
Bu-2,2,2-
trichloroacetimidate in EtOAc at room temperature (Scheme 4-3). The orthogonally 
protected serine (9) was obtained as a white powder after column chromatography. 9 
was fully characterised by 
1
H-NMR and ESI-MS and the data obtained matched that 
previously reported.
241,242
 The yield of 63 % is due to the formation of an unwanted 
impurity that was assumed to be the di-t-Butyl protected serine.  
 
Scheme  4-3: Preparation of orthogonally protected serine (9). Reagents and conditions: tBu-
2,2,2-trichloroacetimidate, EtOAc, rt,16 h. 
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Conversion of 9 to the protected iodo-alanine (10) was achieved via reaction with 
iodine, imidazole and triphenylphosphine (PPh3). The reaction proceeded in good 
yield (68 %) to give 10 as a white powder after column chromatography. 10 was 
fully characterised and the beta CH2 protons in the 
1
H NMR displayed the expected 
up field/down field shift (from 3.92 ppm to 3.59 ppm) and the characteristic 516.3 
[M+Na]
+
 isotope was observed in the mass spectra obtained.  
 
Scheme  4-4: Iodination of (9). Reagents and conditions: I2, PPh3, imidazole, DCM, rt, 16 h. 
 
The final stage in the synthesis of fluorinated amino acid (11) involved a Negishi 
reaction step, which is a palladium-catalysed cross-coupling reaction between α-
amino acids and organozinc iodides to synthesis of
 
complex molecules by providing 
an efficient means of (C–C) bond formation.243-248 For the preparation of 11, iodo-
alanine (10) was reacted with 3-iodobenzotrifluoride in a solution of iodine (I2) in 
dry DMF with suspended zinc and catalysed by Bis(dibenzylideneacetone)palladium 
(Pd(dba)2) and 2-Dicyclohexylphosphino-2′,6′-dimethoxybiphenyl (Sphos)  (Scheme 
4-5) to give a good yields (65 %) after column purification. Since the major 
drawback of the Negishi coupling is the relative sensitivity of organozinc reagents 
towards oxygen and moisture,
249
 the reaction is carried out in dry DMF and under 
argon atmosphere. 
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Scheme  4-5: Synthesis of fluoro tagged phenylalanine (11). Reagents and conditions: 
Pd(dba)2, zinc, Sphos, 3-Iodobenzotrifluoride, dry DMF, inert atmosphere, 16 h. 
 
The trifluoro-phenylalanine (11) was fully characterised. 
19
F-NMR analysis (Figure 
4-13) showed two different fluorine environments, one at - 62.84 ppm and a second 
one at - 62.97 ppm. This implies that rotation about the C−C bond from the benzene 
ring to the CF3 group is restricted. The splitting in the CF3 peak is similar to 
published spectra of CF3-labeled amino acids.
250,251
 
 
Figure  4-13: The doubling of the fluorine peaks in the 19F NMR spectra of 11 in D2O. 
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For the synthesis of the fluorinated nano-1 peptide (13), a free carboxylic acid on the 
fluoro amino acid is needed. Therefore, deprotection of the t-butyl ester from 11 was 
achieved by stirring the protected amino acids in a mixture of DCM and TFA for 5 
hours (Scheme 4-6), which afforded the product in 76 % yield.  
 
Scheme  4-6: C-terminus deprotection of 11. Reagents and conditions: TFA, DCM, rt., 5 h. 
 
The free C-terminus fluoro tagged amino acid (12) was coupled with the first section 
of the nano-1 peptide (1) though a manual SPPS coupling at room temperature. The 
fluoro peptide-resin was then reloaded into the peptide synthesiser; the rest of nano-1 
peptide sequence was coupled using the microwave coupling. When all of the amino 
acids were coupled, a final Fmoc deprotection step was carried out using 20 % 
piperidine/DMF, and the peptide was then cleaved from the resin, Scheme 4-7 
illustrates the synthesis route of 13. 
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Scheme  4-7: The synthetic route to fluorinated nano-1 peptide, 13.  
 
MALDI-TOF mass analysis of the crude peptide was used to confirm the presence of 
the correct peptide. Then fluorinated nano-1 peptide (13) was purified using reverse 
phase HPLC (RP-HPLC). Fractions that were shown by mass spectrometry analysis 
to contain 13 were pooled and lyophilisation afforded the peptide as a white powder.  
 
4.2.1.4. Circular Dichroism of Synthesised Peptides  
The circular dichroism (CD) spectroscopy is used to characterise the secondary 
structures of synthesised peptides. The CD spectra were collected at 100 µM 
concentration in phosphate buffered saline solution (PBS). This low concentration 
was chosen to prevent intermolecular interactions which may affect the CD values 
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obtained. The data is presented in mean residue ellipticity units which take into 
account the chain length and concentration of samples. The CD spectra of 
synthesised peptides are shown in Figure 4-14. The original design of nano-1 
peptide has a 3.6 residues per turn.
124
 Thus the one heptad nano-1 peptide, (Ac-
(VaFd)1/4) which is 9 amino acid residues, is found to be too short to form a helix.
120
 
Similarly, both of the synthesised short nano-1 peptides, acetylated short nano-1 (6) 
and free N terminus short nano-1 (5), are not expected to be able to adopt a 
significant degree of α-helical structure. Therefore, this section focuses on the CD 
characterisation of the synthesised nano-1 peptides, free N-terminus nano-1 (3), 
acetylated nano-1 (4), and fluorinated nano-1 peptide (13). 
 
Figure  4-14: CD spectra of synthesised nano-1 peptides. (Black line) free N terminus nano-
1 (3), (Red line) Ac nano-1 (4), and (Blue line) fluorinated nano-1 peptide (13). 
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The CD spectra of acetylated nano-1 (4) shows strong negative band at ~ 200 nm and 
a weaker band at ~ 226 nm, suggesting a mixture of helical and unordered 
conformations, which is in agreement with previously published studies.
120,124,252,253
 
The CD spectrum of free N-terminus nano-1 peptide (3) shows similar bands to 
acetylated nano-1 (4) spectra (a strong negative band at ~ 200 nm and a weaker band 
at ~ 226 nm). This indicates that N-terminus capping did not have any major effect 
on the nano-1 peptide’s helicity. Furthermore, the CD spectrum of fluorinated nano-1 
peptide (13) was found to exhibit similar peaks to the CD spectra of synthesised 
nano-1 peptides (3 and 4). This implied that the modification on the phenylalanine 
(Phe) residue with the CF3 group does not affect the peptide’s helicity. 
 
4.2.2. Dispersion of SWNTs with Nano-1 Peptides 
Previous studies have demonstrated that nano-1 peptide, (VaFd)4/4, coats and 
debundles SWNTs and promotes the assembly of the coated nanotubes into novel 
hierarchical structures.
120,124
 Phe residues in nano-1 (Section 4.2.1) can interact with 
the SWNT’s hydrophobic surface via π–π stacking interaction. Among different 
types of SWNTs, HiPco produced SWNTs have been used here in the dispersion 
experiments. The HiPco process usually produces large amounts of high-quality 
SWNTs. However, they typically contain ~ 35 wt% impurities (i.e. iron 
nanoparticles). Therefore, before the noncovalent interaction of HiPco SWNTs with 
the synthesised nano-1 peptides (Section 4.2.1), HiPco SWNTs were purified in a 
two-step method. First, as-produced HiPco SWNTs were heated at 400  C for 30 min 
to break the carbon shell around the metal catalyst. Then, catalyst nanoparticles were 
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dissolved by stirring the SWNTs in (6 M) HCl solution overnight. The purified 
SWNTs were characterised by Raman, UV-Vis-NIR, and TGA (see Appendix A). 
Furthermore, the extinction coefficient of purified SWNTs was experimentally 
determined by making a series of dilutions of purified SWNTs dispersion in 1 % 
SDS solution at 700 nm (see Appendix B). However, the calculated extinction 
coefficient (ε700 = 37.3 mL mg
−1 
cm
-1
) is found to be lower than the previously 
reported value of 39.0 mL mg
-1
 cm
-1
 for purified SWNTs at the same wavelegnth.
159
  
The dispersant concentration plays an important role in the ability to disperse CNTs, 
however due to the limited amount available of the synthesised peptides it was not 
possible to determine if the concentration of 1.0 mM used was high enough to 
saturate the system (meaning that a further increase dispersant would not affect the 
amount of CNT suspended) or not (meaning that an increase in dispersant would 
further increase the amount of CNT suspended). Nano-1 peptide/purified SWNT 
complex was prepared by mixing 1.0 mg of purified SWNTs with 1.0 mM of the 
synthesised peptide solution via probe ultrasonication for 15 min in an ice bath. 
Table 4-1 shows the synthesised peptides used in SWNTs dispersions.  
Type of modification Dispersant Peptide No. residues 
 
N terminus capping 
Free N terminus nano-1 (3) 29 
Acetylated nano-1 (4) 29 
Free N terminus short nano-1(5) 12 
Acetylated short nano-1 (6) 12 
Fluoro Tagged Phe Fluorinated nano-1 (13) 29 
Table  4-1: List of modified nano-1 peptides used to disperse purified SWNTs. 
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The sonication was followed by centrifugation to remove bundled and aggregated 
nanotubes to afford a homogeneous supernatant dispersion. Differences among the 
modified nano-1 peptides/purified SWNT dispersions were observed visually. The 
darker solutions indicating a higher concentration of SWNTs. Figure 4-15 shows an 
image of modified nano-1 peptides/SWNT complexes and purified SWNTs 
dispersion in water as a control after sonication and centrifugation. 
 
Figure  4-15: Peptide/purified SWNTs complex aqueous dispersion after sonication and 
centrifugation. Dispersion from right to left: fluorinated nano-1(13)/purified SWNTs, Ac 
nano-1(4)/purified SWNTs, free N-terminus nano-1(3)/SWNTs, Ac short nano-1(6)/purified 
SWNTs, free N-terminus short nano-1(5)/purified SWNTs. 
 
Based on the SWNTs supernatant colour intensity, short nano-1 peptides, free N 
terminus (5) and acetylated (6), appears to disperse less efficiently than nano-1 
peptides, free N terminus (3) and acetylated (4), and fluorinated nano-1 peptide (13). 
More detailed characterisation of the quality and quantity of the dispersed SWNTs 
can be obtained from the UV-Vis-NIR absorption spectra of the dispersion. Figure 
4-16 shows the UV-Vis-NIR spectra of dispersed purified SWNTs with a series of 
modified nano-1 peptides in water. 
Chapter 4 
89 
 
 
Figure  4-16: UV-Vis-NIR absorption spectra of modified nano-1 peptides/purified SWNTs 
complexes dispersion. (Black line) Ac nano-1(4)/purified SWNTs, (Cyan line) fluorinated 
nano-1(13)/purified SWNTs, (Red line) free N terminus nano-1(3)/purified SWNTs, (Green 
line) Ac short nano-1(6)/purified SWNTs, (Blue line) free N terminus short nano-
1(5)/purified SWNTs. 
 
Individual nanotubes are active in the UV–Vis region and exhibit characteristic 
bands corresponding to additional absorption due to 1D van Hove singularities. 
Bundled CNTs, however, are hardly active in the wavelength region between 200 
and 1300 nm. Modified nano-1 peptides/purified SWNTs complexes absorption 
spectrum shows well-resolved features absorption peaks that extend throughout the 
metallic (~ 440 – 645 nm) and semiconducting nanotubes (830 – 1600 nm, and 600 – 
800 nm) absorption regions. This indicates that the nanotubes dispersed as 
individuals and/or as very small bundles in aqueous solution by the dispersant 
peptides. UV-Vis absorption intensity is proportional to the amount of SWNTs 
dissolved in the solution. Thus, UV-Vis-NIR absorption is used to determine the 
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concentration of the dispersed SWNTs in the supernatant through application of the 
Beer-Lambert Law and calculated extinction coeﬃcient of purified SWNTs at 700 
nm (ε700 = 37.3 mL mg
−1 
cm
-1
). Table 4-2 shows the concentration of dispersed 
nanotubes. 
Dispersion Conc. of Purified SWNTs 
µg mL
-1
 
SDS/purified SWNTs (control) 196.4 
Free N terminus nano-1(3)/purified SWNTs 434.7 
Acetylated nano-1(4)/purified SWNTs 586.9 
Free N terminus short nano-1(5)/purified SWNTs 47.4 
Acetylated short nano-1(6)/purified SWNTs 167.9 
Fluorinated nano-1(13)/purified SWNTs 506.0 
Table  4-2: Concentration dispersed purified SWNTs by modified nano-1 peptides. Nano-1 
peptides concentration: 1 mM mL
-1
, SDS concentration: 1 % by weight. 
  
Table 4-2 shows that the concentration of dispersed nanotubes by the SDS solution 
is less than that of the four heptad nano-1, acetylated nano-1 (4), free N-terminus 
nano-1 (3), and fluorinated nano-1 (13). However, it is higher than the concentration 
of dispersed nanotubes with the one heptad nono-1 peptides, acetylated (6) and free 
N-terminus (5). The concentration of dispersed purified SWNTs by the four heptad 
nano-1 is higher than that of short nano-1. These results agree with the previous 
studies.
120,213
 Furthermore, the concentration of the aqueous dispersion of acetylated 
short nano-1 (6)/purified SWNTs complex was found to be higher than free N-
terminus short nano-1 (5)/purified SWNTs complex. Acetylated short nano-1 (6) 
dispersed purified SWNTs at a concentration of 167.9 µg mL
-1
, whereas free N-
terminus short nano-1 (5) gave 47.4 µg mL
-1
. On the contrary, four heptad nano-1 
peptides, acetylated (4) and free N terminus (3), dispersed almost similar amount of 
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purified SWNT; acetylated nano-1 (4) dispensed 586.9 µg mL
-1
 of purified SWNTs, 
while free N-terminus nano-1 (3) dispensed 434.7 µg mL
-1
. These results show that 
peptide’s N-terminus capping has a greater effect on short nano-1 peptides ability to 
disperse nanotubes comparing to nano-1 peptides; short nano-1 peptide is 9 amino 
acid residues, while nano-1 peptide is 29 amino acid residues. These results can be 
rationalised by the fact that N-terminus capping stabilise an α-helix by forming an 
additional hydrogen bond to a main-chain NH group.
237,238,254
 The concentration of 
purified SWNTs dispersed by fluorinated nano-1 peptide (13) was found to be 
similar to nanotubes dispersed by four heptad nano-1 peptides (3 and 4). This 
suggests that the fluorinated phenylalanine residue did not have a major effect on 
either peptide’s helicity, or its ability to fold around the nanotubes surface.  
 
4.2.3. 19F NMR of Fluorinated Nano-1 Peptide/Purified SWNTs Complex  
Fluorinated nano-1 peptide (13)/SWNTs composite was prepared so that the 
interaction between the nanotube and the peptide could be monitored with 
19
F 
NMR.
255,256
 The idea was that the signal in the 
19
F NMR spectrum for the fluorinated 
nano-1 peptide (13) would change as it went from being free in the solution to being 
immobilised on the SWNT. This binding should broaden the 
19
F NMR signal, 
perhaps to the extent that it becomes unseen.
256
 
19
F NMR will be sensitive to changes 
in the van der Waals or electrostatic environments expected with the binding.  
Trifluoroacetic acid (TFA) used in the cleavage cocktail of fluorinated nano-1 
peptide (13) is known to have a strong 
19
F NMR peak at -78.5 ppm. Thus, 
Trifluoroethanol (TFE) was added to fluorinated nano-1 peptide (13)/purified 
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SWNTs complex dispersion to act as an external reference peak of a known shift and 
relative intensity, -77 ppm. Thus, the relative integrals of 
19
F NMR peaks mentioned 
will be as a ratio of the integral for the peak to the integral for the TFE peak. The 
19
F 
NMR spectrum of fluorinated nano-1 peptide (13) has been recorded as a control 
sample. As seen in Figure 4-17, the peptide solution in deuterium oxide (D2O) 
displays the relative peak intensities of 0.7 at - 62.24 ppm. Upon the interaction of 
the peptide with purified SWNTs, the peptide’s peaks have disappeared, Figure 4-
18. This suggests that the peptide is bound to nanotube’s surface, thus its CF3
 δF
 19
F 
NMR peak has broaden to the extent that it is unseen in the spectra.   
 
Figure  4-17: 19F NMR spectra of fluorinated nano-1 peptide (13) (control) in D2O. 
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Figure  4-18: 19F NMR spectra of fluorinated nano-1 peptide (13)/purified SWNTs 
composite dispersion in D2O. Inset picture shows the dispersion before running the 
19
F NMR 
analysis.  
 
It was thought that after the dispersed purified SWNTs sediment from the solution 
the 
19
F NMR signal of the peptide would reappear. However, 
19
F NMR spectra of the 
dispersion did not show any peaks as shown in Figure 4-19. This is thought to be 
due to the fact that the peptide has sedimented from the dispersion while still 
noncovently attached to the SWNTs. Therefore, more research needs to be done on 
this project.  
Chapter 4 
94 
 
 
Figure  4-19: 19F NMR of fluorinated nano-1 peptide (13)/purified SWNTs composite in D2O 
after sedimented from the dispersion. Inset picture shows the crashed out purified SWNTs 
before running the 
19
F NMR analysis. 
 
4.2.4. Enzyme Digestion of Nano-1 Peptide/SWNTs Complex 
Functionalised SWNTs are able to cross cell membranes and accumulate in the 
cytoplasm, and even reach the nucleus, without being cytotoxic (concentrations up to 
10 mM).
257-259
 Therefore, they could act as carriers that transport and deliver 
bioactive components into cells. In fact, SWNTs enhance the uptake of molecules 
that have previously demonstrated a low cellular penetration.
260
 For example, the 
cellular uptake of free peptides is often extremely poor, thus their conjugations to 
nanotubes’ surfaces allow improvements in the delivery of such biological 
molecules.
260
 This is due to the fact that nanotubes have a high loading capacity, due 
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to their high aspect ratio, have the potential to be the ideal shuttle for peptide 
molecules.
261
 For example Pantarotto et al.
262,263
 were the first to develop a vaccine 
delivery system by covalently linking bioactive peptides to amino-derivatised 
SWNTs. Since then many aspects concerning the dispersion, stability and the 
behaviour of SWNTs in biological settings have already been investigated in separate 
studies. Peptide stability toward proteolytic degradation is important for its 
therapeutic applications as a means of increasing the plasma half-life.
264,265
 However, 
relatively little is known about SWNTs/peptide hybrids regarding enzymatic 
degradation. This section studies the stability of peptide/SWNTs hybrids as a 
function of enzyme digestion. The results discussed in (Section 4.2.2) showed that 
Ac nano-1 peptide (4) exhibited high dispersion ability towards purified SWNTs due 
to π−π stacking of the peptide aromatic residues on the surface of SWNT. Trypsin 
cleaves peptides at the C-terminal side of positively charged residues (arginine (Arg), 
and lysine (Lys)).
266
 Trypsin digestion of Ac nano-1(4) (as a control sample) and Ac 
nano-1(4)/purified SWNTs dispersion incubated with 5 µL trypsin in the presence of 
2 µL dithiothreitol (DTT) at 37 °C for 24 h were performed. The distribution of Lys 
and Arg residues in Ac nano-1 (4) is such that trypsin digestion yields peptide 
fragments, shown in Table 4-3 and Figure 4-20.  
Peptide Calculated 
Mass               
(Exact Mass) 
Digested Peptide 
Fragment 
Sequence 
Observed Mass 
([M+H]
+
, 
*
[M+2H]
2+
,
**
[M+4H]
4+
) 
 
Ac nano-1 peptide (4) 
 
(Ac-
EVEAFEKKVAAFE
SKVQAFEKKVEAF
EHG-CONH2) 
 KKVEAFEHG-
Amide 
916.4 
 KVAAFESKV 751.12 
 KKVEAFEHG *458.44 
3352 KVEAFEHG *394.57 
 KVAAFESKV *376.23 
 KVQAFEKK *361.23 
 KKVVEAFEHG **229.17 
Table  4-3: LR-MS (ESI-TQD) data for Trypsin/DTT digested Ac nano-1(4) (control). 
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Figure  4-20: Mass spectrum of trypsin/DTT digested Ac nano-1(4) (control). 
 
After the trypsin/DTT incubated with the Ac nano-1(4)/purified SWNTs dispersion, 
the dark black colour of the dispersion indicates that the nanotubes are still dispersed 
by Ac nano-1(4) is seen (Figure 4-21).   
 
Figure  4-21: Ac nano-1(4)/purified SWNTs dispersion after incubation with trypsin/DTT.  
 
Mass spectra of the digested Ac nano-1(4)/purified SWNTs show the digested 
peptide fragments peaks, similar to the control sample. However, its mass spectrum 
also shows the undigested peptide peak which is highlighted in Figure 4-22. It is 
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thought that folding of the peptide around nanotube surface protects it from trypsin 
degradation. Thus, mass spectra of Ac nano-1(4)/purified SWNTs dispersion 
incubation with trypsin/DTT shows undigested peptide peaks, which are free in the 
solution.  
 
Figure  4-22: Mass spectrum of Ac nano-1(4)/purified SWNTs dispersion after incubation 
with trypsin/DTT. 
 
Similarly, the trypsin degradation of Ac short nano-1(6)/purified SWNTs complex 
was investigated. Table 4-4 summarises the mass of trypsin digested fragments of 
Ac short nano-1 (6) (control). The calculated fragments were observed in the mass 
spectra of digested peptide (control), which indicates a complete degradation of the 
peptide. (Figure 4-23) highlights the digested Ac short nano-1 (6) (control).  
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Peptide Calculated 
Mass             
(Exact Mass) 
Digested Peptide 
Fragment 
Sequence 
Observed Mass 
([M+H]
+
, 
*
[M+2H]
2+
) 
Ac short nano-1 (6) 
Ac-EVEAFEKKY-
CONH2 
1182.5 Ac-EVEAFEKKY-
Amide 
*592.6 
 
Ac-EVEAFEKK 
 
511.5 
Table  4-4: LR-MS (ESI-TQD) data for trypsin/DTT digested Ac short nano-1(6) (control). 
 
 
Figure  4-23: Mass spectrum of trypsin/DTT digested Ac short nano-1(6) (control). 
 
Figure 4-24 shows that purified SWNTs crashed out from the dispersion after Ac 
short nano-1(6)/purified SWNTs incubation with trypsin/DTT.  
 
Chapter 4 
99 
 
 
Figure  4-24: Ac nano-1(4)/purified SWNTs complex after incubation with trypsin/DTT.  
 
The trypsin digested Ac nano-1(6)/purified SWNTs dispersion was analysed by mass 
spectroscopy, Figure 4-25. The mass spectra shows that Ac short nano-1(6) wrapped 
around the nanotube surface were completely digested resulting in a series of 
fragments similar to control sample. Both the full length and short nano-1 peptides 
interact with the SWNT in a dynamic manner. Ac short nano-1 (6) is likley to 
undergo a more rapid exhange between bound and unbound states (i.e. it does not 
bind to the SWNTs as strongly as the full length nano-1 (4)) and thus it is to be 
expceted that peptide 6 should show a great amount of degradation compared to Ac 
nano-1 peptide (4). This is exaclty what the data from the afforementioned 
degradation studies supports.  
 
Figure  4-25: Mass spectrum of trypsin/DTT digested Ac short nano-1(6)/purified SWNTs. 
Solution  
SWNTs 
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4.3. Conclusion  
In conclusion, the effect of N-terminus acetylation on a peptides efficiency to 
disperse SWNTs has been studied. Knowing that peptide’s N-terminus acetylation 
has a greater effect on short peptides helical stability compared to long sequence 
peptides, thus four modified versions of a previously reported nano-1 was 
synthesised. The short versions of nano-1 peptide, acetyled and free N-terminus short 
nano-1, had a lower ability to dispense SWNTs than nano-1 peptides, acetyled and 
free N-terminus short nano-1. However, it was found that acetyled short nano-1had a 
better tendency to disperse the nanotubes than its free N-terminus. Whereas, N-
terminus of the synthesised nano-1 peptide, acetyled and free N-terminus nano-1, did 
not significantly affect their ability to disperse SWNTs. Additionally, a fluorinated 
nano-1 peptide has been synthesised to study the interaction between the peptide 
with the surface of SWNTs with 
19
F NMR. The 
19
F NMR of fluorinated nano-1 
peaks has disappeared from the spectra after its interaction with SWNTs. This is 
thought to be due to peptide’s noncovalent bonding to the nanotube’s surface, thus 
broaden its CF3
 δF
 19
F NMR peak to the extent that it is unseen in the spectra. Finally, 
this chapter presents the first investigation of enzymatic degradation of 
peptide/SWNTs composite. It was found that when Ac nano-1 (6) was non-
covalently mixed with SWNTs that it was enzymatically digested more slowly than 
short Ac nano-1 peptide (4) by trypsin. This thought to be due to the more rapid 
exchange that short Ac nano-1 peptide (6) will have between its SWNT bound and 
unbound forms compared to to full length Ac nano-1 (4) (NB- this hypothesis makes 
the reasonable assumption that a peptide will only be digested when unbound and 
free in solution). 
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5. PEPTOID NONCOVALENT FUNCTIONALISATION OF SINGLE 
WALLED CARBON NANOTUBES 
 
5.1. Introduction  
Noncovalent functionalisation of SWNTs with surfactants facilitates the modification 
of their hydrophobic surfaces and imparts dispersibility without changing their 
electronic properties.
98
 The surfactants act to lower the energetic cost of 
hydrophilic/hydrophobic interfaces, allowing for water-insoluble materials to be 
dispersed in the aqueous phase.
216
 However, the commonly used surfactants for 
SWNTs dispersion do not facilitate higher order-structures or impart 
biocompatibility for biomedical applications.
267
 Thus, alternative biomolecules, such 
as α-peptides,209 proteins,115,268 amino acids,269,270 enzymes,271 and DNA,272-274 have 
been explored to import biocompatibility to SWNTs dispersions. All of the 
aforementioned biomolecules are unique in their ability to fold and self-assemble 
into specific secondary structures through hydrogen bonds, van der Waals forces, 
hydrophobic interactions, and electrostatic interactions.
275
 Thus, it is widely accepted 
that various noncovalent intermolecular interactions, such as π–π, CH–π, and van der 
Waals interactions, play a significant role in promoting the biomolecules wrapping 
around SWNTs.
276
 Consequently, α-peptides can naturally assemble into a wide 
range of configurations and so they can spontaneously assemble onto nanotubes. It 
has been shown that by coating SWNTs with amphiphilic helical α-peptides offers a 
suitable noncovalent approach for debundling SWNTs. Additionally, peptide 
functionalised SWNTs permits the organisation of individually dispersed nanotubes 
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into useful assemblies for developing SWNT-based nanomaterials or nanodevices.
209
 
Therefore, for biomedical applications efforts have been devoted to exploring the 
potential biological applications of SWNTs/peptide conjugates.
257
 However, 
polypeptides are susceptible to degradation by proteases, have limited thermal 
stability, and are effected by environmental influences such as pH, solvent polarity, 
and ionic strength. Additionally, studies suggested that helical wrapping of relatively 
rigid peptides on the highly curved surface of the SWNTs hinders their ability to 
interact with the cylindrical SWNT surface.
277
 Therefore, there is a need to 
investigate peptidomimetics which while retaining the required peptide properties to 
interact with SWNTs have stability towards biodegradability and display backbone 
rigidity. In recent years, by taking inspiration from peptides, non-natural oligomers 
that mimic the fundamental molecular features of α-peptides have been synthesised. 
These include, γ-peptides,278 β-peptides,279 and most recently peptoids. Peptoids 
(oligomers of N-substituted glycines) were developed in the late-1980s by Farmer 
and Ariȅen as novel peptidomimetic that would mimic the biological function of 
bioactive α-peptides.280 
Peptoids are non-natural oligomers in which the side chain of an α-amino acid is 
shifted to the backbone amide nitrogen. Consequently, as the backbone nitrogen 
atom in peptoids carries an alkyl side chain peptoids lack both hydrogen bonding 
capacity and stereogenicity along the backbone. Thus, they are generally more 
flexible than peptides, as their tertiary backbone amides can easily adopt both cis and 
trans conformations.
281,282
A schematic comparison of peptide and peptoid structure 
is given in Figure 5-1. 
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Figure  5-1: A comparison of the structures of generic α-peptoid and peptide oligomers. 
 
A lack of hydrogen bonding ability has several important implications for the 
secondary structure of peptoids. Peptoids also have enhanced proteolytic stability, 
bioavailability and cellular uptake relative to α-peptides.283. 
The peptoids are constructed from C- to N-terminus by either the monomer
284
 or 
submonomer
284
 methods, which are analogous to standard solid-phase methods for 
peptide synthesis (Scheme 5-1). 
 
Scheme  5-1: Peptoid synthesis methods (A) monomer method (B) Submonomer method. 
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The invention of the submonomer solid-phase synthesis method by Zuckermann was 
a major breakthrough for peptoid synthesis
284
 (Scheme 5-1, B). This method is based 
on alternating the acylation reaction with a haloacetic acid of a resin-bound 
secondary amine, uses a carbodiimide or other suitable carboxylate activation 
method. Then introduce the side chain by SN2-nucleophilic displacement of the 
halogen with an excess of primary amine. This can be accomplished either manually 
or automatically using a synthesiser.
285,286
 
Due to peptoid oligomers’ lack of conformational rigidity in comparison to α-
peptides, displaying the proper amide side chain functionality is critical for their 
folding. However, even without the hydrogen bonding capacity and the chiral 
backbone, researchers have developed methods to stabilise helical, loop and turn 
motifs in peptoids to fold into well-defined secondary structures depending on 
electrostatic and steric interactions,
283,287-289
 giving rise to random coils or well-
defined secondary structures (e.g., helices) in some cases. It has been shown that 
several types of noncovalent interactions, including, hydrophobic,
290,291
 ionic,
292,293
 
hydrogen bonding,
294
 and aromatic interactions,
295,296
 can all stabilise peptoid 
secondary structures. For example, introducing of bulky chiral substituents in peptoid 
amide side chains engenders a steric repulsion between side chains, and has 
promising implications for the design of stably folded peptoid.
287
 Similarly, 
negatively charged side chains cause charge-charge repulsion with backbone 
carbonyls and exhibit polyproline type I helix structure.
297,298
 In addition, 
hydrophobic interactions
299
 and n–π* interactions have also been predicted to play a 
role in peptoid folding.
300
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An extensive body of work, including computational,
297
 solution phase 2D-NMR, 
circular dichroism (CD), electron spin resonance spectroscopy (EPR) and X-ray 
signal crystal diffraction (SC-XRD) experiments, has demonstrated that the peptoid’s 
helix is induced to bulky aromatic groups adjacent to the nitrogen on the main chain. 
These significantly reduce the conformational freedom in the chain backbone. 
Several common monomers used for this purpose are shown in Figure 5-2.  
 
Figure  5-2: Common sub-monomers, used to induce a helical secondary structure in peptoid 
oligomers. 
 
As a consequence, the backbone freedom is limited to a certain range of angles to 
prevent electronic repulsions with the aromatic rings of the side chain and 
neighbouring carbonyl groups of the peptoid backbone. Therefore, the helix 
formation is largely controlled by the steric and electronic properties of the sub-
monomers used.
297,301-306 
Therefore, the bulky side chains induce repeated cis amide 
bond conformation and the chirality at the α-position induces handedness of helical 
structure along the peptoid backbone. The peptoid helix and threaded loop represent 
the best characterised peptoid secondary structural motifs, which are adopted by 
peptoids comprised mainly of α-chiral monomers. A peptoid’s helix is usually a 
three-residue-per-turn helix with all-cis amide bonds, similar structures to the type-I 
polyproline peptide α-helices that are commonly seen in proteins Figure 5-3.307,308 
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Figure  5-3: A representative model of the peptoid helix (Nspe)10. The structure has 
been generated using molecular mechanics. The backbone is highlighted in green. 
Reproduced from [307] with permission of The Royal Society of Chemistry. 
 
In the early 2000’s, Barron developed a set of predictive rules for helix formation in 
peptoids best helicity is observed if the bulky side chain contains an aromatic group 
at the i and i + 3 positions.
236
 However, in case of hetero oligomeric peptoids can 
fold into stable helices if at least 50 % of the monomers contain a chiral centre. 
Furthermore, the helices are stabilised if the C-terminal residue is α-chiral and also as 
the peptoid chain increases in length, i.e. decamers and longer.
301,302,304,305,307 
The 
helix can be recognised by a CD spectrum with well-deﬁned peaks at 192, 202 and 
218 nm, similar to the CD spectra of α-peptide helices, and this pattern serves as a 
useful diagnostic for helical structure in peptoids.  
In the previous study, Chapter 4, it was found that the noncovalent interaction 
between nano-1 peptides and purified SWNTs increases with increasing the number 
of aromatic amino acid residues in the peptide. However, the absence of backbone 
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hydrogen bonds and thus flexible conformation in peptoid makes it a strong 
candidate for the dispersion of carbon nanotubes.  
This chapter investigates the synthesis and characterisation of a series of chiral linear 
peptoids, followed by a discussion of their noncovalent interaction with SWNTs 
produced by the HiPco method to aid their dispersion in aqueous medium. The 
functionalised SWNT material was characterised by UV-Vis-NIR, and Raman 
spectroscopy, and the location and distribution of the functional groups determined 
using atomic force microscopy (AFM), and transmission electron microscopy 
(TEM). This is first research in which peptoids have been used for the dispersion of 
CNTs. 
 
5.2. Results and Discussion  
5.2.1. Synthesis of Chiral Peptoid Library (Carried out by Hannah L. Bolt, 
Cobb group) 
Given the helical structural dependence of amphiphilic peptide binding to SWNTs, it 
is reasonable to expect that the binding interaction should be optimal for a flexibly 
helical structure. Given peptoids lack of conformational rigidity, they could be 
considered as good candidates for interacting with the curved side wall of SWNT. 
Taking the inspiration from the importance of aromaticity content in peptide’s 
amphiphilic helical on SWNTs’ dispersion, Chapter 4, the first part of this project 
has focused upon the synthesis of series of α-chiral linear peptoids for interacting 
with and dispersing SWNTs.  
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Previous research has revealed that a decrease in the α-helical content of the peptide 
facilitates their adsorption onto curved walls of CNTs.
309
 Varying the percentage of 
α–chiral aromatic side chains along with the chain length affects the helicity in a 
peptoid. Thus, in order to evaluate the role of aromatic residues, and degree of 
helicity of peptoids toward their interaction with SWNTs, a series of peptoids were 
synthesised of the same sequence, based on the previous work of Barron
310
 but 
varying in the number of residues. As a peptoid helix has 3 residues per turn and is 
stabilised by the incorporation of one or more aromatic faces running parallel to the 
helix axis (i.e., aromatic side chains at the i, i + 3 positions). The synthesised peptoid 
sequences were is chosen to contain a repeating motif of three residues with the 
repeating subunit structure: (NlysNspeNspe)n, (Figure 5-4). 
 
Figure  5-4: Monomers used in peptoid synthesis and peptoid’s motif. 
 
The chiral aromatic residue (Nspe) is used to induce a repeated cis amide bond 
conformation. It is also introduces handedness of helical structure along the peptoid 
backbone, because it can exhibit not only steric repulsions between bulky side 
chains, but also electronic repulsions between aromatic π and carbonyl lone-pair 
electrons.
287
 The bulky nature of the aromatic residue leads to a water-insoluble 
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peptoid, and since water solubility is a critical property of most biologically active 
molecules and for the CNTs dispersion in aqueous medium, lysine-type side chain 
(Nlys) was included in the oligomer. The hydrophilic monomer aids the water 
solubility of the peptoid and encourages the formation of an amphiphilic helix in 
solution. The peptoids have two faces, the hydrophobic groups on one face and the 
hydrophilic groups on the other face. Additionally, because the helical structure is 
further stabilised at longer peptoid oligomer lengths, a series of varying length 
peptoids were synthesised as shown in Table 5-1.  
Peptoid Motif No. Residues No. Aromatic Residues 
(Nspe) 
(NlysNspeNspe)2 (14) 6 4 
(NlysNspeNspe)3 (15) 9 6 
(NlysNspeNspe)4  (16) 12 8 
(NlysNspeNspe)6 (17) 18 12 
Table  5-1: Summary of the synthesised peptoids structure. 
 
5.2.1.1. Circular Dichroism of Synthesised Peptoids  
Peptoids share the same backbone structure as peptides and that backbone amide 
groups are also the predominant chromophores in peptoids. Since, the amide bond is 
acutely sensitive chromophore to the structural; solvation, and electronic 
environment, circular dichroism (CD) spectroscopy can allow rapid assessment and 
classification of a peptoid’s secondary structure. Figure 5-5 shows the CD spectra 
observed for all of the synthesised peptoids. All spectra were collected at 50 µM 
concentration in phosphate buffered saline solution (PBS), to prevent intermolecular 
interactions which may affect the CD values obtained.  
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Figure  5-5: CD spectra of synthesised peptoids. (Green line) (NlysNspeNspe)6 (17), (Purple 
line) (NlysNspeNspe)4 (16), (Red line) (NlysNspeNspe)3 (15), (Blue line) (NlysNspeNspe)2 
(14). 
 
The electronic interactions occur between backbone carbonyls and the π–electron 
clouds of the aromatic rings in Nspe lead to the formation of a distinct helical 
structure that in turn gives rise to an exaction split π–π* transition in the CD 
spectrum, as observed for peptide-helices.
297
 Therefore, the synthesised peptoids 
gave characteristic CD spectral features at ~ 202 nm and 218 nm, which suggests that 
these peptoids are forming helices in solution and confirms results from Barron.
310
 
The peak intensities increased with chain length due to helix stabilisation provided 
by cooperative interactions that propagate down the ordered chain. Since peptoid 
helices often have 3 residues per turn, it is unsurprising that a 6 residue peptoid (14) 
shows weaker helicity as it is too short to form a fully a helix. However, a CD 
spectrum of a 18 residues peptoid (17) does not show the characteristic CD spectrum 
Chapter 5 
111 
 
of helical structure, an alternative explanation would be that exciton and coupled 
oscillator interactions between aromatic side chains (Nspe) can make substantial 
contributions to the CD profile.
297
  
 
5.2.2. Noncovalent Functionalisation of SWNTs with Peptoids 
5.2.2.1. Noncovalent Functionalisation of Purified SWNTs with Peptoids 
Purified SWNTs (see Appendix A) were noncovalently functionalised by dispersion 
in aqueous solutions of 1.0 mM of a series of synthesised peptoids (Section 5.2.1) 
via probe ultrasonication for 15 min in an ice bath. The sonication was followed by 
centrifugation to give a homogeneous, black dispersion. Visual inspection of SWNT 
dispersion can provide an initial qualitative evaluation of the effectiveness of a 
peptoid in dispersing the SWNTs. Figure 5-6. The dispersions were characterised 
using UV-Vis-NIR spectroscopy to determine the relative amount of individual 
SWNTs versus ropes or bundles in the suspensions and also the net concentration of 
the dispersed nanotubes. 
.  
Figure  5-6: Peptoid/purified SWNTs composite aqueous dispersion after sonication and 
centrifugation. Dispersion from left to right: (NlysNspeNspe)2 (14)/purified SWNTs, 
(NlysNspeNspe)3 (15)/purified SWNTs, (NlysNspeNspe)4 (16)/purified SWNTs, 
(NlysNspeNspe)6 (17)/purified.  
 SWNTs 
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The SWNTs concentration in each dispersion after sonication, centrifugation, and 
separating the supernatant was determined from optical absorption spectroscopy 
using the Beer-Lambert law and purified SWNTs extinction coefficient of 37.3 mL 
mg
-1
 cm
-1
 and absorption values at λ = 700 nm (see Appendix B). The noncovalent 
interaction of peptoids with the side walls of SWNTs is thought to be accomplished 
in a similar way to the amphiphilic nano-1 peptides previously discussed in Chapter 
4. Therefore, the efficiency was compared for each system using the UV-Vis-NIR 
absorption behaviour of the SWNT solutions, Table 5–2 compares between the 
dispersion of puriﬁed with peptoids and nano-1 peptides.  
Dispersant Total No. 
Residues 
Ratio  
Hydrophilic/ 
Hydrophobic 
Total No. 
Hydrophobic 
Residues 
Conc. Dispersed 
Purified SWNTs 
µg mL
-1 
SDS (control) / / / 196.4 
(NlysNspeNspe)2 (14) 6 1:2 4 5.7 
(NlysNspeNspe)3 (15) 9 1:2 6 218.8 
(NlysNspeNspe)4 (16) 12 1:2 8 701.5 
(NlysNspeNspe)6 (17) 18 1:2 12 672.0 
Ac(VaFd)4/4 (4) 29 1:0.16 8 586.9 
(VaFd)4/4 (3) 29 1:0.16 8 434.7 
Ac(VaFd)1/4 (6) 9 1:0.3 2 167.9 
(VaFd)1/4 (5) 9 1:0.3 2 47.4 
Table  5-2: Concentration of dispersed purified SWNTs by peptides and peptoids determined 
for their UV-Vis-NIR absorption after sonication and centrifugation. 
 
Results in Table (5-2) show that increasing the number of hydrophobic residues by 
increasing the peptoid chain length while retaining the same hydrophilic/hydrophobic 
ratio results in an increase in dispersed nanotube concentration. This is similar to 
what was found for nano-1 peptides in Chapter 4. It was found that the longer nano-
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1 peptides (3 and 4) dispersed more purified SWNTs than short nano-1 peptides (5 
and 6). This indicates that number of hydrophobic residues play a key role in 
nanotubes noncovalent dispersion, thus, it is thought that the synthesised peptoids 
noncovalently disperse SWNTs through π–π stacking interactions between the 
peptoid’s hydrophobic residues and SWNT surface in similar way to nano-1 
peptides. It is worth mentioning that the saturation concentration of the synthesised 
peptoids was not determined due their limited available amounts, thus increasing the 
concentration of the peptoid might have resulted in an increase in the concentration 
of the dispersed SWNTs.  
It was found that the concentration of dispersed SWNT by short nano-1 peptides (3 
and 4) is less than (NlysNspeNspe)4 (16) despite the fact that both have the same 
number of hydrophobic residues (8 hydrophobic residues). Peptide 3 dispersed 434.7 
μg mL-1 and peptide 4 dispersed 586.9 μg mL-1 while peptoid 16 dispersed 701.5 μg 
mL
-1
 of purified carbon nanotubes. The rationale for the differences in dispersed 
SWNTs is thought to be due to the decrease in the hydrophilic/hydrophobic ratio 
between  nano-1 peptides (3 and 4) and  peptoid (16) (i.e. 3 and 4 have a 1:0.16 ratio 
while 16 has a 1:2 ratio). This suggests that although aromatic residues in both the 
peptide and peptoid sequences play a vital role in their ability to disperse CNTs, the 
ratio of hydrophilic and hydrophobic residues is very important for the successful 
dispersion of SWNTs.  
The π–π stacking interaction between the hydrophobic residues of the peptoids 
studied and the extended π–electron system of CNTs is considered to be the main 
driving force for peptoid adsorption onto SWNTs. It is thought that the flexible 
peptoids spontaneously fold into spring-like conformations that match the geometry 
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of carbon nanotube to minimise the interfacial energy of nanotube/water interface. 
Thus, peptoid hydrophilic residues, Nlys, occupy one face of peptoid’s helix and 
interact via hydrogen bonding with water to stabilise the peptoid/SWNTs complex, 
while π–bonds in hydrophobic residues, Nspe, located on the other face of the helix 
interact with the delocalised π–bonds in the side wall of SWNT in a similar way to 
that previously discussed by Dieckmann.
124
 Scheme 5-2 illustrates the proposed 
noncovalent interaction between peptoid’s helix and purified SWNTs. 
 
Scheme  5-2: Proposed interaction between purified SWNTs and peptoid 14. The helical 
backbone is shown in blue, and the hydrophobic residue (Nspe) are shown in red. 
 
The well-resolved features in the absorption spectra of the peptoid/SWNT dispersion 
shown in Figure 5-7 further demonstrate the debundling of SWNTs in aqueous 
solution by peptoids. The discrete peaks that extend throughout the metallic (440 – 
645 nm) and semiconducting (830 – 1600 nm and 600 – 800 nm) regions due to 
interband transitions between van Hove singularities in the density of states (DOS) of 
individual SWNTs, indicating the presence of SWNTs as individuals and/or as very 
small bundles with these dispersants. Furthermore, they indicate that under applied 
dispersion conditions a peptoid performs well as a general dispersal agent and does 
not select for tubes of specific type (metallic or semiconducting). 
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Figure  5-7: UV-Vis-NIR spectra of the dispersed purified SWNTs with peptoids. (Green 
line) (NlysNspeNspe)6 (17)/purified SWNTs, (Red line) (NlysNspeNspe)4 (16)/purified 
SWNTs, (Blue line) (NlysNspeNspe)3 (15)/purified SWNTs, (Orange line) (NlysNspeNspe)2 
(14)/purified SWNTs 
 
In order to study the stability of peptoid/purified SWNTs aqueous dispersion with 
respect to time, the concentration of dispersed SWNTs was measured 4 weeks after 
the initial preparation of peptoid/purified SWNTs dispersion as shown in (Table 5-
3).  
Dispersant Conc. Dispersed 
Purified SWNTs 
µg mL
-1 
Conc. Dispersed Purified 
SWNTs After 4 weeks    
µg mL
-1 
(NlysNspeNspe)2 (14) 5.7 0 
(NlysNspeNspe)3 (15) 218.8 80.8 
(NlysNspeNspe)4 (16) 701.5 658.5 
(NlysNspeNspe)6 (17) 672.0 513.0 
Table  5-3: Comparison between the concentration of peptoid/purified SWNTs after 4 weeks.  
Chapter 5 
116 
 
The above results showed that concentration of dispersed purified SWNTs in all 
peptoid/purified SWNTs complexes have decreased after 4 weeks comparing to their 
concentration measured upon the immediate preparation of the complexes. However, 
(NlysNspeNspe)6 (17)/purified SWNTs and (NlysNspeNspe)4 (16)/purified SWNTs 
showed higher dispersion stability comparing to (NlysNspeNspe)2 (14)/purified 
SWNTs and (NlysNspeNspe)3 (15)/purified SWNTs. Since all peptoids used in these 
dispersions have the same hydrophilic/hydrophobic ratio, thus the difference in 
dispersion stability is thought to be due to difference between peptoids in number of 
hydrophobic residues. Increasing the peptoid’s chain length and thus the total 
number of hydrophobic Nspe residues appears to generate more stable SWNT 
dispersions. This result supports the proposed hypothesis that the key interaction 
driving the SWNT dispersion is between the peptoid’s hydrophobic aromatic 
residues, (i.e. Nspe) and CNTs hydrophobic sidewall. 
 
5.2.2.2. Noncovalent Functionalisation of Oxidised SWNTs with Peptoids 
Oxidised SWNTs were noncovalently functionalised with 18 and 6 residue peptoids, 
17 and 14 respectively. The peptoid/oxidised SWNTs aqueous dispersions were 
prepared following the same method for the dispersion of purified with peptoids 
(Section 5.2.2.1). Figure 5-8 shows the oxidised SWNT aqueous dispersions after 
sonication with peptoids 17 and 14.  
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Figure  5-8: Peptoid/oxidised SWNTs composite aqueous dispersion after sonication and 
centrifugation. Dispersion from left to right: (NlysNspeNspe)2 (14)/oxidised SWNTs, 
(NlysNspeNspe)6 (17)/oxidised SWNTs. 
 
The peptoid (17)/oxidised SWNTs supernatant colour was darker compared to 
peptoid (14)/oxidised SWNTs. This indicates that the 18 residue peptoid (17) has a 
minimum number of aromatic residues necessary to disperse the oxidised nanotubes; 
6 residue peptoid (14) does not disperse the oxidised SWNTs. The dispersions were 
further characterised with the UV-Vis-NIR spectroscopy to determine net 
concentration of the dispersed nanotubes in each sample. The dispersed nanotube 
concentration in each supernatant was determined from optical absorption 
spectroscopy using the Beer-Lambert law and the calculated extinction coefficient of 
14.44 mL mg
-1
 cm
-1
 and absorption values at λ = 700 nm (see Appendix B). Table 
5-3 shows the concentration of oxidised SWNTs in each supernatant.   
Peptoid No. Residues Conc. of Dispersed 
Purified SWNTs 
µg mL
-1 
(NlysNspeNspe)2 (14) 6 0.3 
(NlysNspeNspe)6 (17) 18 44.1 
Table  5-4: Concentration of dispersion oxidised SWNTs with peptoids determined for UV-
Vis-NIR absorption after sonication and centrifugation.  
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The absorption spectra of the peptoid dispersed oxidised SWNT is shown in Figure 
5-9. The 18 residue peptoid (17) showed a higher absorption intensity compared to 
the 6 residue peptoid (14). This indicates that the number of aromatic residues 
present in the peptoid play an important role in dispersing the nanotubes.  
 
Figure  5-9: UV-Vis-NIR spectra of oxidised SWNTs dispersed by peptoids. (Green line) 
(NlysNspeNspe)6 (17)/oxidised SWNTs, (Orange line) (NlysNspeNspe)2 (14)/oxidised 
SWNTs. 
 
Compared to purified SWNT dispersions, the same peptoids (17 and 14) had a 
limited adsorption affinity towards oxidised SWNTs. The low adsorption affinity of 
the peptoids towards oxidised SWNTs is thought to be due to oxygen-containing 
functional groups attached to the surface of the nanotubes sidewall. These functional 
groups disrupt the π–π stacking interaction between the peptoid’s aromatic residues 
and the graphitic surface of nanotube, which played an important role in peptoid 
dispersion of purified SWNTs. This suggests that the observed interaction between 
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peptoids and purified SWNTs is a result of π–π interactions. Thus, the degree of 
interaction increases linearly with number of aromatic residues in the peptoid, due to 
increasing the stacking effect and therefore increases the effectiveness of debundling 
of the SWNTs nanotubes.  
 
5.2.2.3. Characterisation of Noncovalent Functionalisation of Purified 
SWNTs with Peptoids 
Raman spectroscopy is the most important and versatile technique for the 
characterisation of covalently functionalised SWNTs.
311
 However, it is of less 
signiﬁcance for the investigation of noncovalently functionalised SWNTs, due to its 
non-destructive nature to the sp
2 
bonding of the nanotube graphitic honeycomb 
lattice.
127,312-315
 Thus the ID/IG ratio cannot indicate the degree functionalisation in 
noncovalent modification. One of prominent feature in the Raman spectrum of CNTs 
is their G-band mode. This mode is directly related to the G band in graphite and is 
due to the in-plane tangential stretching vibration between two carbon atoms in the 
unit cell. The G band has two components a G
+
 mode and a less intense G
−
 mode. 
Previous research has confirmed that interaction of electron withdrawing molecules 
stiffens the Raman of SWNTs G
+
 band while donating molecules soften the G
+
 
band.
316-318
 It has been suggested that electron donor molecules interact selectively 
with semiconducting SWNTs whereas electron acceptors molecules interact with 
metallic SWNTs giving rise to possible metal↔semiconductor transitions.319 As 
previously discussed in Section 5.2.2.1, the proposed interaction between the 
synthesised peptoids and purified SWNTs is through π–π stacking between peptoid’s 
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benzene ring with the graphitic surface of the nanotube. Therefore, to determine if 
the peptoids coat and debundled the nanotubes, Raman spectra of purified SWNTs 
(control sample) and peptoid/SWNTs composite dispersion have been measured and 
the shifts in the G band recorded. The Raman analyses of peptoid/SWNTs composite 
were measured by drop casting each sample on a silicon substrate and left to dry in 
air. The Raman analyses were repeated ten times at different areas of the sample to 
determine that the observed shifts, while small, are real. Figure 5-10 shows 
representative Raman spectra of purified SWNTs (control sample) and 
peptoid/SWNTs composite dispersion, all spectra normalised to the G band.  
 
Figure  5-10: A representative Raman spectra (633 nm) of peptoid/purified SWNT 
composite: (Green line) (NlysNspeNspe)6 (17)/purified SWNTs, (Red line) (NlysNspeNspe)4 
(16)/purified SWNTs, (Blue line) (NlysNspeNspe)3 (15)/purified SWNTs, (Orange line) 
(NlysNspeNspe)2 (14)/purified SWNTs, (Black line) purified SWNT (control). 
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The spectrum shows a number of well-characterised nanotube resonances; in 
particular, the radial breathing modes (RBMs) in the 100 – 300 cm-1 region, the D-
band at ~ 1306 cm
-1
, the G-band in the 1550 – 1605 cm-1 region, and the 2D-band at 
~ 2602 cm
-1
. The proposed interaction of peptoids with purified nanotubes depends 
on π-π interaction between peptoid’s aromatic residues with the surface nanotube. 
Therefore, it is not surprising that the noncovalent interaction between purified 
SWNTs and peptoid results in a G band upshift compared to purified nanotubes 
(control) (Figure 5-11).  
 
Figure  5-11: A representative Raman G band spectra of peptoid/purified SWNT composites. 
(Green line) (NlysNspeNspe)6 (17)/purified SWNTs, (Red line) (NlysNspeNspe)4 
(16)/purified SWNTs, (Blue line) (NlysNspeNspe)3 (15)/purified SWNTs, (Orange line) 
(NlysNspeNspe)2 (14)/purified SWNTs, (Black line) purified SWNT (control). 
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This shift provides further support of peptoids debundling ability as well as for 
charge transfer between the peptoid and SWNT. Table 5-4 summaries the measured 
G band of purified SWNTs (control sample) and peptoids/purified SWNTs. 
 Dispersion G band 
(cm
-1
) 
G band upshift 
(cm
-1
)  
Purified SWNTs 1584.7 ± 0.8 - 
(NlysNspeNspe)2 (14)/purified SWNTs 1588.7 ± 0.2 4 ± 0.8 
(NlysNspeNspe)3 (15)/purified SWNTs 1589.1 ± 0.2 4.4 ± 0.8 
(NlysNspeNspe)4 (16)/purified SWNTs 1589.3 ± 0.1 4.6 ± 0.8 
(NlysNspeNspe)6 (17)/purified SWNTs 1588.2 ± 0.4 3.5 ± 0.9 
Table  5-5: A summary of G band of purified SWNTs (control) and peptoid dispersed 
purified SWNTs. 
 
AFM experiments were used to identify individual or bundled SWNTs in the 
dispersions. The aqueous dispersion of purified SWNTs (control) and 
peptoid/purified SWNTs composites were diluted by factor 10 and drop cast on a 
freshly cleaved mica surface. AFM height measurements were performed on sample 
areas that were free from excess adsorbed peptide and contained SWNTs that 
appeared not to be coated with peptoid. However, since the AFM measurements 
were made on dried samples, these values do not represent the true arrangement of 
the peptoid molecules on the SWNTs in solution. Also, the dilution of the neat 
dispersions may have resulted in the removal of some of the peptoid molecules 
adsorbed on the SWNT surface. AFM height analysis of (NlysNspeNspe)6 
(17)/purified SWNTs composite dispersion ranged from 0.7 to 7.4 nm. Since the 
height of individual SWNTs are known to range from ~ 0.8 – 1.2 nm. The AFM 
results of (NlysNspeNspe)6 (17)/purified SWNTs composite suggest that most of the 
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purified present in the composite are individually dispersed. Figure 5-12 shows a 
representative AFM image of (NlysNspeNspe)6 (17)/purified SWNTs dispersion. 
 
 
Figure  5-12: AFM images of (NlysNspeNspe)6 (17)/purified SWNTs dispersion (top row) 
and height analysis (bottom row). 
 
Electron microscopy has been used to characterise the (NlysNspeNspe)6 (17)/purified 
SWNTs composite. Low-resolution transmission electron microscopy (LRTEM) of 
the dispersion dried on a TEM grid revealed an extensive network of fibre like 
materils coated with a web-like film. High-resolution transmission electron 
microscopy (HRTEM) was used to study the nanoscopic interaction between 
individual nanotubes and the folded peptoid. Figure 5-13 shows a representative 
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high resolution HRTEM and LRTEM image of an individual SWNT efficiently 
coated by an amphiphilic peptoid.  
 
Figure  5-13: TEM images of (NlysNspeNspe)6 (17)/purified SWNTs composite: (Left) 
HRTEM of (NlysNspeNspe)6 (17)/purified SWNTs composite, (Right) LRTEM of 
(NlysNspeNspe)6 (17)/purified SWNTs composite. 
 
The measured average diameter of the (NlysNspeNspe)6 (17)/purified SWNTs 
composite is 3.1 nm, whereas individual SWNT has been previously reported to have 
an approximate diameter of ~ 2 nm. This indicates that the amphiphilic peptoid 
disperses purified SWNT into individual tubes or small bundles. These results also 
closely match those from the interaction amphiphilic peptides with SWNTs.
124,320
 As 
can be seen in the Figure 5-13 inset, the features of the dispersed SWNTs match the 
dimensions expected for a flexible chain peptoid associated with the SWNTs surface.  
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5.3. Conclusion and Future Work   
In summary, a series of chiral amphiphilic peptoids were synthesised based on the 
work by Barron.
245,321
 in which several helical, cationic, facially amphiphilic peptoid 
with antibacterial activity have been designed. The synthesised peptoids vary in the 
number of aromatic residues on the hydrophobic surface of the helix yet have the 
same hydrophilic/hydrophobic ratio. The CD spectra suggested that the peptoids 
were forming a helical conformation in the solution. UV-Vis-NIR absorption spectra 
revealed that the peptoids ability to disperse individual SWNTs increases with 
increasing the number of aromatic residues in the peptoid. Also the stability of these 
dispersions with respect to time has been studied; (NlysNspeNspe)6 (17)/purified 
SWNTs and (NlysNspeNspe)4 (16)/purified SWNTs showed higher dispersion 
stability comparing to (NlysNspeNspe)2 (14)/purified SWNTs and (NlysNspeNspe)3 
(15)/purified SWNTs. Raman spectroscopy was used to probe the peptoid’s impact 
on the electronic structure of the SWNTs. The shift of the Raman G band peak to 
higher frequencies for the peptoid/purified SWNTs composites are suggestive of a 
weak charge-transfer interaction in which the peptoid acts as an electron acceptor and 
the SWNT acts as an electron donor. Altogether, these results suggest that the 
noncovalent peptoid/SWNT interaction does not perturb the electronic structure of 
SWNTs. In this context, designed peptoid may provide an accessible means to 
incorporate the desired electrical properties of SWNTs into biocompatible nanoscale 
electronic devices. TEM and AFM measurements reveal that the chosen peptoids are 
capable of fully coating the SWNT surface and dispersing individual SWNTs and 
will facilitate many applications of SWNTs to medical problems; such as artificial 
muscles or biomedical sensors that can be placed inside the human body.  
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Hybrids of biomolecules and nanomaterials are promising candidates in the 
development of novel therapeutics and electronic devices. Since peptoids are known 
for their potential application as a drug due to their resistance to proteases and long 
life in the human body. The next step for this work would be to study the toxicity, 
cell penetration, and cellar uptake of the biological active peptoid/SWNT composite. 
These biological tests will test the possibility of improving the biological activity of 
peptoids upon their interaction with CNTs. This will open the possibility of using 
peptoid/CNTs composites in biological and medical applications 
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6. NONCOVALENT FUNCTIONALISATION OF SWNTs WITH 
RIBONUCLEOSIDES 
 
6.1. Introduction  
The study of the interaction of biomolecules, such as, peptides,
124,127,210
 
proteins,
107,114,115,268
 and DNA
89
 with SWNTs has emerged as a separate field in 
nanotechnology. In particular, the adsorption of DNA on SWNTs surfaces has 
attracted considerable attention.
322,323
 DNA/SWNTs complexes have potential 
biomedical applications, such as transport of biomolecular agents into cells, optical 
sensing for biological systems,
324
 rapid DNA sequencing,
325
 and diagnosis and 
therapeutic treatment of diseases. This motivated many computational and 
experimental studies to investigate the interaction of DNA, nucleosides,
325,326
 
nucleobases,
327-330
 and nucleotides
331,332
 with SWNTs.  
The solubilisation of SWNTs associated both covalently
274,333
 and noncovalently 
with DNA has been intensively investigated to obtain both theoretical and 
experimental understanding of the DNA/SWNTs interaction.
334-338
 The noncovalent 
interaction of SWNTs with DNA helps the dispersion and separation of SWNTs in 
aqueous and non-aqueous solution, while leaving their unique physical and electronic 
properties unchanged. One of the most effective dispersants is single-stranded DNA 
(ssDNA), which was discovered by Zheng
339
 to disperse bundled SWNTs (Figure 6-
1). The accepted interaction mechanism is helical wrapping, whereby the 
hydrophobic DNA bases preferentially π–π stacking (noncovalent bonding) on the 
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nanotube surface, leaving the hydrophilic sugar-phosphate backbone free to interact 
with the water to promote solubility.
340
 Ikeda et al.
341
 showed that aqueous solubility 
of SWNTs significantly depends on the number of phosphate groups and the type of 
base in the oligonucleotides.  
 
Figure  6-1: The DNA wraps around the hydrophobic surface of SWNTs. Reprinted by 
permission from Macmillan Publishers Ltd: [Nature Materials] [339], copyright (2003). 
 
Several experimental and theoretical studies found that the dispersity is dependent on 
the oligonucleotides sequence, thus certain sequences of ssDNA were more effective 
at dispersing nanotubes than others. In particular, it has been found that pyrimidine 
based oligonucleotides are superior dispersants to purine based oligonucleotides, due 
to stronger self-stacking of the pyrimidine based oligonucleotides in aqueous 
solution.
52
 More recently, it has been shown that the interaction of ssDNA wrapping 
around SWNTs is diameter- and sequence-dependent, making it possible to disperse 
the naturally hydrophobic SWNTs in water and to sort them by their chirality.
53
 
These recognition sequence hybrids, which show high selectivity toward their 
respective chirality SWNTs, suggest a highly ordered ssDNA secondary structure 
proposed to be stabilised by base-SWNTs adsorption as well as by interbase 
hydrogen bonding.
338,342,343
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The nucleobase/SWNT composites are interesting in view of the remarkable 
properties of SWNTs and the recognition properties of nucleobases. The strength of 
nucleobase stacking on the stability of DNA/SWNT complexes has motivated 
several computational studies on the nature of such interactions. For example, 
Johnson et al.
344
 calculated the nucleobase/SWNTs binding free energy differences 
for the four bases and found that they follow the trend guanine < adenine < thymine 
< cytosine in aqueous environment. Figure 6-2 shows the π–π stacking between 
adenine with SWNTs surface. The adenine also has a hydrogen bonding (yellow 
colour) with water molecules. 
 
Figure  6-2: Noncovalent interaction between adenine with the hydrophobic surface of 
SWNTs. Reproduced from [344] with permission of John Wiley and Sons.  
 
Although covalent functionalisation of nanotubes destroys their sp
2
 structure, it has 
been used to attach biomolecules to a nanotube surface. Chris et al.
345
 used covalent 
chemistry to functionalise nanotubes with DNA, which provided stability, 
accessibility, and selectivity during competitive hybridisation when compared to the 
noncovalent approach. Figure 6-3 shows the synthesis of a DNA/SWNT complex 
where the oxidised nanotube is attached to free amino group in the DNA via 
carbodiimide cross-linker (EDC) coupling chemistry.  
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Figure  6-3: Covalent functionalisation of SWNTs with DNA. Capped SWNTs are 
oxidatively opened and then reacted with amine-terminated single-stranded DNA. Reprinted 
from [345]. 
 
Nucleobases and ribonucleosides were covalently attached to a nanotubes surface by 
Micoli et al.
346,347
 The presence of ribonucleosides and nucleobase on the nanotube 
surface improves the dispersibility of the nanohybrid in polar solvents. It also directs 
recognition, through hydrogen bonding, of complementary base pairs in nonpolar 
aprotic solvents (Figure 6-4). 
 
Figure  6-4: Hydrogen bonding between ribonucleoside/SWNTs complexes. Reproduced 
from [347] with permission of John Wiley and Sons. 
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Boncel et al.
348
 synthesised (R)-PLA grafted oxidised MWNTs employing the β-D-
uridine linker (Figure 6-5). They suggested that their method can be used in the 
fabrication of biodegradable composites for medicinal applications.  
 
Figure  6-5: Synthesis of the MWNT-CO–(Oβ-Ur)–(R)-PLA composite. Reprinted from 
Publication [348], Copyright (2013), with permission from Elsevier. 
 
The adsorption of ribonucleosides and nucleobases on the surface of SWNTs are still 
not reported. This chapter investigates the noncovalent interaction between 
ribonucleosides and their compounding nucleobases with SWNTs to provide 
important information about the interaction mechanism.  
The objective of the present study was to investigate the interaction between 
ribonucleosides and SWNTs. In particular, to investigate how the combined effect of 
ribonucleoside substituent groups and the oxygen-containing functional groups of 
SWNT surfaces might affect adsorption.  
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6.2. Results and Discussion  
The high surface area of SWNTs is an important factor in the adsorption of 
biomolecules on their surface. However, the surface area alone is not enough to 
interpret the adsorption characteristics of biomolecules on SWNTs. Adsorption is 
affected by other factors, such as biomolecule molecular structure, and the surface 
chemistry of SWNTs.
349,350
 The inner pores of SWNTs are not available for 
adsorption.
351,352
 The adsorption energy and charge transfer of molecules in groove 
and interstitial sites of the bundles are much higher than those on the surface. 
Therefore, the outer surface of SWNTs is of major importance for the adsorption of 
biomolecules.
352,353
 The noncovalent interaction of both purified and oxidised 
SWNTs with ribonucleosides and nucleobases, ribose molecule were investigated in 
this section.  
 
6.2.1. Oxidation of SWNTs  
Two batches of oxidised SWNTs with different degrees of oxidation were prepared. 
The purified SWNT (Chapter 4) was divided into two batches. The first batch was 
refluxed in 2 M nitric acid, while the second batch was refluxed in 8 M nitric acid. 
Both batches were refluxed at 120 °C for 4 hours.  
The degree of oxidation of oxidised nanotubes (2 M, and 8 M) was estimated using 
thermogravimetric analysis (TGA) in an inert atmosphere, since any covalent 
modifications are labile or decompose upon heating. By assuming that all the weight 
loss is due to the oxidation, an estimation of the degree of oxidation can be made by 
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comparison with the TGA of oxidised nanotubes with purified SWNTs (control). 
When the TGA is attached to a mass spectrometer (TGA-MS) analysis of the 
fragments removed from the nanotube surface upon heating can also be achieved.  
The TGA-MS of oxidised SWNTs (2 M) and (8 M) show a further weight loss at 600 
°C when compared to the purified SWNTs (Figure 6-6). 2 M and 8 M oxidised 
SWNTs lost 6 % and 15 %, respectively, while purified SWNTs lost only 3 % by 
weight. This corresponds to the presence of approximately 1.0 functional group per 
58 and 20 carbon atoms in 2 M and 8 M oxidised SWNTs, respectively. 
 
Figure  6-6: TGA of oxidised and purified SWNTs: (Blue line) purified SWNTs, (Red line) 
oxidised SWNTs (2 M). (Green line) oxidised SWNTs (8 M). 
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Unmodified SWNTs are known to show a minimal or complete lack of solubility in 
common organic solvents.
158
 Thus, they are typically dispersed in water with the aid 
of 1.0 % sodium dodecyl sulfate (SDS) solution. The optical absorption spectrum of 
SDS/purified SWNTs show characteristic absorption peaks in the UV-Vis-NIR range 
that are due to transitions between van Hove singularities in the density of state 
(DOS) of SWNTs.
147,354
 After undergoing an oxidation to introduce oxygen-
containing functional groups to the nanotube surface, the UV-Vis-NIR spectrum of 
oxidised SWNTs displays a suppression of these van Hove singularities, signifying a 
disruption of their electronic structure due to covalent modification of the nanotube 
surface (Figure 6-7).
355
 
 
Figure  6-7: UV-Vis-NIR absorption spectra of purified and oxidised SWNTs: (Blue line) 
SDS/purified SWNTs, (Green line) oxidised SWNTs (8 M), (Red line) oxidised SWNTs (2 
M). 
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The oxidised SWNTs demonstrate an improvement in solubility compared to the 
purified SWNTs which can be explained as a consequence of the introduction of 
oxygen functional groups on the nanotube surface. These functional groups form 
hydrogen bonds with water molecules, thus solubilising the nanotubes in water. The 
concentration of dispersed oxidised nanotubes was found from their absorbance 
value at 700 nm and calculated molar extinction coefficient of oxidised SWNTs (see 
Appendix B). The concentration of dispersed 8 M oxidised SWNTs was 249.3 µg 
mL
-1
, which is higher than that of 2 M oxidised SWNTs (30 µg mL
-1
). This indicates 
that the 8 M nitric acid oxidation result in more oxygen-containing functional groups 
attached to nanotube surface than 2 M oxidised SWNTs which agrees with the TGA 
results.  
Raman spectroscopy is an analytical technique that allows an assessment of the 
sidewall composition of the SWNT sample to be made.
356
 The degree of 
functionalisation can be estimated form the Raman ID/IG ratios before and after 
oxidation treatment. However, it should be noted that Raman is not a quantitative 
tool to accurately determine the amount of functionalisation of the oxidised 
nanotubes. It is merely used for qualitative comparisons between samples, and at 
least ten scans on different areas of the samples were completed for this assessment. 
Oxidised and purified aqueous dispersion were drop-casted to silicon wafer substrate 
for the Raman measurements. Figure 6-8 shows a representative Raman spectra of 2 
M and 8 M oxidised and purified SWNTs (control).  
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Figure  6-8: A representative Raman spectra (633 nm) of purified and oxidised SWNTs 
normalised at the G band: (Blue line) SDS/purified SWNTs, (Green line) oxidised SWNTs 
(8 M), (Red line) oxidised SWNTs (2 M).  
 
As can be observed in Raman spectrum, the characteristic peaks in purified SWNTs, 
D band at 1309 ± 0.8 cm
-1
, and G band at 1584.7 ± 0.8 cm
-1, are identiﬁed. 
Comparing the ratio ID/IG values of functionalised and purified nanotubes, it is 
observed that after oxidation, the ratio values increase as expected. The ID/IG of 8 M 
and 2 M oxidised SWNTs is 0.29 ± 0.02 and 0.17 ± 0.02, respectively, while it is 
0.13 ± 0.07 for purified SWNTs. These results indicate that 8 M oxidised SWNTs 
have higher amount of functional groups on the side walls than 2 M oxidised and 
purified SWNTs.  
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6.2.2. Dispersion of Purified and Oxidised SWNTs with Ribonucleosides 
6.2.2.1. Dispersion of Purified SWNTs  
Previous theoretical studies have suggested that interaction of ribonucleosides with 
unmodified SWNTs depends mainly on π–π stacking. Thus, this section aims to 
investigate the noncovalent functionalisation of purified SWNTs with 
ribonucleosides. 1.0 mM aqueous solutions of ribonucleoside were used to 
noncovalent to disperse purified SWNTs in water. The aqueous ribonucleoside 
solutions were prepared by diluting a stock solution (2 mg 10 mL
-1
)
1
, and the final 
concentration was determined by UV-visible absorption. Figure 6-9 shows the 
ribonucleosides used in the dispersions.  
 
Figure  6-9: Ribonucleosides used in the dispersion of SWNTs. 
 
                                                 
1
 Due to the low solubility of ribonucleosides in water, the 2.0 mg 10 mL
-1
 solution 
ribonucleosides is a saturated solution. 
Chapter 6 
138 
 
1.0 mg of purified SWNTs in 1.0 ml of the ribonucleoside solutions were probe 
sonicated for 15 min in an ice bath. Then the dispersions were centrifuged to 
accelerate the separation of the supernatant phase, which contains the dispersed and 
mostly exfoliated purified SWNTs. The ultrasonication step provides the energy to 
overcome the high van der Waals attraction between the SWNTs, while the 
ribonucleoside stabilises the exfoliated/individualised nanotubes. Given that SWNTs 
supernatant colour intensity provide an initial qualitative evaluation of the amount of 
dispersed SWNTs in the solution. Thus, the quality of ribonucleoside/purified 
SWNTs aqueous dispersions was studied first by simple visual inspection (Figure 6-
10).  
 
Figure  6-10: Ribonucleoside/purified SWNTs supernatant in water after sonication and 
centrifugation: Dispersion from left to right: adenosine/purified SWNTs, guanosine/purified 
SWNTs, thymidine/purified SWNTs, cytidine/purified SWNTs, and uridine/purified 
SWNTs.  
 
The clear supernatant of ribonucleoside/purified SWNTs aqueous dispersion 
suggests that purified SWNTs did not disperse by their noncovalent interaction with 
ribonucleosides. The dispersions were then characterised with UV-Vis-NIR 
spectroscopy. UV-Vis-NIR absorption intensity of nanotube dispersion is 
proportional to their amount of dispersed in the solution. Thus, the low UV-Vis-NIR 
absorption intensity peaks of the ribonucleoside/purified SWNTs dispersion confirms 
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that a very small amount of purified SWNTs are present in the supernatant (Figure 
6–11).  
 
Figure  6-11: UV-Vis-NIR absorption spectra of dispersed purified SWNTs with 
ribonucleosides. (Orange line) adenosine/purified SWNTs, (Blue line) guanosine/purified 
SWNTs, (Green line) thymidine/purified SWNTs, (Red line) cytidine/purified SWNTs, 
(Pink line) uridine/purified SWNTs. 
 
UV-Vis-NIR absorption of ribonucleoside/purified SWNTs dispersion is used to 
determine the concentration of dispersed nanotubes in the supernatant through 
application of Beer-Lambert Law and calculated extinction coeﬃcient of purified 
SWNTs at 700 nm, ε700 = 37.3 mL mg
−1 
cm
-1
 (see Appendix B). Table 6-1 shows 
the concentration of dispersed nanotubes by ribonucleosides after sonication and 
centrifugation.  
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Ribonucleoside Conc. of Dispersed Purified SWNTs 
μg mL-1 
SDS (control) 196.4 
Adenosine 0.1 
Guanosine 0.8 
Thymidine 0.1 
Cytidine 0.2 
Uridine 0.2 
Table  6-1: Concentration of purified SWNTs dispersed by ribonucleosides determined from 
UV-Vis-NIR absorption after sonication and centrifugation 
 
The very low concentration of dispersed purified SWNTs is thought to be due to 
weak hydrophobic interaction/π–π stacking between ribonucleoside and the 
hydrophobic surface of purified SWNTs. The noncovalent interaction between 
purified SWNTs with ribonucleosides is further investigated by dispersing purified 
SWNTs with ribonucleoside’s moieties; nucleobases and ribose sugar. Previous 
theoretical studies suggested that hydrophobic and heterocyclic ring of nucleobases 
play an important role to impart dispersion to nanotubes via π–π stacking. However, 
nucleobase/purified SWNTs dispersion showed very low UV-Vis-NIR absorption 
peaks (Figure 6-12). 
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Figure  6-12: UV-Vis-NIR absorption spectra of dispersed purified SWNTs with 
nucleobases: (Orange line) adenine/purified SWNTs, (Blue line) guanine/purified SWNTs, 
(Green line) thymine/purified SWNTs, (Red line) cytosine/purified SWNTs, (Pink line) 
uracil/purified SWNTs. 
 
This very low UV-Vis-NIR absorption intensity proves that the heterocyclic ring size 
of the nucleobases is not enough to have an efficient π–π stacking interaction with 
the hydrophobic surface of the purified SWNTs. Thus nucleobases dispersed a very 
small amount of purified SWNTs in water (Table 6-2).  
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Nucleobase Conc. of Dispersed Purified SWNTs 
μg mL-1 
SDS (control) 196.4 
Adenine 0.7 
Guanine 2.0 
Thymine 0.2 
Cytosine 0.5 
Uracil 0.5 
Table  6-2: Concentration of purified SWNTs dispersed by nucleobases determined from 
UV-Vis-NIR absorption after sonication and centrifugation. 
 
Similar results were found when purified SWNTs were dispersed with ribose sugar 
(4.2 μg mL-1). These results indicate that there is only weak π–π 
stacking/hydrophobic interaction between nucleobase, ribose sugar, and the 
hydrophobic surface of purified SWNT. Thus they have weak dispersion ability 
towards nanotubes surface.  
 
6.2.2.2. Dispersion of Oxidised SWNTs  
The surface chemistry of SWNTs, in particular oxygen-containing functional groups 
such as OH and COOH, has considerable effects on the adsorption of organic 
molecules.
82,349,357
 As discussed in (Section 6.2.1), more severe oxidation conditions 
introduces more oxygen-containing functional groups on the sidewalls of the 
nanotubes. The overall objective of this section was to investigate the 
nonhydrophobic interactions between ribonucleosides and SWNTs. In particular, to 
investigate how the combined effect of ribonucleoside substituent groups (oxygen 
and amino) and the oxygen-containing functional groups on SWNT surface might 
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affect adsorption. The oxidised nanotubes, 2 M and 8 M, were noncovalently 
functionalised with ribonucleosides following the same method used for the 
dispersion of purified SWNTs (Section 6.2.2.1). The supernatants colour intensity 
provides an initial qualitative estimation of nanotubes’ amount in the dispersion. 
Figure 6-13 shows ribonucleoside/oxidised SWNTs supernatants after sonication 
and centrifugation. 
 
Figure  6-13: Ribonucleoside/oxidised SWNTs aqueous dispersions after sonication and 
centrifugation. Dispersion from left to right: (Top) adenosine/oxidised SWNTs (2 M), 
guanosine/oxidised SWNTs (2 M), thymidine/oxidised SWNTs (2 M), cytidine/oxidised 
SWNTs (2 M), uridine/oxidised SWNTs (2 M). (Bottom) adenosine/oxidised SWNTs (8 M), 
guanosine/oxidised SWNTs (8 M), thymidine/oxidised SWNTs (8 M), cytidine/oxidised 
SWNTs (8 M), uridine/oxidised SWNTs (8 M). 
 
By comparing the ribonucleoside/oxidised SWNTs (2 M and 8 M) supernatant colour 
with ribonucleoside/purified SWNTs (Section 6.2.2.1), it is clear that oxygen-
containing functional groups on nanotubes’ surface have a signiﬁcant influence on 
their interaction with ribonucleosides. Ribonucleoside/oxidised SWNTs (8 M) 
supernatant has a signiﬁcantly darker colour than ribonucleoside/oxidised SWNTs (2 
M). Knowing that 8 M oxidised nanotubes has a higher degree of oxidation than the 
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2 M oxidised nanotubes (Section 6.2.1). Thus, based on the supernatant colour 
intensity, it is thought that increasing the number of oxygen-containing functional 
groups on the nanotube surface resulted in a better interaction with ribonucleosides. 
The ribonucleoside/oxidised nanotube (2 M and 8 M) dispersion are characterised 
with UV-Vis-NIR spectroscopy to determine the relative amount of individual 
SWNTs versus ropes or bundles in the suspensions and also the net concentration of 
the dispersed nanotubes. Figure 6-14, and Figure 6-15 show UV-Vis-NIR 
absorption spectra of ribonucleoside/oxidised SWNTs (8 M) and 
ribonucleoside/oxidised SWNTs (2 M) dispersions, respectively.  
 
Figure  6-14: UV-Vis-NIR absorption spectra of ribonucleoside/oxidised SWNTs (8 M) 
aqueous dispersion. (Blue line) guanosine/oxidised SWNTs (8 M), (Green line) 
thymidine/oxidised SWNTs (8 M), (Red line) cytidine/oxidised SWNTs (8 M), (Pink line) 
uridine/oxidised SWNTs (8 M). (Orange line) adenosine/oxidised SWNTs (8 M). 
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Figure  6-15: UV-Vis-NIR absorption spectra of dispersed SWNTs (2 M) with 
ribonucleosides: (Pink line) uridine/oxidised SWNTs (2 M), (Blue line) guanosine/oxidised 
SWNTs (2 M), (Orange line) adenosine/oxidised SWNTs (2 M), (Red line) 
cytidine/oxidised SWNTs (2 M), (Green line) thymidine/oxidised SWNTs (2 M).  
 
The UV-Vis-NIR spectra of ribonucleoside/oxidised SWNTs (2 M) composites show 
low intensity and broad absorption peaks. The broad absorption peaks indicate that 
ribonucleosides dispersed the nanotubes in bundles or aggregates. Whereas, fine 
structure in the absorption peaks of ribonucleoside/oxidised SWNTs (8 M) indicate 
the presence of SWNTs as individuals or as very small bundles.
37
 Additionally, the 
discrete peaks of ribonucleoside/oxidised SWNTs (2 M and 8 M) that extend 
throughout the metallic (440 − 645 nm) and semiconducting (830 − 1600 nm) 
indicate ribonucleosides act as a general dispersal agent and do not select for 
nanotubes of specific type (metallic or semiconducting).  
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The concentration of dispersed nanotubes in each supernatant after sonication, 
centrifugation was determined from optical absorption spectroscopy using the Beer-
Lambert law and calculated extinction coeﬃcient of 8 M and 2 M oxidised SWNTs 
at 700 nm (ε700 = 14.14, and 19.19 mL mg
−1
 cm
-1
, respectively)
 
(see Appendix B). 
Table 6-3 shows the concentration of dispersed oxidised SWNTs (2 M and 8 M) by 
ribonucleosides.  
Ribonucleoside Conc. of Dispersed 
Oxidised SWNTs 2 M     
μg mL-1 
Conc. of Dispersed 
Oxidised SWNTs 8 M  
μg mL-1 
H2O (control) 30 249.3 
Adenosine 52.8 84.9 
Guanosine 55.1 389.9 
Thymidine 96.5 375.9 
Cytidine 37.2 244.0 
Uridine 37.3 246.2 
Table  6-3: Concentration of dispersed oxidised SWNTs (2 M and 8 M) by ribonucleosides 
determined from UV-Vis-NIR absorption after sonication and centrifugation. 
 
From the results obtained it can be seen that the concentration of dispersed oxidised 
SWNTs by both the water control and all of the ribonucleosides was greater than that 
of purified SWNTs (Section 6.2.2.1). This suggests that ribonucleosides are not 
engaging in a hydrophobic interaction with the carbon nanotube surface. It worth 
noting  that when the concentration of oxidised SWNTs is changed from 2 M to 8 M 
the differences between the control dispersion (i.e. dispersion in just H2O) and the 
ribonucleosides dispersions changes. When 2 M oxidised SWNTs are used all of the 
ribonucleosides give rise to a higher concentration of dispersed SWNT than the 
control (Table 6-3). However, when 8 M oxidised SWNTs were used adenosine, 
Chapter 6 
147 
 
(and to a lesser extent cytidine, and uridine) the concentration of the dispersed CNTs 
is less than that of the water control. The reason behind the differences observed in 
the dispersions at the two concentrations of oxidised SWNT used is not immediately 
apparent. Additionally, it should be noted that the concentration of dispersed 8 M 
oxidised SWNTs by all of the ribonucleosides is higher than corresponding 2 M 
oxidised SWNTs. This indicates that increasing the number of oxygen-containing 
functional groups increases sites for noncovalent integration with ribonucleosides, 
thus increases the concentration of dispersed nanotubes.  
For further evaluation of the ribonucleoside/oxidised SWNTs (8 M) aqueous 
dispersion stabiliteis as a function of time, the concentraton of oxidised SWNTs (8 
M) in the dispersion was checked with optical absorption measurements. Table (6-4) 
compares between the concentration of dispersed carbon nanotubes in each 
ribonucleoside/oxidised SWNTs (8 M) complex 4 weeks after the initial preparation 
of the solutions.  
Ribonucleoside Conc. of Dispersed 
Oxidised SWNTs 8 M  
μg mL-1 
Conc. of Dispersed 
Oxidised SWNTs 8 
M After 4 Weeks     
μg mL-1 
Adenosine 84.9 56.9 
Guanosine 389.9 363.1 
Thymidine 375.9 356.1 
Cytidine 244.0 228.4 
Uridine 246.2 232.9 
Table  6-4: A comparison between the concentration of dispersed oxidised SWNTs (8 M) by 
ribonucleosides after dispersion and 4 weeks. 
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The concentration of the oxidised SWNTs (8 M) recorded after 4 weeks reflects the 
high stability of these dispersions. This can be explained by a strong hydrogen bond 
between the ribonucleosides and oxygen-containing functional groups on carbon 
nanotube’s surface.  
In order to obtain a better understanding of the nature of this interaction addition of 
nucleobases with oxidised SWNTs (2 M and 8 M) was investigated. Figure 6-16 
shows the individual nucleobases used in the dispersion.  
 
Figure  6-16: Nucleobases used in the dispersion of oxidised SWNTs. 
 
The nucleobase/oxidised nanotubes (2 M and 8 M) composite dispersions were 
prepared in similar way to the ribonucleosides composites (Section 6.2.2.1). Figure 
6-17 shows the nucleobase/oxidised SWNTs (2 M) and nucleobase/oxidised SWNTs 
(8 M) dispersions supernatant after sonication and centrifugation.  
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Figure  6-17: Nucleobase/oxidised nanotubes composites dispersion after sonication and 
centrifugation. Dispersion from left to right: (Top) adenosine/oxidised SWNTs (8 M), 
guanosine/oxidised SWNTs (8 M), thymidine/oxidised SWNTs (8 M), cytidine/oxidised 
SWNTs (8 M), and uridine/oxidised SWNTs (8 M). (Bottom) adenosine/oxidised SWNTs (2 
M), cytidine/oxidised SWNTs (2 M), thymidine/oxidised SWNTs (2 M), uridine/oxidised 
SWNTs (2 M), and guanosine/oxidised SWNTs (2 M). 
  
In comparison with purified SWNTs (Section 6.2.2.1), the nucleobase/oxidised 
SWNTs (2 M, and 8 M) produced a darker supernatant. In addition, the 
nucleobase/oxidised SWNTs (8 M) showed a darker supernatant colour compared to 
nucleobase/oxidised SWNTs (2 M). Figure 6-18, and Figure 6-19 show the UV-Vis-
NIR absorption spectra of nucleobase/oxidised SWNTs (8 M and 2 M) dispersion, 
respectively. It can be seen that the absorption intensity nucleobase/oxidised SWNTs 
(8 M) dispersion is higher than that of ribonucleoside/oxidised SWNTs (2 M).  
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Figure  6-18: UV-Vis-NIR absorption spectra of 8 M oxidised dispersed with nucleobases. 
(Pink line) uracil/oxidised SWNTs (8 M), (Orange line) adenine/oxidised SWNTs (8 M), 
(Red line) cytosine/oxidised SWNTs (8 M), (Blue line) guanine/oxidised SWNTs (8 M), 
(Green line) thymine/oxidised SWNTs (8 M).  
Figure  6-19: UV-Vis-NIR adsorption spectra of 2 M oxidised dispersed with nucleobases. 
(Pink line) uracil/oxidised SWNTs (2M), (Green line) thymine/oxidised SWNTs (2M), 
(Orange line) Adenine/oxidised SWNTs (2M), (Red line) Cytosine/oxidised SWNTs (2M),.  
(Blue line) Guanine/oxidised SWNTs (2M).  
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The results in Table 6-4 show that the concentration of the nucleobase dispersed 
oxidised SWNTs (2 M and 8 M) are less than the ribonucleoside dispersed oxidised 
SWNTs (2 M and 8 M). However, they are higher than the concentration of 
nucleobase dispersed purified SWNTs (Section 6.2.1). The concentration of 
dispersed oxidised SWNTs by the nucleobase increases with increasing the number 
of oxygen functional groups on nanotube surface from 2 M oxidised SWNTs to 8 M 
oxidised SWNTs. However, it should be noted that at 8 M all of the nucleobases give 
rise to a lower concentration of disperse SWNTs compared to the water control. 
These results suggest that here the nucleobases are actually causing the SWNTs to 
aggregate and crash out of solution. Water can form H-bonds with oxygen-
containing functional groups on the oxidised SWNTs. Thus, the overall decrease in 
the concentration of dispersed oxidised nanotubes using ribonucleosides and 
nucleobases compared their dispersion in water suggests that water molecules 
compete with the ribonucleosides and nucleobases over adsorption sites and/or form 
a 3D cluster around the oxygen-containing functional groups, and block the 
adsorption sites nearby.  
Nucleobase  Conc. of Dispersed 
oxidised SWNTs 2 M 
μg mL-1 
Conc. of Dispersed 
oxidised SWNTs 8 M 
μg mL-1  
H2O (control) 30 249.3 
Adenine 46.7 147.6 
Guanine 11.5 94.9 
Thymine 55.7 72.8 
Cytosine 41.5 136.7 
Uracil 69.9 182.1 
Table  6-5: Concentration of dispersed oxidised SWNTs by nucleobases determined for their 
UV-Vis-NIR absorption after sonication and centrifugation. 
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These results provide further evidence that the key dispersing interaction depends on 
the oxygen-containing functional groups on the surface of oxidised SWNTs. 
Furthermore, the variation in the concentration of dispersed oxidised carbon 
nanotubes by nucleobases suggests that they play a key role in ribonucleosides’ 
dispersion affinity towards nanotubes. Nucleobases are known to have a very low 
solubility in water; however, ribonucleosides have slightly higher solubility in water. 
This is due to ribose moiety which interacts with water molecules, thus decreases the 
hydrophobicity of the nucleobase moiety. The interaction of the ribose sugar with 
SWNTs has been studied and its ability to disperse SWNTs is shown in Table 6-5.  
Dispersant Conc. of Dispersed 
Oxidised SWNTs 2 M 
μg mL-1 
Conc. of Dispersed 
Oxidised SWNTs 8 M 
μg mL-1 
H2O (control) 30 249.3 
Ribose 67.7 441.5 
Table  6-6: Concentration of dispersed oxidised SWNTs by ribose sugar determined for UV-
Vis-NIR absorption after sonication and centrifugation. 
 
The concentration of dispersed nanotubes with oxidised SWNTs (2 M and 8 M) is 
higher than purified SWNTs (6.2.2.1). It was speculated that one of the ribose 
hydroxyl groups forms hydrogen bonds with the carboxylic groups on the surface of 
the oxidised SWNTs while the second interacts with water molecules therefore 
increasing the dispersibility of the nanotubes in water. Figure 6-20 illustrates the 
ribose sugar’s ability to individually debundle the 8 M oxidised SWNTs compared to 
the low adsorption intensity of the 2 M oxidised, which also shows the low amount 
of the bundled dispersion.  
Chapter 6 
153 
 
 
Figure  6-20: UV-Vis-NIR absorption spectra of purified and oxidised SWNTs with ribose 
sugar: (Green line) oxidised SWNTs (8 M), (Red line) oxidised SWNTs (2 M). 
 
As all the ribonucleosides have the ribose moiety and vary in their nucleobase 
moiety, the above results imply that the variation in ribonucleosides’ interaction 
affinity towards nanotubes depends on their nucleobase moiety only. Thus, it is 
thought that the nucleobase moiety in a ribonucleoside interacts with oxygen-
containing functional groups on the carbon nanotube surface, while its ribose moiety 
interacts with solvent water molecules. 
In order to further study the effect of the non-covalent interaction between the 
ribonucleosides and the oxidised SWNT’s electronic properties, Raman spectra of 
oxidised SWNTs (8 M) (control) and ribonucleoside/oxidised SWNTs (8 M) 
composites have been measured. The Raman analyses were measured by drop 
casting each sample on a silicon substrate. Figure 6-21 shows a representative 
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Raman spectra of ribonucleoside/oxidised SWNTs (8 M) composites along with 
oxidised SWNTs (8 M) as a reference.  
 
Figure  6-21: A representative Raman spectra (633 nm) of ribonucleoside/oxidised SWNTs 
(8 M) composites and oxidised SWNTs (8 M) as a control: (Black line) oxidised SWNTs (8 
M) (control), (Orange line) adenosine/oxidised SWNTs (8 M), (Red line) cytidine/oxidised 
SWNTs (8 M), (Blue line) guanosine/oxidised SWNTs (8 M), (Green line) 
thymidine/oxidised SWNTs (8 M), (Pink line) uridine/oxidised SWNTs (8 M). 
 
The Raman spectra of ribonucleoside/oxidised SWNT (8 M) composites and 
oxidised SWNTs (8 M) (control) show the characteristic SWNTs resonances; in 
particular, radial breathing modes (RBMs), D-band, G-band, and 2D-band. Table 6-6 
shows that the G-band of the composites does not show any considerable shift 
compared to the oxidised SWNTs (8 M) (control). This further suggests that the 
interaction between ribonucleosides interaction with nanotubes surface is a 
nonhydrophobic interaction.  
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Dispersion G band cm-1 
Oxidised SWNTs (8 M) (control) 1589.2 ± 0.9 
Adenosine/oxidised SWNTs (8 M) 1589.8 ±  0.3 
Guanosine/oxidised SWNTs (8 M) 1590.8  ±  0.3 
Thymidine/oxidised SWNTs (8 M) 1590.4 ± 0.2 
Cytidine/oxidised SWNTs (8 M) 1590.9 ± 0.3 
Uridine/oxidised SWNTs (8 M) 1590.2 ± 0.4 
Table  6-7: Raman G band of purified SWNTs (control) and peptoids dispersed purified 
SWNTs. 
 
The G-band split into G
+
 and G
− 
mode in both oxidised SWNTs (8 M) (control) and 
ribonucleoside/oxidised SWNTs (8 M) composites. This indicates that the dispersed 
nanotubes are a mixture of metallic and semiconducting nanotubes. The noncovalent 
interaction between ribonucleosides and oxidised SWNTs give rise to the change in 
the G
+
 band compared the oxidised SWNTs (control). Figure 6-22 show that the 
intensity of G
+
 band of adenosine/oxidised SWNTs (8 M) is less than that of oxidised 
SWNTs (8 M) (control). While, guanosine/oxidised SWNTs (8 M) composite has a 
higher G
+
 band than oxidised SWNTs (control). Previous researchers have claimed 
that the BWF line intensity for the G-mode of metallic tubes enhanced in 
individualised of nanotubes and can be decreased in a bundled one.
137,358
 Thus, these 
results indicate that adenosine has a very weak interaction with the nanotubes, and 
the dispersed nanotubes are dispersed in bundles. On the other hand, 
guanosine/oxidised nanotube composite shows high intensity of comparing to 
oxidised SWNTs control sample and other ribonucleoside/oxidised nanotube 
composites. This indicates that oxidised SWNTs are individually dispersed by 
guanosine. These results agree with the UV-Vis-NIR absorption intensity of 
ribonucleoside/oxidised SWNTs (8 M) composites.   
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Figure  6-22: A representative Raman G-band spectra of ribonucleoside/oxidised SWNTs (8 
M) composites and oxidised SWNTs (8 M) as a control: (Orange line) adenosine/oxidised 
SWNTs (8 M), (Black line) oxidised SWNTs (8 M) (control), (Pink line) uridine/oxidised 
SWNTs (8 M), (Green line) thymidine/oxidised SWNTs (8 M), (Red line) cytidine/oxidised 
SWNTs (8 M), (Blue line) guanosine/oxidised SWNTs (8 M),   
 
6.2.2.2.1. Effect of pH on Dispersions  
Several possible mechanisms can be used to explain the interaction between SWNTs 
and ribonucleosides. Hydrogen bonding between amine groups on nucleobases and 
oxygen functional groups (e.g., COOH) on SWNTs is not likely to be the primary 
force driving the interaction. This is mainly because if this were true, then the 
affinity of nitrogenous nucleobases to SWNTs would increase with decreasing pH, 
because as pH deceases, there is a transition from the COO
-
 group to the COOH 
group on the surface of the SWNTs. Another possible electron donor acceptor (EDA) 
interaction is that the lone-pair electrons in the nucleobase can act as n–electron-
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donors and might interacts through n–π EDA with the π–electron acceptor of carbon 
nanotubes. However, similar to π–π EDA, n–π EDA interactions usually enhanced at 
high pH, which was experimentally proved to completely impede the dispersion. 
However, experimentally it was found that at high pH the dispersion precipitated 
completely (Table 6-7).  
Dispersion  pH Conc. of Dispersed 
Oxidised SWNTs 2 M 
µg mL
-1 
Conc. of Dispersed 
Oxidised SWNTs 8 M 
µg mL
-1 
 
Adenosine/SWNTs  
2 0 0 
12 0 0 
 
Guanosine/SWNTs 
2 0 0 
12 0 0 
Table  6-8: Concentration of adenosine/SWNTs and guanosine/SWNTs dispersion at 
different pH.  
 
It is thought that Lewis acid base interaction is the main mechanism controlling the 
interaction of nucleobases’ moiety of a ribonucleoside with nanotubes. The NH2 
group in the nucleobases’ moiety serves as the weak Lewis base and the oxygen-
containing functional groups on carbon nanotubes serve as Lewis acids. As 
previously discussed, the adsorption of nucleobases onto oxidised nanotubes was 
stronger the same process with purified nanotubes. This can be explained explains by 
the fact that untreated nanotubes do not possess any oxygen-containing functionality 
and, thus, the Lewis acid base interaction cannot be in effect. 
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6.2.2.2.2. Watson Crick Base-Pairing Effect  
It was found that the mixing two complementary ribonucleoside/oxidised SWNTs (8 
M) composites leads to the precipitation of the SWNTs (Figure 6-23). It is thought 
that Watson Crick base-pairing occurs between ribonucleosides while still 
noncovalently bounded to a carbon nanotube side wall. Thus, mixing two 
complementary ribonucleoside/oxidised SWNTs composites (thymidine/oxidised 
SWNTs with adenosine/oxidised SWNTs) leads to aggregation of the carbon 
nanotubes and thus the sedimentation of the SWNT. 
 
Figure  6-23: Sedimented SWNTs due to Watson Crick base-pairing between 
complementary ribonucleosides. 
 
The same aggregation behavior was observed for guanosine/oxidised SWNTs with 
cytidine/oxidised SWNTs. In theory this pairing of ribonucleosides protocol could 
allow the recovery of SWNTs from aqueous dispersions. Such an H-bonding driven 
recognition process could be of use in a diverse range of methodologies for example 
in the recognition of organic molecules, metals and supramolecular molecules.
346,347
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6.3. Conclusion  
In this chapter, the noncovalent interaction of ribonucleosides, nucleobases, and 
ribose sugar with purified and oxidised SWNTs was studied. The lack of dispersion 
of purified SWNTs by ribonucleosides determined from their UV-Vis-NIR 
absorption indicate that the cyclic and aromatic ring of ribonucleosides, nucleobases 
are too small to disperse the hydrophobic nanotube surface by π–π stacking. On the 
other hand, the ribonucleosides vary in the dispersion ability toward nanotubes 
depends on the number of oxygen-containing functional groups on the nanotube’s 
surface and the competition between water molecules which can from hydrogen 
bonds with oxidised nanotubes, with ribonucleosides and nucleobases over 
adsorption sites. Furthermore, ribonucleosides show different dispersion affinity 
towards oxidised nanotubes of similar number of oxygen-containing functional on 
their surface. Since the ribose moiety is present in all ribonucleosides, it 
demonstrates the important role of the nucleobase moiety in ribonucleoside in 
nanotube dispersion. Additionally, it was found that mixing two complementary 
ribonucleoside/oxidised SWNTs resulted in precipitation of the nanotube due to the 
Watson Crick pairing. These results suggest that the interaction depends on a 
nonhydrophobic interaction between the nucleobase moiety in a ribonucleoside 
interacts with oxygen functional groups on nanotube surface. While, its ribose sugar 
moiety interacts with water molecules. 
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7. COVALENT AND NONCOVALENT FUNCTIONALISATION OF 
GRAPHENE BASED NANOMATERIALS WITH BIOMOLECULES 
 
7.1. Introduction 
7.1.1. Structure  
Graphene is a single atomic layer of sp
2
 two-dimensional (2D) hybridised carbon 
atoms arranged in a honeycomb structure.
359
 As illustrated in Figure 7-1, the 
graphene sheet is a basic building block for graphitic materials of all other 
dimensionalities. The graphene planar sheet can be ‘wrapped’ into a 0D spherical 
C60 buckyball, ‘rolled’ into a 1D carbon nanotube, or ‘stacked’ into 3D graphite.  
 
Figure  7-1: Mother of all graphitic forms. Graphene is a 2D building material for carbon 
materials of all other dimensionalities. It can be wrapped up into 0D buckyballs, rolled into 
1D nanotubes or stacked into 3D graphite. Reprinted by permission from Macmillan 
Publishers Ltd: [Nature Materials] [359] copyright (2007).  
Chapter 7 
161 
 
At the molecular level, a single-layer graphene sheet has two different structural 
regions, basal plane and edge
360
 (Figure 7-2). The graphene basal plane is enriched 
with π electrons where each carbon atoms bonded with three adjacent carbon atoms 
with sp
2
 hybridised orbitals forming robust σ bonds, and the rest of the electrons in 
the p atomic orbitals are delocalised over the basal plane of the graphene sheet 
forming a π bond. Therefore, it is possible for the graphene to interact with the 
molecules through π–π stacking interaction.361  
 
Figure  7-2: A conceptual schematic model of the structure of graphene-indicating its basal 
and edge plane like sites. Reproduced from [362] with permission of The Royal Society of 
Chemistry. 
 
The edge plane graphite contains a variety of sites, often called “armchair” or “zig–
zag” as shown in Figure 7-3.360 The edge of the majority of synthesised graphene 
consists of a mixture of the two motifs. The two edge types leading to different 
electronic and magnetic properties.
363
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Figure  7-3: Edge states of a graphene sheet showing an armchair (Blue) and zigzag (Red) 
edge type.  
 
Although the term graphene refers to a single two-dimensional hexagonal sheet of 
carbon atoms, it is usually stacked into bi- and few-layer graphene. In general few-
layer graphene is defined as being less than ten carbon layers thick, as beyond this 
the electronic structure resembles that of graphite.
359,364
 Therefore, graphene 
properties are sensitive to the number of layers, their stacking configuration and mis-
orientation with respect to each other.
365,366
 In bi- and few-layer graphene, Carbon 
atoms can be stacked in different ways, generating hexagonal or AA stacking, Bernal 
or AB stacking, and rhombohedral or ABC stacking, finally discernible stacking  or 
turbostratic (Figure 7-4).
367
 The interlayer spacing for turbostratic graphene (> 0.342 
nm) has been found to be larger than that of crystalline graphene (0.335 nm), which 
is thought to enable rotation and translation of the graphene sheets due to the 
increased distance resulting in weaker inter-planar bonding.
132
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Figure  7-4: (a) Graphene structure of single two-dimensional hexagonal sheet of carbon 
atoms, (b) bilayer, and (c) tri (few)-layer stacking sequences. Reprinted by permission from 
Macmillan Publishers Ltd: [Nature Physics] [366], copyright (2011). 
 
There is no chemical bond between the individual graphene layers in graphite; rather 
they are bonded to each other through weak van der Waals interactions which makes 
it easy to separate (exfoliate) them into individual graphene sheets.  
 
7.1.2. Synthesis   
Although graphene occurs naturally, graphene oxide does not, and its preparation 
relies on either top-down or bottom-up synthesis method (Figure 7-5). 
 
Figure  7-5: A schematic of top down and bottom up graphene synthesis. Reproduced from 
[368] with permission of The Royal Society of Chemistry. 
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Prior work has shown that the performance of graphene in many applications 
strongly depends on the preparation method, which has been a major topic of 
interest.  
Many approaches have been successful in producing graphene. Top-down methods 
tend to use natural or synthetic graphite and in various ways to ‘peel off’ single 
graphene sheets. Methods such as the Scotch tape stripping, ion sputtering, pulsed 
laser deposition, ball milling and arc discharge are all examples of top-down 
approaches.
368
 Bottom-up methods, on the other hand, usually make use of small 
carbon containing molecules or some other carbon source and build up graphene 
structures by joining carbon atoms together to grow up graphene. Synthetic routes 
such as chemical vapour deposition (CVD), wet chemistry or the so-called Fischer-
Tropsch synthesis, ion implantation, pyrolysis can be regarded as examples of 
bottom-up approaches.
368,369
 Figure 7-6 summaries the synthesis methods of 
graphene oxide. 
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Figure  7-6: Illustration of the Preparation Methods for Graphene and Graphene-Related 
Materials. Reprinted from [370] with the permission with permission from the American 
Chemistry society. 
 
7.1.3. Graphite Oxide and Graphene Oxide (GO) 
Graphite oxide can be described as an atomically thin sheet of graphite with various 
organic functional groups covalently bonded to its basal plane and edges.
371
 
According to recent studies these include epoxy and hydroxyl moieties bonded to the 
basal plane and carbonyl, carboxylic acid and lactol groups on the edges.
166
 The 
presence of these functionalities in random abundance makes graphite oxide a 
chemically complex, inhomogeneous system consisting of a hybrid sp
2
/sp
3
 domain. 
These functional groups provide reactive sites for a variety of surface-modification 
reactions to develop functionalised graphene base nanomaterials. When compared to 
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graphite, the presence of these functional groups between layers also results in the 
interlayer spacing of graphite oxide (6 – 12 Å depending on the amount of 
intercalated water) being larger than that of graphite (3.4 Å)).
372
 However, due to the 
disruption of the conjugated electronic structure by these functional groups, graphene 
oxide is electrically insulating with irreversible defects and disorders.
373
 
Additionally, the presence of the oxygen-containing functional groups makes 
graphite oxide thermally unstable, as it undergoes pyrolysis at elevated 
temperatures.
166
 The most important features of graphite oxide is that it is 
hydrophilic in nature and can be readily exfoliated via thermal treatments or 
sonication in water, to allow stable dispersion consisting mostly of single layered 
sheets which is known as graphene oxide (GO) (Figure 7-7).
80,374,375
  
 
Figure  7-7: Production of GO dispersion from graphite oxide though oxidation and 
exfoliation. Reproduced with permission from [376]; published by [MDPI], [2014]. 
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Graphite oxide can be synthesised through the oxidation of graphite using strong 
acids and oxidants. The first method was introduced in 1859 by Brodie.
377
 This 
method involved several repeated oxidation cycles of graphite powder in a mixture 
of potassium chromate and fuming nitric acid producing a material that contained 
carbon, hydrogen and oxygen in a ratio of roughly 61:2:37. The Brodie method was 
later improved by Staudenmaier (1898),
378
 and even further by Hofmann and König 
(1937).
379
 However, the most signiﬁcant paper on the synthesis of graphite oxide was 
published in 1958 by William Hummers and Richard Offeman,
380
 which was later 
modified by Marcano et al.
381
 The Hummers and Marcano methods involve the 
heating of graphite in sulphuric acid with the addition of potassium permanganate 
and sodium nitrate, which generates nitric acid in situ.  
All of the above methods use strong oxidisers and harsh conditions to oxidise 
graphite flakes into graphene oxide. The harsh oxidation conditions results in a 
significant portion of double bonds of graphite sheet being broken and forming of 
various oxygen containing functional groups which decorate the surface and edges of 
the graphite sheets. Regardless of the oxidation method, the GO produced contains 
the same type of functional groups, but their relative and absolute abundance 
depends on the oxidation conditions, which play the key role in the formation of GO. 
For example, the carbon-to-oxygen elemental ratio (C/O), which is a measure of the 
degree of oxidation of GO, depends on the method used (i.e. nature of the oxidant), 
reaction time, the amount of oxidant, and reaction temperature. Table 7-1 shows the 
effect of the difference in graphite oxidation condition on the C/O ratio in graphite 
oxide. Additionally, the starting material, especially graphite flake size, affects the 
efficiency of the oxidation.  
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Method Oxidant Reaction media C/O ratio 
Staudenmaier KClO3 Fuming HNO3 1.17 
Brodie KClO3 HNO3 + H2SO4 - 
Hofmann KClO3 Non-fuming HNO3 1.15 
Hummers KMnO4 + NaNO3 Conc. H2SO4 0.84 
Marcano KMnO4 H2SO4 + H3PO4 0.74 
Table  7-1: Summary of the effect between graphite oxide synthetic methods on the degree of 
oxidation. 
 
7.1.3.1. Graphene Oxide Structure 
Similar to synthetic methods, the structure of GO has also greatly evolved over time. 
The complexity associated with preferential oxidation of graphite oxide’s aromatic 
domains, and the defects that accompany it makes predicting the oxidation 
mechanism of graphite oxide a challenging problem. In addition to this, the possible 
variability in graphite starting material and its highly amorphous structure makes 
predicting a structural formula for GO a difficult question to answer. Figure 7-8 
summarises several structural models that have been proposed, with the Lerf-
Klinowski perhaps the most wildly accepted. 
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Figure  7-8: Summary of proposed structural models of GO. Reproduced from [382] with 
permission of The Royal Society of Chemistry. 
 
7.1.4. Reduction of Graphene Oxide 
The main reason for GO’s popularity, at least initially, was to synthesise single 
graphene sheet, due to the remarkable electronic and optical properties of graphene. 
As discussed earlier, the oxidation of GO destroys the planar sp
2
 carbons of graphite 
and converts them to sp
3
 carbons.
80,383
 Therefore, the π-electronic conjugation of 
graphite is destroyed in GO, resulting in a significant decrease in electrical 
conductivity and makes GO thermally unstable at elevated temperatures.
384
 The 
reduction reaction is utilised to restore or at least partially restore the GO’s conjugated 
system and thus increases the electrical conductivity and thermal stability of GO close 
to the level of an exfoliated graphene sheet. However, reduced graphene oxide (rGO) 
does not quite resemble either graphene oxide or graphene but is something in between 
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these materials. It is moderately hydrophobic but can be dispersed in water to some 
extent, as well as in several organic solvents. It is a rather good electrical conductor 
but not as good as graphene. Its mechanical properties are closer to GO than pristine 
graphene. There are several methods used for the reduction of GO including 
chemical,
385
 thermal,
386
 electrochemical,
387
 and photochemical methods.
388
  
 
7.1.5. Surface Functionalisation of Graphene Oxide  
The majority of previous graphene based research concentrates on the electronic 
application of graphene; however, research on the biomedical applications of 
graphene nanomaterials are only now ﬂourishing.389,390 This is due to the graphene’s 
high speciﬁc surface area which renders it an ideal substrate for high-density 
biofunctionalisation, facilitating the development of nanomaterial based biomedical 
applications.
391
 However, because graphene based nanomaterials are derived from 
hydrophobic graphite through chemical or physical modiﬁcation; their biological and 
biomedical applications have been hampered by their instability under physiological 
conditions.
392-396
 Therefore, in order to exploit them in such applications, it is critical 
to establish versatile functionalisation method to provide high dispersion stability of 
graphene based nanomaterials with biomolecules or bioactive materials. To improve 
their solubility in physiological media, covalent and noncovalent functionalisation 
methods have been widely utilised for the preparation of biofunctionalised graphene 
based nanomaterials.
397
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7.1.5.1. Noncovalent Functionalisation  
Pristine graphene sheets are hydrophobic in nature, so they are difficult to dissolve in 
polar solvents. This makes functionalisation of graphene sheets important for their 
future applications. The noncovalent interaction of biomolecules with carbon 
graphene based nanomaterials greatly enhances their structural functionality, making 
it possible for these hybrids to be used in biological processes. Noncovalent 
functionalisation of graphene based nanomaterial essentially relies on weak 
interactions, such as π–π stacking interactions, hydrophobic effects, van der Waals 
forces, and electrostatic interactions.
80
 Thus, it preserves the π-system of graphene 
and thus its electronic properties. There are various adsorptive sites on graphene 
nanomaterials surface including ﬂat π–networks, defects, and functional groups 
attached to the surfaces and edges. According to the Lerf-Klinowski model, the 
carbonyl and carboxylic groups remain attached to the edges of the GO sheet, while 
the hydroxyl and epoxy groups are found on the basal plane.
80,371,398
 These groups 
render the GO sheets hydrophilic due to the H-bonding present between the 
carboxylic and hydroxyl groups. Additionally, they provide sites for noncovalent 
functionalising through hydrogen bonding with biomolecules. On the contrary, 
reduced graphene oxide sheets have a very limited number of oxygen-containing 
functional groups, and thus tend to from aggregates with poor dispersion stability 
under physiological conditions.
399
 Although, rGO planar surface provides a high 
capacity for hydrophobic interactions with various biomolecules, it has a tendency to 
agglomerate irreversibly due to its strong hydrophobicity, or even to restack into 
graphite through van der Waals interactions in the absence of stabiliser.
166,400-405
 
Therefore, there is a great challenge for using rGO for biological and biomedical 
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applications. However, their surface modiﬁcation with biomolecules has been used to 
stabilise and improve their utility under physiological conditions. Various 
biomolecules have been reported to be integrated with graphene based nanomaterials, 
such as proteins, nucleic acids, cells, bacteria, and so on, as illustrated in Figure 7-9. 
 
Figure  7-9: Biofunctionalisation of graphene based nanomaterials. Reprinted from [406], 
Copyright (2011), with permission from Elsevier. 
 
7.1.5.1.1. Peptide and Protein 
As a result of their varied surface functional groups and secondary structure, peptides 
and proteins can exfoliate and modify graphene based nanomaterials through 
physical adsorption. Amino acids,
407,408
 peptides
409,410
 and proteins
411
 bind to the 
planar or edge of graphene via π–π stacking or electrostatic interactions. The 
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aromatic residue in amino acids, peptides or proteins can adsorb onto graphene and 
reduced graphene oxide (rGO) by π–π stacking. On the other hand, their noncovalent 
interaction with GO is based on the electrostatic interaction between charged or polar 
residues in amino acids, peptides and proteins with the oxygen containing groups of 
GO. 
π–π stacking is an attractive interaction between aromatic rings, especially carbon 
nanomaterials and aromatic groups. A previous study investigated the interaction of 
aromatic amino acids (Phe, His, Tyr, and Trp) with graphene, suggested that the 
aromatic rings of the amino acids prefer to orient in parallel with respect to the plane 
of the graphene sheet, the so-called π–π interactions. Remarkably, the polarisability 
of the aromatic ring and the strength of the interaction are highly correlated: the 
higher the polarisability is, the greater the binding strength is, following the trend: 
His < Phe < Tyr < Trp. They also found that the binding strength with CNTs was 
weaker than that with the graphene sheet, which may be associated with the surface 
curvature.  
Hydrophobic interactions are another important contribution to proteins and peptides 
interaction with graphene based nanomaterials. Hydrophobic interactions tend to 
minimise the non-polar surface, by clustering hydrophobic groups to avoid exposure 
to hydrophilic media. Since graphene based nanomaterials have large hydrophobic 
areas, they tend to bind to the partially exposed non-polar residues of proteins and 
peptide. For example, Kowalewski et al.
412
 reported that on hydrophobic graphite 
surfaces, the Alzheimer’s amyloid β-peptide (Aβ) forms uniform, elongated β-sheet, 
whereas less-ordered particulate aggregates appear both at hydrophilic mica and 
positively charged surfaces. Sheng et al.
413,414
 used molecular dynamics simulations 
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(MD) to study the interaction between ionic complementary peptide EAK16-II 
(AEAEAKAKAEAEAKAK) on the hydrophobic surface of graphene. They found 
that the hydrophobic interaction is the main force to govern the peptide adsorption, 
and the inter-peptide electrostatic interaction affects the adsorption rate. Guo et al.
415
 
investigated by density functional theory the interaction between carbon 
nanostructures with tripeptide arginine-glycine-aspartic acid. Their results revealed 
that GO has a stronger interaction with tripeptide than the pristine and the defective 
graphene because of oxygen-containing functional. The oxygen-containing 
functional groups are able to form hydrogen bonds with the functional groups of 
tripeptide. The comparison of its interaction on the GO model with OH, epoxy, and 
mixed OH/epoxy groups reveals that diﬀerent oxygen-containing functional groups 
have distinguishing binding ability with tripeptide. While Chen et al.
416
 prepared 
biocompatible and stable rGO suspension by using L-lysine amino acid as a reducing 
agent and sodium cholate as a stabiliser. 
The hydrophobic interaction between proteins and peptide with graphene based 
nanomaterials usually unfolds the protein's and peptides’ native structure.417-419 This 
is probably due to the fact that the hydrophobic graphene based nanomaterials bind 
more tightly with unfolded proteins, which have more hydrophobic residues exposed 
than the native proteins and peptides. Moreover, it was found that graphene may 
possess a higher capability than CNTs to break α-helices due to proteins and peptides 
are more favourable surface curvature.
309
 Peptides adsorption on graphitic 
nanomaterials changes the physiochemical properties of both the proteins and the 
graphitic nanomaterials, leading to an alteration of their properties.
420
 Peptides and 
proteins are more flexible than graphitic nanomaterials. During the interaction 
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process, graphitic nanomaterials surface disturbs the native structure of peptides and 
proteins as well as their self-assembly pathway.
421,422
 Since peptides and proteins 
biological activity is influenced by their secondary structure, these conformational 
changes, could lead to the loss of function (e.g. enzyme activity). Therefore, 
resolving the peptide’s structure upon their interaction with graphene like 
nanomaterials is fundamentally important for their application.
423
 Molecular 
dynamics simulations has been used in elucidating the structure of adsorbed 
biopolymers at carbon nanomaterials surfaces, thereby enabling a deeper 
understanding of the connections between biopolymers’ structure and carbon 
nanomaterial geometry. It is evident from the MD simulations on adsorption of 
peptides and proteins depend mainly upon the size, curvature and surface chemistry 
of CNTs and graphene oxides.
424,425
 Zuo et al.
426
 studied the adsorption of protein 
villin headpiece (HP35) on graphene using large scale molecular dynamics 
simulations (Figure 7-10). Their results indicated that the π–π stacking interactions 
between the graphene and HP35’s aromatic residues play a key role in this 
adsorption. 
 
Figure  7-10: (Left) A typical structure of HP35 adsorbed on the graphene surface. Here, 
HP35 is shown as a cartoon with red helix and green loop, the graphene is shown as the cyan 
lines. (Right) The superposition of the adsorbed HP35 structure on graphene (red) with its 
native structure (green). Reprinted with permission from [426]. Copyright (2011) American 
Chemical Society. 
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Radic et al.
427
 used rapid discrete-molecular-dynamics simulations to examine the 
binding of graphene and graphene oxide with peptides, fatty acids, and cellulose. 
Their simulations revealed that the amphiphilicity of cellulose, peptide and palmitic 
acid, owing to their differences in hydrocarbon content, conformational flexibility, 
and molecular geometry, displayed distinct binding affinities for the graphene 
derivatives. Katoch et al.
428
 used atomic force microscopy (AFM), Raman 
spectroscopy, fourier transform infrared (FTIR) spectroscopy, and molecular 
dynamics simulations to investigate the dodecamer peptide (GAMHLPWHMGTL) 
binding behaviour to graphene and graphite (Figure 7-11). FTIR spectra of the 
adsorbed peptide on graphene indicate that the peptide’s helical structure is disrupted 
upon the interaction with graphene surface. 
 
Figure  7-11: Molecular dynamics based structure of the dodecamer peptide (a) in vacuum, 
(b) in water, and (c) on a graphene sheet. Reprinted with permission from [428]. Copyright 
(2012) American Chemical Society. 
 
Guo et al.
429
 studied the effect of planarity of graphene on protein conformations. 
Their results indicate that β-sheet-rich proteins have almost no loss of secondary 
structures upon interaction with graphene, while α-helical proteins involves a partial 
loss of α-helices upon interaction.  
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7.1.5.1.2. Enzymes 
Like proteins, enzymes are long, linear chains of amino acids that fold to 3D 
structures. Immobilisation of enzymes on certain solid substrate is an efficient way to 
improve their performance. Among a range of materials that have been employed as 
solid matrixes for enzyme immobilisation, graphene or GO seems to be an ideal 
choice with the unique 2D structure, ﬂat plane, tunable functionalities, structural 
characteristics. GO used as a matrix for enzyme immobilisation was first reported by 
Zhang et al.
430,431
 They studied the noncovalent interaction between horseradish 
peroxidase (HRP) and lysozyme molecules onto GO. By varying the immobilisation 
conditions for both HRP and lysozyme, they demonstrated that the HRP and 
lysozyme immobilisations on the GO were dominated by the electrostatic interaction 
between negatively charged GO sheets and enzyme molecules. Moreover, the flat 
surface of GO makes it possible to observe the native immobilised enzyme in situ 
with AFM, as shown in Figure 7-12. 
 
Figure  7-12: AFM images of the GO-bound HRP with (A) lower and (B) higher enzyme 
loadings acquired in a liquid cell. (C) Schematic model of the GO-bound HRP. (D) Initial 
reaction rates of GO-bound HRP vs. HRP concentration. Reprinted with permission from 
[430]. Copyright (2010) American Chemical Society. 
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The electrostatic interactions between enzyme molecules and GO are complicated 
because the charge status of the surface functional groups of the enzyme depends 
strongly on the environmental conditions. Additionally, surface density of the 
oxygen-containing functional groups on the GO are varied with the preparation 
procedure and storage conditions. Therefore, different enzymes could exhibit 
different enzyme loadings and stabilities on the GO.
361
 Zhang et al.
432
 studied the 
possibility of hydrophobic interactions between rGO and two model enzymes, HRP 
and oxalate oxidase (OxOx). Their result implied that the interaction between the 
enzymes and rGO is dominated by the hydrophobic interaction. Furthermore, the 
results indicate that the hydrophobic interaction between the enzymes and rGO is 
stronger than the electrostatic interaction between the enzymes and GO (Figure 7-
13). 
 
Figure  7-13: HRP (A) and OxOx (B) loadings on GO and CRGO as a function of the total 
amount of enzyme. GO and CRGO weights are all 1 mg. Reproduced from [432] with 
permission of John Wiley and Sons. 
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7.1.5.1.3. DNA 
The large 2D aromatic surface of graphene makes it an ideal substrate for adsorption 
of DNA. The DNA molecule and graphene sheet are ideal nanostructures to fabricate 
novel nanobiohybrid materials to construct highly sensitive nanobioelectronic 
devices including sensors and chips.
433,434
 Furthermore, the adsorption of DNA on an 
electrode surface may lead to new approaches to deliver drugs in DNA grooves.
435-437
 
Wu et al.
438
 investigated the noncovalent interaction between GO and DNA. They 
found that the adsorption of DNA on GO is affected by several factors, such as 
cations, pH, organic solvent and temperature. Generally, shorter DNA binds to the 
surface with faster kinetics and higher adsorption efficiency. However, by adding c-
DNA to form double-stranded (dsDNA) and increasing temperature, desorption can 
occur, as shown in Figure 7-14. 
 
Figure  7-14: Dye labelled DNA adsorption and desorption on GO. Reprinted with 
permission from [438]. Copyright (2011) American Chemical Society. 
 
Lu et al.
439
 demonstrated the ability of water-soluble GO as a platform for the 
sensitive and selective detection of DNA and proteins. Figure 7-15 shows a 
schematic representation of this detection platform. 
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Figure  7-15: Schematic representation of the target-induced fluorescence change of the 
ssDNA-dye-GO complex. Reproduced from [439] with permission of John Wiley and Sons. 
 
The fluorescence emission indicated that the GO noncovalent interaction with dye-
labelled ssDNA completely quenches the fluorescence of the dye (Figure 7-15). 
However, in the presence of a target, the binding between the dye-labelled DNA and 
target molecule altered the conformation of dye-labelled DNA, and disturbed the 
interaction between the dye-labelled DNA and GO. This feature could result in a 
fluorescence-enhanced detection system that is sensitive and selective to the target 
molecule. On the other hand, GO scarcely interacts with the rigid structure of dsDNA 
probably due to the efficient shielding of nucleobases within the negatively charged 
phosphate backbone of dsDNA.
440
 Thus, according to the fluorescence quenching of 
DNA-GO complex, Huang et al.
441
 found that GO can selectively remove ssDNA 
from dsDNA with a simple mixing and centrifugation operation as shown in Figure 
7-16. 
 
Figure  7-16: GO-based selective removal of ssDNA. Reprinted with permission from [441]. 
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7.1.5.1.4. Small Molecules   
The interaction of graphene with DNA, nucleobases, and nucleosides has potential 
medical and industrial applications. Several experimental and computational studies 
have focused on studying the binding of diﬀerent nucleosides and their derivatives 
on graphene like materials. In computational studies, Antony et al.
442
 calculated the 
interaction energy of DNA nucleobases with graphene with the dispersion-corrected 
density functional theory method and obtained the order guanine > adenine > 
thymine > cytosine. Vovusha et al.
443
 studied the interaction of nucleobases and 
aromatic amino acids with graphene and graphene oxide (GO) by ab initio density 
functional theory. Their results indicated that GO complexes are stabilised by 
hydrogen bonding interactions whereas graphene complexes are stabilised by π–π 
interactions, leading to enhanced binding energies for GO complexes compared to G 
complexes (Figure 7-17). Similar observations were found by Xu et al.
444
 
 
Figure  7-17: The hydrogen bonding between nucleobases and graphene based 
nanomaterials. Reprinted with permission from [443]. Copyright (2013) American Chemical 
Society. 
 
Single solute adsorption isotherm study of DNA nucleobases at the graphite-water 
interface showed that the adsorption strength to vary guanine > adenine > thymine > 
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cytosine.
445
 Similar calculations suggested that cytosine has a very weak interaction 
with graphene surfaces.
446
 It is interesting to note that the majority of studies shown 
that nucleobases and nucleosides binding to graphene surface depend on π–π 
interactions. However, work by Spiwok et al.
447
 showed that nucleobases interaction 
with graphene form hydrogen-bonded complexes in vacuum but prefer π–π stacking 
in partially and fully solvated systems as shown in Figure 7-18. 
 
Figure  7-18: Interaction between nucleobases and nucleosides. Reprinted with permission 
from [447]. Copyright (2011) American Chemical Society. 
 
Theoretical and AFM measurements show that nucleobases bind to graphene more 
strongly through π–π stacking as well as hydrogen bonding interaction.448 Varghese 
et al.
329
 carried out experimental investigation to study the binding of nucleobases 
and nucleosides with graphene using isothermal titration calorimetry (ITC). They 
found that the relative interaction energies of the nucleobases decrease in the order 
guanine > adenine > cytosine > thymine in aqueous solutions. The studies on the 
effect of carbon nanomaterials topography on the noncovalent interaction show that 
the curvature of the nanomaterial has a strong influence on their noncovalent 
interaction.
449,450
 Umadevi et al.
330
 studied interaction of graphene and CNTs of 
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different radius with the nucleobases using dispersion-corrected DFT based approach 
and observed that the binding energy depends on the curvature of the nanomaterial. 
 
7.1.5.2. Covalent Functionalisation  
Compared to the noncovalent modification of graphene, the covalent approach offers 
the advantage of achieving permanent stabilisation of the functionalised graphene 
sheets.
451
 Furthermore, it provides the opportunity to impart aqueous solubility, 
processability, and biocompatibility to graphene.
452
 However, the main drawback of 
this approach is that it is associated with destroying the sp
2
 of the π network into a 
sp
3
 conﬁguration leading to a partial or total loss of π–π conjugation. As a 
consequence, the intrinsic physical, chemical and electronic properties could be 
altered considerably. 
The covalent functionalisation of graphene oxide is the most exploited method for 
the connection of solubilising bioactive moieties to graphene surface. Therefore, lots 
of effort has been made towards constructing hybrids of biological and carbon 
nanocomposites due to their paramount importance in both biosensing and drug 
delivery.
453
 
Because of the one-atom-thick flat sheet nature of graphene, the chemical reactivity 
of this carbon nanoform may occur on the π surface and/or on the edges.454 On the 
basal plane, sp
2
 hybridisation of carbon leads to a strong covalent bonding as well as 
to delocalisation of the π electrons. Therefore, the covalent interaction of the basal 
plane leads to modification of the π–π conjugation and thus the electron density 
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distribution and the physical and chemical properties. The carbon atoms in the basal 
plane are protected by their π–conjugation system.453 Thus, during the covalent 
addition, the basal carbon has to protrude outward from the plane to adopt a 
tetrahedral sp
3
 geometry, causing strain in the plane. Therefore, their covalent 
modification usually encounters large energy barriers.
455
 On the other hand, the edge 
of graphene oxide can undergo reaction with low energy barriers as their sp
3
 
hybridisation have a tetrahedral geometry thus does not imply additional strain for 
the basal carbon atoms.
391,453,456
 Therefore, edge carbon atoms are preferred in 
covalent addition reactions. 
Different techniques have been explored for the covalent derivatisation of GO, but 
this section will concentrate in the covalent modification of GO related to the 
preparation of materials for biological purposes, which mainly involve esterification, 
and amidation of the carboxyl groups.
457,458
 Addition of nucleophilic species, amines 
or hydroxyls, produce covalently attached functional groups to GO via the formation 
of amides or esters often require activation of the carboxylic acid group either by 
converting it to acid derivatives via the acyl chloride or by using coupling 
activators.
459-461
 Figure 7-19 shows the direct and indirect coupling leads to the 
formation of ester and amide bonds. In the indirect route for esterification and 
amidation that utilises SOCl2, GO is typically exfoliated in relatively non-
nucleophilic solvents and then refluxed with a large excess of the chlorinating agent, 
followed by the addition of a nucleophile. While the direct route involves utilising 
coupling agents, including such as 1-ethyl-3-(3-dimethylaminopropyl)- carbodiimide 
(EDC), N,N′-dicyclohexylcarbodiimide (DCC), or 2-(7-aza-1H-benzotriazole-1-yl)-
1,1,3,3-tetramethyluronium hexaﬂuorophosphate (HATU), GO is first exfoliated in a 
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polar solvent (typically DMF or NMP) and then treated with a catalytic amount of 
N,N-dimethylaminopyridine (DMAP), N-hydroxysuccinimide (NHS), or another 
carboxylic acid activator. Subsequent addition of nucleophilic species, such as 
amines or hydroxyls, produce covalently attached functional groups to graphene 
oxide platelets via the formation of amides or esters.
80
 
 
Figure  7-19: Activation of GO's peripheral carboxylic acid groups with either SOCl2 or a 
coupling agents, and subsequent condensation with an alcohol or an amine. Reproduced 
from [382] with permission of The Royal Society of Chemistry. 
 
7.1.5.2.1. Amidation  
On GO, amidation proceeds mainly through the reaction between the -COOH group 
native to GO and the -NH2 group of the functional molecule, or vice versa. Various 
NH2 terminated functional groups have been anchored onto graphene. He et al.
462
 
reported the synthesised GO-Fe3O4 hybrid in a two-step process. In the first, Fe3O4 
was modiﬁed by tetraethyl orthosilicate and (3-aminopropyl) triethoxysilane to 
introduce amino groups on its surface. Then, with the aid of N-hydroxysuccinnimide 
(NHS) and 1-ethyl-3-(3-dimethyaminopropyl)carbodiimide (EDC), GO-Fe3O4 hybrid 
was obtained from the condensation reaction between amino group of Fe3O4 and 
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carboxylic group of GO. The synthesis process of GO-Fe3O4 hybrid is schematically 
illustrated in Figure 7-20.  
 
Figure  7-20: Schematic of the fabrication of GO-Fe3O4 hybrid. Reprinted from [462], 
Copyright (2010), with permission from Elsevier. 
 
The synthesised hybrids not only have great potential as an effective absorbent for 
removing cationic dyes in water, but also could be used to prepare rGO–Fe3O4 
hybrids and magnetic GO ﬁlms, which is suitable for many other applications such as 
fabrication of functional polymer composites, sensors, heterogeneous catalysts, and 
drug delivery. 
Similarly, Shen et al.
461
 studied the functionalisation of GO with biomaterials, 
including adenine, cystine, nicotamide and ovalbumin (OVA) through diimide-
activated amidation. The process used in this study involved two steps, ﬁrstly 
carboxylic acid groups on GO were activated by N-ethyl-N′-(3-
dimethylaminopropyl)carbodiimide hydrochloride (EDAC) with stable active ester 
formed by the addition of N-hydroxysuccinimide (NHS). Second, the active ester 
was reacted with the amine groups on biomaterials, forming an amide bond between 
GO and biomaterials (Figure 7-21). 
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Figure  7-21: A Schematic diagram to produce GOS-based biocomposites. Reprinted from 
[461], Copyright (2011), with permission from Elsevier. 
 
Mungse et al.
463
 developed a chemical approach for selective inclusion of long alkyl 
chains on the edges and defects sites of reduced graphene oxide sheets through the 
amide linkage. The carboxylic functionalities, which were selectively introduced in 
the rGO by mild oxidation, were converted into acyl chlorides using thionyl chloride. 
Subsequently, the acylated-rGO sample was reacted with octadecylamine (ODA). 
Presence of long alkyl chains in the ODA-rGO sheets facilitated their stable 
dispersion in commercial engine oil, which is very important for their eﬃcient 
tribological performance. Using the same amidation technique, Chu et al.
464
 grafted 
CdTe nanorods on a GO surface through an amidation reaction between acyl 
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chlorides of GO and amino groups of the L-cysteine capped CdTe nanorods    
(Figure 7-22). The intrinsic optical properties of the GO–CdTe hybrid material may 
make a promising candidate for graphene- and GO-based materials in optoelectronic 
applications. 
 
Figure  7-22: Synthesis procedure of GO–CdTe hybrid materials through the amidation 
reaction. Reproduced from [464] with permission of The Royal Society of Chemistry. 
 
Liu et al.
94
 and Sun et al.
465
 reported the synthesis of PEGylated nano-GO conjugate 
via carbodiimide catalysed amide formation for delivery of water-insoluble cancer 
drugs and found that the functionalised graphene sheets are biocompatible and stable 
in various biological solutions without obvious toxicity (Figure 7-23). 
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Figure  7-23: Schematic draw of cancer drug (SN38) loaded NGO-PEG. Reprinted with 
permission from [94]. Copyright (2008) American Chemical Society. 
 
Sun et al.
465
 explored ﬁrst the properties of PEGylated NGO for cell imaging. 
Amine-terminated PEG stars (6-armed branched PEG molecules) were grafted onto 
NGO sheets via carbodiimide activation chemistry by formation of amide bonds. The 
resulting functionalised NGO exhibited intrinsic photoluminescence in the near-
infrared range (NIR), providing a NIR probe for cellular imaging. They further 
conjugated PEG-NGO to a B-cell speciﬁc antibody, Rituximab, to selectively 
recognize and bind B-cell lymphoma, proving selective targeting (Figure 7-24). 
 
Figure  7-24: A schematic drawing illustrating the selective binding and cellular imaging of 
NGO–PEG conjugated with anti-CD20 antibody, Rituxan. Reprinted with permission from 
[465].  
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Later on, Yang et al.
466
 investigated the in vivo behaviour of NGO by labelling PEG-
NGO with Cy7, a commonly used NIR ﬂuorescent probe, via amide bond. Their vivo 
ﬂuorescence imaging revealed a remarkably high tumour uptake of NGO, and 
PEGylated NGO showed efficient tumour passive targeting and relatively low 
retention in the reticulo-endothelial system (RES). Irradiation of tumour-bearing 
mice with a low-power NIR laser led to complete ablation of the tumour (Figure 7-
25) showing the potential of graphene derivatives for in vivo PTT. 
 
Figure  7-25: NGS with PEG functionalisation and labelled by Cy7. Reprinted with 
permission from [466]. Copyright (2010) American Chemical Society. 
 
Ali et al.
467
 combined between the direct and indirect amidation techniques for the 
synthesis of antiapolipoprotein B 100 functionalised-aminated reduced graphene 
oxide or detection of low density lipoprotein (LDL or lipid) cholesterol. In the first 
step, the carboxylic groups introduced to rGO were converted into acyl chlorides 
using thionyl chloride. Subsequently, acylated-rGO sample was reacted with 
ethyleendiamine (EDA). Then, the NH2-rGO covalently functionalised with 
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antiapolipoprotein B 100 using EDC/NHS coupling chemistry detection of low 
density lipoprotein (LDL or lipid) cholesterol (Figure 7-26). 
 
Figure  7-26: Apo-lipoprotein B 100 functionalisation on an NH2-rGO sheet for LDL 
detection. Reprinted with permission from [467]. Copyright (2014) American Chemical 
Society. 
 
7.1.5.2.2. Esterification  
The presence of -COOH groups native to graphene renders their functionalisation 
with CH2OH-terminated functional groups feasible, i.e., esterification. There are a 
number of studies addressing this process.
459,468,469
 Yang et al.
470
 covalently grafted 
polysaccharides (hydroxypropyl cellulose and chitosan) onto graphene oxide by 
simple esterification reactions. The oxidation introduced carboxyl groups in 
graphene oxide were then converted into acyl chloride with thionyl chloride (SOCl2). 
Subsequently, hydroxypropyl cellulose or chitosan was covalently grafted onto the 
activated graphene oxide through esterification reactions. The polysaccharide-
functionalised graphenes have potential applications in biological and medical ﬁelds, 
Chapter 7 
192 
 
such as drug delivery, transplant device, and biosensors. Namvari et al.
471
 
synthesised a magnetic nanocomposite of citric-acid-functionalised GO which acts as 
an efficient adsorbent to remove methylene blue from (MB) contaminated water. The 
peripheral carboxylic acids of GO were converted into acyl chloride by treating GO 
with thionyl chloride. Citric acid (CA) was covalently grafted onto the GO through a 
simple esterification reaction. Then, Fe3O4 magnetic nanoparticles (MNPs) were 
chemically deposited onto the GO-CA hybrid. The hybrid surface was negatively 
charged, thus the nanocomposite had a high adsorption capacity with the cationic 
MB. The high adsorption capacity accompanied by the ease of separation by an 
external magnetic field makes the synthesised nanocomposite a powerful separation 
tool to be utilised in wastewater treatment. Salavagione et al.
472
 employed two 
synthetic strategies for grafting poly(vinyl alcohol) (PVA) on G, as shown in Figure 
7-27. The first involves the direct esterification of GO in presence of the N,N′-
dicyclohexylcarbodiimide (DCC) and 4-dimethylaminopyridine (DMAP) catalyst, 
while the second goes through converting GO into acid chloride by reacting with 
SOCl2, followed by coupling with hydroxyl group of PVA. They found that covalent 
linkages between the GO and the PVA are responsible for remarkably altering the 
crystallinity and thermal stability.  
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Figure  7-27: Esterification of Graphite Oxide with PVA. Reprinted with permission from 
[472]. Copyright (2009) American Chemical Society. 
 
Yu et al.
473
 reported functionalisation of GO with −CH2OH terminated regioregular 
poly(3-hexylthiophene) (P3HT) through the formation of ester bonds with the 
carboxyl groups of GO nanoplatelets. The resultant P3HT-grafted GO sheets (G-
P3HT) possess good solubility in common organic solvents. 
Recently, Liu et al.
458
 reported the grafting of hydroxypropyl cellulose (HPC) on GO 
through the esterification reaction in the presence of EDC-HCl and DMAP. HPC-
based materials are useful in removing dyes from aqueous solutions. However, one 
of the main limitations in the practical use of HPC hydrogel is their relatively small 
adsorption capacity. Results shows that the incorporation of GO into HPC hydrogel 
exhibited shows a higher adsorption capacity toward methylene blue compared with 
pure HPC hydrogel. 
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7.2. Results and Discussion 
The objective of the present study is to study the covalent and noncovalent 
functionalisation of rGO with biomolecules, specifically peptide, peptoid, and 
ribonucleosides. The noncovalent functionalisation of rGO investigates the impact of 
the difference in secondary structure of biopolymers (peptides and peptoids) on their 
interaction with rGO. The covalent functionalisation sections studies the 
functionalisation of rGO with cell penetrating peptoid and ribonucleosides to 
improve its solubility in water.  
 
7.2.1. Noncovalent Functionalisation of Reduced Graphene Oxide (rGO) 
with Nano-1 Peptides   
The presence of a large number of hydrophilic oxygen-containing functional groups 
allows GO sheets to readily form stable suspensions in water for several weeks 
without any visible precipitation.
383
 However, the dispersibility of rGO is very low 
and it tends to agglomerate and sediment, therefore hampering further processing of 
the material.
474
  
To better exploit bio-nanotechnology applications it is necessary to gain greater 
understanding of the structure-property relationships of biomolecules at graphitic 
surfaces. The main objective of this section is to study the interaction between rGO 
and helical nano-1 peptides to study the effect of a peptide’s aromatic content on 
rGO dispersion in water. 
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7.2.1.1. Synthesis of Graphene Oxide and Reduced Graphene Oxide 
In order to study the interaction of nano-1 peptides with rGO, graphite oxide was 
first synthesised by the Hummers method.
380
 The graphite oxide was probe sonicated 
for 40 min in an ice bath to exfoliated it and afford GO. Reduced graphene oxide 
(rGO) was formed by reduction with hydrazine monohydrate (N2H4. H2O), which 
generates reduced graphene oxide (rGO). GO and rGO were characterised by Raman 
spectroscopy, and TGA (Appendix D).  
 
7.2.1.2. Synthesis of Nano-1 Peptides   
The degree of folding of a peptide designed to form a helical structure depends on its 
sequence and length.
191,206
 Therefore, in order to investigate the role of peptide 
aromatic content on rGO dispersion, two versions of nano-1 peptide have been 
synthesised (see Chapter 4, Section 4.2.1). The two versions of nano-1 peptide vary 
in the number of aromatic residues on the hydrophobic surface of the helix, and have 
a different helicity.
120
 Table 7-2 shows the nano-1 peptides sequence used in the 
dispersion of rGO. 
Peptide Sequence 
Nano-1 (4) Ac-NH-EVEAFEKKVAAFESK 
VQAFEKKVEAFEHG-CONH2 
Short Nano-1 (6) Ac-NH-EVEAFEKKY- CONH2 
Table  7-2: Nano-1 peptides sequence. 
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7.2.1.3. Dispersion of Reduced Graphene Oxide with Nano-1 Peptides  
This section aims to compare the quality of rGO dispersion where two versions of 
nano-1 peptide are used as a dispersant. To make such a comparison all dispersions 
have been processed at identical concentrations. In all cases the peptide dispersed 
rGO solutions were mixed by probe sonicating the peptide solution (1.0 mL, 1.0 
mM) with rGO (1.0 mg). During the sonication, the provided mechanical energy 
overcomes the van der Waals interactions between rGO sheets and leads to rGO 
sheet exfoliation, whereas at the same time the peptide molecules adsorb onto the 
rGO surface, inhibiting their reaggregation. As this process continues, eventually the 
rGO sheets are exfoliated and become coated by peptide. Any uncoated rGO sheets 
reaggregate and are expected to be heavier than exfoliated sheets, thus having a faster 
sedimentation rate. Thus upon mixing rGO with the peptide, the solution contains 
both well dispersed and sedimentated rGO. The centrifugation process accelerates 
the separation of inefficiently dispersed and sedimentated rGO from stable and well 
dispersed rGO. Thus, the supernatant phase contains the well-dispersed and mostly 
exfoliated rGO which is then taken for UV-Vis-NIR absorbance measurement to 
determine the concentration of rGO present in solution in each case. Figure 7-28 
shows an image of rGO dispersions after sonication and centrifugation with the two 
versions of nano-1 peptide in water, together with unmodified rGO as a reference. As 
the carbon nanomaterials disperse, the solution will becomes darker. Therefore, 
solely based on the supernatant color intensity of unmodified rGO (clear), short 
nano-1(6)/rGO (gray), and nano-1(4)/rGO (dark gray), it can be indicated that the 
amount of solubilised rGO appears to have increased with an increasing number of 
aromatic amino acids in the peptide sequence.  
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Figure  7-28: A visual comparison of the aqueous supernatant of rGO dispersion with nano-1 
peptides. Dispersion from left to right: H2O/rGO (control), nano-1(4)/rGO, short nano-
1(6)/rGO.  
 
Then UV-Vis-NIR absorption spectroscopy was employed to gain further insight into 
the capability of these peptides to disperse rGO. Figure 7-29 shows UV-Vis-NIR 
absorption spectra for the two peptides with rGO dispersions in water, together with 
the spectrum from the dispersion of unmodified rGO as a control. The absorption 
spectra were obtained under identical conditions.  
 
Figure  7-29: UV-Vis-NIR absorption spectra of rGO and nano-1 peptides dispersed rGO. 
(Green line) rGO, (Blue line) short nano-1(6)/rGO, (Red line) nano-1(4)/rGO. 
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The matching absorption spectral traces of the nano-1(4)/rGO and short nano-
1(6)/rGO samples, shown in Figure 7-29, indicate that both peptides are capable of 
dispersing rGO. However, nano-1 (4)/rGO dispersion a displays higher absorption 
compared to that of the short nano-1 (6)/rGO dispersion. In contrast, as expected the 
unmodified reference rGO sample disperse displays a negligible amount as compared 
to the peptides. The concentration of dispersed rGO in these dispersions was 
estimated from their absorbance at 660 nm by using the extinction coefficient of 
rGO. The extinction coefficient of rGO was determined experimentally at 660 nm in 
1 % SDS solution (є660 = 38.7 mL mg
-1 
cm
-1
, see Appendix B), which agrees with 
the reported value using similar conditions. According to the Lambert Beer law, the 
concentration of rGO in these dispersions is shown in Table 7-3.  
Dispersant Conc. of Dispersed rGO. 
μg mL-1 
H2O (control) 2.6 
Short Nano-1(6)  12.1 
Nano-1 (4) 64.3 
Table  7-3: Concentration of dispersed rGO by two versions of nano-1 peptide determined 
from UV-Vis-NIR absorption after sonication and centrifugation. 
 
Both visual inspection and UV-Vis-NIR absorption spectroscopy indicated that rGO 
dispersion with longer peptide chains give a better dispersion than short ones in 
water. This result can be explained in terms of the difference in the number of the 
hydrophobic residues in the sequence between the two peptides. Nano-1 peptide 
displayed the highest capability in dispersing rGO, with more than twice the 
absorbance as measured for the short nano-1(6) dispersion. This suggests that 
increasing the number of hydrophobic residues (phenylalanine, and valine) in the 
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peptide’s sequence increases the amount of rGO that is dispersed. It has previously 
been shown that a peptide’ sequence with more hydrophobic residues to interact with 
the nanomaterials surface allow for increased π–π stacking interactions, thereby 
enhancing the dispersion. Therefore, it is believed that this noncovalent dispersion 
depends on the adsorption of the hydrophobic face of the amphiphilic nano-1 peptide 
on the hydrophobic surface of rGO sheet. As a consequence, the presence of more 
hydrophobic residues in a peptide’s chain increases adsorption to rGO, and thus the 
amount of dispersed rGO. Similar results were found using the same peptides to 
disperse purified SWNTs (Chapter 4).  
Earlier theoretical studies have found that planar graphene sheet signiﬁcantly 
disrupts the helical structure when compared to CNTs. Therefore, the expectation 
was that a helical peptide, represented here by nano-1 peptide (4), would disperse 
less rGO than purified SWNTs. Indeed, by comparing the dispersion results shown in 
Table 7-4 it can be seen that the nano-1 peptide (4) shows better dispersion affinity 
towards purified SWNTs than rGO. A similar dispersion profile can be seen (below) 
when short nano-1 peptide (6) is used in the dispersion of purified SWNTs and rGO. 
Peptide Conc. of 
Dispersed rGO 
μg mL-1 
Conc. of Dispersed 
Purified SWNTs          
μg mL-1 
Nano-1(4) 64.3 586.9 
Short nano-1 (6) 12.1 167.9 
Table  7-4: Concentrations of dispersed rGO and purified SWNTs using the two versions of 
nano-1 peptide determined from UV-Vis-NIR absorption after sonication and centrifugation. 
 
This dispersion affinity can be explained in terms of both the curvature of the 
nanomaterials surface and the helicity of the peptide. Since the same peptides and 
dispersion conditions have been used in the dispersion of both rGO and purified 
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SWNTs, it is obvious that the difference in curvature (planarity) of the surface 
between rGO and SWNTs is primarily responsible for difference in the amount of 
dispersed nanomaterial. Additionally, the amphiphilicity of a dispersant peptide plays 
a key role in the dispersion of carbon nanomaterials. Usually a peptide shows its 
maximum amphiphilicity when forming an α-helix. Therefore, how it adjusts its 
secondary structure (helicity) will affect the amphiphilicity and its stability at the 
water/hydrophobic nanomaterial interface. Therefore, when the nano-1 peptide 
interacts with SWNT, it matches its hydrophobic face against the curved surface of 
SWNT by curving around it without disturbing its helical structure and achieving its 
maximum amphiphilicity. However, this is not possible in rGO because of its rigid 
planner geometry. During nano-1 interaction with rGO, the peptide is thought to 
adjust its conformation by unfolding its helicity to permit the matching of its 
hydrophobic face to the hydrophobic and ﬂat rigid rGO surface. This conformational 
adjustment disrupts the peptide’s helical structure and thus minimises its dispersion 
ability when compared to SWNTs. Therefore, nano-1 (4) was less able to disperse 
rGO (64.3 μg mL-1), while the same peptide dispersed (586.9 μg mL-1) of purified 
SWNTs. In a peptide α-helix, the linear translation is a rise of 5.4 A˚ per turn of the 
helix, which is equal to the product of the translation (1.5 A˚) and circular rotation of 
3.6 residues per turn.
191,475
 Additionally, literature on the helical structures shows 
that the average length of helix is 12 residues. Previous theoretical research on nano-
1 peptide revealed that its helix structure is a seven residue repeating sequence, 
which completes approximately two turns of the helix. Since short nano-1 peptide (6) 
is one heptad sequence, thus it is expected to show a minimum ability to fold into a 
helix, which previously has been proven by Zorbas et al.
120
 Short nano-1 peptide (6) 
affinity to interact with rGO and SWNTs followed nano-1 peptide’s behaviour 
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towards them, as it dispersed only 12.1 μg mL-1 of rGO while the same peptide 
dispersed 167.9 μg mL-1 of SWNTs. A Raman spectrum is used to obtain the 
structural information of rGO sheets in their nano-1 peptides composite. Raman 
spectra of rGO (control) and nano-1 peptides/rGO composite have been measured by 
drop casting each sample’s aqueous dispersion on silicon substrate and left to dry in 
air. 
Raman spectra of rGO (control) and nano-1 peptides/rGO composite have been 
measured by drop casting each sample’s aqueous dispersion on silicon substrate and 
left to dry in air. Raman analyses were repeated ten times at different areas of each 
sample. Figure 7-30 shows a representative G band normalised Raman spectra of 
nano-1(4)/rGO, short nano-1 (6)/rGO along with rGO as a reference. 
 
Figure  7-30: A representative Raman spectra (532 nm) of rGO (control) and nano-
1peptides/rGO composites. (Green line) rGO, (Red line) nano-1(4)/rGO, (Blue line) short 
nano-1(6)/rGO. 
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All the Raman spectra exhibit two prominent peaks of the D band and G band as well 
as a very weak 2D band, which is typical characteristic of graphene based 
nanomaterials. Considering that the G-band of carbon nanomaterials is highly 
sensitive to the electronic effects,
476,477
 the change in the G-band position of rGO 
upon its the interaction with nano-1 peptides was investigated. Figure 7-31 compares 
the G mode feature for rGO (control) and peptide/rGO composites. 
 
Figure  7-31: A representative Raman spectra of the tangential mode features for rGO and 
peptide/rGO composites. (Green line) rGO, (Red line) nano-1(4)/rGO and (Blue line) short 
nano-1(6)/rGO. 
 
By comparing the G bands of nano-1(4)/rGO and short nano-1(6)/rGO with rGO, it 
can be seen that the G band of rGO is up shifted in its nano-1(4) and short nano-1 (6) 
composites. Table 7-5 summaries the G peak position and shift of peptide/rGO and 
rGO as a control. 
Chapter 7 
203 
 
Sample G band cm-1 Up Shift 
cm
-1 
rGO (control) 1581.3 ± 0.7 - 
Nano-1(4)/rGO 1583.8 ± 0.7 2.5 ± 0.9 
Short nano-1(6)/rGO 1584.0 ± 0.7 2.7 ± 0.9 
Table  7-5: A comparison between the G band of rGO and peptide dispersed rGO. 
 
This upshift supports the proposed interaction mechanism between nano-1 (4) and 
short nano-1 (6) and rGO that peptides’ aromatic residues interact via π–π stacking 
with the rGO surface. Furthermore, it supplies an evidence for a weak charge transfer 
between rGO and nano-1 peptides which is in agreement with previous reports.
253,478-
482
 
 
7.2.2. Noncovalent Functionalisation of Reduced Graphene Oxide with 
(NlysNspeNspe)6 Peptoid   
There have been extensive studies on the adsorption of peptides and proteins onto 
nanomaterials which, it has been shown, can affect both the structure and function of 
these biomolecules. The adsorption of peptides and proteins on the surface of carbon 
nanomaterials is often accompanied with the loss of proteins’ native conformation, 
and this is a major concern in the development of the potential of nanomaterials in 
various applications. Among carbon nanomaterials, the CNTs and graphene-based 
nanomaterials have the capability to disrupt the α-helical structures of short peptides, 
and due to its low surface curvature, graphene possesses the additional capability to 
distort α-helical conformations.  
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Peptides have been used to disperse graphene-like materials, as they have the ability 
to interact with the graphene surface. Although graphene-like materials’ ﬂat surface 
could be ideal for π–π stacking interaction with the aromatic residues in the peptide 
chain, however the results discussed in (Section 7.2.1) suggest that the rGO’s flat 
rigid surface might disrupt the helical conformation of the peptide upon binding and 
hence disperse only a limited amount of rGO. Compared to peptides the absence of 
hydrogen-bond donors in the peptoid’s backbone leads to a greater chain flexibility 
and prevents intra- and inter-chain hydrogen bonding. The rigidity of peptide’s 
backbone decrease its adsorption onto SWNTs.
418
 Whereas, compared to peptides the 
absence of hydrogen-bond donors in peptoid’s backbone leads to a greater chain 
flexibility and prevents intra- and inter-chain hydrogen bonding which is thought to 
help them to fold around the curved surface of the side walls of SWNTs. In a 
previous chapter (see Chapter 5) it was concluded that due to the peptoids’ 
backbone flexibility they showed a better ability, compared to nano-1 peptides, to 
curl around the curved SWNTs to disperse them in water. The 18 residue peptoid 
(NlysNspeNspe)6 (17) dispersed 672.0 µg mL
-1
 of purified SWNTs, while nano-1 
peptide (4) dispersed 586.9 µg mL
-1
. Therefore; it is thought that the flexible 
backbone of the peptoid will allow a better noncovalent interaction of the peptoid’s 
hydrophobic face with the flat rGO surface than the peptide. 
 
7.2.2.1. Synthesis of (NlysNspeNspe)6 Peptoid  
Among the tested peptoids and peptides for the dispersion of purified SWNTs, 18 
residue peptoid (17) had high dispersion affinity toward the nanotubes (see Chapter 
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5). Therefore, 18 residue peptoid (17) was chosen to study impact of the dispersant 
chain flexibility on their ability to disperse the rGO. Peptoid 17 contain six repeating 
motif of three residues with the repeating subunit structure: (NlysNspeNspe)6. Figure 
7-32 show the 18 residue peptoid (17) motif. 
 
Figure  7-32: Synthesised peptoid (17) repeating unit.  
 
The peptoids were routinely synthesised on Rink amide linker-derivatised solid 
supports using the submonomer synthesis method developed by Zuckermann.
284
 The 
peptoid 17 has an amphiphilic nature; the two hydrophobic chiral aromatic residues 
(Nspe) induce a repeated cis amide bond conformation and handedness of helical 
structure along the peptoid backbone. While the hydrophilic lysine-type side chain 
(Nlys) residue aids the water solubility of the peptoid and encourages the formation 
of an amphiphilic helix in solution, and peptoid (17) showed a strong helicity CD 
spectrum (see Chapter 5). 
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7.2.2.2. Dispersion of Reduced Graphene Oxide (rGO) with Peptoids 
1.0 mg mL
-1
 of rGO was noncovalently functionalised by dispersion in 1.0 mM 
aqueous solution of 18 residue peptoid (17) (see Chapter 5) via probe ultra-
sonication for 20 min in an ice bath. The concentration of 17 is set to 1.0 mM to 
ensure assembly of the peptoid on the rGO surface. Then, the (NlysNspeNspe)6 
(17)/rGO dispersion was centrifuged to accelerate the removal of suspended rGO that 
were not efficiently solubilised and thus aggregates, leaving the black-coloured 
supernatant aqueous solution which contains the stable and well-dispersed rGO. 
Figure 7-33 shows rGO dispersion by 17 after sonication and centrifugation, and 
rGO dispersion in water as a control. 
 
Figure  7-33: Visual comparison of rGO aqueous supernatant after sonication and 
centrifugation. Dispersion from left to right: rGO (control), (NlysNspeNspe)6 (17)/rGO. 
 
rGO sonication in water is carried out as a control; rGO sedimentation immediately 
and irreversibly after the centrifugation to give a clear supernatant. By contrast, the 
addition of 17 to the rGO suspension in water prevented rGO sheet agglomeration 
and leads to a visually homogeneous black dispersion.  
The (NlysNspeNspe)6 (17)/rGO complex supernatant was further characterised by 
UV-Vis-NIR spectroscopy. The UV-Vis-NIR spectra of rGO (control) and peptoid 
(17)/rGO dispersion solutions are shown in Figure 7-34. Due to rGO’s (control) very 
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limited dispersion in water its UV-Vis-NIR spectra did not exhibit a well-defined 
absorption peak. As expected, the peptoid 17 coated rGO sample showed a much 
higher absorbance compared to rGO (control). The peptoid works as a surfactant 
through its noncovalent interaction with the hydrophobic surface of rGO. Therefore, 
(NlysNspeNspe)6 (17)/rGO complex shows a strong UV-Vis-NIR absorbance 
corresponding to π–π* transitions of C-C bonds of rGO. Additionally, this significant 
increase in the absorbance of (NlysNspeNspe)6 (17)/rGO corresponds to a darkening 
of the solution which could clearly be seen with the eye (Figure 7-33) and indicated 
that more rGO is dispersed in the supernatant. 
 
Figure  7-34: UV-Vis-NIR spectra of (NlysNspeNspe)6 (17)/rGO composite (Orange line) 
and rGO (control) (Green line). 
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The amount of rGO retained in the supernatant after sonication and centrifugation 
was taken as a relative measure of the ability of the peptoid to disperse rGO in water. 
Such an amount was estimated by determining the absorbance of the peptoid 
(17)/rGO complex at a wavelength of 660 nm. Although rGO is known to exhibit a 
well-deﬁned absorption peak at 268 – 270 nm (provided that the sheets have been 
well reduced), the latter wavelength was not used in the present measurements. This 
is because many peptoid displayed a strong absorbance in the 200 – 300 nm 
wavelength range, which could not be compensated for in the double-beam 
spectrophotometer. However, the peptoid 17 did not exhibit absorption at 
wavelengths above 400 nm. Thus, any absorbance measured at a given wavelength 
above 400 nm could be safely related to the amount of dispersed rGO according to 
the Beer-Lambert law and the determined extinction coefficient (see Appendix B), 
as shown in Table 7-6.  
Dispersant Conc. of Dispersed rGO 
µg mL
-1 
H2O (control) 2.6 
(NlysNspeNspe)6 (17) 93.8 
Nano-1 (4) 64.3 
Table  7-6: Concentration of dispersed rGO by nano-1 peptide (4) and (NlysNspeNspe)6 (17) 
determined from UV-Vis-NIR after sonication and centrifugation. 
 
The concentration of rGO dispersed in the supernatant after centrifugation was 
greater in the peptoid dispersed rGO then nano-1 (4) dispersed rGO (64.3 μg mL-1, 
see Section 7.2.1). This is likely to arise from the flexibility of the peptoid’s 
backbone compared to the peptide’s backbone, which allows assembly on the flat 
rigid surface of the rGO sheets without disrupting the peptoid’s helicity. The flexible 
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backbone of the peptoids allows assembly on the flat rigid surface of the rGO sheets, 
leading it to disperse more rGO than the nano-1 helical peptide. 
The rGO (control) and (NlysNspeNspe)6 (17)/rGO aqueous dispersions were drop 
casted to silicon wafer substrate and left to dry in air for Raman measurements. Their 
Raman spectra are normalised to G band and is repeated at least ten times from 
different areas of the sample. Figure 7-35 shows a representative Raman spectra of 
rGO (control), and (NlysNspeNspe)6 (17)/rGO complex. 
 
Figure  7-35: A representative normalised Raman spectra (532 nm) of rGO and peptoid 
dispersed rGO: (Green line) rGO (control), (Orange line) (NlysNspeNspe)6 (17)/rGO. 
 
The Raman spectra of both samples exhibit characteristic Raman bands of graphene 
based nanomaterials, namely D, G and weak 2D band. However, the G band of 
(NlysNspeNspe)6 (17)/rGO appears at 1583.3 ± 0.9 cm
-1
, while it is appears at 1581.3 
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± 0.7 cm
-1 
for
 
rGO (control), Figure 7-36. The (NlysNspeNspe)6 (17)/rGO G band 
upshift of 2.1 ± 1.1 cm
-1
 comparing to the control rGO sample indicates that there is 
a π–π stacking interaction between peptoid’s aromatic residue interacts and rGO 
surface. Moreover, this upshift suggests a weak charge transfer between the rGO and 
the peptoid. These shifts are similar to those reported by in which carbon 
nanomaterials were noncovalently dispersed with aromatic molecules.
318
 
 
Figure  7-36: A representative Raman spectra of the tangential mode features for rGO and 
peptoid/rGO composite: (Green line) rGO, (Orange line) (NlysNspeNspe)6 (17)/rGO. 
 
7.2.3. Noncovalent Functionalisation of Reduced Graphene Oxide with 
Ribonucleosides  
Most previous investigations carried out to study the interaction of DNA nucleobases 
and nucleosides with graphene were based on theoretical approaches. Therefore, this 
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section experimentally investigates a noncovalent functionalisation of reduced 
graphene oxide (rGO) with ribonucleosides (adenosine, cytidine, guanidine, 
thymidine, and uridine) and its nucleobases. 
The desired aqueous ribonucleoside solution to disperse rGO was prepared by 
diluting a stock solution (2.0 mg 10 mL
-1
). To prepare ribonucleoside/rGO complex 
dispersion, 1.0 mg mL
-1 
of rGO was added to 1.0 mM of each ribonucleoside 
aqueous solution. The ribonucleoside/rGO solution was probe sonicated for 20 min 
in an ice bath, and then centrifuged to remove inefficiently dispersed and sedimented 
rGO from stable and well dispersed rGO. Thus, the supernatant phase contains the 
well dispersed and mostly exfoliated rGO. Visual observation suggested uridine 
appears to have the highest dispersion affinity towards rGO necessary to suspend 
rGO in water compared to other tested ribonucleosides. Figure 7-37 shows rGO 
dispersions after sonication and centrifugation for the ribonucleosides series.  
 
Figure  7-37: A visual comparison between rGO aqueous supernatant with a series of 
ribonucleosides after sonication and centrifugation. Dispersion from left to right; 
adenosine/rGO, cytidine/rGO, guanidine/rGO, thymidine/rGO and uridine/rGO. 
 
This observation was conﬁrmed by UV-Vis-NIR absorption spectroscopy, as shown 
in Figure 7-38. The UV-Vis-NIR spectra of rGO (control) exhibited an absorption 
band correspond to π–π* electronic transition, indicating that most of oxygen-
containing functional groups on the GO surface are removed and the conjugated 
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structure is restored. However, due to rGO hydrophobic nature and the absence of a 
surfactant, this peak was very weak, which indicates that the reduction removed most 
of the oxygen-containing functional groups on the GO. On the other hand, comparing 
to absorption of rGO, ribonucleoside/rGO complexes had higher absorption intensity 
due to the noncovalent interaction between rGO and the ribonucleoside. 
 
Figure  7-38: UV-Vis-NIR spectra of ribonucleoside/rGO complexes aqueous supernatant: 
(Blue line) Adenosine/rGO, (Red line) cytidine/rGO, (Green line) guanidine/rGO, (Cyan 
line) thymidine/rGO and (Orange line) uridine/rGO. 
 
rGO’s UV-Vis-NIR absorption is proportional to its concentration dispersed in 
solution. Thus, dispersion rGO’s concentration in the ribonucleoside/rGO 
supernatant was determined from their absorbance at 660 nm using Beer-Lambert 
law and calculated extinction coefficient of rGO at 660 nm (Appendix B). Table 7-7 
shows the concentration of rGO in ribonucleoside/rGO supernatant determined using 
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UV-Vis-NIR absorption. The UV-Vis-NIR absorbance intensity of uridine/rGO 
complex shows higher absorption intensity comparing to other complexes and rGO 
(control) at 660 nm, indicating that an increasing amount of rGO was in the 
uridine/rGO complex dispersed solution. 
Ribonucleoside Conc. of Dispersed rGO 
µg mL
-1 
H2O (control) 2.6 
Adenosine 21.1 
Cytidine  5.9 
Guanidine 5.1 
Thymidine  13.7 
Uridine 24.4 
Table  7-7: Concentration of dispersed rGO with series of ribonucleosides determined from 
their UV-Vis-NIR adsorption after sonication and centrifugation. 
 
Among the five tested ribonucleosides, uridine shows the highest interaction affinity 
towards rGO and guanidine shows the lowest, which is in agreement with its dark 
supernatant colour shown in Figure 7-37. The low concentration of dispersed rGO 
by the ribonucleosides suggests that there is a weak binding energy with rGO 
surface, which parallels with what has been theoretically predicted by Antony et 
al.
442
 and Varghese et al.
329
 The low amount of dispersed rGO by these 
ribonucleosides is thought to be due to the small ring (cyclic and aromatic) of these 
ribonucleosides, thus their ability to disperse rGO in the aqueous solution is quite 
limited.  
The concentration of dispersed rGO by ribose sugar alone is 22.4 µg mL
-1
,
 
which is 
less than the concentration of dispersed rGO by uridine. Figure 7-39 shows the UV-
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Vis-NIR of ribose/rGO supernatant. This indicates that the interaction between ribose 
and rGO is a nonhydrophobic interaction as the limited number of oxygen-containing 
functional groups on rGO surfaces resulted in a very weak interaction between ribose 
and rGO’s hydrophobic surface. 
 
Figure  7-39: UV-Vis-NIR of ribose/rGO after sonication and centrifugation. 
 
To investigate the effect of nucleobase moieties in ribonucleoside interaction with 
rGO, the rGO dispersion with the aid of series of nucleobases; cytosine, guanine, 
adenine, thymine, and uracil, were studied. The nucleobase/rGO complexes were 
prepared following the same dispersion method used for the preparation of 
ribonucleoside/rGO complexes. The faint grey colour of nucleobase/rGO complexes 
supernatant after the sonication and centrifugation shown in Figure 7-40 suggest that 
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the nucleobases have a very limited ability to disperse rGO compared to 
ribonucleosides (Figure 7-37).  
 
Figure  7-40: A Visual comparison between rGO aqueous dispersion supernatant with a 
series of nucleobases after sonication and centrifugation. Dispersion from left to right: 
cytosine/rGO, adenine/rGO, guanine/rGO, uracil/rGO.  
 
The rGO dispersion solution colour is proportional with its quantity in the solution. 
Therefore, Based on the above visual comparison in Figure 7-40 of nucleobases 
interaction with rGO in water, it is thought that uracil dispersed higher quantity of 
rGO than the rest of nucleobases.  
The noncovalent interaction between nucleobases and rGO was monitored by UV-
Vis-NIR spectroscopy. As shown in Figure 7-41, nucleobases/rGO complexes 
dispersion supernatant exhibited a characteristic rGO absorption peak attributed to 
the π–π* electronic transitions of sp2 C–C bonds in rGO. 
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Figure  7-41: UV-Vis-NIR spectra of nucleobases/rGO complexes supernatant: (Blue line) 
adenine/rGO, (Red line) cytosine/rGO, (Green line) guanine/rGO, (Cyan line) 
thymine/rGO and (Orange line) uracil/rGO. 
 
The low absorption intensity spectrum of nucleobases/rGO complexes suggests that 
the nucleobases noncovalent interaction of nucleobases’ ring (cyclic and aromatic) 
with rGO was not effective in dispersing rGO in water. Additionally, UV-Vis-NIR 
absorption spectra of nucleobases/rGO complexes were used to evaluate the 
concentration of the dispersed rGO in nucleobases/rGO complex supernatant. The 
rGO concentration in the nucleobases/rGO complexes supernatant after sonication 
and centrifugation calculated from the rGO absorbance at 660 nm using Beer-
Lambert law and calculated extinction coefficient of rGO (see Appendix B). Table 
7-8 shows the concentration of rGO in nucleobase/rGO complexes supernatant 
determined using UV-Vis-NIR absorption. 
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Nucleobase Conc. of Dispersed rGO 
µg mL
-1 
H2O (control) 2.6 
Adenine 7.8 
Cytosine 10.2 
Guanine 9.0 
Thymine 2.9 
Uracil 12.7 
Table  7-8: Concentration of dispersed rGO with a series of nucleobases determined from 
their UV-Vis-NIR absorption after sonication and centrifugation. 
 
As can be seen from Table 7-8 the low amount of dispersed rGO by nucleobases 
indicates that nucleobases have a very limited dispersion efficacy towards rGO. This 
indicates that there is a very weak noncovalent interaction, although, the planar 
surface of rGO is presented as an ideal system for π–π interaction with the planar 
ring of nucleobases and ribonucleosides. However, the low amount of dispersed rGO 
by nucleobases shown in Table 7-8 indicate that the small purine’s and pyrimidine’s 
ring (aromatic ring in adenosine and guanosine purine ribonucleosides and cyclic 
ring in cytosine, thymidine, and uracil pyrimidine ribonucleosides) has a limited 
interaction efficiency towards rGO. Therefore, it is thought that there is a very weak 
π-π stacking interaction between the nucleobases and the hydrophobic surface of the 
rGO, due to the small ring size of the nucleobases. Similar results were found when 
ribonucleosides were used in dispersing purified SWNTs (Chapter 6), indicating 
that π–π interaction probably is not the main interaction driving SWNTs dispersion 
in water. Thus, it is thought that the high dispersion affinity of ribonucleosides 
towards oxidised SWNTs (Chapter 6, Section 6.2.2.2) is due to the nonhydrophobic 
interaction.  
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Pervious theoretical studies have shown that the size and curvature of carbon 
nanomaterials play an important role in their non-bonded interactions. Although, the 
above experimental results suggests that ribonucleosides have limited dispersion 
efficiency towards the hydrophobic surface of both rGO and SWNTs. It also 
indicated that ribonucleosides had higher dispersion affinity towards rGO then 
purified SWNTs, as uridine dispersed 24.4 µg mL
-1
 of rGO, while it dispensed 0.2 µg 
mL
-1 
of purified SWNTs. This is probably is due topological difference between rGO 
and SWNTs. Since the ribonucleosides tend to have π–π stacking type of interactions 
with the hydrophobic surface of rGO and purified SWNTs, thus as the curvature 
decreases, there will be more eﬃcient stacking between the rGO and the 
ribonucleoside surface. These results parallel with pervious theoretical studies which 
show that molecules binding energy increases as the curvature decreases and reaches 
the maximum for graphene.
420,449
 
Raman spectroscopy was also used to probe the ribonucleoside’s impact on the 
electronic structure of the rGO. The Raman analyses were measured by drop casting 
each sample’s aqueous dispersion on silicon substrate left to dry in air. The Raman 
analyses were repeated ten times at different areas of the sample. Figure 7-42 shows 
representative Raman spectra of rGO (control) and ribonucleoside/rGO normalised to 
G band.  
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Figure  7-42: A representivtive Raman spectra (532 nm) of rGO and ribonucleoside/rGO 
complexes: (Blue line) Adenosine/rGO, (Red line) cytidine/rGO, (Green line) 
guanidine/rGO, (Cyan line) thymidine/rGO, (Orange line) uridine/rGO and (Black line) 
rGO (control).  
 
Raman spectra of rGO and its ribonucleoside composites show the characteristic G 
and D band of graphene base nanomaterials at 1581 – 1588 and 1338 – 1350 cm-1, 
respectively. Previous studies have demonstrated that the tangential vibrational 
modes for carbon nanomaterials are sensitive to doping. Specifically, the G band 
peak was shown to shift to lower frequencies for electron donor dopants and to 
higher frequencies for electron acceptor dopants. The G band peak of all 
ribonucleoside/rGO dispersions are up shifted with respect to that of rGO (control). 
Figure 7-43 compares the G mode feature for rGO (control) and ribonucleoside/rGO 
composites.  
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Figure  7-43: A representivtive Raman spectra showing the tangential mode features for rGO 
and ribonucleoside/rGO complexes: (Blue line) Adenosine/rGO, (Red line) cytidine/rGO, 
(Green line) guanidine/rGO, (Cyan line) thymidine/rGO, (Orange line) uridine/rGO and 
(Black line) rGO (control). 
 
The small G band upshift of ribonucleoside/rGO composite comparing to rGO are 
summarised in Table 7-9. 
Dispersion G band (cm-1) G band Upshift 
cm
-1 
rGO (control) 1581.3 ± 0.7 - 
Adenosine/rGO 1589.0 ± 1.2 7.7 ± 1.4 
Cytidine/rGO 1589.8 ± 1.9 8.5 ± 2.0 
Guanidine/rGO 1588.4 ± 0.9 7.1 ± 1.1 
Thymidine/rGO 1586.2 ± 0.8 4.9 ± 1.1 
Uridine/rGO 1587.2 ± 1.2 5.9 ± 1.4 
Table  7-9: A summary of tangential mode features for rGO and ribonucleoside/rGO 
complexes. 
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These shifts suggest that there is a weak charge transfer between the rGO and 
ribonucleosides. Thus, it suggests that there is weak hydrophobic interaction in 
between ribonucleosides and rGO. 
 
7.2.4. Covalent Functionalisation of Reduced Graphene Oxide with Cell 
Penetrating Peptoid (Ac-Nglu-Nlys-Nlys-Nlys-Nphe) 
GO and rGO has been considered to be a potential carrier for drug delivery 
system,
483,484
 because their 2D structural feature has a large surface area. As a result, 
drugs can be loaded onto both sides of the graphene sheet. For the practical 
application high dispersion stability of graphene based nanomaterials has to be 
provided through biofunctionalisation process, mainly through π–π stacking, 
covalent binding, hydrophobic and electrostatic interaction.
389
 Although noncovalent 
chemistry is attractive because of the preservation of the conjugated π system, 
however, adsorption of water insoluble drugs (such as peptide, protein, and DNA) on 
planar graphene depends mainly on weak hydrophobic interactions, resulting in a 
lower drug loading ratio.
485
 Therefore, covalent functionalisation methods have been 
widely utilised for the preparation of biofunctionalised GO or rGO.
486-488
 
The cellular uptake of free biomolecules in general and peptides in particular is 
extremely poor; therefore conjugation of these molecules onto carbon nanomaterials 
surfaces may allow improvements in the delivery of such biological molecules.
489
 
However, cell penetrating peptides (CPPs) often display an inefficient bioavailability 
due to their proteolysis and opsonisation in the presence of serum.
490
 Unlike CPPs, 
cell penetrating peptoids (CPPos) are highly stable against enzymatic degradation 
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and less toxic mimetics of CPPs.
491-493
 Although CPPos do not always resemble the 
conformational constraints of the respective peptides, as the chirality of the α-carbon 
is lost, they can be modified by a large variety of functional side chains offering a 
toolkit for the development of artificial cell penetrating moieties. The cellular uptake 
mechanism is not yet revealed in all details; however, it is found that the polycationic 
character is a very important feature of CPPos. It is assumed that the positive charges 
allow the CPPos to interact strongly with the negatively charged structures and the 
head groups of membrane phospholipids on the extracellular side of the plasma 
membrane.
494
 A peptoid (17) was previously used for the noncovalent 
functionalisation of rGO and showed limited dispersion ability (93.8 μg mL-1). Thus, 
the main focus of this section is to study the covalent functionalisation of CPPos with 
rGO not only to improve the solubility of rGO in water but also to bring a biological 
function to it. 
 
7.2.4.1. Synthesis of Cell Penetrating Peptoid (CPPo) 
The chosen CPPo sequence, shown in Figure 7-44, was previously reported by 
Kölmel et al.
490
 to have an efficient entry into human cells by endocytosis with 
subsequent endosomal release. The hydrophilic side chain (Nlys) is critical for the 
CPPo’s hydrophilicity and the ability to dissolve in biological fluids. The 
hydrophobic side chain (Nphe) is included in the sequence to support the passage 
through the lipid bilayer cell membrane. The charged residues (Nlys) play an 
important role in the CPPo (18) ability to penetrate the cell membrane.
490
 Thus, in 
order to preserve the Nlys residues in 18, glutamic acid residue (Nglu) has been 
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added to the original CPPo’s sequence. One of the carboxylic groups has been 
acetylated, while the second one left free to react with amino group on the amidated 
rGO. 
 
Figure  7-44: The structure of CPPo (18) and its monomers. 
  
The CPPo was synthesised by Hannah L. Bolt (Cobb group) on Rink amide linker-
derivatised solid supports using the submonomer synthesis method developed by 
Zuckermann.
284
 The synthesis of 18 was achieved following the same methods used 
for the synthesis of peptoids previously mentioned in (Chapter 5). Following the 
synthesis of the peptoids, pure samples were obtained following RP-HPLC and 
confirmed using ESI-MS (Figure 7-45).  
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Figure  7-45: LC-MS of purified CPPo (18). 
 
7.2.4.2. Synthesis of Amidated Reduced Graphene Oxide (Am-rGO) 
For medical and biological applications, rGO sheets should be thoroughly dispersed 
in the water. Hence, the ﬁrst step is to generate the active sites in rGO, where the 
chemical moieties of the CPPo (18) can be introduced to facilitate their dispersion in 
the water. In order to prepare amidated rGO (Am-rGO), carboxylic acid groups as 
active sites were introduced at edges and defect sites of rGO sheets by oxidation 
using (8 M) nitric acid reflux for 24 h at 100  C. The oxidised rGO (Oxi-rGO) has 
higher water dispersion than the hydrophobic rGO, due to introduction of oxygen 
functional groups to the rGO sheet. The concentration of dispersed oxidised-rGO in 
water is 86.7 µg mL
-1
, while dispersed rGO control concentration is 2.6 µg mL
-1
. The 
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thermal decomposition properties of Oxi-rGO were probed using TGA (Figure 7-
46).  
 
Figure  7-46: TGA of Oxi-rGO and rGO under N2. 
 
The TGA profile of rGO shows a high thermal stability, which indicates a low 
amount of oxygen-containing groups on its surface. TGA curve of rGO show a 2.8 % 
loss at 200 °C which is assigned to the decomposition of the residual oxygen 
containing groups, and a 10.5 % loss from 440 to 590 °C which is associated with the 
pyrolysis of the carbon skeleton of rGO.
495
 The oxidation of rGO introduces 
carboxylic groups at the defect sites and edges of rGO, thus, shows a higher weight 
loss as seen in Oxi-rGO. Whereas rGO lost 16.2 % of its dry mass at 900 °C Oxi-
rGO lost 36.5 %, this indicates that in Oxi-rGO there are more functional groups 
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present, hence the higher mass loss, and so the material has successfully been 
oxidised.  
The second step is the formation of amino-terminated rGO by amidation of Oxi-rGO. 
Ethylenediamine (EDA) coupled with the carboxylic groups of Oxi-rGO to 
synthesise amidated rGO. This approach involves first transformation of the 
oxidatively introduced carboxyl groups in Oxi-rGO to rGO-COCl by refluxing with 
an excess of thionyl chloride (SOCl2) in the presence of a small amount of N,N- 
dimethylformamide (DMF). Excess thionyl chloride was removed by filtration, and 
then acylated-rGO product was washed with anhydrous DMF to remove from the 
traces of residual thionyl chloride (Scheme 7-1). 
 
Scheme  7-1: Acetylation of Oxi-rGO with thionyl chloride (SOCl2).  
 
Subsequently, the acylated sample was reacted with excess EDA in the presence of 
N,N-Dimethylformamide (DMF) as a catalyst at room temperature for 24 hours 
under nitrogen atmosphere. Loading of EDA molecules on rGO-COCl through amide 
linkage aﬀorded the EDA-rGO, which was washed several times with ethanol to 
remove residual EDA. As can be seen in Scheme 7-2, this approach has its own 
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downside represented by inter and intra crosslinking between the amidated rGO, 
which may lead to aggregated and/or minimise the available free amino groups to 
react with CPPo. 
 
Scheme  7-2: Amidation of rGO-COCl with ethylenediamine. 
 
7.2.4.3. Covalent Functionalisation of Am-rGO with CPPo 
In order to prepare the CPPo functionalised rGO (CPPo-rGO), the CPPo’s (18) 
carboxylic acid is activated using benzotriazol-1-yl-oxytripyrrolidinophosphonium 
hexafluorophosphate (PyBOP
®
) in anhydrous DMF which form of the active-OAt 
ester, which then reacts with the amino group of the EDA-rGO. In order to enhance 
the activation of carboxyl group, DIEA has been used. After 15 min of activation, the 
EDA-rGO dispersion/DMF was added to the CPPo (18) mixture, and then stirred for 
4 hours at 40  C. The CPPo-rGO was the vacuum-ﬁltered and washed extensively 
with excess methanol, and then dried in a vacuum oven at 60  C for 8 hours. Scheme 
7-3 illustrates the proposed covalent functionalisation route of rGO with the 
synthesised CPPo (18).  
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Scheme  7-3: Covalent functionalisation of CPPo (18) with EDA-rGO. 
 
The aqueous dispersion of EDA-rGO and CPPo-rGO was prepared by probe 
sonication for 20 min in an ice bath, 1.0 mg of each sample in 1.0 mL of deionised 
water. The sonication was followed by centrifugation and separating the supernatant 
from aggregated material. Figure 7-47 compares between the samples supernatant 
after sonication and centrifugation. 
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.   
Figure  7-47: A visual comparison between aqueous supernatant of EDA-rGO (control) and 
CPPo modified rGO supernatant after sonication and centrifugation. Dispersion from left to 
right: CPPo-rGO, EDA-rGO (19).  
 
The light grey colour of CPPo-rGO’s supernatant compared to EA-rGO indicates that 
a limited amount of CPPo-rGO has been dispersed. As expected the dispersion of 
rGO in water (control) gave a clear solution. The dispersions are further 
characterised with UV-Vis-NIR spectroscopy to determine concentration of the 
dispersed rGO in each sample. The dispersed rGO concentration in each composite’s 
supernatant was determined from optical absorption spectroscopy using the Beer-
Lambert law and the calculated rGO extinction coefficient of 38.7 mL mg
-1
 cm
-1
 and 
absorption values at 660 nm (see Appendix B). Table 7-10 shows the concentration 
of rGO in each supernatant. 
Sample Conc. of Dispersed rGO 
µg.mL
-1 
H2O 2.6 
EDA-rGO 40.2 
CPPo-rGO 21.2 
Table  7-10 : Concentration of dispersed rGO in the supernatant of the aqueous dispersion of 
rGO (control), EDA-rGO and CPPo-rGO after sonication and centrifugation. 
 
 
Chapter 7 
230 
 
The UV-Vis-NIR absorption spectra of rGO (control), EDA-rGO and CPPo-rGO 
dispersion in water are shown in Figure 7-48. The absorption spectra of EDA-rGO 
supernatant shows a strong absorption peak at 231 nm which is almost overlapping 
with a small shoulder at 300 nm, which corresponded to the π–π* transitions of the 
aromatic C=C bond and the n–π* transition of the C=O bond, which is arising from 
the conjugated system of GO. However, the absorption spectrum of CPPo-rGO has a 
weak absorption peak at 231 nm indicating that a limited amount of EDA-rGO has 
been covalently grafted with CPPo (18). The control sample, rGO dispersion in 
water, does not show any absorption peak.  
 
Figure  7-48: UV-Vis-NIR spectra of rGO (control) (Green line), EDA-rGO (Blue line) and 
CPPo-rGO (Red line). 
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The limited dispersion of EDA-rGO in water indicates that the chlorine atom has 
been substituted not only by the amide group of the EDA, but also that other 
reactions may have occurred which link the rGO sheets together to make big poorly 
dispersed aggregates. Additionally, the very low dispersion CPPo-rGO in water 
supports the assumption that a crosslinking reaction occurs between EDA-rGO. This 
results in limited number of free amino group for amidation reaction with the 
carboxylic group of CPPo (18). Therefore, only the EDA-rGO with a free amine 
group would react with the carboxylic group of CPPo (18). As a consequence, the 
limited number of CPPo is grafted on reduced graphene sheet, thus only               
21.2 µg mL
-1
 of rGO is dispersed in water. Similar results have been found from 
comparing the thermal gravimetric analysis (TGA) under N2 of CPPo-rGO with 
EDA-rGO (Figure 7-49).  
 
Figure  7-49: TGA of EDA-rGO (Red line) and CPPo-rGO (Blue line) under N2. 
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The TGA of EDA-rGO under nitrogen reveals a major mass loss of about 61.2 % in 
the temperature range of 160 − 260 °C. By comparison, the TGA of the CPPo-rGO 
shows a slight weight loss of about 55.5 % until the temperature reaches 900 °C 
while EDA-rGO lost 77.1 % at the same temperature. These results indicate that the 
amino groups in rGO have formed heat-stable structures via covalent bonding with 
the CPPo (18). Raman spectroscopy is an efficacious tool to probe the structural 
characteristics and properties of graphene-based materials. Figure 7-50 shows a 
representative of G normalised Raman spectrum of rGO (control) and CPPo-rGO. 
The samples are drop casted on a silicon wafer and left to dry in air. The 
measurement repeated 10 times at different areas of the sample.  
 
Figure  7-50: A representative normalised Raman spectra (532 nm) of rGO (Green line), and 
CPPo-rGO (Red line). 
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In the spectrum of rGO, the peak at 1581.3 ± 0.7 cm
−1
 (G-band) corresponds to an 
E2g mode of graphite and is related to the vibration of sp
2
-bonded carbon atoms in a 
2D hexagonal lattice. The peak at 1338.6 ± 0.7 cm
−1 
(D-band, the breathing mode of 
A1g symmetry) is associated with vibrations of carbon atoms with dangling bonds in 
plane terminations of disordered graphite. The Raman ID/IG ratio is widely used to 
evaluate the quality of graphene and graphene-based materials. The ratio is a 
measure of the disorder in the sample, which can be edges, ripples, or any other 
defects, such as doping organic functions in graphene. From the Raman spectrum 
obtained of CPPo-rGO, a ID/IG of 1.4 ± 0.02 can be calculated, compared with ID/IG 
of rGO which is about 1.3. The ID/IG ratio of CPPo-rGO increases in comparison 
with that of starting material, implying the functionalisation process of graphene 
skeleton has introduced an amount of structural disorder in the graphene lattice, 
which also demonstrates that rGO has been chemically modified with CPPo 
molecules. 
 
7.2.5. Covalent Functionalisation of Graphene Oxide with Thymidine and 
Adenosine   
The discussed results in (Section 7.2.3) suggest that there was a very weak 
noncovalent interaction between nucleobases and ribonucleosides with reduced 
graphene oxide (rGO). Therefore, this section studied the covalent functionalisation 
of rGO with ribonucleosides to improve its dispersion in water.  
GO was prepared by a Hummers method using graphite as precursor. As-synthesised 
graphite oxide (50 mg) was exfoliated with deionised water to a concentration of 1.0 
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mg mL
-1
 by probe sonication for 40 min in an ice bath to produce graphene oxide 
(GO). The acetylation of the freeze dried GO (50 mg) was refluxed in an excess 
amount of thionyl chloride (SOCl2) (20 mL) in the presence of anhydrous N,N-
dimethylformaide (DMF) at 80  C for 24 h to yield acyl chloride-bound GO (GO-
COCl). The product was vacuum-ﬁltered and washed with anhydrous DMF. The 
GO-COCl powder was collected immediately and divided into two, then separately 
reacted with a ribonucleoside solution (adenosine, and thymidine) in DMF in the 
presence of catalytic amounts of triethylamine (Et3N) at 130 °C for 72 hours under a 
nitrogen atmosphere. The acetyl chloride reaction with amine group forms hydrogen 
chloride (HCl), which protonates the amine, making it less nucleophilic. Therefore, 
the Et3N is added to neutralise the acid by forming triethylamine hydrochloride salt, 
thus freeing the amine for attack on the acid chloride and allows the reactions to 
proceed to completion. Finally, both of the ribonucleoside/GO composites 
(adenosine/GO, thymidine/GO) were washed with HCl solution (0.5 mM L
-1
) to 
remove any adsorbed ribonucleoside on rGO surface, then and washed with 
deionised water and dried in a vacuum oven at 45 °C. The synthetic route for 
preparation of water-dispersible ribonucleoside/GO composites is illustrated in 
Scheme 7-4. 
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Scheme  7-4: The synthesis route of ribonucloside/GO composite. 
 
To examine the dispersion ability of the prepared ribonucleoside/GO composites, 1.0 
mg of each composite was dispersed in deionised water to make a 1.0 mg mL
-1
 
solution by probe sonication for 20 min in an ice bath. The image shown in Figure 7-
51 provides a visual observation on the dispersion states of each sample. 
 
Figure  7-51: Visual comparison between the aqueous supernatant after sonication and 
centrifugation. Dispersion from left to right: adenosine-GO, thymidine-GO, rGO, and GO 
(control). 
 
In comparison to rGO, GO showed a better water dispersion stability due to the 
presence of covalently bonded oxygen containing groups on the surface. However, 
GO tends to form irreversible agglomerates into multilayeric graphite via strong π–π 
stacking and van der Waals interaction, indicated by the existence of a solid at the 
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bottom of the vial. In contrast, the color of adenosine/GO and thymidine/GO 
supernatant indicates good dispersion efficiency in water. The aqueous dispersions of 
the composites were stable for at least 2 weeks without aggregates. The presence of 
the ribose fragment in the nucleoside moiety covalently grafted to the GO sheet, 
allows the dispersion of the different ribonucleoside/GO complex (i.e. 
adenosine/GO, and thymidine/GO) in water.  
UV-Vis-NIR absorption was used for a direct measurement of the concentration of 
dispersed ribonucleoside/GO supernatant in aqueous supernatant via the Beer-
Lambert law and estimated extinction coefficient of rGO at 660 nm                             
(є660 = 38.7 mL mg
-1
 m
-1
) (Appendix B). The concentration of ribonucleoside/GO 
complexes dispersed in water is shown in Table 7-11.  
Composite Conc. of Dispersed rGO.  
µg mL
-1 
Adenosine/GO 20.8 
Thymidine/GO 22.5 
Table  7-11: Concentration of dispersed ribonucleoside/GO composite in the supernatant 
determined from their UV-Vis-NIR absorption after sonication and centrifugation. 
  
The concentration of thymidine/GO in the supernatant after centrifugation was 
greater than the adenosine/GO. This indicates that the covalent grafting of thymidine 
on graphene was more successful that adenosine. Figure 7-52 illustrates the UV-Vis-
NIR absorption spectra of adenosine/GO, thymidine/GO, GO, adenine, and 
thymidine in water. Both of the ribonucleosides, adenine and thymidine, show a 
sharp peak centred at ~ 260 nm, which is due to the π–π* transition of conjugated 
electrons of the ribonucleoside ring.
496
 While, adenosine/GO and thymidine/GO 
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complexes exhibited a broad peak at around 280 nm and strong peak at ~ 200 nm. 
These results indicate that the utilised high temperature reaction condition resulted in 
a covalent attachment of these ribonucleosides to GO and also a reduction of the GO 
to rGO. However, due to attachment of these groups on GO the resulting composite 
had good dispersion efficiency in water compared to rGO.  
 
Figure  7-52: UV-Vis-NIR absorption spectra of the dispersion supernatant of (Red line) 
adenosine/GO, and (Blue line) thymidine/GO.  
 
The attachment of each ribonucleoside to the graphene sheets was further analysed 
using TGA by heating under a nitrogen atmosphere to 900 °C at a rate of 10 °C. 
min
−1
. Figure 7-53 shows the thermogravimetric profiles of adenosine/GO, 
thymidine/GO, GO. The TGA of GO reveals a major weight loss of about 30 % in 
the temperature range of 200 – 240 °C corresponding to the decomposition of labile 
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oxygen-containing groups and illustrating its thermally instability. Grafting of a 
ribonucleoside on the graphene sheet in adenosine/GO and thymidine/GO may 
increase the thermal stability of GO leads to low weight loss. While GO lost 65 % at 
350 °C adenosine/GO and thymidine/GO showed a lower weight lost. These results 
indicate that the oxygen-based groups in GO have formed heat-stable structures via 
covalent bonding with the thymidine and adenosine moieties. Additionally, the 
difference in the amount of weight loss between the two composites suggested that 
thymidine the covalent attachment of was more successful than the adenosine.  
 
Figure  7-53: TGA of (Blue line) GO, (Red line) thymidine/G, (Black line) adenosine/GO 
under N2. 
 
To verify the selective molecular recognition by the complementary ribonucleosides; 
thymidine and adenosine on GO, the aqueous dispersion of adenosine/GO, and 
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thymidine/GO composites were shaken for 2 min. immediately after that the mixture 
start to precipitate was formed as shown in Figure 7-54. 
 
Figure  7-54: The mixture of aqueous dispersion of adenosine/GO and thymidine/GO after 2 
min shaking. 
  
The presence of complementary hydrogen bonding arrays, i.e. donor sites comprising 
the NH amide and NH amine, and acceptor sites comprising the O and N 
functionalities, allow ribonucleosides to oligomerise via hydrogen bonding.
497
 Thus, 
the interaction between ribonucleoside groups attached to GO shown in Scheme 7-5 
affects the dispersibility behaviour of ribonucleoside-rGO in H2O as polar solvents 
able to interact via H-bonds with the complementary sites of ribonucleoside.  
 
 
Scheme  7-5: Schematic representation of the recognition processes between complementary 
base pairs, adenosine-GO/thymidine-GO. 
 
The changes of structure from GO to ribonucleoside grafted GO are also reflected in 
the Raman spectroscopy. The Raman spectra of adenosine/GO and thymidine/GO are 
compared with GO, thymidine and adenosine in Figure 7-55.sipersions were drop 
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casted on silicon wafer and left to dry in air , their Raman were repeated at less 10 
times at different areas of the sample. 
 
Figure  7-55: A representative Raman spectra (532 nm) of adenosine (Black line), thymidine 
(Red line), GO (Blue line), adenosine/GO (Green line), thymidine/GO (Pink line). 
 
The Raman spectrum of GO displays broadened G band at 1597.6 ± 1.5 cm
–1 
and D 
band at 1344.0 ± 1.7 cm
–1
. Similar bands are seen in the Raman spectra of 
adenosine/GO and thymidine/GO. However, both composites show an additional 
band fused into their D band. This additional peak is assigned to presence of 
ribonucleosides. 
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7.3. Conclusion  
In this chapter, rGO was covalently and noncovalently functionalised with a series of 
biomolecules. It was found that nano-1 peptide had the highest capability in 
dispersing rGO compared to its short version, short nano-1 peptide. This suggests 
that increasing the number of hydrophobic residues (Phe, and Val) in the peptide’s 
sequence increases the amount of rGO that is dispersed. Thus, it is believed that this 
noncovalent dispersion depends on the adsorption of the hydrophobic face of the 
amphiphilic nano-1 peptide on the hydrophobic surface of a rGO sheet. However, the 
concentration of dispersed rGO by these peptides was found to less than that of 
purified SWNTs (Chapter 4). This is thought to be due the planarity of rGO surface 
and the helicity of the peptide. It was believed that the interaction of biomolecules 
with higher backbone flexibility can show a higher dispersion affinity towards rGO. 
Thus, a peptoid with an 18 residues was used in the dispersion of rGO. It was found 
that the concentration of rGO dispersed by the peptoid was higher than that of nano-1 
peptides. This shows that the flexibility of the peptoid’s backbone compared to the 
peptide’s backbone allows it to assembly on the flat rigid surface of the rGO sheets 
without disrupting the peptoid’s helicity.   
In a similar context, rGO was noncovalently functionalised with ribonucleosides, 
nucleobases, and ribose. The optical absorption of these composites indicated that 
ribonucleosides and its nucleases, and ribose moieties have very limited dispersion 
affinity towards rGO. Thus, it was that thought that there is a very weak π–π stacking 
interaction between the ribonucleosides and the hydrophobic surface of the rGO; due 
to the small ring size of the ribonucleosides they show very dispersion affinity 
towards rGO. However, they dispersion ability is still higher than nucleobases. This 
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is thought to be due the presence of the ribose moiety in ribonucleosides, which 
decreases its hydrophobicity and thus increases its solubility in water. In all pervious 
dispersions, the Raman spectroscopy of dispersion of rGO composites showed a shift 
in its G band comparing to rGO (control). This up shift provides evidence that the 
interaction mechanism between these biomolecules and rGO depends on the 
biomolecule’s aromatic residues via π stacking with the rGO surface. Furthermore, it 
supplies an evidence for a weak charge transfer between them. 
This chapter also studied the covalent functionalisation of rGO with a cell 
penetrating peptoid (CPPo), thymidine, and adenosine. In both cases, the rGO was 
converted to its acetylated form then reacted with the biomolecules. The 
concentration of the aqueous dispersion of CPPo/rGO, thymidine/rGO, and 
adenosine/rGO found to higher than the unmodified rGO. Furthermore, The TGA 
analysis of the covalently functionalised rGO with these biomolecules showed a 
higher weight loss than the unmodified rGO. This provided is further evidence for 
the covalent grafting of rGO with biomolecules. The Raman spectra of the covalent 
rGO composites shows increases in the ID/IG comparison with that of starting 
material, implying the functionalisation process of graphene skeleton has introduced 
an amount of structural disorder in the graphene lattice. 
 
. 
. 
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8.  Thesis Conclusion  
 
The focus of this thesis has been the exploration SWNTs and rGO covalent and 
noncovalent functionalisation with peptides, peptoids, and ribonucleosides in water 
to gain a better understanding on the factors that controls the dispersion of 
nanomaterials with biomolecules.  
The results in Chapter 4 showed that peptide N-terminus acetylation has a greater 
effect on short sequence peptide ability to disperse SWNTs compared to long 
sequence peptide. It was found that acetyled short nano-1 had a better tendency to 
disperse the purified SWNTs than its free N-terminus version. While N-terminus 
acetylation of long sequence nano-1 peptide did not a significant effect on their 
ability to disperse purified SWNTs.  
Additionally, the 
19
F NMR signal of fluorinated nano-1 peptide used to study the 
interaction between the peptide with the side wall of purified SWNTs disappeared 
from the spectra after its interaction with the nanotubes. This is thought to be due to 
peptide’s noncovalent bonding to the nanotube side wall. However, the signal did not 
appear after the sedimentation of nanotubes. This is thought to be due to the fact that 
the peptide has sedimented from the dispersion while still noncovently attached to 
the SWNTs.  
Finally, this chapter investigated the enzymatic degradation of peptide/SWNTs 
composite. It was found that when Ac nano-1 (6) was non-covalently mixed with 
SWNTs that it was enzymatically digested more slowly than short Ac nano-1 peptide 
(4) by trypsin. This thought to be due to the more rapid exchange that short Ac nano-
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1 peptide (6) will have between its SWNT bound and unbound forms compared to to 
full length Ac nano-1 (4) 
In Chapter 5 a series of chiral amphiphilic peptoids which vary in the number of 
aromatic residues on the hydrophobic surface of the helix yet have the same 
hydrophilic/hydrophobic ratio were synthesised. The absorption spectra of the 
peptoid/SWNTs dispersions revealed that the peptoids ability to disperse individual 
SWNTs increases with increasing the number of aromatic residues in the peptoid. 
Also the stability of these dispersions with respect to time has been studied. It was 
found that peptoid/purified SWNTs dispersion stability increased with increasing the 
number of residues in the peptoid. The Raman G band peak shift to higher 
frequencies suggested that peptoid acts as an electron acceptor and the SWNT acts as 
an electron donor (charge-transfer interaction). Altogether, these results suggest that 
the noncovalent peptoid/SWNT interaction does not perturb the electronic structure 
of SWNTs. In this context, designed peptoid may provide an accessible means to 
incorporate the desired electrical properties of SWNTs into biocompatible nanoscale 
electronic devices. TEM and AFM measurements reveal that the chosen peptoids are 
capable of fully coating the SWNT surface and dispersing individual SWNTs and 
will facilitate many applications of SWNTs to medical problems; such as artificial 
muscles or biomedical sensors that can be placed inside the human body. Hybrids of 
biomolecules and nanomaterials are promising candidates in the development of 
novel therapeutics and electronic devices. Since peptoids are known for their 
potential application as a drug due to their resistance to proteases and long life in the 
human body. The next step for this work would be to study the toxicity, cell 
penetration, and cellar uptake of the biological active peptoid/SWNT composite. 
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These biological tests will test the possibility of improving the biological activity of 
peptoids upon their interaction with CNTs. This will open the possibility of using 
peptoid/CNTs composites in biological and medical applications 
The noncovalent interaction of ribonucleosides, nucleobases, and ribose sugar with 
purified and oxidised SWNTs was investigated in Chapter 6. The results indicated 
the interaction of these biomolecules with oxidised SWNTs vary in the dispersion 
ability toward nanotubes depends on the number of oxygen-containing functional 
groups on the nanotube’s surface and the competition between water molecules 
which can from hydrogen bonds with oxidised nanotubes, with ribonucleosides and 
nucleobases over adsorption sites. Additionally, it was found that mixing two 
complementary ribonucleoside/oxidised SWNTs resulted in precipitation of the 
nanotube due to the Watson Crick pairing. These results suggest that the interaction 
depends on a nonhydrophobic interaction between the nucleobase moiety in a 
ribonucleoside interacts with oxygen functional groups on nanotube surface. While, 
its ribose sugar moiety interacts with water molecules. This interaction will 
undoubtedly provide a new and exciting playground in the ribonucleosides self-
assembly for the development of novel make functional architectures. 
Finally, in Chapter 7 the noncovalent and noncovalent functionalisation of rGO with 
series of biomolecules including peptide, peptoid, and ribonucleosides has been 
studied.  
The aqueous dispersion of rGO with peptides and peptoids indicated that the 
interaction of rGO with biomolecules with higher backbone flexibility can show 
higher dispersion affinity towards rGO. Thus, the concentration of rGO dispersed by 
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the peptoid was higher than that of nano-1 peptides. This shows that the flexibility of 
the peptoid’s backbone compared to the peptide’s backbone allows it to assembly on 
the flat rigid surface of the rGO sheets without disrupting the peptoid’s helicity. 
In a similar context, rGO noncovalently functionalised with ribonucleosides, 
nucleobases, and ribose was studied. The optical absorption of these composites 
indicated that ribonucleosides and its nucleases, and ribose moieties have very 
limited dispersion affinity towards rGO. Thus, it was that thought that there is a very 
weak π-π stacking interaction between the ribonucleosides and the hydrophobic 
surface of the rGO; due to the small ring size of the ribonucleosides they show very 
dispersion affinity towards rGO. However, they dispersion ability is still higher than 
nucleobases. This is thought to be due the presence of the ribose moiety in 
ribonucleosides, which decreases its hydrophobicity and thus increases its solubility 
in water. The Raman G band peak up shift provides evidence that the interaction 
mechanism between these biomolecules and rGO depended on the biomolecule’s 
aromatic residues via π stacking with the rGO surface. Furthermore, it supplies an 
evidence for a weak charge transfer between them. 
Finally this chapter studied the covalent functionalisation of rGO with a cell 
penetrating peptoid (CPPo), thymidine, and adenosine. In functionalisations, the rGO 
was converted to its acetylated form then reacted with the biomolecules. Although 
the concentration of the aqueous dispersion of CPPo/rGO, thymidine/rGO, and 
adenosine/rGO was very limited, it was higher than the concentration of unmodified 
rGO in water. 
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9. EXPERIMENTAL SECTION 
 
9.1. Materials and Reagents  
All reagents used in this project were purchased from Sigma Aldrich and used 
without further purification unless otherwise specified. Peptide synthesis grade DMF 
was obtained from AGTC Bioproducts (Hessle, UK), PyBOP from Apollo Scientific 
(Stockport, UK) and NMR solvents which were purchased from Cambridge Isotopes 
Inc., supplied by Goss Scientific (Crewe, UK). All resins were purchased from 
Novabiochem (Darmstadt, Germany). These chemicals were used without further 
purification and stored under appropriate conditions, as detailed in the 
manufacturer’s instructions. Solvents were removed under reduced pressure using a 
Büchi Rotavapor R11. The following centrifuges were used: an Eppendorf centrifuge 
5415D (for 1.5 mL tubes). Aqueous solutions were lyophilised using a Christ Alpha 
1-2 LD Plus freeze-drier. 
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9.2. Equipment Methodology 
9.2.1. Raman Spectroscopy 
Raman spectra were recorded using a Horiba Jobin Yvon LabRam Evolution HR 
spectrometer in a back scattered confocal configuration using a Nd:YAG laser (532 
nm, 2.33 eV.) for graphene based nanomateriales and He:Ne Laser (633 nm, 1.96 
eV.) for carbon nanotube samples. The spectrometer was equipped with a CCD 
detector.  The samples were prepared by drop casting them onto silicon slides then 
left to dry in air before analysing. All spectra were referenced to the position of the 
A1g Raman active mode of Silicon at 520 cm
-1
. All spectra were nomliaed to the G 
band. Analysis of the data was performed using the proprietary Labspec 6 data, 
where peak fits were obtained using classical least square (CLS) fitting with 
lineshapes that were permitted to have asymmetric, Gaussian and Lortenzian 
character.  
 
9.2.2. Ultraviolet-Visible-Near Infrared (UV-Vis-NIR) Spectroscopy  
UV-vis spectroscopy was performed on a Perkin Elmer Lambda 900 UV/Vis/NIR 
spectrometer over a wavelength range of 200 – 1300 nm. Where necessary the 
samples were diluted prior to measurement, such that the absorbance of the sample 
remained below 2.5, and the absorbance of the original solution was found by 
multiplying the obtained value by the dilution factor. Measurements were taken 
using 0.2 cm paired quartz cuvettes for the sample and the blank. 
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9.2.3. Sonication of Carbon Nanomaterials 
Dispersions of graphitic material were prepared by probe sonicating (probe model: 
Cole Parmer Ultrasonic Processor (750 W), ¾” probe tip) 1 mg of the sample in 1 mL 
of selected solvent for 15 min for CNTs and 20 min for graphene nanomaterials (30 
% amplitude, pulse 5 sec on: 5 sec off (total time 30 min and 40 min, respectively)). 
External ice baths was used to cool the mixture during sonication. Then the 
dispersion is centrifuged at 6.000 rpm for 90 sec.  
 
9.2.4. Atomic Force Microscopy (AFM) 
Analyses were carried out in Tapping‐Mode (TM‐AFM), in air at r.t., using a using a 
Nanoscope IV scanning probe microscop. The surfaces for AFM analyses were 
prepared as follows: the carbon nanomaterial dispersion was drop casted on a freshly 
cleaved mica surfaces. Then they left to dry in air. Surfaces were imaged with nitride 
‐doped silicon tips (cantilever: thickness = 25 μm, length = 25 μm, frequency f0 = 70 
kHz, force constant k = 0.4 N/m; Veeco). Analysis of the AFM images was carried 
out using Nanscope analysis 1.5 software.  
 
9.2.5. Transmission electron microscopy (TEM) 
Microscopy was conducted on a JOEL-2100 FEG TEM operated at 80 kV under high 
vacuum conditions. Samples for TEM were prepared by drop depositing onto holey 
carbon TEM grids (Cu, 300 mesh, SPI Supplies) a dispersion of the nanomaterial. 
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Samples were left to dry in air before imaging and then loaded into the TEM using a 
Gatan model 914 single tilt holder. HRTEM images were collected on a Gatan Orius 
camera. Data analysis was conducted using the proprietary Digital Micrograph 
software. 
 
9.2.6. Thermogravimetric Analysis (TGA) 
TGA was carried out using a Perkin Elmer Pyris I. Carbon samples (1 – 10 mg) were 
heated in a ceramic boat from 30 – 120  C/10 °C per min, the temperature was then 
held at 120 °C for 30 min to remove any residual solvent. After this the sample was 
heated under compressed air in a ceramic pan from room temperature to 900 
°
C at a 
rate of 10 
°
C per min. 
 
9.2.7. Thermogravimetric Analysis – Mass Spectrometry (TGA-MS) 
TGA– MS was performed on a Perkin-Elmer Pyris 1 TGA in a helium atmosphere. 
The TGA was coupled to a HIDEN HPR20 mass spectrometer which used evolved 
gas analysis to determine the released species. Carbon samples (1 – 3 mg) were 
heated in a ceramic boat from 30 – 120  C/10 °C per min, the temperature was then 
held at 120 °C for 30 min, and then heated to 900 °C at a rate of 10 
°
C per min. 
. 
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9.2.8. Mass Spectroscopy (MS) Liquid Chromatography Electrospray 
Ionisation Mass Spectrometry (LC-MS) 
Analytical LC– MS data were obtained using a triple quadrupole mass spectrometer 
equipped with an Acquity UPLC (Waters Ltd, UK) and a photodiode array detector. 
Samples were injected onto the Acquity UPLC BEH C8 column 1.7 μm (2.1 mm × 
50 mm) with a flow rate of 0.6 mL min
-1
 and a linear gradient of 5–95 % of solvent 
B over 3.8min (A = 0.1 % formic acid in H2O, B = 0.1 % formic acid in MeCN). The 
flow was introduced into the electrospray ion source of the Aquity TQD mass 
spectrometer. 
 
9.2.9. Matrix Assisted Laser Desorption/Ionisation-Time of Flight Mass 
Spectrometry (MALDI-TOF MS) 
MALDI-ToF mass spectra were obtained using an Autoflex II ToF/ToF mass 
spectrometer with a 337 nm nitrogen laser (Bruker Daltonik GmBH) operating in 
positive mode. Samples were dissolved in 1:1 deionised water (0.1 % TFA)/MeCN. 
The sample solution (1mg mL
-1) was mixed with the matrix solution (an α-cyano-4-
hydroxycinnamic acid matrix) in a ratio of 1:9 and 1 µL of this was spotted onto a 
metal target and placed into the MALDI ion source. 
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9.2.10. Circular Dichroism Spectroscopy (CD) 
Circular dichroism measurements were conducted using a Jasco Model J-1500 
spectropolarimeter fitted with a Jasco J815 MCB-100 mini circulation bath. All 
measurements were carried out using 0.1 cm path length and 500 µL quartz cuvette. 
The peptoid and peptide concentration are based on their dry weight after 
lyophilisation. Samples were made to 1 mM in distilled water, and then diluted to 50 
µM for the peptoid and 100 μM for the peptide in a phosphate buffered solution 
(PBS). 300 µL of this solution was transferred to a cuvette for the measurements. All 
data collection was taken at room temperature and data was collected as an 
accumulation of 10 measurements, adjusted by the background spectrum of the PBS 
buffer. Scans were conducted at 50 nm/min between 260 – 190 nm, 1 nm data pitch, 
5 mdeg sensitivity and a 2 sec response. 
Mean residue molar ellipticity [θ] was obtained using the equation: 
θ] =  
Where θobs is measured ellipticity (degrees), M is the molecular weight (g mol-1), n 
is the number of residues, l is path length (cm), and c is the concentration of 
biomolecule (mg mL
-1
). 
 
9.2.11. High Performance Liquid Chromatography (HPLC) 
Crude biomolecules (peptides, and peptoids) were purified by reversed-phase high-
performance liquid chromatography (RP-HPLC) using a Speck and Burke Analytical 
Chapter 9 
253 
 
C-18 column (5.0 µm, 10.0 x 250 mm) attached to a PerkinElmer Series 200 LC 
Pump and 785A UV/Vis Detector. For preparative runs, concentrations up to 30 mg 
mL
-1
 (1.0 mL) were injected and peak fractions of interest pooled and lyophilised. 
All samples were prepared by dissolving their crude powder in H2O/acetonitrile then 
centrifuged before injection to remove undissolved material. A flow rate of 2 mL 
min
-1
 was used for all separations. The aqueous phase (solvent A) consisted of a 
mixture (v/v) 95 % H2O/5% CH3CN with 0.1 % TFA while the organic phase 
(solvent B) consisted of a mixture (v/v) 5 % H2O/95 % CH3CN with 0.1 % TFA. 
Initial injections of each biomolecule sample were set to 45 to 90 min for linear 
gradients of 0-100 % of solvent B to detect different compound peaks, and either 
shorter times or shorter gradients (from solvent A to B) applied for subsequent 
injections depending on each peptide sequence. A UV-Vis lamp was used as detector 
and 280 nm was the wavelength selected in all cases to monitor and detect the 
chromophore of the aromatic residue–which was part of the synthesised peptides and 
peptoids sequence. 
 
9.2.12. Nuclear Magnetic Resonance (NMR) 
1
H, 
13
C, 
19
F NMR spectra were obtained on the following machines; Varian 
Mercury-400 and 700 MHz, Varian VNMRS-600 MHz and Bruker Avance-400 and 
700 MHz spectrometers. Chemical shifts are reported in parts per million (δ ppm) 
and are referenced to residual solvent peaks. J couplings are reported in megahertz 
(MHz). Multiplicities: s = singlet, d = doublet, dd = doublet of doublets, ddd = 
doublet of doublet of doublets, dt, doublet of triplets, m = multiplet, t = triplet, q = 
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quartet, bd = broad doublet, bs = broad singlet, app s = apparent singlet, app d = 
apparent doublet, app t = apparent triplet, app td = apparent triplet doublet. All 
organic synthesis reactions were monitored by TLC using Merck precoated silica gel 
plates.  
 
9.3. General experimental procedures 
9.3.1. Negishi Chemistry 
Acid washed zinc dust (4.00 eq.) was placed in a pyrex test tube flask fitted with a 
screw top that could b opened when chemicals were added at the time that vacuum or 
argon were applied. The reaction flask was evacuated under heating at 100 ˚C for at 
least 30 minutes with vigorous stirring. After this the reaction mixture was cooled to 
70 ˚C and vacuum line stopped, then placed under a positive pressure of argon. Then 
anhydrous DMF (0.5 mL) and I2 (0.015 g) were added and the light grey suspension 
stirred for a further 20 min. The reaction mixture was then cooled to 50 ˚C followed 
by the addition of the corresponding iodoalanine (1.00 eq.) in anhydrous DMF (0.5 
mL). After stirring for 20 minutes under argon, addition of the catalyst Pd(dba)2 
(0.03 eq.), the 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl (SPhos) (0.010 eq.) 
and the relevant aryl halide (1 eq.) were added and the resulting black mixture stirred 
at 50 ˚C under argon for a minimum of 5 hours. The reaction mixture was sealed to 
keep in the Argon and cooled to room temperature whilst stirring overnight. The 
cooled reaction mixture was purified via column chromatography without work-up 
(SiO2; 80/20 hexane/EtOAc → 100 % EtOAc and if impure a second column was 
run using SiO2; 100 % CH2Cl2).  
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9.3.2. Fmoc-SPPS Peptide Synthesis  
9.3.2.1. Microwave Assisted Automated Fmoc-SPPS 
Peptide syntheses were undertaken on a CEM Liberty microwave peptide synthesiser 
fitted with a Discover microwave unit and a 30 mL PTFE reaction vessel. Pre-
synthesis swelling of the resin was carried out in DMF for 1 h at room temperature. 
Microwave assisted coupling cycles were carried out for 10 min at 75 °C (25 W) 
with amino acid (5.0 eq.), TBTU (5.0 eq.) and DIPEA (10.0 eq.). In the case of 
double couplings, the vessel was drained after the first cycle and coupling cycle was 
repeated with fresh reagents. The Fmoc deprotection step was carried out for 10 min 
at 75 °C (45 W) with a solution of 20 % piperidine in DMF.  
 
9.3.2.2. Manual Fmoc-SPPS 
Manual SPPS was carried out at room temperature for 2 hours with amino acid (4.0 
eq.), TBTU (5.0 eq.) and DIPEA (10.0 eq.) in a fritted polypropene vessel. For 
successive couplings the vessel was drained after the each coupling cycle and the 
coupling cycle was repeated with fresh reagents. The Fmoc deprotection step was 
carried out for 15 min with a solution of 20 % piperidine in DMF, followed by a 
further treatment for 15 min with a fresh solution of 20 % piperidine in DMF. In all 
steps agitation was provided by rolling.  
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9.3.2.3. Peptide Cleavage  
Pre-cleavage the peptide-resins, in a fritted polypropene vessel, were washed with 
DCM (x 3) and ether (x 3) and left to air dry for 5 min. Subsequently the peptide-
resins were treated with a (4 mL per 0.1 mmol of resin) solution of 2.5 % TIPS and 
2.5 % H2O in TFA for 4 h at room temperature. The resin was then removed by 
filtration and the filtrate was added dropwise to ice-cold diethyl ether. After 
centrifugation the supernatant was removed and the pellets suspended in fresh ether 
and centrifuged again. Following further centrifugation, the supernatant was 
discarded. The resulting solid peptide was dissolved in deionised water and 
lyophilised. 
 
9.3.2.4. Peptide Sequences Capping 
Acetylation of the peptide N-terminus was accomplished by suspending the peptide-
resin in a 20 % (v/v) solution of acetic anhydride in DMF in a fritted polypropene 
vessel for 45 min. For successive acetylation the vessel was drained after the 
acetylation reaction was repeated with fresh reagents. 
 
9.3.3. Synthesis of Peptoids (Carried out by Hannah L. Bolt, Cobb Group) 
Fmoc-protected Rink Amide resin (normally 100 – 300 mg, 0.1 – 0.3 mmol) was 
swollen in DMF (minimum 1 h, room temperature, overnight preferred) and 
deprotected with piperidine (20 % in DMF v/v, 2 x 20 min). After DMF washing, the 
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resin was treated with bromoacetic acid (8 eq. wrt. resin, 2 M in DMF) and DIC (8 
eq. wrt. resin, 2 M in DMF) for 15 min at 50 ˚C on a heated shaker with a metal 
block (400 rpm). The resin was washed three times with DMF, before the desired 
amine submonomer was added (4 eq. wrt. resin, 1 M in DMF) and allowed to react 
for 15 min at 50 ˚C. The resin was washed three times with DMF again. The 
bromoacetylation and amine displacement steps were repeated until the final 
submonomer had been added and the desired peptoid sequence had been obtained. 
Cleavage was performed with TFA (95 %), TIPS (2.5 %) and H2O (2.5 %) for 90 
min at room temperature. The cleavage cocktail was collected in a 50 ml falcon tube 
and precipitated with 50 mL diethyl ether. The solution was centrifuged for 15 min at 
5,000 rpm. Afterwards, the ether phase was decanted. The crude was dissolved in 
acidified H2O (with 0.1 % TFA) or a mixture of acidified H2O and MeCN, and 
lyophilized. The crude products were redissolved in acidified H2O (with 0.1 % TFA) 
or a mixture of acidified H2O and MeCN, and purified by RP-HPLC. A typical 
method used for the purification was 0 – 50 % B over 60 min then 50 – 100 % B 
over 15 minutes (A = 0.1 % TFA in 95 % H2O and 5 % MeCN, B = 0.1 % TFA in 5 
% H2O and 95 % MeCN) at 250 nm wavelength. Relevant fractions were collected, 
lyophilised and analysed by LC-MS and MALDI-TOF. 
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9.4. Peptide Synthesis 
9.4.1. Synthesis of Nano-1 First Section (1) 
General procedure for microwave assisted automated Fmoc-SPPS synthesis outlined 
in Section 9.3.2.1 was followed on a 0.10 mmol scale with rink amide resin (0.77 
mmol g
-1
). Fmoc-His(Trt)-OH double coupling was carried out at a reduced 
temperature (10 min at 50 °C (25 W). The peptide left on resin. The MALDI-MS m/z 
[M + H]
+
 = 1962.8. 
 
9.4.2. Synthesis of Nano-1 peptide (2) 
The synthesised first section of nano1- peptide (1) was reloaded into CEM and the 
automated Fmoc-SPPS synthesis (Section 9.3.2.1) was continued to from nano-1 
peptide (2). A small amount of the synthesised peptide was cleaved for 
characterisation (MALDI-MS [M + H] 
+
 = 3312.8).   
 
9.4.3. Synthesis of Free N-terminus Nano-1 (3) 
Half of the synthesised nano-1 peptide (2) manually cleaved form the resin (Section 
9.3.2.3), purified by HPLC (Section 9.2.11). Maldi TOF MS proves the formation of 
the acetylated nano-1,3, MALDI [M + H]
+
 = 3312.8.   
 
Chapter 9 
259 
 
9.4.4. Synthesis of Acetylated N-terminus Nano-1 Peptide (4) 
The second half of nano-1 peptide (2) was acetylated following the method outlined 
in Section 9.3.2.4. Finally the peptide cleaved from the resin (Section 9.3.2.3) and 
purified by RP-HPLC (Section 9.2.11). MALDI confirms the formation of the 
acetylated nano-1, 4, m/z [M + H]
+
 = 3353.4 
 
9.4.5. Synthesis of Free N-terminus Short Nano-1 Peptide (5) 
The synthesis of short nano-1 peptide was carried out using the automated Fmoc-
SPPS synthesis (Section 9.3.2.1) on 0.05 mmol scale with rink amide resin (0.77 
mmol g
-1
). MALDI proves the successful synthesis of free-N terminus short nano-1 
peptide, 3, m/z [M + H]
+
 = 1141.6.  
 
9.4.6. Synthesis of Acetylated Short Nano-1 Peptide (6) 
Acetyled short nano-1 peptide (6) synthesised following the general Fmoc-SPPS 
synthesis on a 0.05 mmol scale with rink amide resin (0.77 mmol g
-1
). Then N 
terminus of the peptide was acetylated by method outlined in Section 9.3.2.4. 
Finally, it is cleaved from the resin using the procedure outlined in Section 9.3.2.3. 
The peptide was purified by RP-HPLC (Section 9.2.11). Acetylated N-terminus short 
nano-1 peptide MALDI, 6, m/z [M + Na]
+
 = 1205. 
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9.4.7. Synthesis of Fluorinated Nano-1 Peptide (13)   
The resin attached first section nano-1 (1) was manually double coupled to the 
synthesised fluorinated amino acid (12) following the general manual peptide 
synthesis outlined in Section 9.3.2.2. A small amount of the peptide was cleaved for 
characterization (MALDI-MS m/z [M
+
 + H] =2203.2 confirmed that product. Then 
the peptide-resin was reloaded into CEM and the automated Fmoc-SPPS synthesis 
(Section 9.3.2.1) was continued to from fluorinated amino acid (12). Finally, the 
peptide was cleaved from the resin using the procedure outlined in Section 9.3.2.3. 
The peptide was purified by RP-HPLC (Section 9.2.11).  
 
9.5. Synthesis of Peptoids 
The following table shows the amine sub-monomers used to synthesise peptoids. All 
peptoids were synthesised (Section 9.5), cleaved from the resin and purified by RP-
HPLC. 
Monomer Chemical Structure Amine Sub-monomer 
 
Nlys 
N-(4-aminobutyl) glycine 
 
 
N-Boc-1,4-diaminobutane 
 
Nspe  
N(S-phenylethyl) glycine 
 
(S)-(−)-α-
Methylbenzylamine 
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Nphe  
N-(phenylmethyl) glycine 
 
Benzylamine 
Nglu                                       
N-(2-carboxyethyl) glycine 
 
 
Table1: Monomers and sub-monomer precursors used for peptoid synthesis.  
 
Sequence LC-MS 
m/z = [M+H]
+
 
*m/z = [M+2H]
2+
 
Accurate Mass  
m/z = [M+2H]
2+
 
RP-
HPLC 
Elution 
(% 
MeCN) 
Calculated Observed Calculated Observed 
(NlysNspeNspe)2 (14) 917.55 917.58 459.7842 459.7801 34% 
(NlysNspeNspe)3 (15) 1368.82 1368.26 684.9157 684.9142 35% 
(NlysNspeNspe)4 (16) 1819.08 1818.97 910.0473 910.0494 40% 
(NlysNspeNspe)6 (17) *1360.30 *1360.73 1360.8119 1360.8058 47% 
(Ac-Nglu-Nlys-Nlys-
Nlys-Nphe) (18) 
719.43 720.17 - - 45% 
Table 2: Analysis data for synthesised peptoids 
 
9.6. Synthesis of Small Organic Molecules  
9.6.1. (S)-tert-butyl-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-
hydroxypropanoate  (9) 
t-Bu-2,2,2,-trichloroacetimidate (2.03 g, 9.29 mmol) in 
EtOAc (20 ml) was added to a stirred solution of  
Fmoc-Ser-OH, 8 (2.0 g, 6.14 mmol) and the resulting 
solution was left to stir overnight. Solvent was removed under reduced pressure and 
the crude product obtained was purified via column chromatography (Hex-EtOAc, 
80:20) to yield the desired product, 9 (1.50 g, 63 %) as a white solid. m.p: 130 
o
C;                    
1
H-NMR δH (400 MHz; CDCl3), 1.49 (s, 9H, CO2
t
Bu), 3.92 (dd, 2H, J = 11.0 β-
CH2), 4.23 (m, 1H, J = 7.5 Fmoc-CHCH2), 4.32 (m, 1H, J = 7.6, α-CH), 4.41 (d, 2H, 
J = 7.1, Fmoc-CHCH2), 5.68 (d, 1H, J = 6.8, NH), 7.30 to 7.33 (appt, 2H, Fmoc-
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ArH), 7.38 to 7.42 (appt, 2H, Fmoc-ArH), 7.60 (d, 2H, J = 7.2, Fmoc-ArH), 7.78 (d, 
2H, J = 7.3, Fmoc-ArH); Spectral data obtained matched that previously 
reported
241,498
. 
1
H-NMR analysis of the product after column purification showed a 
minor impurity. The impurity was removed by re-dissolving the product in ether (20 
ml) and washing with water (3× 10 ml).  
 
9.6.2.  (R)-tert-butyl-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-iodo-
propanoate (10) 
PPh3 (0.99 g, 3.78 mmol), imidazole (0.25 g, 3.78 
mmol) and iodine (0.96 g, 3.78 mmol) were added 
sequentially to a stirred solution of 9  (1.50 g, 3.91 
mmol) in DCM (20 ml) and the reaction mixture as left to stir at rt for 16 h. Removal 
of the solvent under reduced pressure provided the crude product which was purified 
via column chromatography (Hex-EtOAc, 90:10) to afford 10 (1.00 g, 68%) as a 
thick yellow oil. 
1
H-NMR (400 MHz; CDCl3), 1.51 (s, 9H, CO2
t
Bu), 3.59 (dd, 2H, J 
= 3.3, 2.0 Hz, β-CH2), 4.23 (t, 1H, J = 7.2 Hz, Fmoc-CHCH2), 4.33 (dd, 1H, J = 10.4, 
7.2 Hz, α-CH), 4.44 – 4.37 (m, 2H, Fmoc-CHCH2), 5.66 (d, 1H, J = 6.7 Hz, NH), 
7.75 (d, 2H, J = 7.5 Hz, Fmoc-ArH), 7.60 (d, 2H, J = 7.4 Hz, Fmoc-ArH), 7.39 (appt, 
2H, J = 7.2 Hz, Fmoc-ArH), 7.31 (m, 2H, J = 7.5, 2.6, 1.0 Hz, Fmoc-ArH); MS (ESI 
+ve) m/z 516.3 [M + Na]
 +
. Spectral data obtained for 10 matched that previously 
reported.
499,500
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9.6.3. (S)-tert-butyl-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-
(trifluoromethyl)phenyl)propanoate (11). 
The synthesis of the amino acid was performed using the 
Negishi reaction outlined in Section 6.2.1. After finishing the 
reaction, the solvent was removed under reduced pressure 
provided the crude product which was purified via column 
chromatography (Hex-EtOAc, 70:30) to afford the purified product 11 (0.29 g, 65%) 
as a white solid. vmax (solid)/cm
-1
 2979 (w, C-H), 2239.7 (w, C≡N), 1719.6 (s , bd 
C=O amide), 1500.6 (m, bd N-H), 1450.2 and 1369.5 (m, C-H), 1318.5 (m, C-N), 
1286.5 and 1258.4 (C-O ester), 1176.6 and 1136.7 (s, bd C-F), 1050 (C-O ester), 794 
and 740 (m, bd C-H); 
1
H-NMR (400 MHz; CDCl3), 1.39 (9H, s, CO2
t
Bu), 3.19 (dd, 
2H, J = 10.8, 6.3, β-CH2), 4.18 (t, 1H, J = 6.8, Fmoc-CHCH2), 4.41-4.35 (m, 1H, α-
CH), 4.50 (dd, 2H, J = 19.1, Fmoc-CHCH2,), 5.33 (d, 1H, J = 7.6, NH), 7.30 (appt, 
2H, Fmoc-ArH), 7.39 (m, 2H, Fmoc-ArH), 7.56 (m, 2H, Fmoc-ArH), 7.71 (m, 1H, 
ArH), 7.76 (d, 2H, ArH) 7.90 (m, 1H, ArH), 7.99 (m, 2H, ArH), 8.01 (m, 1H, ArH);
 
13
C-NMR δC (100 MHz; CDCl3) 169.5, 155.5, 143.5 (d, 1C, J = 12.5), 142.4 (d, 1C, 
J = 38.5), 141.3 (d, 1C, J = 5.2), 135.7, 134.6, 133.3, 130.0, 127.8, 127.0 (d, 1C, J = 
3.1), 125.6 (m, 1C, CF3), 125.5 (d, 1C, J = 10.2), 120.0 (d, 1C, J = 3.6), 115.3, 114.7, 
108.63, 83.5, 66.9, 54.6, 47.3, 38.3, 27.9 (d, J = 7.0 Hz) ; F-NMR δF (376 MHz; 
CDCl3) -62.84 (bs, 2F, Ar-CF3), -62.97 (bs, 1F, Ar-CF3); MS (ESI +ve) m/z 
537.1999 [M + H]
 +
. 
 
Chapter 9 
264 
 
9.6.4. (S)-tert-butyl-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-
(trifluoromethyl)phenyl)propanoic acid  (12) 
Trifluoroacetic acid (4 ml) was added dropwise to a 
solution of 11 (0.29 g, 0.54 mmol) in DCM (4 ml). The 
resulting solution was stirred at room temperature for 
5h. Removal of the solvent under reduced pressure and 
the residue washed and concentrated twice with ether 
(10 ml). This yielded the product 76%. 
1
H-NMR δH (400 MHz, CDCl3), δH 3.33 (dd, 
1H, J = 13.8, 5.6 Hz, β-CH2, 3.17 (dd, 1H, J = 14.0, 5.2 Hz, β-CH2), 4.16 (appt, 1H, J 
= 6.2 Hz, Fmoc CHCH2), 4.51–4.37 (m, 2H, Fmoc CHCH2), 4.67 (d, 1H, J = 6.5 Hz, 
α-CH), 5.27 (d, 1H, J = 7.3 Hz, NH), 7.28 (m, 2H, J = 7.4, Fmoc-ArH), 7.35 (m, 2H, 
J = 7.4, Fmoc-ArH),7.39 (m, 1H, J = 7.6, ArH), 7.50 to 7.55 (m, 2H, Fmoc-ArH), 
7.69 (m, 1H, ArH), 7.75 (appd, 1H, ArH,), 7.90 (appd, 1H, J = 8.4, ArH), 8.00 (appt, 
2H, J = 7.6, Fmoc-ArH), 12.89 (1H, s, CO2H). 
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9.7. Preparation of CNTs  
9.7.1. Purification of SWNTs 
As-synthesised SWNTs produced by the HiPco method and supplied by Unidym, 
USA (6 wt % Iron impurities, 35 wt % Ash impurities) were purified by heating in 
air at 400 °C for 30 min, then soaking in 6.0 M HCl at rt. overnight. They were then 
filtrated over a polycarbonate membrane (0.45 μm), and washed with copious 
amounts of high-purity water until pH-neutral. Finally, the nanotubes were dispersed 
in ethanol, filtered, removed from the membrane and allowed to dry in vacuum oven 
overnight at 60 °C.  
 
9.7.2. Oxidation of SWNTs 
Two batches of oxidised HiPco SWNTs were prepared. Purified HiPco SWNTs (100 
mg) were refluxed in 100 mL nitric acid (2 M, and 8 M) for 4 h at 120 °C to yield     
2 M and 8 M oxidised HiPco SWNTs, respectively. Following the reﬂux, both 
samples were treated similarly: after the sample had cooled it was filtered over a 
polycarbonate membrane (0.45 μm), and then rinsed with water, until the ﬁltrate was 
colourless and reached the pH of the distilled water. The sample was then washed 
with 500 mL of sodium hydroxide (NaOH, 0.05 M), producing a yellow/brown 
filtrate. The base washing was continued until the filtrate is colourless. The resulting 
nanotubes were then washed with distilled water until neutral. Finally, the product 
was washed with hydrochloric acid (HCl, 0.05 M, 500 mL) and again returned to 
neutral with distilled water. Finally, the oxidised nanotubes were dried in a vacuum 
oven at 60 °C for 24 h.  
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9.8. Preparation of Graphene Based Nanomaterials  
9.8.1. Synthesis of Graphene Oxide  
Graphene oxide was synthesised using Hummer’s method380 as shown Figure 1:  
 
Figure 1: Synthesis of GO by Hummer’s method.  
 
Firstly, graphite powder (1.0 g, 1.0 eq. wt.) and sodium nitrate (NaNO3, 0.5 g, 0.5 eq. 
wt.) were dispersed by stirring in concentrated sulphuric acid (H2SO4, 23 mL, S.G. 
1.83, 1 eq. wt.) at 0 °C using a Grant LTD6G recalculating cooler. Then potassium 
permanganate (KMnO4, 3 g, 3.0 eq. wt.) was slowly added to the suspension, 
ensuring that the reaction temperature did not rise above 10 °C. Then the reaction 
was heated to 35 °C in a water bath for 30 min, during this time the viscosity of the 
reaction mixture increased greatly and it becomes difficult to stir. High purity water 
(46 mL, 2.0 eq. vol.) was then added causing an exothermic reaction to occur. This 
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increase in temperature was supplemented with external heating and the reaction was 
heated to 95 °C for 15 min. Following this, the reaction was cooled to room 
temperature and decanted into 140 ml (6.1 eq. vol.) of high purity water. The 
remaining active manganese species were quenched by the addition of H2O2 (1 mL, 
30 %) over a period 15 min. The colour of the suspension changed to bright yellow. 
Secondly, several workups were followed to isolate and purify the graphite oxide 
produced by the reaction; centrifugation and washing with high purity water until 
neutral. Finally, graphite oxide samples were exfoliated to form GO by probe 
sonication. Samples were dispersed in high purity water at concentrations of 1.0 mg 
ml
-1
 and probe sonicated for a total of 40 min (Section 9.2.3). 
 
9.8.2. Synthesis of Reduced Graphene Oxide (rGO) 
Exfoliated GO at a concentration of 1.0 mg mL
-1
 in high purity water was added to 
hydrazine monohydrate (N2H4. H2O, 1.0 μL per 3 mg of GO) and refluxed at 80 °C 
for 24 h. The solution quickly changed from a dark brown to a black colour, 
indicative of the formation of rGO. Then the reaction was cooled to room 
temperature and the rGO produced was isolated via vacuum ﬁltration over a 
polycarbonate membrane (pore size 0.25 μ).  
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9.8.3. Synthesis of Oxidised rGO (Oxi-rGO) 
(100 mg) of rGO was refluxed in 100 mL of 8 M HNO3 for 24 h at 100 °C. The 
oxidised rGO was collected via vacuum ﬁltration over a polycarbonate membrane 
(0.25 μ), then rinsed with deionised water, dried in vacuum at 60 °C overnight. 
 
9.8.4. Synthesis of Synthesis of Acylated-rGO (rGO-COCl) 
The oxidised rGO (100 mg) was refluxed in a mixture of thionyl chloride (SOCl2, 5 
mL) and dimethylformamide (DMF, 20 mL) at 80 °C overnight. Then filtered via 
vacuum ﬁltration over a polycarbonate membrane (pore size 0.45 μm), and washed 
with dry DMF. 
 
9.8.5. Synthesis of EDA-rGO 
(100 mg) of acylated-rGO (rGO-COCl) was stirred in 10 mL of 50:50 mixture of 
ethylene diamine (EDA) and dimethylformamide (DMF) under nitrogen atmosphere 
at rt. over night. Then washed with ethanol several times and dried at 60 °C 
overnight in vacuum. 
 
 
Chapter 9 
269 
 
9.8.6. Synthesis of CPPo-rGO 
A mixture of 15.0 mg CPPo (18), 8.0 mg PyBOP, 10.0 ml DIEA in 3 ml anhydrous 
DMF was prepared in order to enhance activation of carboxyl groups by DIEA. After 
15 min of activation, EDA-rGO (10.0 mg) dispersed in anhydrous DMF (15 mL) 
were added to the mixture. The obtained mixture was then sonicated for 4 h at 40 °C. 
The product was then diluted with 300 mL of methanol and vacuum-ﬁltered using a 
polycarbonate membrane (0.05 mm pore size), after which the ﬁltranate was washed 
extensively with excess methanol. Finally, CPPo-rGO was dried in a vacuum oven at 
60 °C for 8 h. 
 
9.8.7. Synthesis of of Thymidine/GO and Adensine/rGO Composites 
Freeze dried GO (50 mg) was acetylated by refluxing it in an excess amount of 
thionyl chloride (SOCl2, 20 mL) in the presence of anhydrous N,N-
dimethylformamide (DMF, 5 mL) at 80  C for 24 h to yield GO-COCl. The GO-
COCl powder was collected immediately by distillation and washed with anhydrous 
DMF. Then divided into two, and then separately reacted with a 125 mg 
ribonucleoside solution (adenosine, and thymidine) in 10 mL of DMF in the presence 
of 0.5 mL of triethylamine at 130 °C for 72 h in nitrogen atmosphere. The produced 
adenosine/rGO was further washed with HCl solution (0.5 mMol) once and 
deionised water three times and dried at vacuum oven at 45 °C for 8 h 
 
References 
270 
 
References 
1. H. W. Kroto, J. R. Heath, S. C. O'Brien, R. F. Curl and R. E. Smalley, 
Nature, 1985, 318, 162-163. 
2. S. Iijima, Nature, 1991, 354, 56-58. 
3. S. Iijima and T. Ichihashi, Nature, 1993, 363, 603-605. 
4. D. S. Bethune, C. H. Klang, M. S. de Vries, G. Gorman, R. Savoy, J. 
Vazquez and R. Beyers, Nature, 1993, 363, 605-607. 
5. H. Jie, in Carbon Nanotubes, ed.  M. Meyyappan, CRC Press, New York, 
2004, ch.1, pp. 2-104. 
6. D. B. Zhang, E. Akatyeva and T. Dumitrica, Phys. Rev. Lett., 2011, 106, 
2555031-2555034. 
7. N. K. Mehra, V. Mishra and N. K. Jain, Biomaterials, 2014, 35, 1267-1283. 
8. M. Monthioux and V. L. Kuznetsov, Carbon, 2006, 44, 1621-1623. 
9. P. M. Ajayan, Chem. Rev., 1999, 99, 1787-1800. 
10. W. Zhang, Z. Zhang and Y. Zhang, Nanoscale Res. Lett., 2011, 6, 555-555. 
11. M. S. Dresselhaus, G. Dresselhaus, J. C. Charlier and E. Hernandez, Philos. 
T. R. Soc. A, 2004, 362, 2065-2098. 
References 
271 
 
12. A. Thess, R. Lee, P. Nikolaev, H. J. Dai, P. Petit, J. Robert, C. H. Xu, Y. H. 
Lee, S. G. Kim, A. G. Rinzler, D. T. Colbert, G. E. Scuseria, D. Tomanek, J. 
E. Fischer and R. E. Smalley, Science, 1996, 273, 483-487. 
13. A. Krueger, in Carbon Materials and Nanotechnology, Wiley-VCH Verlag 
GmbH & Co. KGaA, Germany, 2010,.ch.3, pp. 123-281. 
14. T. W. Odom, J. L. Huang, P. Kim and C. M. Lieber, J. Phys. Chem. B, 2000, 
104, 2794-2809. 
15. M. S. Dresselhaus, G. Dresselhaus, R. Saito and A. Jorio, Phys. Rep., 2005, 
409, 47-99. 
16. E. T. Thostenson, Z. Ren and T.-W. Chou, Composites Sci. Technol., 2001, 
61, 1899-1912. 
17. S. A. Hodge, M. K. Bayazit, K. S. Coleman and M. S. P. Shaffer, Chem. Soc. 
Rev., 2012, 41, 4409-4429. 
18. R. Saito, M. Fujita, G. Dresselhaus and M. S. Dresselhaus, Appl. Phys. Lett., 
1992, 60, 2204-2206. 
19. C. Liu and H.-M. Cheng, Mater. Today, 2013, 16, 19-28. 
20. C. A. Dyke and J. M. Tour, J. Phys. Chem. A, 2004, 108, 11151-11159. 
21. W. Kratschmer, L. D. Lamb, K. Fostiropoulos and D. R. Huffman, Nature, 
1990, 347, 354-358. 
22. C. Journet and P. Bernier, Appl. Phys. A: Mater. Sci. Process, 1998, 67, 1-9. 
References 
272 
 
23. D. M. Guldi and N. Martín, Carbon Nanotubes and Related Structures: 
Synthesis, Characterization, Functionalization, and Applications, Wiley-
VCH Verlag GmbH & Co. KGaA, Germany, 2010. 
24. S S. Yahachi, O. Mitsumasa, F. Naoya, Y. Tadanobu, T. Masato and H. 
Takayoshi, Jpn. J. Appl. Phys., 1994, 33, L526-L529. 
25. C. Journet, W. K. Maser, P. Bernier, A. Loiseau, M. L. de la Chapelle, S. 
Lefrant, P. Deniard, R. Lee and J. E. Fischer, Nature, 1997, 388, 756-758. 
26. I. Hinkov, S. Farhat and C. D. Scott, Carbon, 2005, 43, 2453-2462. 
27. T. Guo, P. Nikolaev, A. Thess, D. T. Colbert and R. E. Smalley, Chem. Phys. 
Lett., 1995, 243, 49-54. 
28. T. Guo, P. Nikolaev, A. G. Rinzler, D. Tomanek, D. T. Colbert and R. E. 
Smalley, J. Phys. Chem., 1995, 99, 10694-10697. 
29. R. T. K. Baker, Carbon, 1989, 27, 315-323. 
30. S. N. Marinkovic, J. Serb. Chem. Soc., 2008, 73, 891-913. 
31. J. Mohsen and K. Asieh Dehghani, in Syntheses and Applications of Carbon 
Nanotubes and Their Composites, ed. Satoru Suzuki, InTech, 2013, ch.4, pp. 
54-76. 
32. V. N. Popov, Mater. Sci. Engin. R, 2004, 43, 61-102. 
33. J. Kong, A. M. Cassell and H. J. Dai, Chem. Phys. Lett., 1998, 292, 567-574. 
References 
273 
 
34. J. Kong, H. T. Soh, A. M. Cassell, C. F. Quate and H. Dai, Nature, 1998, 395, 
878-881. 
35. M. J. Bronikowski, P. A. Willis, D. T. Colbert, K. A. Smith and R. E. 
Smalley, J. Vac. Sci. Technol. A, 2001, 19, 1800-1805. 
36. P. Nikolaev, M. J. Bronikowski, R. K. Bradley, F. Rohmund, D. T. Colbert, 
K. A. Smith and R. E. Smalley, Chem. Phys. Lett., 1999, 313, 91-97. 
37. I. W. Chiang, B. E. Brinson, A. Y. Huang, P. A. Willis, M. J. Bronikowski, J. 
L. Margrave, R. E. Smalley and R. H. Hauge, J. Phys. Chem. B, 2001, 105, 
8297-8301. 
38. S. Cataldo, P. Salice, E. Menna and B. Pignataro, Energy Environ. Sci., 2012, 
5, 5919-5940. 
39. T.-J. Park, S. Banerjee, T. Hemraj-Benny and S. S. Wong, J. Mater. Chem., 
2006, 16, 141-154. 
40. R. C. Haddon, Science, 1993, 261, 1545-1550. 
41. M. A. Hamon, M. E. Itkis, S. Niyogi, T. Alvaraez, C. Kuper, M. Menon and 
R. C. Haddon, J. Am. Chem. Soc., 2001, 123, 11292-11293. 
42. D. Srivastava, D. W. Brenner, J. D. Schall, K. D. Ausman, M. F. Yu and R. S. 
Ruoff, J. Phys. Chem. B, 1999, 103, 4330-4337. 
43. S. Niyogi, M. A. Hamon, H. Hu, B. Zhao, P. Bhowmik, R. Sen, M. E. Itkis 
and R. C. Haddon, Acc. Chem. Res., 2002, 35, 1105-1113. 
References 
274 
 
44. R. C. Haddon, J. Am. Chem. Soc., 1990, 112, 3385-3389. 
45. R. C. Haddon, Acc. Chem. Res., 1988, 21, 243-249. 
46. D. A. Britz and A. N. Khlobystov, Chem. Soc. Rev., 2006, 35, 637-659. 
47. Y. Chen, R. C. Haddon, S. Fang, A. M. Rao, W. H. Lee, E. C. Dickey, E. A. 
Grulke, J. C. Pendergrass, A. Chavan, B. E. Haley and R. E. Smalley, J. 
Mater. Res., 1998, 13, 2423-2431. 
48. Y. Miyata, T. Kawai, Y. Miyamoto, K. Yanagi, Y. Maniwa and H. Kataura, 
J. Phys. Chem. C, 2007, 111, 9671-9677. 
49. A. A. Balandin, Nat. Mater., 2011, 10, 569-581. 
50. S. Berber, Y.-K. Kwon and D. Tománek, Phys. Rev. Lett., 2000, 84, 4613-
4616. 
51. M. S. Dresselhaus, G. Dresselhaus and A. Jorio, Annu. Rev. Mater. Res., 
2004, 34, 247-278. 
52. J. Hone, M. C. Llaguno, N. M. Nemes, A. T. Johnson, J. E. Fischer, D. A. 
Walters, M. J. Casavant, J. Schmidt and R. E. Smalley, Appl. Phys. Lett., 
2000, 77, 666-668. 
53. J. P. Lu, Phys. Rev. Lett., 1997, 79, 1297-1300. 
54. J. N. Coleman, U. Khan, W. J. Blau and Y. K. Gun’ko, Carbon, 2006, 44, 
1624-1652. 
References 
275 
 
55. D. Tomanek, A. Jorio, M. S. Dresselhaus and G. Dresselhaus, Top Appl. 
Phys., 2008, 111, 1-12. 
56. A. Peigney, C. Laurent, E. Flahaut, R. R. Bacsa and A. Rousset, Carbon, 
2001, 39, 507-514. 
57. C. H. Sun, L. C. Yin, F. Li, G. Q. Lu and H. M. Cheng, Chem. Phys. Lett., 
2005, 403, 343-346. 
58. L. A. Girifalco, M. Hodak and R. S. Lee, Phys. Rev. B, 2000, 62, 13104-
13110. 
59. P. Singh, S. Campidelli, S. Giordani, D. Bonifazi, A. Bianco and M. Prato, 
Chem. Soc. Rev., 2009, 38, 2214-2230. 
60. K. L. Lu, R. M. Lago, Y. K. Chen, M. L. H. Green, P. J. F. Harris and S. C. 
Tsang, Carbon, 1996, 34, 814-816. 
61. Q. H. Cheng, S. Debnath, E. Gregan and H. J. Byrne, J. Phys. Chem. C, 2010, 
114, 8821-8827. 
62. A. Hirsch, Angew. Chem., Int. Ed., 2002, 41, 1853-1859. 
63. G. Jia, H. Wang, L. Yan, X. Wang, R. Pei, T. Yan, Y. Zhao and X. Guo, 
Environ. Sci. Technol., 2005, 39, 1378-1383. 
64. G. Tobias, E. Mendoza and B. Ballesteros, in Encyclopedia of 
Nanotechnology, ed. B. Bhushan, Springer Netherlands, 2nd end., 2015, ch. 
48-2, pp. 1-12. 
References 
276 
 
65. D. Tasis, N. Tagmatarchis, A. Bianco and M. Prato, Chem. Rev., 2006, 106, 
1105-1136. 
66. J. Zhang, H. L. Zou, Q. Qing, Y. L. Yang, Q. W. Li, Z. F. Liu, X. Y. Guo and 
Z. L. Du, J. Phys. Chem. B, 2003, 107, 3712-3718. 
67. L. J. Meng, C. L. Fu and Q. H. Lu, Prog. Nat. Sci., 2009, 19, 801-810. 
68. J. L. Bahr, J. Yang, D. V. Kosynkin, M. J. Bronikowski, R. E. Smalley and J. 
M. Tour, J. Am. Chem. Soc., 2001, 123, 6536-6542. 
69. C. A. Dyke and J. M. Tour, Nano Lett., 2003, 3, 1215-1218. 
70. J. L. Bahr and J. M. Tour, Chem. Mater., 2001, 13, 3823-3824. 
71. C. A. Dyke and J. M. Tour, J. Am. Chem. Soc., 2003, 125, 1156-1157. 
72. E. T. Mickelson, C. B. Huffman, A. G. Rinzler, R. E. Smalley, R. H. Hauge 
and J. L. Margrave, Chem. Phys. Lett., 1998, 296, 188-194. 
73. Y. Ying, R. K. Saini, F. Liang, A. K. Sadana and W. E. Billups, Org. Lett., 
2003, 5, 1471-1473. 
74. M. Holzinger, J. Abraham, P. Whelan, R. Graupner, L. Ley, F. Hennrich, M. 
Kappes and A. Hirsch, J. Am. Chem. Soc., 2003, 125, 8566-8580. 
75. K. S. Coleman, S. R. Bailey, S. Fogden and M. L. H. Green, J. Am. Chem. 
Soc., 2003, 125, 8722-8723. 
References 
277 
 
76. K. Kamaras, M. E. Itkis, H. Hu, B. Zhao and R. C. Haddon, Science, 2003, 
301, 1501-1501. 
77. T. Nakamura, M. Ishihara, T. Ohana, A. Tanaka and Y. Koga, Chem. 
Commun., 2004, 1336-1337. 
78. S. Qin, D. Qin, W. T. Ford, J. E. Herrera, D. E. Resasco, S. M. Bachilo and 
R. B. Weisman, Macromolecules, 2004, 37, 3965-3967. 
79. S. Banerjee, T. Hemraj-Benny and S. S. Wong, Adv. Mater., 2005, 17, 17-29. 
80. D. R. Dreyer, S. Park, C. W. Bielawski and R. S. Ruoff, Chem. Soc. Rev., 
2010, 39, 228-240. 
81. M. J. O'Connell, P. Boul, L. M. Ericson, C. Huffman, Y. H. Wang, E. Haroz, 
C. Kuper, J. Tour, K. D. Ausman and R. E. Smalley, Chem. Phys. Lett., 2001, 
342, 265-271. 
82. L. Y. Piao, Q. R. Liu, Y. D. Li and C. Wang, J. Phys. Chem. C, 2008, 112, 
2857-2863. 
83. M. Vizuete, M. Barrejón, M. J. Gómez-Escalonilla and F. Langa, Nanoscale, 
2012, 4, 4370–4381. 
84. Wei Yana,Dai-Wen Panga, Sheng-Fu Wanga and Yuan-Di Zhaoa, Fuller. 
Nanotub. Carb. N., 2005, 13, 309. 
85. H. Wang, Curr. Opin. Colloid Interface Sci., 2009, 14, 364-371. 
References 
278 
 
86. T. Wei, M. A. Carignano and I. Szleifer, J. Phys. Chem. B, 2012, 116, 10189-
10194. 
87. S. M. Tomasio and T. R. Walsh, J. Phys. Chem. C, 2009, 113, 8778-8785. 
88. C. Y. Hu, Y. J. Xu, S. W. Duo, R. F. Zhang and M. S. Li, J. Chin. Chem. 
Soc., 2009, 56, 234-239. 
89. N. Nakashima, S. Okuzono, H. Murakami, T. Nakai and K. Yoshikawa, 
Chem. Lett., 2003, 32, 456-457. 
90. N. Hadidi, F. Kobarfard, N. Nafissi-Varcheh and R. Aboofazeli, Int. J. 
Nanomedicine, 2011, 6. 
91. G. Prencipe, S. M. Tabakman, K. Welsher, Z. Liu, A. P. Goodwin, L. Zhang, 
J. Henry and H. J. Dai, J. Am. Chem. Soc., 2009, 131, 4783-4787. 
92. N. Nakayama-Ratchford, S. Bangsaruntip, X. Sun, K. Welsher and H. Dai, J. 
Am. Chem. Soc., 2007, 129, 2448-2449. 
93. J. Chattopadhyay, F. de Jesus Cortez, S. Chakraborty, N. K. H. Slater and W. 
E. Billups, Chem. Mater., 2006, 18, 5864-5868. 
94. R. J. Liu Z, Sun X, Dai H. , J. Am. Chem. Soc., 2008, 130, 10876–10877. 
95. K. Kostarelos, A. Bianco and M. Prato, Nat. Nano, 2009, 4, 627-633. 
96. P. Randhawa, J. S. Park, S. Sharma, P. Kumar, M. S. Shin and S. S. Sekhon, 
J. Nanoelectron. Optoelectron., 2012, 7, 279-286. 
References 
279 
 
97. J. C. Goak, S. H. Lee, J. H. Han, S. H. Jang, K. B. Kim, Y. Seo, Y. S. Seo and 
N. Lee, Carbon, 2011, 49, 4301-4313. 
98. L. Vaisman, H. D. Wagner and G. Marom, Adv. Colloid Interface Sci., 2006, 
128–130, 37-46. 
99. A. J. Blanch, C. E. Lenehan and J. S. Quinton, J. Phys. Chem. B, 2010, 114, 
9805-9811. 
100. V. C. Moore, M. S. Strano, E. H. Haroz, R. H. Hauge, R. E. Smalley, J. 
Schmidt and Y. Talmon, Nano Lett., 2003, 3, 1379-1382. 
101. Y. Q. Tan and D. E. Resasco, J. Phys. Chem. B, 2005, 109, 14454-14460. 
102. H. S. Kim, W. I. Park, M. Kang and H. J. Jin, J. Phys. Chem. Solids, 2008, 
69, 1209-1212. 
103. M. F. Islam, E. Rojas, D. M. Bergey, A. T. Johnson and A. G. Yodh, Nano 
Lett., 2003, 3, 269-273. 
104. R. Rastogi, R. Kaushal, S. K. Tripathi, A. L. Sharma, I. Kaur and L. M. 
Bharadwaj, J. Colloid Interface Sci., 2008, 328, 421-428. 
105. C. C. Ge, J. F. Du, L. N. Zhao, L. M. Wang, Y. Liu, D. H. Li, Y. L. Yang, R. 
H. Zhou, Y. L. Zhao, Z. F. Chai and C. Y. Chen, Proc. Natl. Acad. Sci. U. S. 
A., 2011, 108, 16968-16973. 
106. S. Marchesan and M. Prato, Chem. Commun., 2015, 51, 4347-4359. 
107. N. Saifuddin, A. Z. Raziah and A. R. Junizah, J. Chem., 2013, 2013, 1-18. 
References 
280 
 
108. Y. X. Wang and H. Q. Ai, J. Phys. Chem. B, 2009, 113, 9620-9627. 
 
109. Y. Lin, S. Taylor, H. P. Li, K. A. S. Fernando, L. W. Qu, W. Wang, L. R. Gu, 
B. Zhou and Y. P. Sun, J. Mater. Chem., 2004, 14, 527-541. 
110. Z. Su, K. Mui, E. Daub, T. Leung and J. Honek, J. Phys. Chem. B, 2007, 111, 
14411-14417. 
111. K. Kurppa, H. Jiang, G. R. Szilvay, A. G. Nasibulin, E. I. Kauppinen and M. 
B. Linder, Angew. Chem. Int. Ed., 2007, 46, 6446-6449. 
112. D. Nepal and K. E. Geckeler, Small, 2007, 3, 1259-1265. 
113. N. W. S. Kam and H. Dai, J. Am. Chem. Soc., 2005, 127, 6021-6026. 
114. K. Matsuura, T. Saito, T. Okazaki, S. Ohshima, M. Yumura and S. Iijima, 
Chem. Phys. Lett., 2006, 429, 497-502. 
115. R. J. Chen, Y. Zhang, D. Wang and H. Dai, J. Am. Chem. Soc., 2001, 123, 
3838-3839. 
116. S. C. Tsang, J. J. Davis, M. L. H. Green, H. A. O. Hill, Y. C. Leung and P. J. 
Sadler, J. Chem. Soc., Chem. Commun., 1995, 17, 1803–1804. 
117. Y. Kang, Q. Wang, Y. C. Liu, J. W. Shen and T. Wu, J. Phys. Chem. B, 2010, 
114, 2869-2875. 
References 
281 
 
118. M. Sheikholeslam, M. Pritzker and P. Chen, Langmuir, 2012, 28, 12550-
12556. 
119. Siqun Wang1, Elen S. Humphreys, Sung-Yoon Chung, Daniel F. Delduco, 
Steven R. Lustig, Hong Wang, Kimberley N. Parker, Nancy W. Rizzo, 
Shekhar Subramoney, Yet-Ming Chiang and Anand Jagota, Nat. 
Mater., 2003, 2, 196 - 200 
120. V. Zorbas, A. L. Smith, H. Xie, A. Ortiz-Acevedo, A. B. Dalton, G. R. 
Dieckmann, R. K. Draper, R. H. Baughman and I. H. Musselman, J. Am. 
Chem. Soc., 2005, 127, 12323-12328. 
121. S.-F. Chin, R. H. Baughman, A. B. Dalton, G. R. Dieckmann, R. K. Draper, 
C. Mikoryak, I. H. Musselman, V. Z. Poenitzsch, H. Xie and P. Pantano, Exp. 
Biol. Med., 2007, 232, 1236-1244. 
122. W. Y. Chen, L. S. Wang, H. T. Chiu, Y. C. Chen and C. Y. Lee, J. Am. Soc. 
Mass Spectrom., 2004, 15, 1629-1635. 
123. C. G. Salzmann, M. A. H. Ward, R. M. J. Jacobs, G. Tobias and M. L. H. 
Green, J. Phys. Chem. C, 2007, 111, 18520-18524. 
124. G. R. Dieckmann, A. B. Dalton, P. A. Johnson, J. Razal, J. Chen, G. M. 
Giordano, E. Muñoz, I. H. Musselman, R. H. Baughman and R. K. Draper, J. 
Am. Chem. Soc., 2003, 125, 1770-1777. 
References 
282 
 
125. S. Wang, E. S. Humphreys, S.-Y. Chung, D. F. Delduco, S. R. Lustig, H. 
Wang, K. N. Parker, N. W. Rizzo, S. Subramoney, Y.-M. Chiang and A. 
Jagota, Nat Mater, 2003, 2, 196-200. 
126. X. Li, W. Chen, Q. Zhan, L. Dai, L. Sowards, M. Pender and R. R. Naik, J. 
Phys. Chem. B, 2006, 110, 12621-12625. 
127. M. S. Arnold, M. O. Guler, M. C. Hersam and S. I. Stupp, Langmuir, 2005, 
21, 4705-4709. 
128. J. M. Brown, Molecular Spectroscopy, Oxford University Press, Oxford, 
1998. 
129. S. Arepalli, S. W. Freiman, S. A. Hooker, and K. D. Migler, Measurement 
issues in single-wall carbon nanotubes, National Institute of Standards and 
Technology, Gaithersburg, 2008. 
130. R. S. Das and Y. K. Agrawal, Vib. Spectrosc., 2011, 57, 163-176. 
131. F. Tuinstra and J. L. Koenig, J. Chem. Phys, 1970, 53, 1126-1130. 
132. L. M. Malard, M. A. Pimenta, G. Dresselhaus and M. S. Dresselhaus, Phys. 
Rep., 2009, 473, 51-87. 
133. U. J. Kim, C. A. Furtado, X. Liu, G. Chen and P. C. Eklund, J. Am. Chem. 
Soc., 2005, 127, 15437-15445. 
134. M. S. Dresselhaus, A. Jorio and R. Saito, Annu. Rev, Condens. Matter. Phys., 
2010, 1, 89-108. 
References 
283 
 
135. A. C. Ferrari and J. Robertson, Phil. Trans. R. Soc. Lond. A, 2004, 362, 2477-
2512. 
136. A. C. Ferrari and J. Robertson, Phys. Rev. B, 2000, 61, 14095-14107. 
137. F. Hennrich, R. Krupke, S. Lebedkin, K. Arnold, R. Fischer, D. E. Resasco 
and M. M. Kappes, J. Phys. Chem. B, 2005, 109, 10567-10573. 
138. A. Jorio, C. Fantini, M. S. S. Dantas, M. A. Pimenta, A. G. Souza Filho, G. 
G. Samsonidze, V. W. Brar, G. Dresselhaus, M. S. Dresselhaus, A. K. Swan, 
M. S. Ünlü, B. B. Goldberg and R. Saito, Phys. Rev. B, 2002, 66, 115411. 
139. A. M. Rao, E. Richter, S. Bandow, B. Chase, P. C. Eklund, K. A. Williams, 
S. Fang, K. R. Subbaswamy, M. Menon, A. Thess, R. E. Smalley, G. 
Dresselhaus and M. S. Dresselhaus, Science, 1997, 275, 187-191. 
140. A. Jorio, A. G. Souza Filho, G. Dresselhaus, M. S. Dresselhaus, A. K. Swan, 
M. S. Ünlü, B. B. Goldberg, M. A. Pimenta, J. H. Hafner, C. M. Lieber and 
R. Saito, Phys. Rev. B, 2002, 65, 155412. 
141. A. Jorio, M. A. Pimenta, A. G. S. Filho, R. Saito, G. Dresselhaus and M. S. 
Dresselhaus, New J. Phys., 2003, 5, 139, 139.1-139.17. 
142. J. L. Hughes and E. Krausz, in Encyclopedia of Inorganic and Bioinorganic 
Chemistry, Wiley, New Jersey, 2011. 
143. C. Backes, in Noncovalent Functionalization of Carbon Nanotubes, Springer, 
Berlin, 2012, ch. 1, pp. 1-37. 
References 
284 
 
144. J. S. Lauret, C. Voisin, G. Cassabois, P. Roussignol, C. Delalande, A. 
Filoramo, L. Capes, E. Valentin and O. Jost, Physica E, 2004, 21, 1057-1060. 
145. F. Wang, Y. B. Zhang, C. S. Tian, C. Girit, A. Zettl, M. Crommie and Y. R. 
Shen, Science, 2008, 320, 206-209. 
146. J. Hone, B. Batlogg, Z. Benes, A. T. Johnson and J. E. Fischer, Science, 2000, 
289, 1730-1733. 
147. L. Vanhove, Phys. Rev., 1953, 89, 1189-1193. 
148. G. A. Rance, D. H. Marsh, R. J. Nicholas and A. N. Khlobystov, Chem. Phys. 
Lett., 2010, 493, 19-23. 
149. D. Wunderlich, F. Hauke and A. Hirsch, J. Mater. Chem., 2008, 18, 1493-
1497. 
150. B. Wu, D. C. Geng and Y. Q. Liu, Nanoscale, 2011, 3, 2074-2085. 
151. S. M. Bachilo, M. S. Strano, C. Kittrell, R. H. Hauge, R. E. Smalley and R. B. 
Weisman, Science, 2002, 298, 2361-2366. 
152. G. A. Rance, D. H. Marsh, R. J. Nicholas and A. N. Khlobystov, Chem. Phys. 
Lett., 2010, 493, 19-23. 
153. M. E. Itkis, D. E. Perea, R. Jung, S. Niyogi and R. C. Haddon, J. Am. Chem. 
Soc., 2005, 127, 3439-3448. 
154. R. Sen, S. M. Rickard, M. E. Itkis and R. C. Haddon, Chem. Mater., 2003, 
15, 4273-4279. 
References 
285 
 
155. M. E. Itkis, D. E. Perea, S. Niyogi, S. M. Rickard, M. A. Hamon, H. Hu, B. 
Zhao and R. C. Haddon, Nano Lett., 2003, 3, 309-314. 
156. M. C. Hersam, Nat. Nano, 2008, 3, 387-394. 
157. S. H. Jeong, K. K. Kim, S. J. Jeong, K. H. An, S. H. Lee and Y. H. Lee, 
Synth. Met., 2007, 157, 570-574. 
158. J. L. Bahr, E. T. Mickelson, M. J. Bronikowski, R. E. Smalley and J. M. 
Tour, Chem. Commun., 2001, 193-194. 
159. B. J. Landi, H. J. Ruf, J. J. Worman and R. P. Raffaelle, J. Phys. Chem. B, 
2004, 108, 17089-17095. 
160. S. Kumar, I. Kaur, N. Kumari, S. Jain, K. Dharamveer, V. K. Jindal, N. K. 
Verma and L. Bharadwaj, Appl. Nanosci., 2014, 4, 19-26. 
161. M. A. Novak, S. Surwade, J. Prokop, K. Bolotin, J. Hone, L. Brus, C. 
Nuckolls and H. Liu, J. Am. Chem. Soc., 2014, 136, 8536-8539. 
162. M.-F. Yu, M. J. Dyer and R. S. Ruoff, J. Appl. Phys., 2001, 89, 4554-4557. 
163. A. Vilalta-Clemente, Phys. Adv. Mater., 2008, pp. 1-10. 
164. B. Cappella and G. Dietler, Surf. Sci. Rep., 1999, 34, 1-104. 
165. S. Magonov and N. Yerina, in Handbook of Microscopy for Nanotechnology, 
eds. N. Yao and Z. Wang, ed. N. Yao and Z. L. Wang, Springer US, New 
York, 2005, ch. 4, pp. 113-155. 
References 
286 
 
166. S. Stankovich, D. A. Dikin, R. D. Piner, K. A. Kohlhaas, A. Kleinhammes, Y. 
Jia, Y. Wu, S. T. Nguyen and R. S. Ruoff, Carbon, 2007, 45, 1558-1565. 
167. S. Bellucci, G. Gaggiotti, M. Marchetti, F. Micciulla, R. Mucciato and M. 
Regi, J. Phys. Conf. Ser., 2007, 61, 99-104. 
168. A. Suresh, in Metallic Nanocrystallites and their Interaction with Microbial 
Systems, Springer, Netherlands, 2012, ch. 1, pp. 1-23. 
169. J. F. Mongillo, Nanotechnology 101, ABC-CLIO, London, 2007. 
170. J. C. H. Spence, Experimental high-resolution electron microscopy, Oxford 
University Press, 1988. 
171. S. Pekker, J. P. Salvetat, E. Jakab, J. M. Bonard and L. Forró, J. Phys. Chem. 
B, 2001, 105, 7938-7943. 
172. D. Bom, R. Andrews, D. Jacques, J. Anthony, B. Chen, M. S. Meier and J. P. 
Selegue, Nano Lett., 2002, 2, 615-619. 
173. E. Mansfield, A. Kar and S. A. Hooker, Anal. Bioanal. Chem., 2010, 396, 
1071-1077. 
174. S. Arepalli, P. Nikolaev, O. Gorelik, V. G. Hadjiev, H. A. Bradlev, W. 
Holmes, B. Files and L. Yowell, Carbon, 2004, 42, 1783-1791. 
175. M. Reichenbächer and J. Popp, Challenges in Molecular Structure 
Determination, Springer, Berlin, 2012. 
References 
287 
 
176. Matthias Mann, Ronald C. Hendrickson and A. Pandey, Annu. Rev. Biochem., 
2001, 70, 437-473. 
177. D. Gilg, B. Riedl, A. Zier and M. F. Zimmermann, Pharm. Acta. Helv., 1996, 
71, 383-394. 
178. W. M. A. Niessen and D. Falck, in Analyzing Biomolecular Interactions by 
Mass Spectrometry, J. Kool, W. M. A. Niessen, Wiley-VCH Verlag GmbH & 
Co. KGaA, Germany, 2015,.ch1, pp. 1-54. 
179. N. J. Greenfield, Anal. Biochem., 1996, 235, 1-10. 
180. S. M. Kelly and N. C. Price, Curr. Protein Pept. Sci., 2000, 1, 349-384. 
181. R. Gopal, J. S. Park, C. H. Seo and Y. Park, Int. J. Mol. Sci., 2012, 13, 3229-
3244. 
182. B. M. Bulheller, A. Rodger and J. D. Hirst, PCCP, 2007, 9, 2020-2035. 
183. S. M. Kelly, T. J. Jess and N. C. Price, Biochim. Biophys. Acta, 2005, 1751, 
119-139. 
184. B. A. Wallace and R. W. Janes, Curr. Opin. Chem. Biol., 2001, 5, 567-571. 
185. N. Berova, K. Nakanishi and R. Woody, Circular Dichroism: Principles and 
Applications, Wiley, USA, 2000. 
186. S. Brahms and J. Brahms, J. Mol. Biol., 1980, 138, 149-178. 
187. A. L. Rucker and T. P. Creamer, Protein Sci., 2002, 11, 980-985. 
References 
288 
 
188. I. Gokce, R. W. Woody, G. Anderluh and J. H. Lakey, J. Am. Chem. Soc., 
2005, 127, 9700-9701. 
189. A. J. Miles and B. A. Wallace, Chem. Soc. Rev., 2006, 35, 39-51. 
190. B. Ranjbar and P. Gill, Chem. Biol. Drug Des., 2009, 74, 101-120. 
191. A. J. Doig, Prog. Mol. Biol. Transl. Sci., 2008, 83, pp. 1-52. 
192. C. Richard, F. Balavoine, P. Schultz, T. W. Ebbesen and C. Mioskowski, 
Science, 2003, 300, 775-778. 
193. Y. Kang and T. A. Taton, J. Am. Chem. Soc., 2003, 125, 5650-5651. 
194. G. von Maltzahn, S. Vauthey, S. Santoso and S. U. Zhang, Langmuir, 2003, 
19, 4332-4337. 
195. N. M. B. Cogan, C. J. Bowerman, L. J. Nogaj, B. L. Nilsson and T. D. 
Krauss, J. Phys. Chem. C, 2014, 118, 5935-5944. 
196. S. R. Friling, R. Notman and T. R. Walsh, Nanoscale, 2010, 2, 98-106. 
197. C. C. Chiu, M. C. Maher, G. R. Dieckmann and S. O. Nielsen, ACS Nano, 
2010, 4, 2539-2546. 
198. A. S. Klimenko and G. R. Dieckmann, in Peptide Materials, ed. C. Alemán, 
A. Bianco and M. Venanzi, John Wiley & Sons, UK, 2013,.ch. 8, pp. 217-
245. 
199. T. R. Walsh and S. M. Tomasio, Mol. Biosyst., 2010, 6, 1707-1718. 
References 
289 
 
200. S. Q. Wang, E. S. Humphreys, S. Y. Chung, D. F. Delduco, S. R. Lustig, H. 
Wang, K. N. Parker, N. W. Rizzo, S. Subramoney, Y. M. Chiang and A. 
Jagota, Nat. Mater., 2003, 2, 196-200. 
201. W. J. Jeong and Y. B. Lim, Macromol. Biosci., 2012, 12, 49-54. 
202. Y. Hashida, T. Umeyama, J. Mihara, H. Imahori, M. Tsujimoto, S. Isoda, M. 
Takano and M. Hashida, J. Pharm. Sci., 2012, 101, 3398-3412. 
203. E. L. Bakota, L. Aulisa, D. A. Tsyboulski, R. B. Weisman and J. D. 
Hartgerink, Biomacromolecules, 2009, 10, 2201-2206. 
204. D. A. Tsyboulski, E. L. Bakota, L. S. Witus, J.-D. R. Rocha, J. D. Hartgerink 
and R. B. Weisman, J. Am. Chem. Soc., 2008, 130, 17134-17140. 
205. Z. Fu, Y. Luo, P. Derreumaux and G. Wei, Biophys. J., 2009, 97, 1795-1803. 
206. E. P. O'Brien, G. Stan, D. Thirumalai and B. R. Brooks, Nano Lett., 2008, 8, 
3702-3708. 
207. L. F. Zheng, D. Jain and P. Burke, J. Phys. Chem. C, 2009, 113, 3978-3985. 
208. D. Kase, J. L. Kulp, M. Yudasaka, J. S. Evans, S. Iijima and K. Shiba, 
Langmuir, 2004, 20, 8939-8941. 
209. V. Zorbas, A. Ortiz-Acevedo, A. B. Dalton, M. M. Yoshida, G. R. 
Dieckmann, R. K. Draper, R. H. Baughman, M. Jose-Yacaman and I. H. 
Musselman, J. Am. Chem. Soc., 2004, 126, 7222-7227. 
References 
290 
 
210. C.-c. Chiu, G. R. Dieckmann and S. O. Nielsen, Pept. Sci., 2009, 92, 156-
163. 
211. C. Rajesh, C. Majumder, H. Mizuseki and Y. Kawazoe, J. Chem Phys., 2009, 
130, 124911. 
212. Z. D. Su, T. Leung and J. F. Honek, J. Phys. Chem. B, 2006, 110, 23623-
23627. 
213. H. Xie, E. J. Becraft, R. H. Baughman, A. B. Dalton and G. R. Dieckmann, J. 
Pept. Sci., 2008, 14, 139-151. 
214. C. G. Salzmann, G. K. C. Lee, M. A. H. Ward, B. T. T. Chu and M. L. H. 
Green, J. Mater. Chem., 2008, 18, 1977-1983. 
215. E. J. Wallace, R. S. G. D'Rozario, B. M. Sanchez and M. S. P. Sansom, 
Nanoscale, 2010, 2, 967-975. 
216. C.-c. Chiu, G. R. Dieckmann and S. O. Nielsen, J. Phys. Chem. B, 2008, 112, 
16326-16333. 
217. M. G. Rüther, F. Frehill, J. E. O'Brien, A. I. Minett, W. J. Blau, J. G. Vos and 
M. in het Panhuis, J. Phys. Chem. B, 2004, 108, 9665-9668. 
218. P. J. Ren, A. M. Zheng, X. L. Pan, X. W. Han and X. H. Bao, J. Phys. Chem. 
C, 2013, 117, 23418-23424. 
References 
291 
 
219. A. Kitaygorodskiy, W. Wang, S.-Y. Xie, Y. Lin, K. A. Shiral Fernando, X. 
Wang, L. Qu, B. Chen and Y.-P. Sun, J. Am. Chem. Soc., 2005, 127, 7517-
7520. 
220. C. Engtrakul, M. F. Davis, K. Mistry, B. A. Larsen, A. C. Dillon, M. J. Heben 
and J. L. Blackburn, J. Am. Chem. Soc., 2010, 132, 9956-9957. 
221. D. J. Nelson, H. Rhoads and C. Brammer, J. Phys. Chem. C, 2007, 111, 
17872-17878. 
222. D. J. Nelson and R. Kumar, J. Phys. Chem. C, 2013, 117, 14812-14823. 
223. R. Marega, V. Aroulmoji, F. Dinon, L. Vaccari, S. Giordani, A. Bianco, E. 
Murano and M. Prato, J. Am. Chem. Soc., 2009, 131, 9086-9093. 
224. R. Prakash, S. Washburn, R. Superfine, R. E. Cheney and M. R. Falvo, Appl. 
Phys. Lett., 2003, 83, 1219-1221. 
225. S. L. Grage, U. H. N. Duerr, S. Afonin, P. K. Mikhailiuk, I. V. Komarov and 
A. S. Ulrich, J. Magn. Reson., 2008, 191, 16-23. 
226. M. Holzinger, O. Vostrowsky, A. Hirsch, F. Hennrich, M. Kappes, R. Weiss 
and F. Jellen, Angew. Chem. Int. Ed., 2001, 40, 4002-4005. 
227. A. Kumari and K. Dorai, J. Phys. Chem. A, 2011, 115, 6543-6550. 
228. L. Kiss, E. Forro, S. Fustero and F. Fulop, Org. Biomol. Chem., 2011, 9, 
6528-6534. 
References 
292 
 
229. T. Vagt, E. Nyakatura, M. Salwiczek, C. Jackel and B. Koksch, Org. Biomol. 
Chem., 2010, 8, 1382-1386. 
230. A. Sutherland and C. L. Willis, Nat. Prod. Rep., 2000, 17, 621-631. 
231. Y. Tang, G. Ghirlanda, N. Vaidehi, J. Kua, D. T. Mainz, W. A. Goddard, W. 
F. DeGrado and D. A. Tirrell, Biochem., 2001, 40, 2790-2796. 
232. L. Hunter, S. Butler and S. B. Ludbrook, Org. Biomol. Chem., 2012, 10, 
8911-8918. 
233. N. L. Ogihara, M. S. Weiss, D. Eisenberg and W. F. Degrado, Protein Sci., 
1997, 6, 80-88. 
234. Ricardo M. F. Fernandes, Bárbara Abreu, Bárbara Claro, Matat Buzaglo, 
Oren Regev, István Furó, and Eduardo F. Marques, Langmuir, 2015, 31, 
10955-10965. 
235. K. R. Shoemaker, P. S. Kim, E. J. York, J. M. Stewart and R. L. Baldwin, 
Nature, 1987, 326, 563-567. 
236. F. A. Quiocho, J. S. Sack and N. K. Vyas, Nature, 1987, 329, 561-564. 
237. N. J. Greenfield, W. E. Stafford and S. E. Hitchcock-Degregori, Protein Sci., 
1994, 3, 402-410. 
238. B. Forood, E. J. Feliciano and K. P. Nambiar, PNAS, 1993, 90, 838-842. 
239. C. S. Dexter, R. F. W. Jackson and J. Elliott, J. Org. Chem., 1999, 64, 7579-
7585. 
References 
293 
 
240. M. Kruppa, G. Imperato and B. Konig, Tetrahedron, 2006, 62, 1360-1364. 
241. L. Le Corre, C. Gravier-Pelletier and Y. Le Merrer, Eur. J. Org. Chem., 2007, 
2007, 5386-5394. 
242. S. van Zutphen, E. A. Stone, S. van Rijt, M. S. Robillard, G. A. van der 
Marel, H. S. Overkleeft, H. den Dulk, J. Brouwer and J. Reedijk, J. Inorg. 
Biochem., 2005, 99, 2032-2038. 
243. S. Kotha, K. Lahiri and D. Kashinath, Tetrahedron, 2002, 58, 9633-9695. 
244. J. Zhou and G. C. Fu, J. Am. Chem. Soc., 2003, 125, 12527-12530. 
245. S. E. Denmark and M. H. Ober, Adv. Synth. Catal., 2004, 346, 1703-1714. 
246. J. A. Casares, P. Espinet, B. Fuentes and G. Salas, J. Am. Chem. Soc., 2007, 
129, 3508-3509. 
247. N. Wang, Chin. J. Org. Chem., 2011, 31, 1319-1323. 
248. X.-F. Wu, J. Schranck, H. Neumann and M. Beller, Chem. Asian J., 2012, 7, 
40-44. 
249. K. C. Nicolaou, P. G. Bulger and D. Sarlah, Angew. Chem., Int. Ed., 2005, 
44, 4442-4489. 
250. A. N. Tkachenko, D. S. Radchenko, P. K. Mykhailiuk, S. Afonin, A. S. 
Ulrich and I. V. Komarov, Angew. Chem. Int. Edit., 52, 6504-6507. 
References 
294 
 
251. S. L. Grage, U. H. N. Duerr, S. Afonin, P. K. Mikhailiuk, I. V. Komarov and 
A. S. Ulrich, J. Magn. Reson., 2008, 191, 16-23. 
252. H. Xie, A. Ortiz-Acevedo, V. Zorbas, R. H. Baughman, R. K. Draper, I. H. 
Musselman, A. B. Dalton and G. R. Dieckmann, J. Mater. Chem., 2005, 15, 
1734-1741. 
253. V. Z. Poenitzsch, D. C. Winters, H. Xie, G. R. Dieckmann, A. B. Dalton and 
I. H. Musselman, J. Am. Chem. Soc., 2007, 129, 14724-14732. 
254. A. Chakrabartty, A. J. Doig and R. L. Baldwin, PNAS, 1993, 90, 11332-
11336. 
255. M. A. Kubasik, E. Daly and A. Blom, Chembiochem, 2006, 7, 1056-1061. 
256. F. Evanics, J. L. Kitevski, I. Bezsonova, J. Forman-Kay and R. S. Prosser, 
BB-Gen. Sub., 2007, 1770, 221-230. 
257. A. Bianco, K. Kostarelos and M. Prato, Curr. Opin. Chem. Biol., 2005, 9, 
674-679. 
258. R. G. Mendes, A. Bachmatiuk, B. Buchner, G. Cuniberti and M. H. Rummeli, 
J. Mater. Chem. B, 2013, 1, 401-428. 
259. D. Pantarotto, J.-P. Briand, M. Prato and A. Bianco, Chem. Commun., 2004, 
16-17. 
260. C. Klumpp, K. Kostarelos, M. Prato and A. Bianco, Biochim. Biophys. Acta., 
2006, 1758, 404-412. 
References 
295 
 
261. K. Ajima, M. Yudasaka, T. Murakami, A. Maigne, K. Shiba and S. Ijima, 
Mol. Pharm., 2005, 2, 475-480. 
262. D. Pantarotto, C. D. Partidos, R. Graff, J. Hoebeke, J. P. Briand, M. Prato and 
A. Bianco, J. Am. Chem. Soc., 2003, 125, 6160-6164. 
263. D. Pantarotto, C. D. Partidos, J. Hoebeke, F. Brown, E. Kramer, J. P. Briand, 
S. Muller, M. Prato and A. Bianco, Chem. Biol., 2003, 10, 961-966. 
264. J. Svenson, W. Stensen, B.-O. Brandsdal, B. E. Haug, J. Monrad and J. S. 
Svendsen, Biochem., 2008, 47, 3777-3788. 
265. M. Werle and A. Bernkop-Schnürch, Amino Acids, 2006, 30, 351-367. 
266. J. V. Olsen, S.-E. Ong and M. Mann, Mol. Cell. Proteomics, 2004, 3, 608-
614. 
267. R. Haggenmueller, S. S. Rahatekar, J. A. Fagan, J. Chun, M. L. Becker, R. R. 
Naik, T. Krauss, L. Carlson, J. F. Kadla, P. C. Trulove, D. F. Fox, H. C. 
DeLong, Z. Fang, S. O. Kelley and J. W. Gilman, Langmuir, 2008, 24, 5070-
5078. 
268. K. Jiang, L. S. Schadler, R. W. Siegel, X. Zhang, H. Zhang and M. Terrones, 
J. Mater. Chem., 2004, 14, 37-39. 
269. V. Georgakilas, N. Tagmatarchis, D. Pantarotto, A. Bianco, J.-P. Briand and 
M. Prato, Chem. Commun., 2002, 3050-3051. 
References 
296 
 
270. A. de Leon, A. F. Jalbout and V. A. Basiuk, Chem. Phys. Lett., 2008, 457, 
185-190. 
271. F. Bomboi, A. Bonincontro, C. La Mesa and F. Tardani, J. Colloid Interface 
Sci., 2011, 355, 342-347. 
272. Z. T. Xiao, X. Wang, X. Xu, H. Zhang, Y. Li and Y. H. Wang, J. Phys. 
Chem. C, 2011, 115, 21546-21558. 
273. N. Nakashima, S. Okuzono, H. Murakami, T. Nakai and K. Yoshikawa, 
Chem. Lett., 2003, 32, 782-782. 
274. S. E. Baker, W. Cai, T. L. Lasseter, K. P. Weidkamp and R. J. Hamers, Nano 
Lett., 2002, 2, 1413-1417. 
275. P. J. Halling, J. Chem. Technol. Biotechnol., 1995, 62, 105-105. 
276. Y.-L. Zhao and J. F. Stoddart, Acc. Chem. Res., 2009, 42, 1161-1171. 
277. M. Naito, K. Nobusawa, H. Onouchi, M. Nakamura, K. Yasui, A. Ikeda and 
M. Fujiki, J. Am. Chem. Soc., 2008, 130, 16697-16703. 
278. S. Hanessian, X. Luo and R. Schaum, Tetrahedron Lett., 1999, 40, 4925-
4929. 
279. D. H. Appella, L. A. Christianson, I. L. Karle, D. R. Powell and S. H. 
Gellman, J. Am. Chem. Soc., 1996, 118, 13071-13072. 
280. P. S. Farmer and E. J. Ariëns, Trends Pharmacol. Sci., 1982, 3, 362-365. 
References 
297 
 
281. R. N. Zuckermann, Biopolymers, 2011, 96, 545-555. 
282. R. M. J. Liskamp, D. T. S. Rijkers, J. A. W. Kruijtzer and J. Kemmink, 
ChemBioChem, 2011, 12, 1626-1653. 
283. D. Zhang, S. H. Lahasky, L. Guo, C.-U. Lee and M. Lavan, Macromolecules, 
2012, 45, 5833-5841. 
284. R. J. Simon, R. S. Kania, R. N. Zuckermann, V. D. Huebner, D. A. Jewell, S. 
Banville, S. Ng, L. Wang, S. Rosenberg and C. K. Marlowe, PNAS, 1992, 89, 
9367-9371. 
285. H. J. Olivos, P. G. Alluri, M. M. Reddy, D. Salony and T. Kodadek, Org. 
Lett., 2002, 4, 4057-4059. 
286. B. C. Gorske, S. A. Jewell, E. J. Guerard and H. E. Blackwell, Org. Lett., 
2005, 7, 1521-1524. 
287. P. Armand, K. Kirshenbaum, A. Falicov, R. L. Dunbrack Jr, K. A. Dill, R. N. 
Zuckermann and F. E. Cohen, Fold Des., 1997, 2, 369-375. 
288. T. S. Burkoth, E. Beausoleil, S. Kaur, D. Tang, F. E. Cohen and R. N. 
Zuckermann, Chem. Biol., 2002, 9, 647-654. 
289. B. Carsten, G. Robert and H. Hans-Jörg, Phys. Biol., 2006, 3, S1-S9. 
290. R. S. Spolar, J. H. Ha and M. T. Record, PNAS, 1989, 86, 8382-8385. 
291. N. T. Southall, K. A. Dill and A. D. J. Haymet, J. Phys. Chem. B, 2002, 106, 
521-533. 
References 
298 
 
292. R. Montserret, M. J. McLeish, A. Böckmann, C. Geourjon and F. Penin, 
Biochem., 2000, 39, 8362-8373. 
293. S. Kumar and R. Nussinov, ChemBioChem, 2002, 3, 604-617. 
294. M. Meot-Ner, Chem. Rev., 2005, 105, 213-284. 
295. M. L. Waters, Curr. Opin. Chem. Biol., 2002, 6, 736-741. 
296. M. L. Waters, Pept. Sci., 2004, 76, 435-445. 
297. C. W. Wu, K. Kirshenbaum, T. J. Sanborn, J. A. Patch, K. Huang, K. A. Dill, 
R. N. Zuckermann and A. E. Barron, J. Am. Chem. Soc., 2003, 125, 13525-
13530. 
298. E. J. Robertson, G. K. Olivier, M. Qian, C. Proulx, R. N. Zuckermann and G. 
L. Richmond, PNAS, 2014, 111, 13284-13289. 
299. J. K. Pokorski, L. M. Miller Jenkins, H. Feng, S. R. Durell, Y. Bai and D. H. 
Appella, Org. Lett., 2007, 9, 2381-2383. 
300. B. C. Gorske, B. L. Bastian, G. D. Geske and H. E. Blackwell, J. Am. Chem. 
Soc., 2007, 129, 8928-8929. 
301. P. Armand, K. Kirshenbaum, R. A. Goldsmith, S. Farr-Jones, A. E. Barron, 
K. T. V. Truong, K. A. Dill, D. F. Mierke, F. E. Cohen, R. N. Zuckermann 
and E. K. Bradley, PNAS, 1998, 95, 4309-4314. 
302. K. Kirshenbaum, A. E. Barron, R. A. Goldsmith, P. Armand, E. K. Bradley, 
K. T. V. Truong, K. A. Dill, F. E. Cohen and R. N. Zuckermann, PNAS, 
1998, 95, 4303-4308. 
References 
299 
 
303. J. Seo, A. E. Barron and R. N. Zuckermann, Org. Lett., 2010, 12, 492-495. 
304. C. W. Wu, T. J. Sanborn, K. Huang, R. N. Zuckermann and A. E. Barron, J. 
Am. Chem. Soc., 2001, 123, 6778-6784. 
305. C. W. Wu, T. J. Sanborn, R. N. Zuckermann and A. E. Barron, J. Am. Chem. 
Soc., 2001, 123, 2958-2963. 
306. R. C. N. C.B Gorske, Z.S. Bowden, T.A Kufe, and A.M. Childs, J. Org. 
Chem., 2013, 78, 11172 - 11183. 
307. S. A. Fowler and H. E. Blackwell, Org. Biomol. Chem., 2009, 7, 1508-1524. 
308. K. Huang, C. W. Wu, T. J. Sanborn, J. A. Patch, K. Kirshenbaum, R. N. 
Zuckermann, A. E. Barron and I. Radhakrishnan, J. Am. Chem. Soc., 2006, 
128, 1733-1738. 
309. K. Balamurugan, E. R. A. Singam and V. Subramanian, J. Phys. Chem. C, 
2011, 115, 8886-8892. 
310. N. P. Chongsiriwatana, J. A. Patch, A. M. Czyzewski, M. T. Dohm, A. 
Ivankin, D. Gidalevitz, R. N. Zuckermann and A. E. Barron, PNAS, 2008, 
105, 2794-2799. 
311. Z. L. Yao, N. Braidy, G. A. Botton and A. Adronov, J. Am. Chem. Soc., 
2003, 125, 16015-16024. 
312. Z. Li, T. Kameda, T. Isoshima, E. Kobatake, T. Tanaka, Y. Ito and M. 
Kawamoto, Langmuir, 2015, 31, 3482-3488. 
References 
300 
 
313. A. L. Alpatova, W. Q. Shan, P. Babica, B. L. Upham, A. R. Rogensues, S. J. 
Masten, E. Drown, A. K. Mohanty, E. C. Alocilja and V. V. Tarabara, Water 
Res., 2010, 44, 505-520. 
314. C. Roquelet, J.-S. Lauret, V. Alain-Rizzo, C. Voisin, R. Fleurier, M. Delarue, 
D. Garrot, A. Loiseau, P. Roussignol, J. A. Delaire and E. Deleporte, 
Chemphyschem, 2010, 11, 1667-1672. 
315. R. Anjana, M. K. Vaishnavi, D. Sherlin, S. P. Kumar, K. Naveen, P. S. Kanth 
and K. Sekar, Bioinformation, 2012, 8, 1220-1224. 
316. C.-S. Park, C. J. Lee and E. K. Kim, PCCP, 2015, 17, 16243-16245. 
317. R. Podila, P. Vedantam, P. C. Ke, J. M. Brown and A. M. Rao, J. Phys. 
Chem. C, 2012, 116, 22098-22103. 
318. H. J. Shin, S. M. Kim, S. M. Yoon, A. Benayad, K. K. Kim, S. J. Kim, H. K. 
Park, J. Y. Choi and Y. H. Lee, J. Am. Chem. Soc., 2008, 130, 2062-2066. 
319. C. N. R. Rao and R. Voggu, Mater. Today, 2010, 13, 34-40. 
320. A. B. Dalton, A. Ortiz-Acevedo, V. Zorbas, E. Brunner, W. M. Sampson, S. 
Collins, J. M. Razal, M. Miki Yoshida, R. H. Baughman, R. K. Draper, I. H. 
Musselman, M. Jose-Yacaman and G. R. Dieckmann, Adv. Funct. Mater., 
2004, 14, 1147-1151. 
321. J. A. Patch and A. E. Barron, J. Am. Chem. Soc., 2003, 125, 12092-12093. 
References 
301 
 
322. S. C. Tsang, Z. Guo, Y. K. Chen, M. L. H. Green, H. A. O. Hill, T. W. 
Hambley and P. J. Sadler, Angew. Chem. Int. Edit. Engl., 1997, 36, 2198-
2200. 
323. Z. J. Guo, P. J. Sadler and S. C. Tsang, Adv. Mater., 1998, 10, 701-703. 
324. D. A. Heller, E. S. Jeng, T.-K. Yeung, B. M. Martinez, A. E. Moll, J. B. 
Gastala and M. S. Strano, Science, 2006, 311, 508-511. 
325. S. Meng, P. Maragakis, C. Papaloukas and E. Kaxiras, Nano Lett., 2007, 7, 
45-50. 
326. H. Wang and A. Ceulemans, Phys. Rev. B, 2009, 79, 1954191- 1954196. 
327. V. Verdolino, R. Cammi, B. H. Munk and H. B. Schlegel, J. Phys. Chem. B, 
2008, 112, 16860-16873. 
328. A. Das, A. K. Sood, P. K. Maiti, M. Das, R. Varadarajan and C. N. R. Rao, 
Chem. Phys. Lett., 2008, 453, 266-273. 
329. N. Varghese, U. Mogera, A. Govindaraj, A. Das, P. K. Maiti, A. K. Sood and 
C. N. R. Rao, Chemphyschem, 2009, 10, 206-210. 
330. D. Umadevi and G. N. Sastry, J. Phys. Chem. Lett., 2011, 2, 1572-1576. 
331. A. L. Frischknecht and M. G. Martin, J. Phys. Chem. C, 2008, 112, 6271-
6278. 
332. V. A. Karachevtsev, A. M. Plokhotnichenko, M. V. Karachevtsev and V. S. 
Leontiev, Carbon, 2010, 48, 3682-3691. 
References 
302 
 
333. M. Hazani, R. Naaman, F. Hennrich and M. M. Kappes, Nano Lett., 2003, 3, 
153-155. 
334. R. R. Johnson, A. Kohlmeyer, A. T. C. Johnson and M. L. Klein, Nano Lett., 
2009, 9, 537-541. 
335. B. Maji, S. K. Samanta and S. Bhattacharya, Nanoscale, 2014, 6, 3721-3730. 
336. E. S. Jeng, A. E. Moll, A. C. Roy, J. B. Gastala and M. S. Strano, Nano Lett., 
2006, 6, 371-375. 
337. J. H. Kim, M. Kataoka, D. Shimamoto, H. Muramatsu, Y. C. Jung, T. Tojo, 
T. Hayashi, Y. A. Kim, M. Endo, M. Terrones and M. S. Dresselhaus, 
Chemphyschem, 2009, 10, 2414-2417. 
338. D. Roxbury, X. M. Tu, M. Zheng and A. Jagota, Langmuir, 2011, 27, 8282-
8293. 
339. M. Zheng, A. Jagota, E. D. Semke, B. A. Diner, R. S. Mclean, S. R. Lustig, 
R. E. Richardson and N. G. Tassi, Nat. Mater., 2003, 2, 338-342. 
340. M. Zheng, A. Jagota, M. S. Strano, A. P. Santos, P. Barone, S. G. Chou, B. A. 
Diner, M. S. Dresselhaus, R. S. Mclean, G. B. Onoa, G. G. Samsonidze, E. D. 
Semke, M. Usrey and D. J. Walls, Science, 2003, 302, 1545-1548. 
341. A. Ikeda, T. Hamano, K. Hayashi and J.-i. Kikuchi, Org. Lett., 2006, 8, 1153-
1156. 
342. X. Tu, S. Manohar, A. Jagota and M. Zheng, Nature, 2009, 460, 250-253. 
References 
303 
 
343. C. Y. Khripin, S. Manohar, M. Zheng and A. Jagota, J. Phys. Chem. C, 2009, 
113, 13616-13621. 
344. R. R. Johnson, A. T. C. Johnson and M. L. Klein, Small, 2010, 6, 31-34. 
345. D. Chris, G. Martin, F. Michael, W. Sean, S. Richard and E. Dorothy, 
Nanotechnol., 2002, 13, 601-604. 
346. A. Micoli, M. Quintana and M. Prato, Supramol. Chem., 2013, 25, 567-573. 
347. A. Micoli, A. Turco, E. Araujo-Palomo, A. Encinas, M. Quintana and M. 
Prato, Chem. Eur. J., 2014, 20, 5397-5402. 
348. S. Boncel, M. Brzeziński, J. Mrowiec-Białoń, D. Janas, K. K. K. Koziol and 
K. Z. Walczak, Mater. Lett., 2013, 91, 50-54. 
349. W. Chen, L. Duan, L. Wang and D. Zhu, Environ. Sci. Technol., 2008, 42, 
6862-6868. 
350. B. Pan, D. Lin, H. Mashayekhi and B. Xing, Environ. Sci. Technol., 2008, 42, 
5480-5485. 
351. K. Yang, L. Zhu and B. Xing, Environ. Sci. Technol., 2006, 40, 1855-1861. 
352. Z. Jijun, B. Alper, H. Jie and L. Jian Ping, Nanotechnol., 2002, 13, 195-200. 
353. S. Zhang, T. Shao, S. S. K. Bekaroglu and T. Karanfil, Environ. Sci. 
Technol., 2009, 43, 5719-5725. 
References 
304 
 
354. H. Kataura, Y. Kumazawa, Y. Maniwa, I. Umezu, S. Suzuki, Y. Ohtsuka and 
Y. Achiba, Synth. Met., 1999, 103, 2555-2558. 
355. J. L. Bahr and J. M. Tour, J. Mater. Chem., 2002, 12, 1952-1958. 
356. M. S. Dresselhaus, A. Jorio, M. Hofmann, G. Dresselhaus and R. Saito, Nano 
Lett., 10, 751-758. 
357. B. Pan and B. Xing, Environ. Sci. Technol., 2008, 42, 9005-9013. 
358. C. Jiang, K. Kempa, J. Zhao, U. Schlecht, U. Kolb, T. Basché, M. Burghard 
and A. Mews, Phys. Rev. B, 2002, 66, 161404-161444. 
359. A. K. Geim and K. S. Novoselov, Nat. Mater., 2007, 6, 183-191. 
360. R. L. McCreery, Chem. Rev., 2008, 108, 2646-2687. 
361. Y. Zhang, C. Y. Wu, S. W. Guo and J. Y. Zhang, Nanotechnol. Rev., 2013, 2, 
27-45. 
362. D. A. C. Brownson and C. E. Banks, Analyst, 2010, 135, 2768-2778. 
363. C. N. R. Rao, K. Biswas, K. S. Subrahmanyam and A. Govindaraj, J. Mater. 
Chem., 2009, 19, 2457-2469. 
364. K. S. Novoselov, A. K. Geim, S. V. Morozov, D. Jiang, Y. Zhang, S. V. 
Dubonos, I. V. Grigorieva and A. A. Firsov, Science, 2004, 306, 666-669. 
365. B. Partoens and F. M. Peeters, Phys. Rev. B, 2006, 74, 0754041- 07540411. 
366. M. Freitag, Nat. Phys., 2011, 7, 596-597. 
References 
305 
 
367. J. Hass, W. A. de Heer and E. H. Conrad, J. Phys-Condens. Mat., 2008, 20. 
323202.  
368. R. S. Edwards and K. S. Coleman, Nanoscale, 2013, 5, 38-51. 
369. K. T. H. Bonex W Mwakikunga, in Graphene - Synthesis, Characterization, 
Properties and Applications, ed. P. J. Gong, InTech, 2011, ch. 5, pp. 59-78. 
370. A. Ambrosi, C. K. Chua, A. Bonanni and M. Pumera, Chem. Rev., 2014, 114, 
7150-7188. 
371. A. Lerf, H. Y. He, M. Forster and J. Klinowski, J. Phys. Chem. B, 1998, 102, 
4477-4482. 
372. A. Buchsteiner, A. Lerf and J. Pieper, J. Phys. Chem. B, 2006, 110, 22328-
22338. 
373. A A. Mathkar, D. Tozier, P. Cox, P. J. Ong, C. Galande, K. Balakrishnan, A. 
L. M. Reddy and P. M. Ajayan, J. Phys. Chem. Lett., 2012, 3, 986-991. 
374. M. Lotya, Y. Hernandez, P. J. King, R. J. Smith, V. Nicolosi, L. S. Karlsson, 
F. M. Blighe, S. De, Z. M. Wang, I. T. McGovern, G. S. Duesberg and J. N. 
Coleman, J. Am. Chem. Soc., 2009, 131, 3611-3620. 
375. Y. Hernandez, V. Nicolosi, M. Lotya, F. M. Blighe, Z. Y. Sun, S. De, I. T. 
McGovern, B. Holland, M. Byrne, Y. K. Gun'ko, J. J. Boland, P. Niraj, G. 
Duesberg, S. Krishnamurthy, R. Goodhue, J. Hutchison, V. Scardaci, A. C. 
Ferrari and J. N. Coleman, Nat. Nanotechnol., 2008, 3, 563-568. 
References 
306 
 
376. B. Garg, T. Bisht and Y. C. Ling, Molecules, 2014, 19, 14582-14614. 
377. B. C. Brodie, Philos. Trans. R. Soc. Lond., 1859, 149, 249-259. 
378. L. Staudenmaier, Ber. Dtsch. Chem. Ges., 1898, 31, 1481-1487. 
379. U. Hofmann and E. König, Z. Anorg. Allg. Chem., 1937, 234, 311-336. 
380. W. S. Hummers and R. E. Offeman, J. Am. Chem. Soc., 1958, 80, 1339-1339. 
381. D. C. Marcano, D. V. Kosynkin, J. M. Berlin, A. Sinitskii, Z. Z. Sun, A. 
Slesarev, L. B. Alemany, W. Lu and J. M. Tour, ACS Nano, 2010, 4, 4806-
4814. 
382. D. R. Dreyer, A. D. Todd and C. W. Bielawski, Chem. Soc. Rev., 2014, 43, 
5288-5301. 
383. J. I. Paredes, S. Villar-Rodil, A. Martinez-Alonso and J. M. D. Tascon, 
Langmuir, 2008, 24, 10560-10564. 
384. T. Kuila, A. K. Mishra, P. Khanra, N. H. Kim and J. H. Lee, Nanoscale, 
2013, 5, 52-71. 
385. Q. Tang, Z. Zhou and Z. F. Chen, Nanoscale, 2013, 5, 4541-4583. 
386. X. F. Gao, J. Jang and S. Nagase, J. Phys. Chem. C, 2010, 114, 832-842. 
387. Y. Y. Shao, J. Wang, M. Engelhard, C. M. Wang and Y. H. Lin, J. Mater. 
Chem., 2010, 20, 743-748. 
References 
307 
 
388. A. L. Stroyuk, N. S. Andryushina, N. D. Shcherban', V. G. Il'in, V. S. Efanov, 
I. B. Yanchuk, S. Y. Kuchmii and V. D. Pokhodenko, Theor. Exp. Chem., 
2012, 48, 2-13. 
389. V. C. Sanchez, A. Jachak, R. H. Hurt and A. B. Kane, Chem. Res. Toxicol., 
2012, 25, 15-34. 
390. Y. Zhang, T. R. Nayak, H. Hong and W. B. Cai, Nanoscale, 2012, 4, 3833-
3842. 
391. C. Spinato, C. Ménard-Moyon and A. Bianco, in Functionalization of 
Graphene, ed. V. Georgakilas, Wiley-VCH Verlag GmbH & Co. KGaA, 
Germany, 2014, ch4, pp. 95-138. 
392. M. C. Duch, G. R. S. Budinger, Y. T. Liang, S. Soberanes, D. Urich, S. E. 
Chiarella, L. A. Campochiaro, A. Gonzalez, N. S. Chandel, M. C. Hersam 
and G. M. Mutlu, Nano Lett., 2011, 11, 5201-5207. 
393. H. Ali-Boucetta, D. Bitounis, R. Raveendran-Nair, A. Servant, J. Van den 
Bossche and K. Kostarelos, Adv. Healthcare Mater., 2013, 2, 433-441. 
394. H. Y. Mao, S. Laurent, W. Chen, O. Akhavan, M. Imani, A. A. Ashkarran 
and M. Mahmoudi, Chem. Rev., 2013, 113, 3407-3424. 
395. B. J. Hong, O. C. Compton, Z. An, I. Eryazici and S. T. Nguyen, ACS Nano, 
2012, 6, 63-73. 
396. M. Lotya, P. J. King, U. Khan, S. De and J. N. Coleman, ACS Nano, 2010, 4, 
3155-3162. 
References 
308 
 
397. I. V. Pavlidis, M. Patila, U. T. Bornscheuer, D. Gournis and H. Stamatis, 
Trends Biotechnol., 2014, 32, 312-320. 
398. H. Y. He, J. Klinowski, M. Forster and A. Lerf, Chem. Phys. Lett., 1998, 287, 
53-56. 
399. C. Hou, H. Quan, Y. Duan, Q. Zhang, H. Wang and Y. Li, Nanoscale, 2013, 
5, 1227-1232. 
400. X. Y. Qi, K. Y. Pu, X. Z. Zhou, H. Li, B. Liu, F. Boey, W. Huang and H. 
Zhang, Small, 2010, 6, 663-669. 
401. P. Laaksonen, A. Walther, J. M. Malho, M. Kainlauri, O. Ikkala and M. B. 
Linder, Angew. Chem., Int. Ed., 2011, 50, 8688-8691. 
402. L. Q. Xu, W. J. Yang, K. G. Neoh, E. T. Kang and G. D. Fu, 
Macromolecules, 2010, 43, 8336-8339. 
403. G. X. Wang, X. P. Shen, B. Wang, J. Yao and J. Park, Carbon, 2009, 47, 
1359-1364. 
404. L. J. Cote, F. Kim and J. Huang, J. Am. Chem. Soc., 2009, 131, 1043-1049. 
405. M. J. Fernández-Merino, J. I. Paredes, S. Villar-Rodil, L. Guardia, P. Solís-
Fernández, D. Salinas-Torres, D. Cazorla-Amorós, E. Morallón, A. Martínez-
Alonso and J. M. D. Tascón, Carbon, 2012, 50, 3184-3194. 
406. Y. Wang, Z. H. Li, J. Wang, J. H. Li and Y. H. Lin, Trends. Biotechnol., 
2011, 29, 205-212. 
References 
309 
 
407. Y. Z. Hu, J. F. Shen, N. Li, M. Shi, H. W. Ma, B. Yan, W. B. Wang, W. S. 
Huang and M. X. Ye, Polym. Compos., 2010, 31, 1987-1994. 
408. T. A. Pham, J. S. Kim, B. G. Cho, S. M. Son and Y. T. Jeong, Synth. React. 
Inorg. M., 2011, 41, 1257-1262. 
409. G. Shim, J. Lee, J. Kim, H. J. Lee, Y. B. Kim and Y. K. Oh, RSC Adv., 2015, 
5, 49905-49913. 
410. S. N. Kim, Z. F. Kuang, J. M. Slocik, S. E. Jones, Y. Cui, B. L. Farmer, M. C. 
McAlpine and R. R. Naik, J. Am. Chem. Soc., 2011, 133, 14480-14483. 
411. V. K. Kodali, J. Scrimgeour, S. Kim, J. H. Hankinson, K. M. Carroll, W. A. 
de Heer, C. Berger and J. E. Curtis, Langmuir, 2011, 27, 863-865. 
412. T. Kowalewski and D. M. Holtzman, PNAS, 1999, 96, 3688-3693. 
413. Y. B. Sheng, W. Wang and P. Chen, Protein Sci., 2010, 19, 1639-1648. 
414. Y. B. Sheng, W. Wang and P. Chen, J. Phys. Chem. C, 2010, 114, 454-459. 
415. Y. N. Guo, X. Lu, J. Weng and Y. Leng, J. Phys. Chem. C, 2013, 117, 5708-
5717. 
416. C. B. Chen, J. Li, R. Li, G. Y. Xiao and D. Y. Yan, New J. Chem., 2013, 37, 
2778-2783. 
417. L. Ou, Y. Luo and G. Wei, J. Phys. Chem. B, 2011, 115, 9813-9822. 
References 
310 
 
418. K. Balamurugan, R. Gopalakrishnan, S. S. Raman and V. Subramanian, J. 
Phys. Chem. B, 2010, 114, 14048-14058. 
419. Z. L. Gu, Z. X. Yang, Y. Chong, C. C. Ge, J. K. Weber, D. R. Bell and R. H. 
Zhou, Sci. Rep., 2015, 5, 9. 
420. T T. Mesaric, L. Baweja, B. Drasler, D. Drobne, D. Makovec, P. Dusak, A. 
Dhawan and K. Sepcic, Carbon, 2013, 62, 222-232. 
421. M. Stefani, Int. J. Mol. Sci., 2008, 9, 2515-2542. 
422. M. Stefani, Neuroscientist, 2007, 13, 519-531. 
423. B. Akdim, R. Pachter, S. S. Kim, R. R. Naik, T. R. Walsh, S. Trohalaki, G. Y. 
Hong, Z. F. Kuang and B. L. Farmer, Acs. Appl. Mater. Interfaces, 2013, 5, 
7470-7477. 
424. G. Raffaini and F. Ganazzoli, Langmuir, 2013, 29, 4883-4893. 
425. C. E. Giacomelli and W. Norde, Biomacromolecules, 2003, 4, 1719-1726. 
426. G. Zuo, X. Zhou, Q. Huang, H. P. Fang and R. H. Zhou, J. Phys. Chem. C, 
2011, 115, 23323-23328. 
427. S. Radic, N. K. Geitner, R. Podila, A. Kakinen, P. Y. Chen, P. C. Ke and F. 
Ding, Sci. Rep., 2013, 3, 1-8. 
428. J. Katoch, S. N. Kim, Z. F. Kuang, B. L. Farmer, R. R. Nalk, S. A. Tatulian 
and M. Ishigami, Nano Lett., 2012, 12, 2342-2346. 
References 
311 
 
429. J. Guo, X. Yao, L. Ning, Q. Wang and H. Liu, RSC Advances, 2014, 4, 9953-
9962. 
430. J. Zhang, F. Zhang, H. Yang, X. Huang, H. Liu, J. Zhang and S. Guo, 
Langmuir, 2010, 26, 6083-6085. 
431. F. Zhang, B. Zheng, J. L. Zhang, X. L. Huang, H. Liu, S. W. Guo and J. Y. 
Zhang, J. Phys. Chem. C, 2010, 114, 8469-8473. 
432. Y. Zhang, J. Y. Zhang, X. L. Huang, X. J. Zhou, H. X. Wu and S. W. Guo, 
Small, 2012, 8, 154-159. 
433. T. Premkumar and K. E. Geckeler, Prog. Polym. Sci., 2012, 37, 515-529. 
434. M. Liu, Q. A. Zhang, H. M. Zhao, S. Chen, H. T. Yu, Y. B. Zhang and X. 
Quan, Chem. Commun., 2011, 47, 4084-4086. 
435. M. H. Alshehri, B. J. Cox and J. M. Hill, Eur. Phys. J. D, 2013, 67, 226-275. 
436. A. M. O. Brett and A. M. Chiorcea, Langmuir, 2003, 19, 3830-3839. 
437. N. S. Green and M. L. Norton, Anal. Chim. Acta, 2015, 853, 127-142. 
438. M. Wu, R. Kempaiah, P.-J. J. Huang, V. Maheshwari and J. Liu, Langmuir, 
2011, 27, 2731-2738. 
439. C. H. Lu, H. H. Yang, C. L. Zhu, X. Chen and G. N. Chen, Angew. Chem., 
Int. Ed., 2009, 48, 4785-4787. 
440. E. Morales-Narvaez and A. Merkoci, Adv. Mater., 2012, 24, 3298-3308. 
References 
312 
 
441. P. J. J. Huang and J. W. Liu, Nanomaterials, 2013, 3, 221-228. 
442. J. Antony and S. Grimme, PCCP, 2008, 10, 2722-2729. 
443. H. Vovusha, S. Sanyal and B. Sanyal, J. Phys. Chem. Lett., 2013, 4, 3710-
3718. 
444. Z Z. Xu, B. R. Meher, D. Eustache and Y. Wang, J. Mol. Graphics Model., 
2014, 47, 8-17. 
445. S. J. Sowerby, C. A. Cohn, W. M. Heckl and N. G. Holm, PNAS, 2001, 98, 
820-822. 
446. Y.-H. Zhang, K.-G. Zhou, K.-F. Xie, C.-H. Liu, H.-L. Zhang, Y. Peng and 
Y.-Q. Xiong, J. Nanosci., 2009, 08, 5-8. 
447. V. Spiwok, P. Hobza and J. Rezac, J. Phys. Chem. C, 2011, 115, 19455-
19462. 
448. S. Panigrahi, A. Bhattacharya, S. Banerjee and D. Bhattacharyya, J. Phys. 
Chem. C, 2012, 116, 4374-4379. 
449. D. Umadevi and G. N. Sastry, Chemphyschem, 2013, 14, 2570-2578. 
450. Y. X. Wang and Y. X. Bu, J. Phys. Chem. B, 2007, 111, 6520-6526. 
451. K. P. Loh, Q. Bao, P. K. Ang and J. Yang, J. Mater. Chem., 2010, 20, 2277-
2289. 
452. A. Hirsch, J. M. Englert and F. Hauke, Acc. Chem. Res., 2013, 46, 87-96. 
References 
313 
 
453. L. Yan, Y. B. Zheng, F. Zhao, S. J. Li, X. F. Gao, B. Q. Xu, P. S. Weiss and 
Y. L. Zhao, Chem. Soc. Rev., 2012, 41, 97-114. 
454. L. Rodriguez-Perez, M. A. Herranz and N. Martin, Chem. Commun., 2013, 
49, 3721-3735. 
455. X. F. Gao, Y. Wang, X. Liu, T. L. Chan, S. Irle, Y. L. Zhao and S. B. B. 
Zhang, PCCP, 2011, 13, 19449-19453. 
456. M. Quintana, E. Vazquez and M. Prato, Acc. Chem. Res., 2013, 46, 138-148. 
457. S. K. Singh, M. K. Singh, P. P. Kulkarni, V. K. Sonkar, J. J. A. Grácio and D. 
Dash, ACS Nano, 2012, 6, 2731-2740. 
458. X. Y. Liu, Y. F. Zhou, W. Y. Nie, L. Y. Song and P. P. Chen, J. Mater. Sci., 
2015, 50, 6113-6123. 
459. M. Namvari and H. Namazi, J. Mater. Sci., 2015, 50, 5348-5361. 
460. A. A. Arbuzov, V. E. Muradyan, B. P. Tarasov, and E. A. Sokolov, 
Nanomaterials, 2013, 3, 3-39. 
461. J. F. Shen, B. Yan, M. Shi, H. W. Ma, N. Li and M. X. Ye, J. Colloid 
Interface Sci., 2011, 356, 543-549. 
462. F. A. He, J. T. Fan, D. Ma, L. M. Zhang, C. Leung and H. L. Chan, Carbon, 
2010, 48, 3139-3144. 
463. H. P. Mungse and O. P. Khatri, J. Phys. Chem. C, 2014, 118, 14394-14402. 
References 
314 
 
464. J. Chu, X. Li and P. Xu, J. Mater. Chem., 2011, 21, 11283-11287. 
465. X. M. Sun, Z. Liu, K. Welsher, J. T. Robinson, A. Goodwin, S. Zaric and H. 
J. Dai, Nano Res., 2008, 1, 203-212. 
466. K. Yang, S. A. Zhang, G. X. Zhang, X. M. Sun, S. T. Lee and Z. A. Liu, 
Nano Lett., 2010, 10, 3318-3323. 
467. M. A. Ali, K. Kamil Reza, S. Srivastava, V. V. Agrawal, R. John and B. D. 
Malhotra, Langmuir, 2014, 30, 4192-4201. 
468. Y. Jiang, Z. J. Jiang, S. Cheng and M. L. Liu, Electrochim. Acta, 2014, 146, 
437-446. 
469. M. Namvari and H. Namazi, Carbohydr. Res., 2014, 396, 1-8. 
470. Q. Yang, X. J. Pan, K. Clarke and K. C. Li, Ind. Eng. Chem. Res., 2012, 51, 
310-317. 
471. M. Namvari and H. Namazi, Polym. Int., 2014, 63, 1881-1888. 
472. H. J. Salavagione, M. A. Gomez and G. Martinez, Macromolecules, 2009, 42, 
6331-6334. 
473. D. Yu, Y. Yang, M. Durstock, J.-B. Baek and L. Dai, ACS Nano, 2010, 4, 
5633-5640. 
474. D. Luo, G. Zhang, J. Liu and X. Sun, J. Phys. Chem. C, 2011, 115, 11327-
11335. 
References 
315 
 
475. B. Apostolovic, M. Danial and H. A. Klok, Chem. Soc. Rev., 2010, 39, 3541-
3575. 
476. G. L. C. Paulus, Q. H. Wang and M. S. Strano, Acc. Chem. Res., 2013, 46, 
160-170. 
477. A. C. Ferrari, Solid State Commun., 2007, 143, 47-57. 
478. M. Jana, S. Saha, P. Khanra, P. Samanta, H. Koo, N. C. Murmu and T. Kuila, 
J. Mater. Chem. A, 2015, 3, 7323-7331. 
479. E. Y. Choi, T. H. Han, J. H. Hong, J. E. Kim, S. H. Lee, H. W. Kim and S. O. 
Kim, J. Mater. Chem., 2010, 20, 1907-1912. 
480. K. S. Kim, Y. M. Um, J.-r. Jang, W.-S. Choe and P. J. Yoo, Acs. Appl. Mater. 
Interfaces, 2013, 5, 3591-3598. 
481. A. Ghosh, K. V. Rao, S. J. George and C. N. R. Rao, Chem. Eur. J., 2010, 16, 
2700-2704. 
482. H. Q. Li, L. N. Han, J. J. Cooper-White and I. Kim, Nanoscale, 2012, 4, 
1355-1361. 
483. G. C. Wei, R. H. Dong, D. Wang, L. Feng, S. L. Dong, A. X. Song and J. C. 
Hao, New J. Chem., 2014, 38, 140-145. 
484. Y. H. Park, S. Y. Park and I. In, J. Ind. Eng. Chem., 2015, 30, 190–196. 
485. G. C. Wei, M. M. Yan, R. H. Dong, D. Wang, X. Z. Zhou, J. F. Chen and J. 
C. Hao, Chem. Eur. J., 2012, 18, 14708-14716. 
References 
316 
 
486. R. Kanchanapally, B. P. Viraka Nellore, S. S. Sinha, F. Pedraza, S. J. Jones, 
A. Pramanik, S. R. Chavva, C. Tchounwou, Y. Shi, A. Vangara, D. Sardar 
and P. C. Ray, RSC Adv., 2015, 5, 18881-18887. 
487. H. Wang, Q. Zhang, X. Chu, T. Chen, J. Ge and R. Yu, Angew. Chem. Int. 
Ed., 2011, 50, 7065-7069. 
488. S. Goenka, V. Sant and S. Sant, J. Controlled Release, 2014, 173, 75-88. 
489. L. Lacerda, S. Raffa, M. Prato, A. Bianco and K. Kostarelos, Nano Today, 
2007, 2, 38-43. 
490. D. Kölmel, D. Fürniss, S. Susanto, A. Lauer, C. Grabher, S. Bräse and U. 
Schepers, Pharmaceuticals, 2012, 5, 1265-1281. 
491. J. E. Murphy, T. Uno, J. D. Hamer, F. E. Cohen, V. Dwarki and R. N. 
Zuckermann, PNAS, 1998, 95, 1517-1522. 
492. P. A. Wender, D. J. Mitchell, K. Pattabiraman, E. T. Pelkey, L. Steinman and 
J. B. Rothbard, PNAS, 2000, 97, 13003-13008. 
493. T. Schroder, K. Schmitz, N. Niemeier, T. S. Balaban, H. F. Krug, U. 
Schepers and S. Brase, Bioconj. Chem., 2007, 18, 342-354. 
494. W. Huang, J. Seo, J. S. Lin and A. E. Barron, Mol. Biosyst., 2012, 8, 2626-
2628. 
495. J. Q. Liu, L. Tao, W. R. Yang, D. Li, C. Boyer, R. Wuhrer, F. Braet and T. P. 
Davis, Langmuir, 2010, 26, 10068-10075. 
References 
317 
 
496. B. Wozniak and J. Dera, in Light Absorption in Sea Water, Springer, New 
York, 2007, ch.2, pp 11-81. 
497. S. Sivakova and S. J. Rowan, Chem. Soc. Rev., 2005, 34, 9-21. 
498. M. Ginisty, C. Gravier-Pelletier and Y. Le Merrer, Tetrahedron: Asymmetry, 
2006, 17, 142-150. 
499. T. Yajima, T. Tonoi, H. Nagano, Y. Tomita and K. Mikami, Eur. J. Org. 
Chem., 2010, 2461-2464. 
500. L. Jobron and G. Hummel, Org. Lett., 2000, 2, 2265-2267. 
Appendix A 
A1 
 
Appendix A: Characterisation of Purified SWNTs 
 
Figure 1: UV-Vis-NIR absorption of purified SWNTs in 1% SDS after sonication and 
centrifugation. 
 
Figure 2: TGA-Ms of purified SWNTs under N2 atmosphere.  
Appendix A 
A2 
 
 
Figure 3: TGA-Ms of purified SWNTs under air atmosphere. 
 
Figure 4: A representative Raman spectra (633 nm) of purified SWNTs normalised to the G 
band.  
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Appendix B: Extinction Coefficient of Carbon Nanomaterials 
1. Extinction Coefficient of Purified SWNTs:  
 
Figure 5: UV-Vis-NIR absorption of purified SWNTs at different concentrations in water. 
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2. Extinction Coefficient of 2 M Oxidised SWNTs 
 
Figure 6: UV-Vis-NIR absorption of oxidised SWNTs (2 M) at different concentrations in 
water. 
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3. Extinction Coefficient of 8 M Oxidised SWNTs 
 
Figure 7: UV-VIS-NIR absorption of oxidised SWNTs (8 M) at different concentrations in 
water. 
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4. Extinction Coefficient of Reduced Graphene Oxide (rGO) 
 
Figure 8: UV-Vis-NIR absorption of rGO in water. 
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Appendix C: Characterisation of Peptoids 
1. Characterisation of (NlysNspeNspe)2 (14) 
Figure 9: HR-LC MS of (NlysNspeNspe)2 (14) 
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2. Characterisation of (NlysNspeNspe)3 (15) 
 Figure 10: HR-LC MS of (NlysNspeNspe)3 (15) 
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C3 
 
3. Characterisation of (NlysNspeNspe)4 (16) 
 Figure 11: HR-LC MS of (NlysNspeNspe)4 (16) 
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4. Characterisation of (NlysNspeNspe)6 (17) 
 Figure 12: HR-LC MS of (NlysNspeNspe)6 (17) 
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5. Characterisation of Ac-Nglu-Nlys-Nlys-Nlys-Nphe (18) 
 Figure 13: HR-LC MS of Ac-Nglu-Nlys-Nlys-Nlys-Nphe (18) 
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D1 
 
Appendix D: Characterisation of GO and rGO 
 
Figure 14: TGA curves of graphite (Blue line), GO (Red line), and rGO (Pink line). 
 
 
Figure 15: A representative Raman spectra (532 nm ) of GO (Blue line), and rGO (Red 
line) normalised to G band. 
 
